<html lang="en" class="pb-page fonts-loaded fonts-loaded" data-request-id="4e6e2af5-9471-4cd8-a920-4a9adbf6bdec" style="--article-sticky-top: 82.00019999999999px; --scroll-padding: 163.594px auto auto;"><head data-pb-dropzone="head"><meta name="pbContext" content=";product:product:elsevier\:product\:cell;issue:issue:pii\:S0092867420X00043;website:website:cell-site;ctype:string:Journal Content;journal:journal:cell;pageGroup:string:Article View;page:string:Show Full Text;article:article:pii\:S0092867421000027;requestedJournal:journal:cell;wgroup:string:Default Website Group;subPage:string:Full Text">




<!-- if there is any customization for Responsive Project widget  -->


























    
    







    
            
        



        
                <meta name="robots" content="noarchive,nocache">
            
    






    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1, user-scalable=1">











        <meta property="og:title" content="Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition">
    


        <meta property="og:type" content="Article">
    


        <meta property="og:url" content="https://www.cell.com/cell/abstract/S0092-8674(21)00002-7">
    



        <meta property="og:site_name" content="Cell">
    


        <meta property="og:image" content="https://www.cell.com/cms/asset/2d13c384-f548-49d4-ac18-ae25c1766315/fx1.jpg">
    


        <meta property="og:description" content="A whole-exome and transcriptome meta-analysis of over 1,000 patients treated with
immune checkpoint blockade across seven tumor types highlights the potential of multivariable
prediction models that consider both tumor- and T-cell-intrinsic mechanisms of response.">
    











        <meta name="twitter:title" content="Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition">
    




        <meta name="twitter:image" content="https://www.cell.com/cms/asset/2d13c384-f548-49d4-ac18-ae25c1766315/fx1.jpg">
    


        <meta name="twitter:description" content="A whole-exome and transcriptome meta-analysis of over 1,000 patients treated with
immune checkpoint blockade across seven tumor types highlights the potential of multivariable
prediction models that consider both tumor- and T-cell-intrinsic mechanisms of response.">
    

        <meta name="twitter:card" content="summary_large_image">
    











    
    
            
            
        <link rel="canonical" href="https://www.cell.com/cell/fulltext/S0092-8674(21)00002-7">
    


<meta name="tdm-reservation" content="1">
<meta name="tdm-policy" content="https://www.elsevier.com/tdm/tdmrep-policy.json">

<title>Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition: Cell</title><meta name="citation_journal_title" content="Cell"> <meta name="citation_journal_abbrev" content="Cell"> <meta name="citation_publisher" content="Elsevier"> <meta name="citation_title" content="Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition"> <meta name="citation_date" content="2021/02/04"> <meta name="citation_online_date" content="2021/01/27"> <meta name="citation_volume" content="184"> <meta name="citation_issue" content="3"> <meta name="citation_firstpage" content="596"> <meta name="citation_lastpage" content="614.e14"> <meta name="citation_pmid" content="33508232"> <meta name="citation_abstract_html_url" content="https://www.cell.com/action/showAbstract?pii=S0092867421000027"> <meta name="citation_fulltext_html_url" content="https://www.cell.com/action/showFullText?pii=S0092867421000027"> <meta name="citation_pdf_url" content="https://www.cell.com/action/showPdf?pii=S0092867421000027"> <meta name="citation_issn" content="0092-8674"> <meta name="citation_issn" content="1097-4172"> <meta name="citation_language" content="English"> <meta name="citation_doi" content="10.1016/j.cell.2021.01.002"> <meta name="citation_pmid" content="33508232"> <meta name="citation_author" content="Kevin Litchfield"><meta name="citation_author_institution" content="Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK"><meta name="citation_author_institution" content="Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK"><meta name="citation_author" content="James L. Reading"><meta name="citation_author_orcid" content="0000-0001-5381-978X"><meta name="citation_author_institution" content="Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK"><meta name="citation_author_institution" content="Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK"><meta name="citation_author" content="Clare Puttick"><meta name="citation_author_institution" content="Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK"><meta name="citation_author" content="Krupa Thakkar"><meta name="citation_author_institution" content="Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK"><meta name="citation_author_institution" content="Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK"><meta name="citation_author" content="Chris Abbosh"><meta name="citation_author_institution" content="Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK"><meta name="citation_author" content="Robert Bentham"><meta name="citation_author_orcid" content="0000-0003-0487-8980"><meta name="citation_author_institution" content="Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK"><meta name="citation_author" content="Thomas B.K. Watkins"><meta name="citation_author_institution" content="Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK"><meta name="citation_author" content="Rachel Rosenthal"><meta name="citation_author_institution" content="Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK"><meta name="citation_author" content="Dhruva Biswas"><meta name="citation_author_orcid" content="0000-0001-9141-5188"><meta name="citation_author_institution" content="Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK"><meta name="citation_author" content="Andrew Rowan"><meta name="citation_author_institution" content="Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK"><meta name="citation_author" content="Emilia Lim"><meta name="citation_author_institution" content="Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK"><meta name="citation_author" content="Maise Al Bakir"><meta name="citation_author_institution" content="Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK"><meta name="citation_author" content="Virginia Turati"><meta name="citation_author_institution" content="Stem Cell Group, Cancer Institute, University College London, London WC1E 6DD, UK"><meta name="citation_author" content="José Afonso Guerra-Assunção"><meta name="citation_author_institution" content="Bill Lyons Informatics Centre, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK"><meta name="citation_author" content="Lucia Conde"><meta name="citation_author_institution" content="Bill Lyons Informatics Centre, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK"><meta name="citation_author" content="Andrew J.S. Furness"><meta name="citation_author_institution" content="Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK"><meta name="citation_author" content="Sunil Kumar Saini"><meta name="citation_author_orcid" content="0000-0003-3382-9432"><meta name="citation_author_institution" content="Department of Health Technology, Technical University of Denmark, Copenhagen, Denmark"><meta name="citation_author" content="Sine R. Hadrup"><meta name="citation_author_institution" content="Department of Health Technology, Technical University of Denmark, Copenhagen, Denmark"><meta name="citation_author" content="Javier Herrero"><meta name="citation_author_institution" content="Bill Lyons Informatics Centre, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK"><meta name="citation_author" content="Se-Hoon Lee"><meta name="citation_author_institution" content="Department of Health Sciences and Technology, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea"><meta name="citation_author_institution" content="Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea"><meta name="citation_author" content="Peter Van Loo"><meta name="citation_author_orcid" content="0000-0003-0292-1949"><meta name="citation_author_institution" content="Cancer Genomics Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK"><meta name="citation_author" content="Tariq Enver"><meta name="citation_author_institution" content="Stem Cell Group, Cancer Institute, University College London, London WC1E 6DD, UK"><meta name="citation_author" content="James Larkin"><meta name="citation_author_orcid" content="0000-0001-5569-9523"><meta name="citation_author_institution" content="Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK"><meta name="citation_author" content="Matthew D. Hellmann"><meta name="citation_author_orcid" content="0000-0002-2670-9777"><meta name="citation_author_institution" content="Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, and Parker Center for Cancer Immunotherapy, 885 2nd Avenue, New York, NY 10017, USA"><meta name="citation_author" content="Samra Turajlic"><meta name="citation_author_institution" content="Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK"><meta name="citation_author_institution" content="Cancer Dynamics Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK"><meta name="citation_author" content="Sergio A. Quezada"><meta name="citation_author_email" content="s.quezada@ucl.ac.uk"><meta name="citation_author_orcid" content="0000-0002-9763-1700"><meta name="citation_author_institution" content="Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK"><meta name="citation_author_institution" content="Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK"><meta name="citation_author" content="Nicholas McGranahan"><meta name="citation_author_email" content="nicholas.mcgranahan.10@ucl.ac.uk"><meta name="citation_author_institution" content="Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK"><meta name="citation_author" content="Charles Swanton"><meta name="citation_author_email" content="charles.swanton@crick.ac.uk"><meta name="citation_author_institution" content="Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK"><meta name="citation_author_institution" content="Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK"><meta name="citation_keywords" content="neoantigen; mutation; immunogenicity; checkpoint inhibitors; immunotherapy; biomarkers; CXCL9; clonal TMB; meta-analysis"><meta name="citation_reference" content="citation_title=Clock-like mutational processes in human somatic cells; citation_author=L.B. Alexandrov; citation_author=P.H. Jones; citation_author=D.C. Wedge; citation_author=J.E. Sale; citation_author=P.J. Campbell; citation_author=S. Nik-Zainal; citation_author=M.R. Stratton; citation_journal_title=Nat. Genet.; citation_volume=47; citation_firstpage=1402; citation_lastpage=1407; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer; citation_author=V. Anagnostou; citation_author=N. Niknafs; citation_author=K. Marrone; citation_author=D.C. Bruhm; citation_author=J.R. White; citation_author=J. Naidoo; citation_author=K. Hummelink; citation_author=K. Monkhorst; citation_author=F. Lalezari; citation_author=M. Lanis; citation_author=et al.; citation_journal_title=Nat. Can.; citation_volume=1; citation_firstpage=99; citation_lastpage=111; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Gapped sequence alignment using artificial neural networks: application to the MHC class I system; citation_author=M. Andreatta; citation_author=M. Nielsen; citation_journal_title=Bioinformatics; citation_volume=32; citation_firstpage=511; citation_lastpage=517; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes; citation_author=J.V. Aredo; citation_author=S.K. Padda; citation_author=C.A. Kunder; citation_author=S.S. Han; citation_author=J.W. Neal; citation_author=J.B. Shrager; citation_author=H.A. Wakelee; citation_journal_title=Lung Cancer; citation_volume=133; citation_firstpage=144; citation_lastpage=150; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma; citation_author=N. Auslander; citation_author=G. Zhang; citation_author=J.S. Lee; citation_author=D.T. Frederick; citation_author=B. Miao; citation_author=T. Moll; citation_author=T. Tian; citation_author=Z. Wei; citation_author=S. Madan; citation_author=R.J. Sullivan; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=24; citation_firstpage=1545; citation_lastpage=1549; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade; citation_author=M. Ayers; citation_author=J. Lunceford; citation_author=M. Nebozhyn; citation_author=E. Murphy; citation_author=A. Loboda; citation_author=D.R. Kaufman; citation_author=A. Albright; citation_author=J.D. Cheng; citation_author=S.P. Kang; citation_author=V. Shankaran; citation_author=et al.; citation_journal_title=J.&nbsp;Clin. Invest.; citation_volume=127; citation_firstpage=2930; citation_lastpage=2940; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer; citation_author=V.P. Balachandran; citation_author=M. Łuksza; citation_author=J.N. Zhao; citation_author=V. Makarov; citation_author=J.A. Moral; citation_author=R. Remark; citation_author=B. Herbst; citation_author=G. Askan; citation_author=U. Bhanot; citation_author=Y. Senbabaoglu; citation_author=Australian Pancreatic Cancer Genome Initiative; citation_author=Garvan Institute of Medical Research; citation_author=Prince of Wales Hospital; citation_author=Royal North Shore Hospital; citation_author=University of Glasgow; citation_author=St Vincent’s Hospital; citation_author=QIMR Berghofer Medical Research Institute; citation_author=University of Melbourne, Centre for Cancer Research; citation_author=University of Queensland, Institute for Molecular Bioscience; citation_author=Bankstown Hospital; citation_author=Liverpool Hospital; citation_author=Royal Prince Alfred Hospital, Chris O’Brien Lifehouse; citation_author=Westmead Hospital; citation_author=Fremantle Hospital; citation_author=St John of God Healthcare; citation_author=Royal Adelaide Hospital; citation_author=Flinders Medical Centre; citation_author=Envoi Pathology; citation_author=Princess Alexandria Hospital; citation_author=Austin Hospital; citation_author=Johns Hopkins Medical Institutes; citation_author=ARC-Net Centre for Applied Research on Cancer; citation_author=et al.; citation_journal_title=Nature; citation_volume=551; citation_firstpage=512; citation_lastpage=516; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Genome doubling shapes the evolution and prognosis of advanced cancers; citation_author=C.M. Bielski; citation_author=A. Zehir; citation_author=A.V. Penson; citation_author=M.T.A. Donoghue; citation_author=W. Chatila; citation_author=J. Armenia; citation_author=M.T. Chang; citation_author=A.M. Schram; citation_author=P. Jonsson; citation_author=C. Bandlamudi; citation_author=et al.; citation_journal_title=Nat. Genet.; citation_volume=50; citation_firstpage=1189; citation_lastpage=1195; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=UV signature mutations; citation_author=D.E. Brash; citation_journal_title=Photochem. Photobiol.; citation_volume=91; citation_firstpage=15; citation_lastpage=26; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma; citation_author=D.A. Braun; citation_author=Y. Hou; citation_author=Z. Bakouny; citation_author=M. Ficial; citation_author=M. Sant’ Angelo; citation_author=J. Forman; citation_author=P. Ross-Macdonald; citation_author=A.C. Berger; citation_author=O.A. Jegede; citation_author=L. Elagina; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=26; citation_firstpage=909; citation_lastpage=918; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Simple pooling versus combining in meta-analysis; citation_author=D.M. Bravata; citation_author=I. Olkin; citation_journal_title=Eval. Health Prof.; citation_volume=24; citation_firstpage=218; citation_lastpage=230; citation_publication_date=2001; "><meta name="citation_reference" content="citation_title=Improved survival with T&nbsp;cell clonotype stability after anti-CTLA-4 treatment in cancer patients; citation_author=E. Cha; citation_author=M. Klinger; citation_author=Y. Hou; citation_author=C. Cummings; citation_author=A. Ribas; citation_author=M. Faham; citation_author=L. Fong; citation_journal_title=Sci. Transl. Med.; citation_volume=6; citation_firstpage=238ra70; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade; citation_author=B. Chapuy; citation_author=C. Stewart; citation_author=A.J. Dunford; citation_author=J. Kim; citation_author=K. Wienand; citation_author=A. Kamburov; citation_author=G.K. Griffin; citation_author=P.H. Chen; citation_author=A. Lako; citation_author=R.A. Redd; citation_author=et al.; citation_journal_title=Blood; citation_volume=134; citation_firstpage=2369; citation_lastpage=2382; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade; citation_author=L. Chen; citation_author=L. Diao; citation_author=Y. Yang; citation_author=X. Yi; citation_author=B.L. Rodriguez; citation_author=Y. Li; citation_author=P.A. Villalobos; citation_author=T. Cascone; citation_author=X. Liu; citation_author=L. Tan; citation_author=et al.; citation_journal_title=Cancer Discov.; citation_volume=8; citation_firstpage=1156; citation_lastpage=1175; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Single-cell copy number variation detection; citation_author=J. Cheng; citation_author=E. Vanneste; citation_author=P. Konings; citation_author=T. Voet; citation_author=J.R. Vermeesch; citation_author=Y. Moreau; citation_journal_title=Genome Biol.; citation_volume=12; citation_firstpage=R80; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy; citation_author=M.T. Chow; citation_author=A.J. Ozga; citation_author=R.L. Servis; citation_author=D.T. Frederick; citation_author=J.A. Lo; citation_author=D.E. Fisher; citation_author=G.J. Freeman; citation_author=G.M. Boland; citation_author=A.D. Luster; citation_journal_title=Immunity; citation_volume=50; citation_firstpage=1498; citation_lastpage=1512.e5; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T&nbsp;cell epitopes; citation_author=D. Chowell; citation_author=S. Krishna; citation_author=P.D. Becker; citation_author=C. Cocita; citation_author=J. Shu; citation_author=X. Tan; citation_author=P.D. Greenberg; citation_author=L.S. Klavinskis; citation_author=J.N. Blattman; citation_author=K.S. Anderson; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=112; citation_firstpage=E1754; citation_lastpage=E1762; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy; citation_author=D. Chowell; citation_author=L.G.T. Morris; citation_author=C.M. Grigg; citation_author=J.K. Weber; citation_author=R.M. Samstein; citation_author=V. Makarov; citation_author=F. Kuo; citation_author=S.M. Kendall; citation_author=D. Requena; citation_author=N. Riaz; citation_author=et al.; citation_journal_title=Science; citation_volume=359; citation_firstpage=582; citation_lastpage=587; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy; citation_author=D. Chowell; citation_author=C. Krishna; citation_author=F. Pierini; citation_author=V. Makarov; citation_author=N.A. Rizvi; citation_author=F. Kuo; citation_author=L.G.T. Morris; citation_author=N. Riaz; citation_author=T.L. Lenz; citation_author=T.A. Chan; citation_journal_title=Nat. Med.; citation_volume=25; citation_firstpage=1715; citation_lastpage=1720; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Harmonisation of short-term in&nbsp;vitro culture for the expansion of antigen-specific CD8(+) T&nbsp;cells with detection by ELISPOT and HLA-multimer staining; citation_author=L. Chudley; citation_author=K.J. McCann; citation_author=A. Coleman; citation_author=A.M. Cazaly; citation_author=N. Bidmon; citation_author=C.M. Britten; citation_author=S.H. van der Burg; citation_author=C. Gouttefangeas; citation_author=C. Jandus; citation_author=K. Laske; citation_author=et al.; citation_journal_title=Cancer Immunol. Immunother.; citation_volume=63; citation_firstpage=1199; citation_lastpage=1211; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples; citation_author=K. Cibulskis; citation_author=M.S. Lawrence; citation_author=S.L. Carter; citation_author=A. Sivachenko; citation_author=D. Jaffe; citation_author=C. Sougnez; citation_author=S. Gabriel; citation_author=M. Meyerson; citation_author=E.S. Lander; citation_author=G. Getz; citation_journal_title=Nat. Biotechnol.; citation_volume=31; citation_firstpage=213; citation_lastpage=219; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Cancer immunotherapy efficacy and patients’ sex: a systematic review and meta-analysis; citation_author=F. Conforti; citation_author=L. Pala; citation_author=V. Bagnardi; citation_author=T. De Pas; citation_author=M. Martinetti; citation_author=G. Viale; citation_author=R.D. Gelber; citation_author=A. Goldhirsch; citation_journal_title=Lancet Oncol.; citation_volume=19; citation_firstpage=737; citation_lastpage=746; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=AACR Project GENIE: powering precision medicine through an international consortium; citation_author=A.P.G. Consortium; citation_author=AACR Project GENIE Consortium; citation_journal_title=Cancer Discov.; citation_volume=7; citation_firstpage=818; citation_lastpage=831; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine; citation_author=J.R. Conway; citation_author=E. Kofman; citation_author=S.S. Mo; citation_author=H. Elmarakeby; citation_author=E. Van Allen; citation_journal_title=Genome Med.; citation_volume=10; citation_firstpage=93; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy; citation_author=R. Cristescu; citation_author=R. Mogg; citation_author=M. Ayers; citation_author=A. Albright; citation_author=E. Murphy; citation_author=J. Yearley; citation_author=X. Sher; citation_author=X.Q. Liu; citation_author=H. Lu; citation_author=M. Nebozhyn; citation_author=et al.; citation_journal_title=Science; citation_volume=362; citation_firstpage=362; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Ratios of radical to conservative amino acid replacement are affected by mutational and compositional factors and may not be indicative of positive Darwinian selection; citation_author=T. Dagan; citation_author=Y. Talmor; citation_author=D. Graur; citation_journal_title=Mol. Biol. Evol.; citation_volume=19; citation_firstpage=1022; citation_lastpage=1025; citation_publication_date=2002; "><meta name="citation_reference" content="citation_title=Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy; citation_author=T. Davoli; citation_author=H. Uno; citation_author=E.C. Wooten; citation_author=S.J. Elledge; citation_journal_title=Science; citation_volume=355; citation_firstpage=eaaf8399; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=STAR: ultrafast universal RNA-seq aligner; citation_author=A. Dobin; citation_author=C.A. Davis; citation_author=F. Schlesinger; citation_author=J. Drenkow; citation_author=C. Zaleski; citation_author=S. Jha; citation_author=P. Batut; citation_author=M. Chaisson; citation_author=T.R. Gingeras; citation_journal_title=Bioinformatics; citation_volume=29; citation_firstpage=15; citation_lastpage=21; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Chromosomal instability selects gene copy-number variants encoding core regulators of proliferation in ER+ breast cancer; citation_author=D. Endesfelder; citation_author=R. Burrell; citation_author=N. Kanu; citation_author=N. McGranahan; citation_author=M. Howell; citation_author=P.J. Parker; citation_author=J. Downward; citation_author=C. Swanton; citation_author=M. Kschischo; citation_journal_title=Cancer Res.; citation_volume=74; citation_firstpage=4853; citation_lastpage=4863; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data; citation_author=F. Favero; citation_author=T. Joshi; citation_author=A.M. Marquard; citation_author=N.J. Birkbak; citation_author=M. Krzystanek; citation_author=Q. Li; citation_author=Z. Szallasi; citation_author=A.C. Eklund; citation_journal_title=Ann. Oncol.; citation_volume=26; citation_firstpage=64; citation_lastpage=70; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial; citation_author=L. Fehrenbacher; citation_author=A. Spira; citation_author=M. Ballinger; citation_author=M. Kowanetz; citation_author=J. Vansteenkiste; citation_author=J. Mazieres; citation_author=K. Park; citation_author=D. Smith; citation_author=A. Artal-Cortes; citation_author=C. Lewanski; citation_author=POPLAR Study Group; citation_author=et al.; citation_journal_title=Lancet; citation_volume=387; citation_firstpage=1837; citation_lastpage=1846; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma; citation_author=M. Fontanilles; citation_author=F. Marguet; citation_author=P. Ruminy; citation_author=C. Basset; citation_author=A. Noel; citation_author=L. Beaussire; citation_author=M. Viennot; citation_author=P.J. Viailly; citation_author=K. Cassinari; citation_author=P. Chambon; citation_author=et al.; citation_journal_title=Acta Neuropathol. Commun.; citation_volume=8; citation_firstpage=52; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer; citation_author=S. Gettinger; citation_author=J. Choi; citation_author=K. Hastings; citation_author=A. Truini; citation_author=I. Datar; citation_author=R. Sowell; citation_author=A. Wurtz; citation_author=W. Dong; citation_author=G. Cai; citation_author=M.A. Melnick; citation_author=et al.; citation_journal_title=Cancer Discov.; citation_volume=7; citation_firstpage=1420; citation_lastpage=1435; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma; citation_author=E. Ghorani; citation_author=R. Rosenthal; citation_author=N. McGranahan; citation_author=J.L. Reading; citation_author=M. Lynch; citation_author=K.S. Peggs; citation_author=C. Swanton; citation_author=S.A. Quezada; citation_journal_title=Ann. Oncol.; citation_volume=29; citation_firstpage=271; citation_lastpage=279; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=The T&nbsp;cell differentiation landscape is shaped by tumour mutations in lung cancer; citation_author=E. Ghorani; citation_author=J.L. Reading; citation_author=J.Y. Henry; citation_author=M.R. de Massy; citation_author=R. Rosenthal; citation_author=V. Turati; citation_author=K. Joshi; citation_author=A.J.S. Furness; citation_author=A.B. Aissa; citation_author=S.K. Saini; citation_author=et al.; citation_journal_title=Nat. Can.; citation_volume=1; citation_firstpage=546; citation_lastpage=561; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Predictive biomarkers for checkpoint inhibitor-based immunotherapy; citation_author=G.T. Gibney; citation_author=L.M. Weiner; citation_author=M.B. Atkins; citation_journal_title=Lancet Oncol.; citation_volume=17; citation_firstpage=e542; citation_lastpage=e551; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T&nbsp;cell-mediated suppression of cutaneous tumors; citation_author=A.V. Gorbachev; citation_author=H. Kobayashi; citation_author=D. Kudo; citation_author=C.S. Tannenbaum; citation_author=J.H. Finke; citation_author=S. Shu; citation_author=J.M. Farber; citation_author=R.L. Fairchild; citation_journal_title=J.&nbsp;Immunol.; citation_volume=178; citation_firstpage=2278; citation_lastpage=2286; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Amino acid difference formula to help explain protein evolution; citation_author=R. Grantham; citation_journal_title=Science; citation_volume=185; citation_firstpage=862; citation_lastpage=864; citation_publication_date=1974; "><meta name="citation_reference" content="citation_title=Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients; citation_author=A. Gros; citation_author=M.R. Parkhurst; citation_author=E. Tran; citation_author=A. Pasetto; citation_author=P.F. Robbins; citation_author=S. Ilyas; citation_author=T.D. Prickett; citation_author=J.J. Gartner; citation_author=J.S. Crystal; citation_author=I.M. Roberts; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=22; citation_firstpage=433; citation_lastpage=438; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy; citation_author=J.J. Havel; citation_author=D. Chowell; citation_author=T.A. Chan; citation_journal_title=Nat. Rev. Cancer; citation_volume=19; citation_firstpage=133; citation_lastpage=150; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=B cells and tertiary lymphoid structures promote immunotherapy response; citation_author=B.A. Helmink; citation_author=S.M. Reddy; citation_author=J. Gao; citation_author=S. Zhang; citation_author=R. Basar; citation_author=R. Thakur; citation_author=K. Yizhak; citation_author=M. Sade-Feldman; citation_author=J. Blando; citation_author=G. Han; citation_author=et al.; citation_journal_title=Nature; citation_volume=577; citation_firstpage=549; citation_lastpage=555; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade; citation_author=I.G. House; citation_author=P. Savas; citation_author=J. Lai; citation_author=A.X.Y. Chen; citation_author=A.J. Oliver; citation_author=Z.L. Teo; citation_author=K.L. Todd; citation_author=M.A. Henderson; citation_author=L. Giuffrida; citation_author=E.V. Petley; citation_author=et al.; citation_journal_title=Clin. Cancer Res.; citation_volume=26; citation_firstpage=487; citation_lastpage=504; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=The RNA-binding protein MEX3B mediates resistance to cancer immunotherapy by downregulating HLA-A expression; citation_author=L. Huang; citation_author=S. Malu; citation_author=J.A. McKenzie; citation_author=M.C. Andrews; citation_author=A.H. Talukder; citation_author=T. Tieu; citation_author=T. Karpinets; citation_author=C. Haymaker; citation_author=M.A. Forget; citation_author=L.J. Williams; citation_author=et al.; citation_journal_title=Clin. Cancer Res.; citation_volume=24; citation_firstpage=3366; citation_lastpage=3376; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma; citation_author=W. Hugo; citation_author=J.M. Zaretsky; citation_author=L. Sun; citation_author=C. Song; citation_author=B.H. Moreno; citation_author=S. Hu-Lieskovan; citation_author=B. Berent-Maoz; citation_author=J. Pang; citation_author=B. Chmielowski; citation_author=G. Cherry; citation_author=et al.; citation_journal_title=Cell; citation_volume=165; citation_firstpage=35; citation_lastpage=44; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Tracking the evolution of non-small-cell lung cancer; citation_author=M. Jamal-Hanjani; citation_author=G.A. Wilson; citation_author=N. McGranahan; citation_author=N.J. Birkbak; citation_author=T.B.K. Watkins; citation_author=S. Veeriah; citation_author=S. Shafi; citation_author=D.H. Johnson; citation_author=R. Mitter; citation_author=R. Rosenthal; citation_author=TRACERx Consortium; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=376; citation_firstpage=2109; citation_lastpage=2121; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=The mutational constraint spectrum quantified from variation in 141,456 humans; citation_author=K.J. Karczewski; citation_author=L.C. Francioli; citation_author=G. Tiao; citation_author=B.B. Cummings; citation_author=J. Alföldi; citation_author=Q. Wang; citation_author=R.L. Collins; citation_author=K.M. Laricchia; citation_author=A. Ganna; citation_author=D.P. Birnbaum; citation_author=Genome Aggregation Database Consortium; citation_author=et al.; citation_journal_title=Nature; citation_volume=581; citation_firstpage=434; citation_lastpage=443; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Biased signaling pathways via CXCR3 control the development and function of CD4+ T&nbsp;cell subsets; citation_author=N. Karin; citation_author=G. Wildbaum; citation_author=M. Thelen; citation_journal_title=J.&nbsp;Leukoc. Biol.; citation_volume=99; citation_firstpage=857; citation_lastpage=862; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=The genomic landscape of Merkel cell carcinoma and clinicogenomic biomarkers of response to immune checkpoint inhibitor therapy; citation_author=T.C. Knepper; citation_author=M. Montesion; citation_author=J.S. Russell; citation_author=E.S. Sokol; citation_author=G.M. Frampton; citation_author=V.A. Miller; citation_author=L.A. Albacker; citation_author=H.L. McLeod; citation_author=Z. Eroglu; citation_author=N.I. Khushalani; citation_author=et al.; citation_journal_title=Clin. Cancer Res.; citation_volume=25; citation_firstpage=5961; citation_lastpage=5971; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing; citation_author=D.C. Koboldt; citation_author=Q. Zhang; citation_author=D.E. Larson; citation_author=D. Shen; citation_author=M.D. McLellan; citation_author=L. Lin; citation_author=C.A. Miller; citation_author=E.R. Mardis; citation_author=L. Ding; citation_author=R.K. Wilson; citation_journal_title=Genome Res.; citation_volume=22; citation_firstpage=568; citation_lastpage=576; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints; citation_author=S. Koyama; citation_author=E.A. Akbay; citation_author=Y.Y. Li; citation_author=G.S. Herter-Sprie; citation_author=K.A. Buczkowski; citation_author=W.G. Richards; citation_author=L. Gandhi; citation_author=A.J. Redig; citation_author=S.J. Rodig; citation_author=H. Asahina; citation_author=et al.; citation_journal_title=Nat. Commun.; citation_volume=7; citation_firstpage=10501; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Focal chromosomal copy number aberrations in cancer-Needles in a genome haystack; citation_author=O. Krijgsman; citation_author=B. Carvalho; citation_author=G.A. Meijer; citation_author=R.D. Steenbergen; citation_author=B. Ylstra; citation_journal_title=Biochim. Biophys. Acta; citation_volume=1843; citation_firstpage=2698; citation_lastpage=2704; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=A simple method for displaying the hydropathic character of a protein; citation_author=J. Kyte; citation_author=R.F. Doolittle; citation_journal_title=J.&nbsp;Mol. Biol.; citation_volume=157; citation_firstpage=105; citation_lastpage=132; citation_publication_date=1982; "><meta name="citation_reference" content="citation_title=PD-1 blockade in tumors with mismatch-repair deficiency; citation_author=D.T. Le; citation_author=J.N. Uram; citation_author=H. Wang; citation_author=B.R. Bartlett; citation_author=H. Kemberling; citation_author=A.D. Eyring; citation_author=A.D. Skora; citation_author=B.S. Luber; citation_author=N.S. Azad; citation_author=D. Laheru; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=372; citation_firstpage=2509; citation_lastpage=2520; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome; citation_author=B. Li; citation_author=C.N. Dewey; citation_journal_title=BMC Bioinformatics; citation_volume=12; citation_firstpage=323; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Fast and accurate short read alignment with Burrows-Wheeler transform; citation_author=H. Li; citation_author=R. Durbin; citation_journal_title=Bioinformatics; citation_volume=25; citation_firstpage=1754; citation_lastpage=1760; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Prognostic significance of cyclin D1 expression in renal cell carcinoma: a systematic review and meta-analysis; citation_author=Z. Li; citation_author=J. Liu; citation_author=X. Zhang; citation_author=L. Fang; citation_author=C. Zhang; citation_author=Z. Zhang; citation_author=L. Yan; citation_author=Y. Tang; citation_author=Y. Fan; citation_journal_title=Pathol. Oncol. Res.; citation_volume=26; citation_firstpage=1401; citation_lastpage=1409; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy; citation_author=R.G.H. Lindeboom; citation_author=M. Vermeulen; citation_author=B. Lehner; citation_author=F. Supek; citation_journal_title=Nat. Genet.; citation_volume=51; citation_firstpage=1645; citation_lastpage=1651; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma; citation_author=D. Liu; citation_author=B. Schilling; citation_author=D. Liu; citation_author=A. Sucker; citation_author=E. Livingstone; citation_author=L. Jerby-Arnon; citation_author=L. Zimmer; citation_author=R. Gutzmer; citation_author=I. Satzger; citation_author=C. Loquai; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=25; citation_firstpage=1916; citation_lastpage=1927; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy; citation_author=M. Łuksza; citation_author=N. Riaz; citation_author=V. Makarov; citation_author=V.P. Balachandran; citation_author=M.D. Hellmann; citation_author=A. Solovyov; citation_author=N.A. Rizvi; citation_author=T. Merghoub; citation_author=A.J. Levine; citation_author=T.A. Chan; citation_author=et al.; citation_journal_title=Nature; citation_volume=551; citation_firstpage=517; citation_lastpage=520; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Cyclin D1 amplification in tongue and cheek squamous cell carcinoma; citation_author=H.M. Mahdey; citation_author=A. Ramanathan; citation_author=S.M. Ismail; citation_author=M.T. Abraham; citation_author=M. Jamaluddin; citation_author=R.B. Zain; citation_journal_title=Asian Pac. J. Cancer Prev.; citation_volume=12; citation_firstpage=2199; citation_lastpage=2204; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T&nbsp;cells; citation_author=S. Mariathasan; citation_author=S.J. Turley; citation_author=D. Nickles; citation_author=A. Castiglioni; citation_author=K. Yuen; citation_author=Y. Wang; citation_author=E.E. Kadel; citation_author=H. Koeppen; citation_author=J.L. Astarita; citation_author=R. Cubas; citation_author=et al.; citation_journal_title=Nature; citation_volume=554; citation_firstpage=544; citation_lastpage=548; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma; citation_author=D.F. McDermott; citation_author=M.A. Huseni; citation_author=M.B. Atkins; citation_author=R.J. Motzer; citation_author=B.I. Rini; citation_author=B. Escudier; citation_author=L. Fong; citation_author=R.W. Joseph; citation_author=S.K. Pal; citation_author=J.A. Reeves; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=24; citation_firstpage=749; citation_lastpage=757; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Clonal neoantigens elicit T&nbsp;cell immunoreactivity and sensitivity to immune checkpoint blockade; citation_author=N. McGranahan; citation_author=A.J. Furness; citation_author=R. Rosenthal; citation_author=S. Ramskov; citation_author=R. Lyngaa; citation_author=S.K. Saini; citation_author=M. Jamal-Hanjani; citation_author=G.A. Wilson; citation_author=N.J. Birkbak; citation_author=C.T. Hiley; citation_author=et al.; citation_journal_title=Science; citation_volume=351; citation_firstpage=1463; citation_lastpage=1469; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Allele-specific HLA loss and immune escape in lung cancer evolution; citation_author=N. McGranahan; citation_author=R. Rosenthal; citation_author=C.T. Hiley; citation_author=A.J. Rowan; citation_author=T.B.K. Watkins; citation_author=G.A. Wilson; citation_author=N.J. Birkbak; citation_author=S. Veeriah; citation_author=P. Van Loo; citation_author=J. Herrero; citation_author=C. Swanton; citation_author=TRACERx Consortium; citation_journal_title=Cell; citation_volume=171; citation_firstpage=1259; citation_lastpage=1271.e11; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data; citation_author=A. McKenna; citation_author=M. Hanna; citation_author=E. Banks; citation_author=A. Sivachenko; citation_author=K. Cibulskis; citation_author=A. Kernytsky; citation_author=K. Garimella; citation_author=D. Altshuler; citation_author=S. Gabriel; citation_author=M. Daly; citation_author=M.A. DePristo; citation_journal_title=Genome Res.; citation_volume=20; citation_firstpage=1297; citation_lastpage=1303; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Establishing guidelines to harmonize tumor mutational burden (TMB): in&nbsp;silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project; citation_author=D.M. Merino; citation_author=L.M. McShane; citation_author=D. Fabrizio; citation_author=V. Funari; citation_author=S.J. Chen; citation_author=J.R. White; citation_author=P. Wenz; citation_author=J. Baden; citation_author=J.C. Barrett; citation_author=R. Chaudhary; citation_author=TMB Harmonization Consortium; citation_author=et al.; citation_journal_title=J.&nbsp;Immunother. Cancer; citation_volume=8; citation_firstpage=e000147; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?; citation_author=J.L. Messina; citation_author=D.A. Fenstermacher; citation_author=S. Eschrich; citation_author=X. Qu; citation_author=A.E. Berglund; citation_author=M.C. Lloyd; citation_author=M.J. Schell; citation_author=V.K. Sondak; citation_author=J.S. Weber; citation_author=J.J. Mulé; citation_journal_title=Sci. Rep.; citation_volume=2; citation_firstpage=765; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors; citation_author=D. Miao; citation_author=C.A. Margolis; citation_author=N.I. Vokes; citation_author=D. Liu; citation_author=A. Taylor-Weiner; citation_author=S.M. Wankowicz; citation_author=D. Adeegbe; citation_author=D. Keliher; citation_author=B. Schilling; citation_author=A. Tracy; citation_author=et al.; citation_journal_title=Nat. Genet.; citation_volume=50; citation_firstpage=1271; citation_lastpage=1281; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Copynumber: efficient algorithms for single- and multi-track copy number segmentation; citation_author=G. Nilsen; citation_author=K. Liestøl; citation_author=P. Van Loo; citation_author=H.K. Moen Vollan; citation_author=M.B. Eide; citation_author=O.M. Rueda; citation_author=S.F. Chin; citation_author=R. Russell; citation_author=L.O. Baumbusch; citation_author=C. Caldas; citation_author=et al.; citation_journal_title=BMC Genomics; citation_volume=13; citation_firstpage=591; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients; citation_author=S. Pabla; citation_author=J.M. Conroy; citation_author=M.K. Nesline; citation_author=S.T. Glenn; citation_author=A. Papanicolau-Sengos; citation_author=B. Burgher; citation_author=J. Hagen; citation_author=V. Giamo; citation_author=J. Andreas; citation_author=F.L. Lenzo; citation_author=et al.; citation_journal_title=J.&nbsp;Immunother. Cancer; citation_volume=7; citation_firstpage=27; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma; citation_author=A. Panda; citation_author=A.A. de Cubas; citation_author=M. Stein; citation_author=G. Riedlinger; citation_author=J. Kra; citation_author=T. Mayer; citation_author=C.C. Smith; citation_author=B.G. Vincent; citation_author=J.S. Serody; citation_author=K.E. Beckermann; citation_author=et al.; citation_journal_title=JCI Insight; citation_volume=3; citation_firstpage=e121522; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Loss of PTEN promotes resistance to T&nbsp;cell-mediated immunotherapy; citation_author=W. Peng; citation_author=J.Q. Chen; citation_author=C. Liu; citation_author=S. Malu; citation_author=C. Creasy; citation_author=M.T. Tetzlaff; citation_author=C. Xu; citation_author=J.A. McKenzie; citation_author=C. Zhang; citation_author=X. Liang; citation_author=et al.; citation_journal_title=Cancer Discov.; citation_volume=6; citation_firstpage=202; citation_lastpage=216; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Divergent allele advantage at human MHC genes: signatures of past and ongoing selection; citation_author=F. Pierini; citation_author=T.L. Lenz; citation_journal_title=Mol. Biol. Evol.; citation_volume=35; citation_firstpage=2145; citation_lastpage=2158; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=The impact of cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis; citation_author=B. Ren; citation_author=W. Li; citation_author=Y. Yang; citation_author=S. Wu; citation_journal_title=World J. Surg. Oncol.; citation_volume=12; citation_firstpage=55; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy; citation_author=N. Riaz; citation_author=J.J. Havel; citation_author=S.M. Kendall; citation_author=V. Makarov; citation_author=L.A. Walsh; citation_author=A. Desrichard; citation_author=N. Weinhold; citation_author=T.A. Chan; citation_journal_title=Nat. Genet.; citation_volume=48; citation_firstpage=1327; citation_lastpage=1329; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Tumor and microenvironment evolution during immunotherapy with nivolumab; citation_author=N. Riaz; citation_author=J.J. Havel; citation_author=V. Makarov; citation_author=A. Desrichard; citation_author=W.J. Urba; citation_author=J.S. Sims; citation_author=F.S. Hodi; citation_author=S. Martín-Algarra; citation_author=R. Mandal; citation_author=W.H. Sharfman; citation_author=et al.; citation_journal_title=Cell; citation_volume=171; citation_firstpage=934; citation_lastpage=949.e16; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications; citation_author=A. Rimmer; citation_author=H. Phan; citation_author=I. Mathieson; citation_author=Z. Iqbal; citation_author=S.R.F. Twigg; citation_author=A.O.M. Wilkie; citation_author=G. McVean; citation_author=G. Lunter; citation_author=WGS500 Consortium; citation_journal_title=Nat. Genet.; citation_volume=46; citation_firstpage=912; citation_lastpage=918; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer; citation_author=N.A. Rizvi; citation_author=M.D. Hellmann; citation_author=A. Snyder; citation_author=P. Kvistborg; citation_author=V. Makarov; citation_author=J.J. Havel; citation_author=W. Lee; citation_author=J. Yuan; citation_author=P. Wong; citation_author=T.S. Ho; citation_author=et al.; citation_journal_title=Science; citation_volume=348; citation_firstpage=124; citation_lastpage=128; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=The IPD-IMGT/HLA database: new developments in reporting HLA variation; citation_author=J. Robinson; citation_author=A.R. Soormally; citation_author=J.D. Hayhurst; citation_author=S.G.E. Marsh; citation_journal_title=Hum. Immunol.; citation_volume=77; citation_firstpage=233; citation_lastpage=237; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance; citation_author=W. Roh; citation_author=P.L. Chen; citation_author=A. Reuben; citation_author=C.N. Spencer; citation_author=P.A. Prieto; citation_author=J.P. Miller; citation_author=V. Gopalakrishnan; citation_author=F. Wang; citation_author=Z.A. Cooper; citation_author=S.M. Reddy; citation_author=et al.; citation_journal_title=Sci. Transl. Med.; citation_volume=9; citation_firstpage=eaah3560; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Molecular and genetic properties of tumors associated with local immune cytolytic activity; citation_author=M.S. Rooney; citation_author=S.A. Shukla; citation_author=C.J. Wu; citation_author=G. Getz; citation_author=N. Hacohen; citation_journal_title=Cell; citation_volume=160; citation_firstpage=48; citation_lastpage=61; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution; citation_author=R. Rosenthal; citation_author=N. McGranahan; citation_author=J. Herrero; citation_author=B.S. Taylor; citation_author=C. Swanton; citation_journal_title=Genome Biol.; citation_volume=17; citation_firstpage=31; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Neoantigen-directed immune escape in lung cancer evolution; citation_author=R. Rosenthal; citation_author=E.L. Cadieux; citation_author=R. Salgado; citation_author=M.A. Bakir; citation_author=D.A. Moore; citation_author=C.T. Hiley; citation_author=T. Lund; citation_author=M. Tanić; citation_author=J.L. Reading; citation_author=K. Joshi; citation_author=TRACERx consortium; citation_author=et al.; citation_journal_title=Nature; citation_volume=567; citation_firstpage=479; citation_lastpage=485; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=PyClone: statistical inference of clonal population structure in cancer; citation_author=A. Roth; citation_author=J. Khattra; citation_author=D. Yap; citation_author=A. Wan; citation_author=E. Laks; citation_author=J. Biele; citation_author=G. Ha; citation_author=S. Aparicio; citation_author=A. Bouchard-Côté; citation_author=S.P. Shah; citation_journal_title=Nat. Methods; citation_volume=11; citation_firstpage=396; citation_lastpage=398; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Tumor mutational load predicts survival after immunotherapy across multiple cancer types; citation_author=R.M. Samstein; citation_author=C.H. Lee; citation_author=A.N. Shoushtari; citation_author=M.D. Hellmann; citation_author=R. Shen; citation_author=Y.Y. Janjigian; citation_author=D.A. Barron; citation_author=A. Zehir; citation_author=E.J. Jordan; citation_author=A. Omuro; citation_author=et al.; citation_journal_title=Nat. Genet.; citation_volume=51; citation_firstpage=202; citation_lastpage=206; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response; citation_author=R. Seiler; citation_author=G.N. Thalmann; citation_author=D. Rotzer; citation_author=A. Perren; citation_author=A. Fleischmann; citation_journal_title=Mod. Pathol.; citation_volume=27; citation_firstpage=87; citation_lastpage=95; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients; citation_author=J.H. Shim; citation_author=H.S. Kim; citation_author=H. Cha; citation_author=S. Kim; citation_author=T.M. Kim; citation_author=V. Anagnostou; citation_author=Y.L. Choi; citation_author=H.A. Jung; citation_author=J.M. Sun; citation_author=J.S. Ahn; citation_author=et al.; citation_journal_title=Ann. Oncol.; citation_volume=31; citation_firstpage=902; citation_lastpage=911; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Primary resistance to PD-1 blockade mediated by JAK1/2 mutations; citation_author=D.S. Shin; citation_author=J.M. Zaretsky; citation_author=H. Escuin-Ordinas; citation_author=A. Garcia-Diaz; citation_author=S. Hu-Lieskovan; citation_author=A. Kalbasi; citation_author=C.S. Grasso; citation_author=W. Hugo; citation_author=S. Sandoval; citation_author=D.Y. Torrejon; citation_author=et al.; citation_journal_title=Cancer Discov.; citation_volume=7; citation_firstpage=188; citation_lastpage=201; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma; citation_author=R. Shrestha; citation_author=N. Nabavi; citation_author=Y.Y. Lin; citation_author=F. Mo; citation_author=S. Anderson; citation_author=S. Volik; citation_author=H.H. Adomat; citation_author=D. Lin; citation_author=H. Xue; citation_author=X. Dong; citation_author=et al.; citation_journal_title=Genome Med.; citation_volume=11; citation_firstpage=8; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes; citation_author=S.A. Shukla; citation_author=M.S. Rooney; citation_author=M. Rajasagi; citation_author=G. Tiao; citation_author=P.M. Dixon; citation_author=M.S. Lawrence; citation_author=J. Stevens; citation_author=W.J. Lane; citation_author=J.L. Dellagatta; citation_author=S. Steelman; citation_author=et al.; citation_journal_title=Nat. Biotechnol.; citation_volume=33; citation_firstpage=1152; citation_lastpage=1158; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Systematic identification of mutations and copy number alterations associated with cancer patient prognosis; citation_author=J.C. Smith; citation_author=J.M. Sheltzer; citation_journal_title=eLife; citation_volume=7; citation_firstpage=e39217; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Genetic basis for clinical response to CTLA-4 blockade in melanoma; citation_author=A. Snyder; citation_author=V. Makarov; citation_author=T. Merghoub; citation_author=J. Yuan; citation_author=J.M. Zaretsky; citation_author=A. Desrichard; citation_author=L.A. Walsh; citation_author=M.A. Postow; citation_author=P. Wong; citation_author=T.S. Ho; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=371; citation_firstpage=2189; citation_lastpage=2199; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: an exploratory multi-omic analysis; citation_author=A. Snyder; citation_author=T. Nathanson; citation_author=S.A. Funt; citation_author=A. Ahuja; citation_author=J. Buros Novik; citation_author=M.D. Hellmann; citation_author=E. Chang; citation_author=B.A. Aksoy; citation_author=H. Al-Ahmadie; citation_author=E. Yusko; citation_author=et al.; citation_journal_title=PLoS Med.; citation_volume=14; citation_firstpage=e1002309; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=A transcriptionally and functionally distinct PD-1+ CD8+ T&nbsp;cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade; citation_author=D.S. Thommen; citation_author=V.H. Koelzer; citation_author=P. Herzig; citation_author=A. Roller; citation_author=M. Trefny; citation_author=S. Dimeloe; citation_author=A. Kiialainen; citation_author=J. Hanhart; citation_author=C. Schill; citation_author=C. Hess; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=24; citation_firstpage=994; citation_lastpage=1004; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=12-Chemokine signature, a predictor of tumor recurrence in colorectal cancer; citation_author=R. Tokunaga; citation_author=S. Nakagawa; citation_author=Y. Sakamoto; citation_author=K. Nakamura; citation_author=M. Naseem; citation_author=D. Izumi; citation_author=K. Kosumi; citation_author=K. Taki; citation_author=T. Higashi; citation_author=T. Miyata; citation_author=et al.; citation_journal_title=International Journal of Cancer; citation_volume=147; citation_firstpage=532; citation_lastpage=541; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Immunogenicity of somatic mutations in human gastrointestinal cancers; citation_author=E. Tran; citation_author=M. Ahmadzadeh; citation_author=Y.C. Lu; citation_author=A. Gros; citation_author=S. Turcotte; citation_author=P.F. Robbins; citation_author=J.J. Gartner; citation_author=Z. Zheng; citation_author=Y.F. Li; citation_author=S. Ray; citation_author=et al.; citation_journal_title=Science; citation_volume=350; citation_firstpage=1387; citation_lastpage=1390; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=A variant of a killer cell immunoglobulin-like receptor is associated with resistance to PD-1 blockade in lung cancer; citation_author=M.P. Trefny; citation_author=S.I. Rothschild; citation_author=F. Uhlenbrock; citation_author=D. Rieder; citation_author=B. Kasenda; citation_author=M.A. Stanczak; citation_author=F. Berner; citation_author=A.S. Kashyap; citation_author=M. Kaiser; citation_author=P. Herzig; citation_author=et al.; citation_journal_title=Clin. Cancer Res.; citation_volume=25; citation_firstpage=3026; citation_lastpage=3034; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanoma; citation_author=L.D. Trucco; citation_author=P.A. Mundra; citation_author=K. Hogan; citation_author=P. Garcia-Martinez; citation_author=A. Viros; citation_author=A.K. Mandal; citation_author=N. Macagno; citation_author=C. Gaudy-Marqueste; citation_author=D. Allan; citation_author=F. Baenke; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=25; citation_firstpage=221; citation_lastpage=224; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=PD-1 blockade induces responses by inhibiting adaptive immune resistance; citation_author=P.C. Tumeh; citation_author=C.L. Harview; citation_author=J.H. Yearley; citation_author=I.P. Shintaku; citation_author=E.J. Taylor; citation_author=L. Robert; citation_author=B. Chmielowski; citation_author=M. Spasic; citation_author=G. Henry; citation_author=V. Ciobanu; citation_author=et al.; citation_journal_title=Nature; citation_volume=515; citation_firstpage=568; citation_lastpage=571; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis; citation_author=S. Turajlic; citation_author=K. Litchfield; citation_author=H. Xu; citation_author=R. Rosenthal; citation_author=N. McGranahan; citation_author=J.L. Reading; citation_author=Y.N.S. Wong; citation_author=A. Rowan; citation_author=N. Kanu; citation_author=M. Al Bakir; citation_author=et al.; citation_journal_title=Lancet Oncol.; citation_volume=18; citation_firstpage=1009; citation_lastpage=1021; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Tracking cancer evolution reveals constrained routes to metastases: TRACERx Renal; citation_author=S. Turajlic; citation_author=H. Xu; citation_author=K. Litchfield; citation_author=A. Rowan; citation_author=T. Chambers; citation_author=J.I. Lopez; citation_author=D. Nicol; citation_author=T. O’Brien; citation_author=J. Larkin; citation_author=S. Horswell; citation_author=PEACE; citation_author=TRACERx Renal Consortium; citation_author=et al.; citation_journal_title=Cell; citation_volume=173; citation_firstpage=581; citation_lastpage=594.e12; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Genomic correlates of response to CTLA-4 blockade in metastatic melanoma; citation_author=E.M. Van Allen; citation_author=D. Miao; citation_author=B. Schilling; citation_author=S.A. Shukla; citation_author=C. Blank; citation_author=L. Zimmer; citation_author=A. Sucker; citation_author=U. Hillen; citation_author=M.H.G. Foppen; citation_author=S.M. Goldinger; citation_author=et al.; citation_journal_title=Science; citation_volume=350; citation_firstpage=207; citation_lastpage=211; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Allele-specific copy number analysis of tumors; citation_author=P. Van Loo; citation_author=S.H. Nordgard; citation_author=O.C. Lingjærde; citation_author=H.G. Russnes; citation_author=I.H. Rye; citation_author=W. Sun; citation_author=V.J. Weigman; citation_author=P. Marynen; citation_author=A. Zetterberg; citation_author=B. Naume; citation_author=et al.; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=107; citation_firstpage=16910; citation_lastpage=16915; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=The role of CCND1 alterations during the progression of cutaneous malignant melanoma; citation_author=L. Vízkeleti; citation_author=S. Ecsedi; citation_author=Z. Rákosy; citation_author=A. Orosz; citation_author=V. Lázár; citation_author=G. Emri; citation_author=V. Koroknai; citation_author=T. Kiss; citation_author=R. Ádány; citation_author=M. Balázs; citation_journal_title=Tumour Biol.; citation_volume=33; citation_firstpage=2189; citation_lastpage=2199; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Harmonization of tumor mutational burden quantification and association with response to immune checkpoint blockade in non-small-cell lung cancer; citation_author=N.I. Vokes; citation_author=D. Liu; citation_author=B. Ricciuti; citation_author=E. Jimenez-Aguilar; citation_author=H. Rizvi; citation_author=F. Dietlein; citation_author=M.X. He; citation_author=C.A. Margolis; citation_author=H.A. Elmarakeby; citation_author=J. Girshman; citation_author=et al.; citation_journal_title=JCO Precis. Oncol.; citation_volume=3; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Augmenting immunotherapy impact by lowering tumor TNF cytotoxicity threshold; citation_author=D.W. Vredevoogd; citation_author=T. Kuilman; citation_author=M.A. Ligtenberg; citation_author=J. Boshuizen; citation_author=K.E. Stecker; citation_author=B. de Bruijn; citation_author=O. Krijgsman; citation_author=X. Huang; citation_author=J.C.N. Kenski; citation_author=R. Lacroix; citation_author=et al.; citation_journal_title=Cell; citation_volume=178; citation_firstpage=585; citation_lastpage=599.e15; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data; citation_author=K. Wang; citation_author=M. Li; citation_author=H. Hakonarson; citation_journal_title=Nucleic Acids Res.; citation_volume=38; citation_firstpage=e164; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma; citation_author=M.T. Wang; citation_author=G. Chen; citation_author=S.J. An; citation_author=Z.H. Chen; citation_author=Z.M. Huang; citation_author=P. Xiao; citation_author=X.S. Ben; citation_author=Z. Xie; citation_author=S.L. Chen; citation_author=D.L. Luo; citation_author=et al.; citation_journal_title=Dis. Esophagus; citation_volume=25; citation_firstpage=664; citation_lastpage=670; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer; citation_author=L. Wang; citation_author=A. Saci; citation_author=P.M. Szabo; citation_author=S.D. Chasalow; citation_author=M. Castillo-Martin; citation_author=J. Domingo-Domenech; citation_author=A. Siefker-Radtke; citation_author=P. Sharma; citation_author=J.P. Sfakianos; citation_author=Y. Gong; citation_author=et al.; citation_journal_title=Nat. Commun.; citation_volume=9; citation_firstpage=3503; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Moving to a world beyond “p < 0.05”; citation_author=R.L. Wasserstein; citation_author=A.L. Schirm; citation_author=N.A. Lazar; citation_journal_title=Am. Stat.; citation_volume=73; citation_firstpage=1; citation_lastpage=19; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Pervasive chromosomal instability and karyotype order in tumour evolution; citation_author=T.B.K. Watkins; citation_author=E.L. Lim; citation_author=M. Petkovic; citation_author=S. Elizalde; citation_author=N.J. Birkbak; citation_author=G.A. Wilson; citation_author=D.A. Moore; citation_author=E. Grönroos; citation_author=A. Rowan; citation_author=S.M. Dewhurst; citation_author=et al.; citation_journal_title=Nature; citation_volume=587; citation_firstpage=126; citation_lastpage=132; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=UVB-induced tumor heterogeneity diminishes immune response in melanoma; citation_author=Y. Wolf; citation_author=O. Bartok; citation_author=S. Patkar; citation_author=G.B. Eli; citation_author=S. Cohen; citation_author=K. Litchfield; citation_author=R. Levy; citation_author=A. Jiménez-Sánchez; citation_author=S. Trabish; citation_author=J.S. Lee; citation_author=et al.; citation_journal_title=Cell; citation_volume=179; citation_firstpage=219; citation_lastpage=235.e21; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells; citation_author=W. Yang; citation_author=J. Soares; citation_author=P. Greninger; citation_author=E.J. Edelman; citation_author=H. Lightfoot; citation_author=S. Forbes; citation_author=N. Bindal; citation_author=D. Beare; citation_author=J.A. Smith; citation_author=I.R. Thompson; citation_author=et al.; citation_journal_title=Nucleic Acids Res.; citation_volume=41; citation_firstpage=D955; citation_lastpage=D961; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance; citation_author=J. Zhang; citation_author=X. Bu; citation_author=H. Wang; citation_author=Y. Zhu; citation_author=Y. Geng; citation_author=N.T. Nihira; citation_author=Y. Tan; citation_author=Y. Ci; citation_author=F. Wu; citation_author=X. Dai; citation_author=et al.; citation_journal_title=Nature; citation_volume=553; citation_firstpage=91; citation_lastpage=95; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Exploiting temporal collateral sensitivity in tumor clonal evolution; citation_author=B. Zhao; citation_author=J.C. Sedlak; citation_author=R. Srinivas; citation_author=P. Creixell; citation_author=J.R. Pritchard; citation_author=B. Tidor; citation_author=D.A. Lauffenburger; citation_author=M.T. Hemann; citation_journal_title=Cell; citation_volume=165; citation_firstpage=234; citation_lastpage=246; citation_publication_date=2016; "><meta name="citation_abstract" content="<h2>Summary</h2><p>Checkpoint inhibitors (CPIs) augment adaptive immunity. Systematic pan-tumor analyses may reveal the relative importance of tumor-cell-intrinsic and microenvironmental features underpinning CPI sensitization. Here, we collated whole-exome and transcriptomic data for >1,000 CPI-treated patients across seven tumor types, utilizing standardized bioinformatics workflows and clinical outcome criteria to validate multivariable predictors of CPI sensitization. Clonal tumor mutation burden (TMB) was the strongest predictor of CPI response, followed by total TMB and <i>CXCL9</i> expression. Subclonal TMB, somatic copy alteration burden, and histocompatibility leukocyte antigen (HLA) evolutionary divergence failed to attain pan-cancer significance. Dinucleotide variants were identified as a source of immunogenic epitopes associated with radical amino acid substitutions and enhanced peptide hydrophobicity/immunogenicity. Copy-number analysis revealed two additional determinants of CPI outcome supported by prior functional evidence: 9q34 (<i>TRAF2</i>) loss associated with response and <i>CCND1</i> amplification associated with resistance. Finally, single-cell RNA sequencing (RNA-seq) of clonal neoantigen-reactive CD8 tumor-infiltrating lymphocytes (TILs), combined with bulk RNA-seq analysis of CPI-responding tumors, identified <i>CCR5</i> and <i>CXCL13</i> as T-cell-intrinsic markers of CPI sensitivity.</p>"><meta charset="UTF-8"><!--

    Pagebuild admin UI
-->



<script type="text/javascript" src="https://bam.nr-data.net/1/16e2192192?a=916957862&amp;sa=1&amp;v=1177.96a4d39&amp;t=Unnamed%20Transaction&amp;rst=5353&amp;ck=1&amp;ref=https://www.cell.com/cell/fulltext/S0092-8674(21)00002-7&amp;be=3781&amp;fe=5309&amp;dc=4977&amp;af=err,xhr,stn,ins,spa&amp;perf=%7B%22timing%22:%7B%22of%22:1749589107907,%22n%22:0,%22f%22:2836,%22dn%22:2837,%22dne%22:2837,%22c%22:2837,%22s%22:2837,%22ce%22:2837,%22rq%22:2837,%22rp%22:3757,%22rpe%22:4696,%22dl%22:3763,%22di%22:4895,%22ds%22:4977,%22de%22:4989,%22dc%22:5308,%22l%22:5308,%22le%22:5340%7D,%22navigation%22:%7B%7D%7D&amp;fp=4272&amp;fcp=4272&amp;jsonp=NREUM.setToken"></script><script src="https://js-agent.newrelic.com/nr-spa-1177.min.js"></script><script type="text/javascript">
    ;window.NREUM||(NREUM={});NREUM.init={privacy:{cookies_enabled:true}};
    window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{c.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(26),c={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(c.console=!0,o.indexOf("dev")!==-1&&(c.dev=!0),o.indexOf("nr_dev")!==-1&&(c.nrDev=!0))}catch(s){}c.nrDev&&i.on("internal-error",function(t){r(t.stack)}),c.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),c.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(c,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,c){try{l?l-=1:o(c||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,s.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:s.now();i("err",[t,n])}var i=t("handle"),a=t(27),c=t("ee"),s=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError",l=0;s.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(13),t(12),"addEventListener"in window&&t(6),s.xhrWrappable&&t(14),d=!0)}c.on("fn-start",function(t,e,n){d&&(l+=1)}),c.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),c.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),c.on("internal-error",function(t){i("ierr",[t,s.now(),!0])})},{}],3:[function(t,e,n){t("loader").features.ins=!0},{}],4:[function(t,e,n){function r(){_++,T=g.hash,this[u]=y.now()}function o(){_--,g.hash!==T&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var c="-start",s="-end",f="-body",u="fn"+c,d="fn"+s,p="cb"+c,l="cb"+s,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable){var x=t(10),b=t(11),E=t(8),R=t(6),O=t(13),N=t(7),M=t(14),P=t(9),S=t("ee"),C=S.get("tracer");t(16),y.features.spa=!0;var T,_=0;S.on(u,r),S.on(p,r),S.on(d,o),S.on(l,o),S.buffer([u,d,"xhr-done","xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+s,"clearTimeout"+c,u]),M.buffer([u,"new-xhr","send-xhr"+c]),N.buffer([m+c,m+"-done",m+f+c,m+f+s]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+c]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(M,"send-xhr"+c),a(S,"xhr-resolved"),a(S,"xhr-done"),a(N,m+c),a(N,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,!0),w[v]("load",i,!0),w[v]("popstate",function(){i(0,_>1)},!0)}},{}],5:[function(t,e,n){function r(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var o=t("ee"),i=t("handle"),a=t(13),c=t(12),s="learResourceTimings",f="addEventListener",u="resourcetimingbufferfull",d="bstResource",p="resource",l="-start",h="-end",m="fn"+l,v="fn"+h,w="bstTimer",g="pushState",y=t("loader");y.features.stn=!0,t(8),"addEventListener"in window&&t(6);var x=NREUM.o.EV;o.on(m,function(t,e){var n=t[0];n instanceof x&&(this.bstStart=y.now())}),o.on(v,function(t,e){var n=t[0];n instanceof x&&i("bst",[n,e,this.bstStart,y.now()])}),a.on(m,function(t,e,n){this.bstStart=y.now(),this.bstType=n}),a.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),this.bstType])}),c.on(m,function(){this.bstStart=y.now()}),c.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),"requestAnimationFrame"])}),o.on(g+l,function(t){this.time=y.now(),this.startPath=location.pathname+location.hash}),o.on(g+h,function(t){i("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),f in window.performance&&(window.performance["c"+s]?window.performance[f](u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["c"+s]()},!1):window.performance[f]("webkit"+u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["webkitC"+s]()},!1)),document[f]("scroll",r,{passive:!0}),document[f]("keypress",r,!1),document[f]("click",r,!1)}},{}],6:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){c.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),c=t("wrap-function")(a,!0),s=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1],r=s(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?c(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],7:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var c=r.apply(this,t);return o.emit(n+"start",[t,a],c),c.then(function(t){return o.emit(n+"end",[null,t],c),t},function(t){throw o.emit(n+"end",[t],c),t})})}var o=t("ee").get("fetch"),i=t(27),a=t(26);e.exports=o;var c=window,s="fetch-",f=s+"body-",u=["arrayBuffer","blob","json","text","formData"],d=c.Request,p=c.Response,l=c.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(c,"fetch",s),o.on(s+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(s+"done",[null,e],n)}else o.emit(s+"done",[t],n)}))},{}],8:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],9:[function(t,e,n){function r(t){function e(){s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}function n(){s.emit("jsonp-error",[],p),s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var u=c(a),d="function"==typeof u.parent[u.key];if(d){var p={};f.inPlace(u.parent,[u.key],"cb-",p),t.addEventListener("load",e,!1),t.addEventListener("error",n,!1),s.emit("new-jsonp",[t.src],p)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(u);return e?e[1]:null}function a(t,e){var n=t.match(p),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function c(t){var e=t.match(d);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var s=t("ee").get("jsonp"),f=t("wrap-function")(s);if(e.exports=s,o()){var u=/[?&](?:callback|cb)=([^&#]+)/,d=/(.*)\.([^.]+)/,p=/^(\w+)(\.|$)(.*)$/,l=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?f.inPlace(Node.prototype,l,"dom-"):(f.inPlace(HTMLElement.prototype,l,"dom-"),f.inPlace(HTMLHeadElement.prototype,l,"dom-"),f.inPlace(HTMLBodyElement.prototype,l,"dom-")),s.on("dom-start",function(t){r(t[0])})}},{}],10:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],11:[function(t,e,n){function r(t){var e=a.context(),n=c(t,"executor-",e),r=new f(n);return a.context(r).getCtx=function(){return e},a.emit("new-promise",[r,e],e),r}function o(t,e){return e}var i=t("wrap-function"),a=t("ee").get("promise"),c=i(a),s=t(26),f=NREUM.o.PR;e.exports=a,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){a.emit("propagate",[null,!o],i),o=o||!t}}var o=!1;s(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var i=e.apply(f,arguments),c=f.resolve(i);return c}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&a.emit("propagate",[t,!0],n),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),s(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),a.on("executor-start",function(t){t[0]=c(t[0],"resolve-",this),t[1]=c(t[1],"resolve-",this)}),a.on("executor-err",function(t,e,n){t[1](n)}),c.inPlace(f.prototype,["then"],"then-",o),a.on("then-start",function(t,e){this.promise=e,t[0]=c(t[0],"cb-",this),t[1]=c(t[1],"cb-",this)}),a.on("then-end",function(t,e,n){this.nextPromise=n;var r=this.promise;a.emit("propagate",[r,!0],n)}),a.on("cb-end",function(t,e,n){a.emit("propagate",[n,!0],this.nextPromise)}),a.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=a.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],12:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],13:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),c="setTimeout",s="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[c,"setImmediate"],c+d),a.inPlace(window,[s],s+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(s+u,r),i.on(c+u,o)},{}],14:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",c)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,g,"fn-",c)}function i(t){y.push(t),h&&(b?b.then(a):v?v(a):(E=-E,R.data=E))}function a(){for(var t=0;t<y.length;t++)r([],y[t]);y.length&&(y=[])}function c(t,e){return e}function s(t,e){for(var n in t)e[n]=t[n];return e}t(6);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=NREUM.o,l=p.XHR,h=p.MO,m=p.PR,v=p.SI,w="readystatechange",g=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],y=[];e.exports=u;var x=window.XMLHttpRequest=function(t){var e=new l(t);try{u.emit("new-xhr",[e],e),e.addEventListener(w,o,!1)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(s(l,x),x.prototype=l.prototype,d.inPlace(x.prototype,["open","send"],"-xhr-",c),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),h){var b=m&&m.resolve();if(!v&&!m){var E=1,R=document.createTextNode(E);new h(a).observe(R,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===w||a()})},{}],15:[function(t,e,n){function r(t){if(!c(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||s(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&s(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",c=1,s="",f="";return o+"@nr="+i+"-"+c+"-"+n+"-"+r+"-"+t+"-"+a+"-"+s+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var c={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(c.d.tk=i),btoa(JSON.stringify(c))}function c(t){return f()&&s(t)}function s(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(23),h=t(17);e.exports={generateTracePayload:r,shouldGenerateTrace:c}},{}],16:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,u.emit("xhr-done",[t],t),c("xhr",[e,n,this.startTime]))}}function o(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=s(e),t.sameOrigin=t.parsedOrigin.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable){var c=t("handle"),s=t(17),f=t(15).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(21),m=t(20),v=t(18),w=window.XMLHttpRequest;a.features.xhr=!0,t(14),t(7),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,t.addEventListener("load",function(n){i(e,t)},!1),h&&(h>34||h<10)||window.opera||t.addEventListener("progress",function(t){e.lastSize=t.loaded},!1)}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var c=0;c<p;c++)e.addEventListener(d[c],this.listener,!1)}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("addEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof w&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url&&(n=t[0].url),n&&(this.parsedOrigin=s(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)})}},{}],17:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,c=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||c),"/"===o.pathname&&(r[t]=o),o}},{}],18:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(20);e.exports=r},{}],19:[function(t,e,n){function r(){}function o(t,e,n){return function(){return i(t,[f.now()].concat(c(arguments)),e?null:this,n),e?void 0:this}}var i=t("handle"),a=t(26),c=t(27),s=t("ee").get("tracer"),f=t("loader"),u=NREUM;"undefined"==typeof window.newrelic&&(newrelic=u);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],p="api-",l=p+"ixn-";a(d,function(t,e){u[e]=o(p+e,!0,"api")}),u.addPageAction=o(p+"addPageAction",!0),u.setCurrentRouteName=o(p+"routeName",!0),e.exports=newrelic,u.interaction=function(){return(new r).get()};var h=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(l+"tracer",[f.now(),t,n],r),function(){if(s.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw s.emit("fn-err",[arguments,this,t],n),t}finally{s.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){h[e]=o(l+e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),i("err",[t,f.now(),!1,e])}},{}],20:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],21:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],22:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?d("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&d("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();n.length>0&&d("lcp",[n[n.length-1]])}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||d("cls",[t])})}function a(t){if(t instanceof h&&!v){var e=Math.round(t.timeStamp),n={type:t.type};e<=p.now()?n.fid=p.now()-e:e>p.offset&&e<=Date.now()?(e-=p.offset,n.fid=p.now()-e):e=p.now(),v=!0,d("timing",["fi",e,n])}}function c(t){d("pageHide",[p.now(),t])}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var s,f,u,d=t("handle"),p=t("loader"),l=t(25),h=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){s=new PerformanceObserver(r);try{s.observe({entryTypes:["paint"]})}catch(m){}f=new PerformanceObserver(o);try{f.observe({entryTypes:["largest-contentful-paint"]})}catch(m){}u=new PerformanceObserver(i);try{u.observe({type:"layout-shift",buffered:!0})}catch(m){}}if("addEventListener"in document){var v=!1,w=["click","keydown","mousedown","pointerdown","touchstart"];w.forEach(function(t){document.addEventListener(t,a,!1)})}l(c)}},{}],23:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",c=0;c<i.length;c++)o=i[c],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],24:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var c=navigator.userAgent,s=c.match(a);s&&c.indexOf("Chrome")===-1&&c.indexOf("Chromium")===-1&&(o="Safari",i=s[1])}e.exports={agent:o,version:i,match:r}},{}],25:[function(t,e,n){function r(t){function e(){t(a&&document[a]?document[a]:document[o]?"hidden":"visible")}"addEventListener"in document&&i&&document.addEventListener(i,e,!1)}e.exports=r;var o,i,a;"undefined"!=typeof document.hidden?(o="hidden",i="visibilitychange",a="visibilityState"):"undefined"!=typeof document.msHidden?(o="msHidden",i="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(o="webkitHidden",i="webkitvisibilitychange",a="webkitVisibilityState")},{}],26:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],27:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],28:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?s(t,c,i):i()}function n(n,r,o,i){if(!p.aborted||i){t&&t(n,r,o);for(var a=e(o),c=m(n),s=c.length,f=0;f<s;f++)c[f].apply(a,r);var d=u[y[n]];return d&&d.push([x,n,r,a]),a}}function l(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return d[t]=d[t]||o(n)}function w(t,e){f(t,function(t,n){e=e||"feature",y[n]=e,e in u||(u[e]=[])})}var g={},y={},x={on:l,addEventListener:l,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:a,aborted:!1};return x}function i(){return new r}function a(){(u.api||u.feature)&&(p.aborted=!0,u=p.backlog={})}var c="nr@context",s=t("gos"),f=t(26),u={},d={},p=e.exports=o();p.backlog=u},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!E++){var t=b.info=NREUM.info,e=l.getElementsByTagName("script")[0];if(setTimeout(u.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return u.abort();f(y,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+b.offset],null,"api"),s("timing",["load",n]);var r=l.createElement("script");r.src="https://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===l.readyState&&i()}function i(){s("mark",["domContent",a()+b.offset],null,"api")}function a(){return R.exists&&performance.now?Math.round(performance.now()):(c=Math.max((new Date).getTime(),c))-b.offset}var c=(new Date).getTime(),s=t("handle"),f=t(26),u=t("ee"),d=t(24),p=window,l=p.document,h="addEventListener",m="attachEvent",v=p.XMLHttpRequest,w=v&&v.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:v,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var g=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1177.min.js"},x=v&&w&&w[h]&&!/CriOS/.test(navigator.userAgent),b=e.exports={offset:c,now:a,origin:g,features:{},xhrWrappable:x,userAgent:d};t(19),t(22),l[h]?(l[h]("DOMContentLoaded",i,!1),p[h]("load",r,!1)):(l[m]("onreadystatechange",o),p[m]("onload",r)),s("mark",["firstbyte",c],null,"api");var E=0,R=t(28)},{}],"wrap-function":[function(t,e,n){function r(t){return!(t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(27),a="nr@original",c=Object.prototype.hasOwnProperty,s=!1;e.exports=function(t,e){function n(t,e,n,o){function nrWrapper(){var r,a,c,s;try{a=this,r=i(arguments),c="function"==typeof n?n(r,a):n||{}}catch(f){p([f,"",[r,a,o],c])}u(e+"start",[r,a,o],c);try{return s=t.apply(a,r)}catch(d){throw u(e+"err",[r,a,d],c),d}finally{u(e+"end",[r,a,s],c)}}return r(t)?t:(e||(e=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,e,o,i){o||(o="");var a,c,s,f="-"===o.charAt(0);for(s=0;s<e.length;s++)c=e[s],a=t[c],r(a)||(t[c]=n(a,f?c+o:o,i,c))}function u(n,r,o){if(!s||e){var i=s;s=!0;try{t.emit(n,r,o,e)}catch(a){p([a,n,r,o])}s=i}}function d(t,e){if(Object.defineProperty&&Object.keys)try{var n=Object.keys(t);return n.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(r){p([r])}for(var o in t)c.call(t,o)&&(e[o]=t[o]);return e}function p(e){try{t.emit("internal-error",e)}catch(n){}}return t||(t=o),n.inPlace=f,n.flag=a,n}},{}]},{},["loader",2,16,5,3,4]);
    ;NREUM.loader_config={accountID:"2095297",trustKey:"2038175",agentID:"916957862",licenseKey:"16e2192192",applicationID:"916957862"}
    ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"16e2192192",applicationID:"916957862",sa:1}
</script>
    <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="dada9834-04e2-4bcd-b5ba-cae44d498dfa"></script>
    <script type="text/javascript">
        function getCookie(name) {
            var value = "; " + document.cookie;
            var parts = value.split("; " + name + "=");
            if (parts.length == 2) {
                return true;
            }
        }
            function OptanonWrapper() {
                var optCookie = getCookie("OptanonAlertBoxClosed");
                var isActiveCategory = "false";
                var isFoundCookieBox = "false";
                if(isActiveCategory == 'false' && isFoundCookieBox == 'false' && optCookie) {
                    OneTrust.InsertScript('/pb-assets/adobe/prod/adobedtm-1616606406233.js', 'head', null, null, '2');
                }
            }
    </script>


<noscript>
    <style>.requiresJS {
        display: none
    }

    .dartAd {
        display: block !important
    }</style>
</noscript>
        <script type="text/javascript" src="/wro/o4ny~selected-legacy.js"></script>
        <link rel="stylesheet" type="text/css" href="/wro/o4ny~selected-legacy.css">
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans">
        <script>window.MSInputMethodContext && document.documentMode && document.write('<script src="https://cdn.jsdelivr.net/gh/nuxodin/ie11CustomProperties@4.1.0/ie11CustomProperties.min.js"><\x2fscript>');</script><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/build-b26f3342b722959c7931.css"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/print-b26f3342b722959c7931.css" media="print"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/themes/theme-cell.css">







        
        
        <script class="optanon-category-4" type="text/plain" async="" src="https://www.youtube.com/iframe_api"></script>
        
    





<!---->
<meta http-equiv="X-UA-Compatible" content="IE=edge">












<script src="https://cdn.cookielaw.org/scripttemplates/202411.2.0/otBannerSdk.js" async="" type="text/javascript"></script><style id="onetrust-style">#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{height:64px;width:64px}#onetrust-banner-sdk .ot-tcf2-vendor-count.ot-text-bold{font-weight:bold}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-banner-sdk button.ot-link-btn:hover,#onetrust-pc-sdk button.ot-link-btn:hover,#ot-sync-ntfy button.ot-link-btn:hover{text-decoration:underline;opacity:1}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type=checkbox]:checked,#onetrust-pc-sdk [type=checkbox]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type=checkbox]:disabled+label::before,#onetrust-pc-sdk [type=checkbox]:disabled+label:after,#onetrust-pc-sdk [type=checkbox]:disabled+label{pointer-events:none;opacity:.8}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type=checkbox]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type=checkbox]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px .1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat;display:inline-flex;justify-content:center;align-items:center}#onetrust-pc-sdk .pc-logo img,#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;max-width:100%}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#fff;background-color:#468254;height:auto;white-space:normal;word-wrap:break-word;padding:.8em 2em;font-size:.8em;line-height:1.2;cursor:pointer;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#2c6415}#ot-sdk-btn.ot-sdk-show-settings:active,#ot-sdk-btn.optanon-show-settings:active{color:#fff;background-color:#2c6415;border:1px solid rgba(162,192,169,.5)}.onetrust-pc-dark-filter{background:rgba(0,0,0,.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk p{font-size:.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info a{margin-right:auto}#onetrust-pc-sdk .ot-pc-footer-logo img{width:136px;height:16px}#onetrust-pc-sdk .ot-pur-vdr-count{font-weight:400;font-size:.7rem;padding-top:3px;display:block}#onetrust-banner-sdk .ot-optout-signal,#onetrust-pc-sdk .ot-optout-signal{border:1px solid #32ae88;border-radius:3px;padding:5px;margin-bottom:10px;background-color:#f9fffa;font-size:.85rem;line-height:2}#onetrust-banner-sdk .ot-optout-signal .ot-optout-icon,#onetrust-pc-sdk .ot-optout-signal .ot-optout-icon{display:inline;margin-right:5px}#onetrust-banner-sdk .ot-optout-signal svg,#onetrust-pc-sdk .ot-optout-signal svg{height:20px;width:30px;transform:scale(0.5)}#onetrust-banner-sdk .ot-optout-signal svg path,#onetrust-pc-sdk .ot-optout-signal svg path{fill:#32ae88}#onetrust-consent-sdk .ot-general-modal{overflow:hidden;position:fixed;margin:0 auto;top:50%;left:50%;width:40%;padding:1.5rem;max-width:575px;min-width:575px;z-index:2147483647;border-radius:2.5px;transform:translate(-50%, -50%)}#onetrust-consent-sdk .ot-signature-health-group{margin-top:1rem;padding-left:1.25rem;padding-right:1.25rem;margin-bottom:.625rem;width:calc(100% - 2.5rem)}#onetrust-consent-sdk .ot-signature-health-group .ot-signature-health-form{gap:.5rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:70%;gap:.35rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-input{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-consent-sdk .ot-signature-health .ot-signature-subtitle{font-size:1.125rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-group-title{font-size:1.25rem;font-weight:bold}#onetrust-consent-sdk .ot-signature-health,#onetrust-consent-sdk .ot-signature-health-group{display:flex;flex-direction:column;gap:1rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-cont{display:flex;flex-direction:column;gap:.25rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-paragraph,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-paragraph{margin:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk .ot-signature-health .ot-health-signature-error,#onetrust-consent-sdk .ot-signature-health-group .ot-health-signature-error{color:#4d4d4d;font-size:min(12px,.75rem)}#onetrust-consent-sdk .ot-signature-health .ot-signature-buttons-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-buttons-cont{margin-top:max(.75rem,2%);gap:1rem;display:flex;justify-content:flex-end}#onetrust-consent-sdk .ot-signature-health .ot-signature-button,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button{flex:1;height:auto;color:#fff;cursor:pointer;line-height:1.2;min-width:125px;font-weight:600;font-size:.813em;border-radius:2px;padding:12px 10px;white-space:normal;word-wrap:break-word;word-break:break-word;background-color:#68b631;border:2px solid #68b631}#onetrust-consent-sdk .ot-signature-health .ot-signature-button.reject,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button.reject{background-color:#fff}#onetrust-consent-sdk .ot-input-field-cont{display:flex;flex-direction:column;gap:.5rem}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:65%}#onetrust-consent-sdk .ot-signature-health-form{display:flex;flex-direction:column}#onetrust-consent-sdk .ot-signature-health-form .ot-signature-label{margin-bottom:0;line-height:20px;font-size:max(14px,.875rem)}@media only screen and (max-width: 600px){#onetrust-consent-sdk .ot-general-modal{min-width:100%}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:100%}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:100%}}#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:"";content:none}#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media(min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media(min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media(min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:.9em;font-weight:400;line-height:38px;letter-spacing:.01em;text-decoration:none;white-space:nowrap;background-color:rgba(0,0,0,0);border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus{color:#333;border-color:#888;opacity:.9}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type=text]:focus,#onetrust-pc-sdk input[type=text]:focus,#ot-sdk-cookie-policy input[type=text]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:.5rem;font-weight:600}#onetrust-banner-sdk input[type=checkbox],#onetrust-pc-sdk input[type=checkbox],#ot-sdk-cookie-policy input[type=checkbox]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk.otFlat.top{top:0px;bottom:auto}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk>.ot-sdk-container{overflow:hidden}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1.25em 0 .625em 2em;overflow:hidden}#onetrust-banner-sdk #onetrust-policy .ot-gv-list-handler{float:left;font-size:.82em;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3;margin-bottom:10px}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a{font-weight:bold;margin-left:5px}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-size:.813em;font-weight:600}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-left:0;padding-right:0}#onetrust-banner-sdk .onetrust-close-btn-ui{width:44px;height:44px;background-size:12px;border:none;position:relative;margin:auto;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{position:absolute;top:50%;transform:translateY(-50%);left:0px}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-policy{margin-left:65px}#onetrust-banner-sdk .ot-b-addl-desc{clear:both;float:left;display:block}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 10px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{display:block;height:auto}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option{margin-bottom:12px;margin-left:0;border:none;float:left;padding:0}#onetrust-banner-sdk .banner-option:first-child{padding-left:2px}#onetrust-banner-sdk .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option-header .ot-arrow-container{display:inline-block;border-top:6px solid rgba(0,0,0,0);border-bottom:6px solid rgba(0,0,0,0);border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;padding:10px 0px 5px 10px;margin-right:10px;height:0px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-dpd-container{float:left}#onetrust-banner-sdk .ot-dpd-title{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-title,#onetrust-banner-sdk .ot-dpd-desc{font-size:.88em;line-height:1.4;color:dimgray}#onetrust-banner-sdk .ot-dpd-title *,#onetrust-banner-sdk .ot-dpd-desc *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text *{margin-bottom:0}#onetrust-banner-sdk.ot-iab-2 .onetrust-vendors-list-handler{display:block;margin-left:0;margin-top:5px;clear:both;margin-bottom:0;padding:0;border:0;height:auto;width:auto}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk.ot-close-btn-link{padding-top:25px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-dpd-desc,#onetrust-banner-sdk .ot-b-addl-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{margin-top:10px;margin-bottom:10px;font-size:1em}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:6px;right:2px}#onetrust-banner-sdk #onetrust-policy{margin-left:0;margin-top:3em}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{top:auto;transform:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline;float:none}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:0;right:0}#onetrust-banner-sdk #onetrust-policy{margin-left:1em;margin-right:1em}#onetrust-banner-sdk .onetrust-close-btn-ui{top:10px;right:10px}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:95%}#onetrust-banner-sdk.ot-iab-2 #onetrust-group-container{width:100%}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-button-group-parent{padding-left:50px}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk #onetrust-button-group button{display:inline-block}#onetrust-banner-sdk #onetrust-button-group{margin-right:0;text-align:center}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler{float:left}#onetrust-banner-sdk .has-reject-all-button #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-accept-btn-handler{float:right}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:calc(100% - 2em);margin-right:0}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{padding-left:0px;text-align:left}#onetrust-banner-sdk.ot-buttons-fw .ot-sdk-three button{width:100%;text-align:center}#onetrust-banner-sdk.ot-buttons-fw #onetrust-button-group-parent button{float:none}#onetrust-banner-sdk.ot-buttons-fw #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}@media only screen and (min-width: 550px){#onetrust-banner-sdk .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}@media only screen and (min-width: 425px)and (max-width: 550px){#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group,#onetrust-banner-sdk.ot-iab-2 #onetrust-policy,#onetrust-banner-sdk.ot-iab-2 .banner-option{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler{float:left}}@media only screen and (min-width: 769px){#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1.25em;width:calc(100% - 7em)}}@media only screen and (min-width: 897px)and (max-width: 1023px){#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:75%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{position:relative;margin:0;right:-22px;top:2px}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{right:-12px}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk .ot-optout-signal{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-title{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text,#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:1em;width:50%;border-right:1px solid #d8d8d8;padding-right:1rem}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-container{width:45%;padding-left:1rem;display:inline-block;float:none}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-title{line-height:1.7}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group-parent{left:auto;right:4%;margin-left:0}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:auto;width:30%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 890px){#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group-parent{padding-left:3%;padding-right:4%;margin-left:0}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{margin-right:0;margin-top:1.25em;width:100%}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button{width:100%;margin-bottom:5px;margin-top:5px}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type{margin-bottom:20px}}@media only screen and (min-width: 1280px){#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:55%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{width:44%;padding-left:2%;padding-right:2%}#onetrust-banner-sdk:not(.ot-iab-2).vertical-align-content #onetrust-button-group-parent{position:absolute;left:55%}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                    #onetrust-consent-sdk #onetrust-policy-text,
                    #onetrust-consent-sdk .ot-b-addl-desc,
                    #onetrust-consent-sdk .ot-dpd-desc,
                    #onetrust-consent-sdk .ot-dpd-title,
                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,
                    #onetrust-banner-sdk .ot-cat-header,
                    #onetrust-banner-sdk .ot-optout-signal
                    {
                        color: #2E2E2E;
                    }
            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {
                    background-color: #E9E9E9;}
             #onetrust-consent-sdk #onetrust-banner-sdk a[href],
                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,
                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn
                        {
                            color: #007398;
                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler {
                            background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,
            #onetrust-consent-sdk #onetrust-banner-sdk:focus {
               outline-color: #000000;
               outline-width: 1px;
            }
            #onetrust-consent-sdk #onetrust-pc-btn-handler,
            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                color: #6CC04A; border-color: #6CC04A;
                background-color:
                #FFF;
            }/*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
#onetrust-pc-sdk.otPcCenter{overflow:hidden;position:fixed;margin:0 auto;top:5%;right:0;left:0;width:40%;max-width:575px;min-width:575px;border-radius:2.5px;z-index:2147483647;background-color:#fff;-webkit-box-shadow:0px 2px 10px -3px #999;-moz-box-shadow:0px 2px 10px -3px #999;box-shadow:0px 2px 10px -3px #999}#onetrust-pc-sdk.otPcCenter[dir=rtl]{right:0;left:0}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk .ot-optout-signal{margin-top:.625rem}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-gn-venlst .ot-ven-item .ot-acc-hdr{min-height:40px}#onetrust-pc-sdk .ot-pc-header{height:39px;padding:10px 0 10px 30px;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk #ot-pc-title,#onetrust-pc-sdk #ot-category-title,#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk #ot-lst-title,#onetrust-pc-sdk .ot-ven-hdr .ot-ven-name,#onetrust-pc-sdk .ot-always-active{font-weight:bold;color:dimgray}#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:55%;font-weight:700}#onetrust-pc-sdk .ot-cat-item p{clear:both;float:left;margin-top:10px;margin-bottom:5px;line-height:1.5;font-size:.812em;color:dimgray}#onetrust-pc-sdk .ot-close-icon{height:44px;width:44px;background-size:10px}#onetrust-pc-sdk #ot-pc-title{float:left;font-size:1em;line-height:1.5;margin-bottom:10px;margin-top:10px;width:100%}#onetrust-pc-sdk #accept-recommended-btn-handler{margin-right:10px;margin-bottom:25px;outline-offset:-1px}#onetrust-pc-sdk #ot-pc-desc{clear:both;width:100%;font-size:.812em;line-height:1.5;margin-bottom:25px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px}#onetrust-pc-sdk a{color:#656565;cursor:pointer}#onetrust-pc-sdk a:hover{color:#3860be}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk button{max-width:394px;padding:12px 30px;line-height:1;word-break:break-word;word-wrap:break-word;white-space:normal;font-weight:bold;height:auto}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk #ot-pc-content{position:absolute;overflow-y:scroll;padding-left:2px;padding-right:30px;top:60px;bottom:110px;margin:1px 3px 0 30px;width:calc(100% - 63px)}#onetrust-pc-sdk .ot-vs-list .ot-always-active,#onetrust-pc-sdk .ot-cat-grp .ot-always-active{float:right;clear:none;color:#3860be;margin:0;font-size:.813em;line-height:1.3}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-track{margin-right:20px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#d8d8d8}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#d8d8d8;scrollbar-darkshadow-color:#d8d8d8;scrollbar-face-color:#d8d8d8;scrollbar-shadow-color:#d8d8d8}#onetrust-pc-sdk .save-preference-btn-handler{margin-right:20px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-right:10px}#onetrust-pc-sdk #ot-pc-desc .privacy-notice-link{margin-left:0;margin-right:8px}#onetrust-pc-sdk #ot-pc-desc .ot-imprint-handler{margin-left:0;margin-right:8px}#onetrust-pc-sdk .ot-subgrp-cntr{display:inline-block;clear:both;width:100%;padding-top:15px}#onetrust-pc-sdk .ot-switch+.ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:initial}#onetrust-pc-sdk ul.ot-subgrps li p,#onetrust-pc-sdk ul.ot-subgrps li h5{font-size:.813em;line-height:1.4;color:dimgray}#onetrust-pc-sdk ul.ot-subgrps .ot-switch{min-height:auto}#onetrust-pc-sdk ul.ot-subgrps .ot-switch-nob{top:0}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr{display:inline-block;width:100%}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-txt{margin:0}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none}#onetrust-pc-sdk ul.ot-subgrps li h5{position:relative;top:5px;font-weight:bold;margin-bottom:0;float:left}#onetrust-pc-sdk li.ot-subgrp{margin-left:20px;overflow:auto}#onetrust-pc-sdk li.ot-subgrp>h5{width:calc(100% - 100px)}#onetrust-pc-sdk .ot-cat-item p>ul,#onetrust-pc-sdk li.ot-subgrp p>ul{margin:0px;list-style:disc;margin-left:15px;font-size:inherit}#onetrust-pc-sdk .ot-cat-item p>ul li,#onetrust-pc-sdk li.ot-subgrp p>ul li{font-size:inherit;padding-top:10px;padding-left:0px;padding-right:0px;border:none}#onetrust-pc-sdk .ot-cat-item p>ul li:last-child,#onetrust-pc-sdk li.ot-subgrp p>ul li:last-child{padding-bottom:10px}#onetrust-pc-sdk .ot-pc-logo{height:40px;width:120px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-refuse-all-handler{margin-bottom:0px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:160px}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{width:100%;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:0 30px;width:calc(100% - 60px);padding-right:0}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo{direction:rtl}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo a{margin-right:25px}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#468254;border:1px solid #fff}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(20px);-ms-transform:translateX(20px);transform:translateX(20px);background-color:#fff;border-color:#fff}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch{outline:#000 solid 1px}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:45px;height:25px}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#767676;border:1px solid #ddd;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:20px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:"";height:18px;width:18px;bottom:3px;left:3px;background-color:#fff;-webkit-transition:.4s;transition:.4s;border-radius:20px}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox label{position:relative;display:inline-block;padding-left:30px;cursor:pointer;font-weight:500}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px;top:auto}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw-cntr .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-tgl-cntr,#onetrust-pc-sdk .ot-arw-cntr{display:inline-block}#onetrust-pc-sdk .ot-tgl-cntr{width:45px;float:right;margin-top:2px}#onetrust-pc-sdk #ot-lst-cnt .ot-tgl-cntr{margin-top:10px}#onetrust-pc-sdk .ot-always-active-subgroup{width:auto;padding-left:0px !important;top:3px;position:relative}#onetrust-pc-sdk .ot-label-status{font-size:.75em;display:none;font-size:.75em;position:relative;top:2px;padding-right:5px;float:left}#onetrust-pc-sdk .ot-arw-cntr{margin-top:-1px}#onetrust-pc-sdk .ot-arw-cntr svg{-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s;transition:all 300ms ease-in 0s;height:10px;width:10px}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-arw{width:10px;margin-left:15px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0}#onetrust-pc-sdk .ot-hlst-cntr{margin-top:5px;display:inline-block;width:100%}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{clear:both;color:#3860be;margin-left:0;font-size:.813em;text-decoration:none;float:left;overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover,#onetrust-pc-sdk .category-host-list-handler:hover{text-decoration-line:underline}#onetrust-pc-sdk .category-vendors-list-handler+a{clear:none}#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{display:inline-block;height:13px;width:13px;background-repeat:no-repeat;margin-left:1px;margin-top:6px;cursor:pointer}#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{margin-bottom:-1px}#onetrust-pc-sdk .back-btn-handler{font-size:1em;text-decoration:none}#onetrust-pc-sdk .back-btn-handler:hover{opacity:.6}#onetrust-pc-sdk #ot-lst-title h3{display:inline-block;word-break:break-word;word-wrap:break-word;margin-bottom:0;color:#656565;font-size:1em;font-weight:bold;margin-left:15px}#onetrust-pc-sdk #ot-lst-title{margin:10px 0 10px 0px;font-size:1em;text-align:left}#onetrust-pc-sdk #ot-pc-hdr{margin:0 0 0 30px;height:auto;width:auto}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#707070;font-style:italic}#onetrust-pc-sdk #vendor-search-handler{height:31px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left;margin-left:15px}#onetrust-pc-sdk .ot-ven-name{display:block;width:auto;padding-right:5px}#onetrust-pc-sdk #ot-lst-cnt{overflow-y:auto;margin-left:20px;margin-right:7px;width:calc(100% - 27px);max-height:calc(100% - 80px);height:100%;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-pc-lst{width:100%;bottom:100px;position:absolute;top:60px}#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr *{visibility:hidden}#onetrust-pc-sdk #ot-pc-lst .ot-tgl-cntr{right:12px;position:absolute}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:right;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-arw{margin-left:10px}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{overflow:hidden;cursor:pointer}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk #ot-sel-blk{overflow:hidden;width:100%;position:sticky;position:-webkit-sticky;top:0;z-index:3}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk .ot-lst-subhdr{width:100%;display:inline-block}#onetrust-pc-sdk .ot-search-cntr{float:left;width:78%;position:relative}#onetrust-pc-sdk .ot-search-cntr>svg{width:30px;height:30px;position:absolute;float:left;right:-15px}#onetrust-pc-sdk .ot-fltr-cntr{float:right;right:50px;position:relative}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;display:inline-block;position:relative;width:32px;height:32px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;padding:0;margin:0}#onetrust-pc-sdk #filter-btn-handler:hover{background-color:#3860be}#onetrust-pc-sdk #filter-btn-handler svg{width:12px;height:12px;margin:3px 10px 0 10px;display:block;position:static;right:auto;top:auto}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{color:#3860be;text-decoration:none;font-weight:100;display:inline-block;padding-top:10px;transform:translate(0, 1%);-o-transform:translate(0, 1%);-ms-transform:translate(0, 1%);-webkit-transform:translate(0, 1%);position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link *,#onetrust-pc-sdk .ot-ven-legclaim-link *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link:hover,#onetrust-pc-sdk .ot-ven-legclaim-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:calc(100% - 160px);height:auto;float:left;word-break:break-word;word-wrap:break-word;vertical-align:middle;padding-bottom:3px}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{letter-spacing:.03em;font-size:.75em;font-weight:400}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #ddd !important}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-last-child(-n+1){padding-bottom:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-child(-n+2):not(.disc-pur){padding-top:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur-cont{display:inline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur{position:relative;width:50% !important;word-break:break-word;word-wrap:break-word;left:calc(30% + 17px)}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur:nth-child(-n+1){position:static}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h5,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h5{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h5{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk #ot-host-lst .ot-sel-all{float:right;position:relative;margin-right:42px;top:10px}#onetrust-pc-sdk #ot-host-lst .ot-sel-all input[type=checkbox]{width:auto;height:auto}#onetrust-pc-sdk #ot-host-lst .ot-sel-all label{height:20px;width:20px;padding-left:0px}#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{overflow:hidden;width:95%}#onetrust-pc-sdk .ot-host-hdr{position:relative;z-index:1;pointer-events:none;width:calc(100% - 125px);float:left}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-desc{display:inline-block;width:90%}#onetrust-pc-sdk .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr>a{text-decoration:underline;font-size:.82em;position:relative;z-index:2;float:left;margin-bottom:5px;pointer-events:initial}#onetrust-pc-sdk .ot-host-name+a{margin-top:5px}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a,#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{color:dimgray;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a{font-weight:bold;font-size:.82em;line-height:1.3}#onetrust-pc-sdk .ot-host-name a{font-size:1em}#onetrust-pc-sdk .ot-host-expand{margin-top:3px;margin-bottom:3px;clear:both;display:block;color:#3860be;font-size:.72em;font-weight:normal}#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{font-size:.688em;line-height:1.4;font-weight:normal}#onetrust-pc-sdk .ot-host-desc{margin-top:10px}#onetrust-pc-sdk .ot-host-opt{margin:0;font-size:inherit;display:inline-block;width:100%}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.8em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-info{border:none;display:inline-block;width:calc(100% - 10px);padding:10px;margin-bottom:10px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk #ot-fltr-modal{width:100%;height:auto;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;overflow:hidden;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal .ot-label-txt{display:inline-block;font-size:.85em;color:dimgray}#onetrust-pc-sdk #ot-fltr-cnt{z-index:2147483646;background-color:#fff;position:absolute;height:90%;max-height:300px;width:325px;left:210px;margin-top:10px;margin-bottom:20px;padding-right:10px;border-radius:3px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk #ot-anchor{border:12px solid rgba(0,0,0,0);display:none;position:absolute;z-index:2147483647;right:55px;top:75px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-btns{margin-left:15px}#onetrust-pc-sdk #filter-apply-handler{margin-right:15px}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:5px;margin-left:15px;min-height:20px;width:75%;position:relative}#onetrust-pc-sdk .ot-fltr-opt p{display:inline-block;margin:0;font-size:.9em;color:#2e3644}#onetrust-pc-sdk .ot-chkbox label span{font-size:.85em;color:dimgray}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox][aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-hostcntr,#onetrust-pc-sdk #ot-selall-licntr,#onetrust-pc-sdk #ot-selall-gnvencntr{right:15px;position:relative;width:20px;height:20px;float:right}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label,#onetrust-pc-sdk #ot-selall-gnvencntr label{float:left;padding-left:0}#onetrust-pc-sdk #ot-ven-lst:first-child{border-top:1px solid #e2e2e2}#onetrust-pc-sdk ul{list-style:none;padding:0}#onetrust-pc-sdk ul li{position:relative;margin:0;padding:15px 15px 15px 10px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk ul li h3,#onetrust-pc-sdk ul li h4{font-size:.75em;color:#656565;margin:0;display:inline-block;width:70%;height:auto;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul li p{margin:0;font-size:.7em}#onetrust-pc-sdk ul li input[type=checkbox]{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-cat-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus,#onetrust-pc-sdk li>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-cat-item>button,#onetrust-pc-sdk .ot-acc-cntr>button,#onetrust-pc-sdk li>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-ven-item>button:focus{outline:0;border:2px solid #000}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-plus-minus>*,#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk .ot-hide-acc .ot-acc-hdr{min-height:30px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt){padding-right:10px;width:calc(100% - 37px);margin-top:10px;max-height:calc(100% - 90px)}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:calc(100% - 2px);padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt{border:unset;background-color:unset}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all-hdr{display:none}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all{padding-right:.5rem}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all .ot-chkbox{right:0}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all{padding-right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{width:auto}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) ul li{border:1px solid #e2e2e2;margin-bottom:10px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-acc-cntr>.ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk.ot-addtl-vendors .ot-sel-all-chkbox{float:right}#onetrust-pc-sdk.ot-addtl-vendors .ot-plus-minus~.ot-sel-all-chkbox{right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-ven-lst:first-child{border-top:none}#onetrust-pc-sdk .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr{background-color:#f9f9fc;padding:5px 0 5px 15px;width:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-plus-minus{vertical-align:middle;top:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-arw-cntr{right:10px}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk .ot-acc-cntr.ot-add-tech .ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-txt{padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-acc-cntr button[aria-expanded=true]~.ot-acc-txt{width:auto}#onetrust-pc-sdk .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0;width:100%}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;vertical-align:middle;display:inline-block}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{margin-left:0;margin-top:10px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none;left:5px;top:9px}#onetrust-pc-sdk #ot-category-title{float:left;padding-bottom:10px;font-size:1em;width:100%}#onetrust-pc-sdk .ot-cat-grp{margin-top:10px}#onetrust-pc-sdk .ot-cat-item{line-height:1.1;margin-top:10px;display:inline-block;width:100%}#onetrust-pc-sdk .ot-btn-container{text-align:right}#onetrust-pc-sdk .ot-btn-container button{display:inline-block;font-size:.75em;letter-spacing:.08em;margin-top:19px}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{position:absolute;top:10px;right:0;z-index:1;padding:0;background-color:rgba(0,0,0,0);border:none}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon svg{display:block;height:10px;width:10px}#onetrust-pc-sdk #clear-filters-handler{margin-top:20px;margin-bottom:10px;float:right;max-width:200px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:rgba(0,0,0,0);border-color:rgba(0,0,0,0);padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#2285f7}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl,#onetrust-pc-sdk .ot-enbl-chr h4~.ot-always-active{right:45px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl+.ot-tgl{right:120px}#onetrust-pc-sdk .ot-enbl-chr .ot-pli-hdr.ot-leg-border-color span:first-child{width:90px}#onetrust-pc-sdk .ot-enbl-chr li.ot-subgrp>h5+.ot-tgl-cntr{padding-right:25px}#onetrust-pc-sdk .ot-plus-minus{width:20px;height:20px;font-size:1.5em;position:relative;display:inline-block;margin-right:5px;top:3px}#onetrust-pc-sdk .ot-plus-minus span{position:absolute;background:#27455c;border-radius:1px}#onetrust-pc-sdk .ot-plus-minus span:first-of-type{top:25%;bottom:25%;width:10%;left:45%}#onetrust-pc-sdk .ot-plus-minus span:last-of-type{left:25%;right:25%;height:10%;top:45%}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:first-of-type,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{transform:rotate(90deg)}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{left:50%;right:50%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk .ot-host-item .ot-plus-minus,#onetrust-pc-sdk .ot-ven-item .ot-plus-minus{float:left;margin-right:8px;top:10px}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-pli-hdr{color:#77808e;overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;width:calc(100% - 2px);border-top-left-radius:3px;border-top-right-radius:3px}#onetrust-pc-sdk .ot-pli-hdr span:first-child{top:50%;transform:translateY(50%);max-width:90px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:10px;max-width:95px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color{background-color:#f4f4f4;border:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color span:first-child{text-align:left;width:70px}#onetrust-pc-sdk li.ot-subgrp>h5,#onetrust-pc-sdk .ot-cat-header{width:calc(100% - 130px)}#onetrust-pc-sdk li.ot-subgrp>h5+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-acc-grpdesc{margin-bottom:5px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-acc-grpcntr .ot-vlst-cntr+.ot-subgrp-cntr{border-top:none}#onetrust-pc-sdk .ot-acc-hdr .ot-arw-cntr+.ot-tgl-cntr,#onetrust-pc-sdk .ot-acc-txt h4+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-subgrp>h5,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header{width:calc(100% - 145px)}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item h5+.ot-tgl-cntr,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header+.ot-tgl{padding-left:28px}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{display:inline-block;width:100%;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk .ot-sel-all{margin:0;position:relative;padding-right:23px;float:right}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;padding-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:auto;float:right;position:relative;right:80px}#onetrust-pc-sdk #ot-selall-licntr label{position:absolute}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:66px}#onetrust-pc-sdk .ot-ven-litgl+.ot-arw-cntr{margin-left:81px}#onetrust-pc-sdk .ot-enbl-chr .ot-host-cnt .ot-tgl-cntr{width:auto}#onetrust-pc-sdk #ot-lst-cnt:not(.ot-host-cnt) .ot-tgl-cntr{width:auto;top:auto;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox label{position:absolute;padding:0;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-acc-grpdesc+.ot-leg-btn-container{padding-left:20px;padding-right:20px;width:calc(100% - 40px);margin-bottom:5px}#onetrust-pc-sdk .ot-subgrp .ot-leg-btn-container{margin-bottom:5px}#onetrust-pc-sdk #ot-ven-lst .ot-leg-btn-container{margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;letter-spacing:0;font-size:.75em;line-height:normal}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{text-decoration:underline;padding:0;font-size:.75em;font-weight:600;line-height:1;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:inherit;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;right:15px;top:15px;width:auto;font-weight:normal}#onetrust-pc-sdk .ot-pgph-link{font-size:.813em !important;margin-top:5px;position:relative}#onetrust-pc-sdk .ot-pgph-link.ot-pgph-link-subgroup{margin-bottom:1rem}#onetrust-pc-sdk .ot-pgph-contr{margin:0 2.5rem}#onetrust-pc-sdk .ot-pgph-title{font-size:1.18rem;margin-bottom:2rem}#onetrust-pc-sdk .ot-pgph-desc{font-size:1rem;font-weight:400;margin-bottom:2rem;line-height:1.5rem}#onetrust-pc-sdk .ot-pgph-desc:not(:last-child):after{content:"";width:96%;display:block;margin:0 auto;padding-bottom:2rem;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk .ot-cat-header{float:left;font-weight:600;font-size:.875em;line-height:1.5;max-width:90%;vertical-align:middle}#onetrust-pc-sdk .ot-vnd-item>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-vnd-item>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{position:relative;border-radius:2px;margin:0;padding:0;border:1px solid #d8d8d8;border-top:none;width:calc(100% - 2px);float:left}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{margin-top:10px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc{padding-left:20px;padding-right:20px;width:calc(100% - 40px);font-size:.812em;margin-bottom:10px;margin-top:15px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul{padding-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul li{padding-top:0;line-height:1.5;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout div+.ot-acc-grpdesc{margin-top:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:first-child{margin-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:last-child,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr:last-child{margin-bottom:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding-top:11.5px;padding-bottom:11.5px;padding-left:20px;padding-right:20px;width:calc(100% - 40px);display:inline-block}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-txt{width:100%;padding:0}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp-cntr{padding-left:20px;padding-right:15px;padding-bottom:0;width:calc(100% - 35px)}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp{padding-right:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpcntr{z-index:1;position:relative}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr{position:absolute;top:50%;transform:translateY(-50%);right:20px;margin-top:-2px}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr .ot-arw{width:15px;height:20px;margin-left:5px;color:dimgray}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{float:none;color:#2e3644;margin:0;display:inline-block;height:auto;word-wrap:break-word;min-height:inherit}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding-left:20px;width:calc(100% - 20px);display:inline-block;margin-top:0;padding-bottom:2px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{position:relative;min-height:25px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl,#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{position:absolute;top:50%;transform:translateY(-50%);right:20px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl+.ot-tgl{right:95px}#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler,#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler+a{margin-top:5px}#onetrust-pc-sdk #ot-lst-cnt{margin-top:1rem;max-height:calc(100% - 96px)}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list,#onetrust-pc-sdk .ot-vnd-serv{width:auto;padding:1rem 1.25rem;padding-bottom:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:600;font-size:.95em;line-height:2;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item{border:none;margin:0;padding:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button{outline:none;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button[aria-expanded=true],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button[aria-expanded=true]{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:first-child{margin-top:.25rem;border-top:unset}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child{margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child button{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 1.75rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-lbl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-cnt,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt{padding-left:40px}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-size:.8em}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-cat-header{font-size:.8em}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv{margin-bottom:1rem;padding:1rem .95rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:700;font-size:.8em;line-height:20px;margin-left:.82rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-cat-header{font-weight:700;font-size:.8em;line-height:20px}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-vnd-serv .ot-vnd-lst-cont .ot-accordion-layout .ot-acc-hdr div.ot-chkbox{margin-left:.82rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr{padding:.7rem 0;margin:0;display:flex;width:100%;align-items:center;justify-content:space-between}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:first-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:first-child{margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:last-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:last-child{margin-right:.5rem;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-always-active{position:relative;right:unset;top:unset;transform:unset}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-plus-minus{top:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-arw-cntr{float:none;top:unset;right:unset;transform:unset;margin-top:-2px;position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-cat-header{flex:1;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-tgl{position:relative;transform:none;right:0;top:0;float:none}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox{position:relative;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label{padding:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label::before{position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox input{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0;z-index:1}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h5.ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h4.ot-cat-header{margin:0}#onetrust-pc-sdk .ot-vs-config .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp h5{top:0;line-height:20px}#onetrust-pc-sdk .ot-vs-list{display:flex;flex-direction:column;padding:0;margin:.5rem 4px}#onetrust-pc-sdk .ot-vs-selc-all{display:flex;padding:0;float:unset;align-items:center;justify-content:flex-start}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf{justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:48px}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{margin:0;padding:0;margin-right:14px;justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-chkbox,#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-tgl{display:inline-block;right:unset;width:auto;height:auto;float:none}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:45px;height:25px}#onetrust-pc-sdk .ot-vs-selc-all .ot-sel-all-chkbox{margin-right:11px;margin-left:.75rem;display:flex;align-items:center}#onetrust-pc-sdk .ot-vs-selc-all .sel-all-hdr{margin:0 1.25rem;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-vnd-list-cnt #ot-selall-vencntr.ot-chkbox{float:unset;right:0}#onetrust-pc-sdk[dir=rtl] #ot-back-arw,#onetrust-pc-sdk[dir=rtl] input~.ot-acc-hdr .ot-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk[dir=rtl] .ot-search-cntr>svg{right:0}@media only screen and (max-width: 600px){#onetrust-pc-sdk.otPcCenter{left:0;min-width:100%;height:100%;top:0;border-radius:0}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:1px 3px 0 10px;padding-right:10px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-btn-container button{max-width:none;letter-spacing:.01em}#onetrust-pc-sdk #close-pc-btn-handler{top:10px;right:17px}#onetrust-pc-sdk p{font-size:.7em}#onetrust-pc-sdk #ot-pc-hdr{margin:10px 10px 0 5px;width:calc(100% - 15px)}#onetrust-pc-sdk .vendor-search-handler{font-size:1em}#onetrust-pc-sdk #ot-back-arw{margin-left:12px}#onetrust-pc-sdk #ot-lst-cnt{margin:0;padding:0 5px 0 10px;min-width:95%}#onetrust-pc-sdk .switch+p{max-width:80%}#onetrust-pc-sdk .ot-ftr-stacked button{width:100%}#onetrust-pc-sdk #ot-fltr-cnt{max-width:320px;width:90%;border-top-right-radius:0;border-bottom-right-radius:0;margin:0;margin-left:15px;left:auto;right:40px;top:85px}#onetrust-pc-sdk .ot-fltr-opt{margin-left:25px;margin-bottom:10px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-bottom:0}#onetrust-pc-sdk #ot-fltr-cnt{right:40px}}@media only screen and (max-width: 476px){#onetrust-pc-sdk .ot-fltr-cntr,#onetrust-pc-sdk #ot-fltr-cnt{right:10px}#onetrust-pc-sdk #ot-anchor{right:25px}#onetrust-pc-sdk button{width:100%}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-sel-all{padding-right:9px}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr{right:0}}@media(min-width: 768px){#onetrust-pc-sdk.ot-tgl-with-label .ot-label-status{display:inline}#onetrust-pc-sdk.ot-tgl-with-label #ot-pc-lst .ot-label-status{display:none}}@media only screen and (max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk.otPcCenter{left:0;top:0;min-width:100%;height:100%;border-radius:0}#onetrust-pc-sdk .ot-pc-header{height:auto;min-height:20px}#onetrust-pc-sdk .ot-pc-header .ot-pc-logo{max-height:30px}#onetrust-pc-sdk .ot-pc-footer{max-height:60px;overflow-y:auto}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{bottom:70px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:70px}#onetrust-pc-sdk #ot-anchor{left:initial;right:50px}#onetrust-pc-sdk #ot-lst-title{margin-top:12px}#onetrust-pc-sdk #ot-lst-title *{font-size:inherit}#onetrust-pc-sdk #ot-pc-hdr input{margin-right:0;padding-right:45px}#onetrust-pc-sdk .switch+p{max-width:85%}#onetrust-pc-sdk #ot-sel-blk{position:static}#onetrust-pc-sdk #ot-pc-lst{overflow:auto}#onetrust-pc-sdk #ot-lst-cnt{max-height:none;overflow:initial}#onetrust-pc-sdk #ot-lst-cnt.no-results{height:auto}#onetrust-pc-sdk input{font-size:1em !important}#onetrust-pc-sdk p{font-size:.6em}#onetrust-pc-sdk #ot-fltr-modal{width:100%;top:0}#onetrust-pc-sdk ul li p,#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{font-size:.6em}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{height:100% !important;overflow:hidden;top:0px}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-cnt{margin:0;height:100%;max-height:none;padding:10px;top:0;width:calc(100% - 20px);position:absolute;right:0;left:0;max-width:none}#onetrust-pc-sdk.ot-shw-fltr .ot-fltr-scrlcnt{max-height:calc(100% - 65px)}}
            #onetrust-consent-sdk #onetrust-pc-sdk,
                #onetrust-consent-sdk #ot-search-cntr,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,
                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after
                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {
                    background-color: #FFF;
                }
               
            #onetrust-consent-sdk #onetrust-pc-sdk h3,
                #onetrust-consent-sdk #onetrust-pc-sdk h4,
                #onetrust-consent-sdk #onetrust-pc-sdk h5,
                #onetrust-consent-sdk #onetrust-pc-sdk h6,
                #onetrust-consent-sdk #onetrust-pc-sdk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-optout-signal
                {
                    color: #2E2E2E;
                }
             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-pgph-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-legclaim-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info a
                    {
                        color: #007398;
                    }
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { text-decoration: underline;}
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle
             {
                background-color: #F8F8F8;
            }
             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets
                            {
                                background-color: #F8F8F8;
                            }
        #onetrust-consent-sdk #onetrust-pc-sdk
            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {
                background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                border-color: #007398;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{
                background-color: transparent;
                border: 1px solid transparent;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {
                background-color: #FFFFFF;
                color: #4D4D4D; border-color: #4D4D4D;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,
            #onetrust-pc-sdk .ot-checkbox input[type="checkbox"]:focus + label::before,
            #onetrust-pc-sdk .ot-chkbox input[type="checkbox"]:focus + label::before {
                outline-color: #000000;
                outline-width: 1px;
                outline-offset: 1px;
            }
            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {
                border: 1px solid #000000;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {
               outline: 1px solid #000000;
               outline-offset: 1px;
            }#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,  #onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{
                    background-image: url('https://cdn.cookielaw.org/logos/static/ot_external_link.svg');
                }
            /*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}
                
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {
                        color: #696969;
                    }
                    
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {
                            color: #696969;
                        }
                    
            
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {
                            background-color: #F8F8F8;
                        }
                    
            .ot-floating-button__front{background-image:url('https://cdn.cookielaw.org/logos/static/ot_persistent_cookie_icon.png')}</style><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><style></style><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><link href="https://crossmark-cdn.crossref.org/widget/v2.0/style.css" type="text/css" rel="stylesheet"></head>
<body class="pb-ui">
    <div class="skip">
        <a href="#page-body-id" id="skipNavigationLink" title="Skip to Main Content" tabindex="0" class="skipToContent">Skip to Main Content</a>
        <a href="#mega-menu-nav" id="skipToMainMenu" title="Skip to Main Menu" tabindex="0" class="skipToContent">Skip to Main Menu</a>
    </div>



    <div id="pb-page-content" data-ng-non-bindable="">
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="ux3-layout-widget" data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" class="ux3">
        
    

        


    

            

            
                <div class="cell fonts-loaded">
            

            <div data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" data-widget-name="ux3-layout-widget"><div>
    

        


    

            

            

            <div id="a1f1ba25-79af-4194-aaa9-66206104a800" class="widget loginPopup none widget-none widget-compact-all"><div class="wrapped"><div class="widget-body body body-none body-compact-all"><div role="dialog" aria-modal="true" aria-label="Login" class="popup login-popup hidden"><div class="content"><a href="#" aria-label="Close login popup" title="Close login popup" role="button" class="close"><i class="icon-close_thin"></i></a><h2 class="login-title">Login to your account</h2><div class="login-form"><p tabindex="-1" class="message error"></p><form action="/action/doLogin?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900002-7" method="post"><input type="hidden" name="redirectUri" value="https://www.cell.com/cell/fulltext/S0092-8674(21)00002-7"><input type="hidden" name="referer" value="/cell/fulltext/S0092-8674(21)00002-7"><input type="hidden" name="ecommRedirect"><input type="hidden" name="code" value="cell-site"><input type="hidden" name="UX3LoginWidget" value="true"><input type="hidden" name="isPopup" value="true"><div class="input-group login-input--wrapper"><div class="label"><label for="login">Email/Username</label></div><input id="login" type="text" name="login" value="" size="15" class="login"><div role="alert" class="error-hint js--hidden"><div class="error-hint__text"><div class="error-text">Your email address is a required field.</div><div class="email-example">E.g., j.smith@mail.com</div></div></div></div><div class="input-group login-input--wrapper"><div class="label"><label for="password">Password</label></div><input id="password" type="password" name="password" value="" autocomplete="off" class="password"><a href="#" class="login__field__action js-show-password">Show</a><div role="alert" class="error-hint js--hidden"><span class="error-hint__text">Your password is a required field.</span></div><div class="actions"><a href="https://www.cell.com/action/requestResetPassword" class="link show-request-reset-password">Forgot password?</a></div></div><div class="remember"><input type="checkbox" name="savePassword" id="a1f1ba25-79af-4194-aaa9-66206104a800-remember" value="1" checked="checked"><label for="a1f1ba25-79af-4194-aaa9-66206104a800-remember">Remember me</label></div><div class="submit"><input type="submit" name="submit" value="Log in" class="button submit primary"></div></form></div><div class="create-account"><div>Don’t have an account?</div><a href="/action/registration?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900002-7" class="show-registration">Create a Free Account</a></div></div></div></div></div></div>

            

        

    

        


    

            

            

            <div role="dialog" aria-modal="true" aria-label="Reset password" class="popup top-drawer request-reset-password-drawer hidden"><div class="content"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" role="button" class="close"><i class="icon-close_thin"></i></a><div class="request-reset"><div class="form"><p class="sub">If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password</p><div tabindex="-1" class="message error"></div><form action="/action/requestResetPassword" method="post" class="request-reset-password-form"><input type="hidden" name="platform"><input type="hidden" name="requestResetPassword" value="true"><input type="hidden" name="codeSite" value="cell-site"><div class="input-group"><div class="label"><label for="reset-password-email">Email*</label></div><input id="reset-password-email" type="text" name="email" value="" size="15" class="email"></div><div class="submit" disabled="disabled"><input type="submit" name="submit" value="Submit" disabled="disabled" class="button primary submit"></div></form></div><div class="success-template hidden"><p>If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password</p></div></div><div class="request-reset-cancel"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" class="cancel">Cancel</a></div></div></div>

            

        

    

        


    

            

            
                <div class="ux3-ads">
            

            <div class="pb-ad">
            <!-- Do Not Modify without contacting ELS-HSOnlineCampaign@elsevier.com -->
<!-- To be kept in sync with Global Commercial Publishing Operations-->
<!-- Start: GPT Async -->
<div id="gpt-Variables" data-adfile="CELLJOURNAL">
	<input type="hidden" id="gptSite" value="cell">
	<input type="hidden" id="gptLoggedIn" value="no">
	<input type="hidden" id="gptAccessType" value="ae:ANON_GUEST|ae:ANON_GUEST">
	<input type="hidden" id="gptDefaultSite" value="cell">
</div>
<div id="gpt-Interscroller" class="gpt-InScrollBox" style="display:none;">
	<div class="gpt-InScrollLabel">ADVERTISEMENT</div>
	<div class="gpt-InScrollContainer">
		<div class="gpt-InScrollWrapper">
			<div class="gpt-InScrollInner">
				<div class="gpt-adinterscroller" data-adsize="interscroller"></div>
			</div>
		</div>
	</div>
	<div class="gpt-InScrollLabel">SCROLL TO CONTINUE WITH CONTENT</div>
</div>
<div id="gpt-DebugDiv" class="gpt-DebugDiv" style="display:none;">
	<div style="width: 100%; display: table;">
		<div style="display: table-row">
			<div style="width: 200px; display: table-cell;">
				<button class="gpt-DebugBtn" onclick="gpt_ShowConsole()">Open GPT Console</button><br>
				<button id="gpt_GrapeShotDebugBtn" class="gpt-DebugBtn" onclick="gpt_GrapeShotDebug();">Open Oracle Keywords</button><br>
				<br>
				<button class="gpt-DebugBtn" onclick="gpt_LoadDebugValues()">Refresh Values</button>
			</div>
			<div style="display: table-cell;">
				<table class="gpt-DebugTable">
					<thead>
						<tr>
							<th>Property</th>
							<th>Value</th>
						</tr>
					</thead>
					<tbody>
						<tr><td class="gpt-DebugTitle">Status</td><td><div class="gptStatus_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Version</td><td><div class="gptVersion_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad File</td><td><div class="gptAdFile_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Disable Ads Flag</td><td><div class="gptDisableAds_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Environment</td><td><div class="gptTestENV_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Init</td><td><div class="gptMoatInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Ready</td><td><div class="gptMoatReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Ready</td><td><div class="gptContextualReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual URL</td><td><div class="gptContextualURL_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Initial Segments</td><td><div class="gptContextualInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Used Segments</td><td><div class="gptContextualResult_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">AdUnit</td><td><div class="gptSite_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">SubAdUnit</td><td><div class="gptPage_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Custom Targeting</td><td><div class="gptCustomTargeting_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad Events</td><td><div class="gptEvent_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Invalid Ad Sizes</td><td><div class="gptInvalidAdSize_Debug"></div></td></tr>
					</tbody>
				</table>
			</div>
		</div>
	</div>
</div>
<style type="text/css">
	.gpt-DebugBtn {
		display: inline-block;
		text-align: center;
		text-decoration: none;
		margin: 2px 0;
		border: solid 1px #122b40;
		border-radius: 0.4em;
		padding: 0.5em 1em;
		color: #ffffff;
		background-color: #204d74;
		font-weight: normal;
		font-size: 12px;
	}

	.gpt-DebugDiv {
		margin: 5px;
	}

	.gpt-DebugTitle {
		font-weight: bold;
	}

	.gpt-DebugTable {
		border: 1px solid #dddddd;
		border-collapse: collapse;
		margin: 5px;
		font-size: 0.9em;
		font-family: sans-serif;
		min-width: 400px;
		margin-bottom: 25px;
	}

		.gpt-DebugTable td:first-child {
			padding: 5px;
		}

		.gpt-DebugTable thead tr th {
			background-color: #d9edf7;
			color: #ffffff;
			text-align: left;
			padding: 5px;
			border-bottom: 2px solid #204d74;
		}

		.gpt-DebugTable th,
		.gpt-DebugTable td {
			padding: 5px;
		}

		.gpt-DebugTable tbody tr {
			border-bottom: 1px solid #dddddd;
		}

			.gpt-DebugTable tbody tr:nth-of-type(even) {
				background-color: #f3f3f3;
			}

			.gpt-DebugTable tbody tr:last-of-type {
				border-bottom: 2px solid #204d74;
			}

	.gpt-InScrollLabel {
		background-color: rgb(0, 0, 0);
		color: rgb(255, 255, 255);
		position: relative;
		max-width: 100vw;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		padding: 0;
		text-align: center;
		width: 100vw !important;
		font-size: 10px;
	}

	.gpt-InScrollBox {
		height: 100vh !important;
		width: 100vw;
		cursor: pointer;
		max-width: 100vw;
		position: relative;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		margin-bottom: 50px;
		padding-top: 5px;
		padding-bottom: 5px;
		z-index: 10001;
		background-color: white;
	}

		.gpt-InScrollBox .gpt-InScrollContainer {
			height: 95vh !important;
			position: relative;
		}

		.gpt-InScrollBox .gpt-InScrollWrapper {
			position: absolute !important;
			top: 0 !important;
			left: 0;
			width: 100%;
			height: 95vh !important;
			border: 0 !important;
			margin: 0 !important;
			padding: 0 !important;
			clip: rect(0, auto, auto, 0) !important;
			-webkit-clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
			clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
		}

		.gpt-InScrollBox .gpt-InScrollInner {
			position: fixed !important;
			top: 0 !important;
			left: 0 !important;
			bottom: 0;
			margin: auto;
			width: 100vw;
			height: 95vh;
			-webkit-transform: translateZ(0) !important;
			display: -webkit-box;
			display: -ms-flexbox;
			display: flex;
			-webkit-box-orient: vertical;
			-webkit-box-direction: normal;
			-ms-flex-direction: column;
			flex-direction: column;
			-webkit-box-align: center;
			-ms-flex-align: center;
			align-items: center;
			-webkit-box-pack: center;
			-ms-flex-pack: center;
			justify-content: center;
			text-align: center;
		}
</style>
<script class="optanon-category-4" type="text/plain">
	//--------------------------------------------------------------------------
	var gpt_Version = '04072023';
	var gpt_AdFile = $('#gpt-Variables').data('adfile');
	var gpt_MaxMOATInitAttempts = 11;
	var gpt_MaxMOATReadyAttempts = 11;
	var gpt_MaxContextualReadyAttempts = 21;
	var gpt_MOATInitAttempts = 0;
	var gpt_MOATReadyAttempts = 0;
	var gpt_ContextualReadyAttempts = 0;
	var gpt_IsProd = true;
	var gpt_StartTime;
	var gs_channels = 'DEFAULT';
	var gpt_ContextualReady = false;
	var gpt_ContextualURL = 'Not enabled outside of Production';
	var gpt_DisableAdsFlagFound = false;

	var gptEvent_Debug = '';
	var gptCustomTargeting_Debug = '';
	var gptSite_Debug = "";
	var gptPage_Debug = "";
	var gptContextualEnabled = false;
	var gptContextualResult_Debug = '';
	var gptContextualInit_Debug = '';
	var gptContextualURL_Debug = '';
	var gptContextualReady_Debug = '';
	var gptMoatReady_Debug = '';
	var gptMoatInit_Debug = '';
	var gptTestENV_Debug = '';
	var gptDisableAds_Debug = '';
	var gptStatus_Debug = 'GPT Still Loading - Refresh Values';
	var gptInvalidAdSize_Debug = '';
	//--------------------------------------------------------------------------
	$(document).ready(function () {
		//Check to see if we are on a development env
		gpt_CheckEnvironment();

		if (!gpt_DisableAdsFlagFound) {
			gpt_StartTime = new Date();
			if (gpt_AdFile !== "PU") {
				//Once the dom has loaded, begin the process to init the ads.
				gpt_InitScripts();
				gpt_CheckForMOATInit();
			}
		}
	});
</script>
<script type="text/javascript">
	function gpt_CheckEnvironment() {
		if ($('#gptDisableAds').length > 0) {
			gptDisableAds_Debug = 'Flag Detected - Ads Disabled';
			gpt_DisableAdsFlagFound = true;
		}
		else {
			gptDisableAds_Debug = 'Ads Enabled';
			gpt_DisableAdsFlagFound = false;
		}
		switch (gpt_AdFile) {
			case 'PU':
				gptContextualEnabled = true;
				if ($("#Environment").val() !== "Prod") {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			case 'JBS':
			case 'LANCET':
				gptContextualEnabled = true;
				if ($(".gpt-ad").length > 0) {
					//Other ads exist, allow the Prestitial
					$(document.body).append("<div class='gpt-ad' data-adsize='prestitial'></div>");
				}
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			default:
				//Cell
				gptContextualEnabled = false;
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
    function gpt_GetNonCMEArticle() {
        var url;
        $('.articleCitation').each(function (i, obj) {
            if ($(obj).find('.toc__item__detials').length > 0) {
                var itemDetails = $(obj).first().find('.toc__item__detials');
                var cmeFound = 0;
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='CME']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='(CME)']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='Education']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='education']").length; }
                if (cmeFound == 0) {
                    var itemLink = $(itemDetails).first().find('.toc__item__title');
                    var linkCount = $(itemLink).first().find("a:contains('CME')").length;
                    if (linkCount == 0) {
                        url = $(itemLink).first().find('a').attr('href');
                        return false;   //Found a URL, break the loop
                    }
                }
            }
        });
        return url;
    }
	//--------------------------------------------------------------------------
	function gpt_GetElapsedTime() {
		var endTime = new Date();
		var timeDiff = endTime - gpt_StartTime; //in ms
		// strip the ms
		timeDiff /= 1000;

		// get seconds
		return seconds = Math.round(timeDiff) + " seconds";
	}
	//--------------------------------------------------------------------------
	function gpt_CheckSSC() {
		//Check for ScreenShot Client
		var gpt_SSC = gpt_GetQuerystring('gpt_ssc', '');
		if (gpt_SSC == '1') {
			//it's the ScreenShotClient, disable MOAT IVT Detection
			$('#gpt-Variables').append('<input type="hidden" id="gptm_data">');
			$('#gptm_data').val(0);
			gpt_Target("m_data");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_LocalSS(adTypeId) {
		window.scrollTo(0, 0);
		gpt_Sleep(1000);
		gpt_ScrollToAd(adTypeId);
		gpt_PreTearsheet(adTypeId);
	}
	//--------------------------------------------------------------------------
	function gpt_InitScripts() {
		if (gpt_AdFile == "PU") {
			if (gpt_IsProd) {
				gpt_ContextualURL = gpt_CheckForNULL($('#canonicalurl').val());
				if (gpt_ContextualURL === null) {
					gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				}
				else {
					gpt_ContextualURL = window.location.origin + gpt_ContextualURL;
				}
				var useSSL = 'https:' == document.location.protocol;
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}
		}
		else {
			//JBS-Cell-Lancet
			var useSSL = 'https:' == document.location.protocol;

			var gads = document.createElement('script');
			gads.async = true;
			gads.type = 'text/javascript';
			gads.src = (useSSL ? 'https:' : 'http:') + '//securepubads.g.doubleclick.net/tag/js/gpt.js';
			document.head.appendChild(gads);

			if (gpt_IsProd && gptContextualEnabled) {
				gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}

			var elsevierMoatHeader = document.createElement('link');
			elsevierMoatHeader.rel = 'preload';
			elsevierMoatHeader.as = 'script';
			elsevierMoatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(elsevierMoatHeader);

			var elsevierMoatAds = document.createElement('link');
			elsevierMoatAds.rel = 'preconnect';
			elsevierMoatAds.src = (useSSL ? 'https:' : 'http:') + '//mb.moatads.com';
			document.head.appendChild(elsevierMoatAds);

			var moatHeader = document.createElement('script');
			moatHeader.async = true; gads.type = 'text/javascript';
			moatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(moatHeader);
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForMOATInit() {
		//Check every 1/10 of a second until MOAT is Loaded or 1 second timeout
		if (gpt_MOATInitAttempts < gpt_MaxMOATInitAttempts) {
			gpt_MOATInitAttempts += 1;
			if (typeof window.moatPrebidApi === "object") {
				//MOAT LOADED
				gptMoatInit_Debug = '0.0' + gpt_MOATInitAttempts + ' seconds';
				gpt_CheckForMOATReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATInit(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not LOADED
			gptMoatInit_Debug = 'Timeout Expired';
			var googletag = googletag || {};
			googletag.cmd = googletag.cmd || [];
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForMOATReady() {
		//Check every 1/10 of a second until MOAT is Ready or 1 second timeout
		if (gpt_MOATReadyAttempts < gpt_MaxMOATReadyAttempts) {
			gpt_MOATReadyAttempts += 1;
			if (window.moatPrebidApi.safetyDataAvailable()) {
				//MOAT Ready
				gptMoatReady_Debug = '0.0' + gpt_MOATReadyAttempts + " seconds";
				gpt_CheckForContextualReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATReady(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not Ready
			gptMoatReady_Debug = 'Timeout Expired';
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForContextualReady() {
		//Check every 1/10 of a second until Contextual is Ready or 2 second timeout
		if (gpt_IsProd && gptContextualEnabled) {
			//Enabled
			if (gpt_ContextualReadyAttempts < gpt_MaxContextualReadyAttempts) {
				gpt_ContextualReadyAttempts += 1;
				if (gpt_ContextualReady) {
					//Contextual Ready
					gptContextualURL_Debug = gpt_ContextualURL;
					gptContextualReady_Debug = '0.0' + gpt_ContextualReadyAttempts + " seconds";
					gptContextualInit_Debug = gs_channels;
					gpt_InitAds();
				}
				else {
					setTimeout(() => { gpt_CheckForContextualReady(); }, 100);
				}
			}
			else {
				//LOG TIMEOUT error
				//REMOVE FOR NOW (SHOULD LOG TO A DIFF LOCATION)
				//TIMEOUT: Contextual Not Ready
				$('#gpt_GrapeShotDebugBtn').remove();
				gptContextualURL_Debug = gpt_ContextualURL;
				gptContextualReady_Debug = 'Timeout Expired';
				gptContextualInit_Debug = "";
				gpt_InitAds();
			}
		}
		else {
			//Not Enabled
			$('#gpt_GrapeShotDebugBtn').remove();
			switch (gpt_AdFile) {
				case 'PU':
				case 'LANCET':
				case 'JBS':
					gptContextualURL_Debug = 'Not enabled outside of Production';
					gptContextualReady_Debug = 'Not enabled outside of Production';
					gptContextualInit_Debug = 'Not enabled outside of Production';
					break;
				case "CELLJOURNAL":
				case "CELLBUCKET":
					gptContextualReady_Debug = 'Not enabled on Cell';
					gptContextualInit_Debug = 'Not enabled on Cell';
					gptContextualURL_Debug = 'Not enabled on Cell';
					break;
			}
			gpt_InitAds();
		}
	}
	//--------------------------------------------------------------------------
	function GPT_GetPageByURL() {
		var host = window.location.host.toLocaleLowerCase()
		var localpath = window.location.pathname.toLocaleLowerCase();

		///Check for Cell.com
		if (host.indexOf('cell.com') >= 0) {
			return null;
		}

		///Check for Cell.com (marlin-stag)
		if (host.indexOf('www-cell-com') >= 0) {
			return null;
		}

		///Check for Lancet
		if (host.indexOf('thelancet') >= 0) {
			return null;
		}

		if (localpath.indexOf('/article/') >= 0) {
			return 'article.fulltext';
		}

		if (localpath.indexOf('/action/dosearch') >= 0) {
			return 'search.searchResults';
		}

		if (localpath.indexOf('/content/') >= 0) {
			return 'periodical.editorial';
		}

		return 'periodical.home';
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForNULL(x, valueifnull) {
		if (typeof valueifnull == "undefined") {
			valueifnull = null;
		}

		if (typeof x == 'undefined') {
			return valueifnull;
		}
		if (x == null) {
			return valueifnull;
		}
		if (x == "null") {
			return valueifnull;
		}
		if ($.trim(x) == '') {
			return valueifnull;
		}

		return x;
	}
	//--------------------------------------------------------------------------
	function gpt_GetAdditionalTargeting() {
		//adds page level targeting of custom variables
		//the id (minus gpt) and the value will be used as a key-value pair
		//eg: <input type="hidden" id="gptissuepii" value="x" class="gpt-Target">
		//eg: target issuepii=x
		$(".gpt-Target").each(function (index) {
			var gptTargetId = $(this).attr('id');
			gptTargetId = gptTargetId.replace('gpt', '').toLowerCase();
			if (gptTargetId !== '') {
				gpt_Target(gptTargetId);
			}
		})
	}
	//--------------------------------------------------------------------------
	function gpt_GetQuerystring(key, default_) {
		//function to read querystring variables
		if (default_ === null) default_ = '';
		key = key.replace(/[\[]/, "\\\[").replace(/[\]]/, "\\\]");
		var regex = new RegExp("[\\?&]" + key + "=([^&#]*)");
		var qs = regex.exec(window.location.href);
		if (qs === null)
			return default_;
		else
			return qs[1];
	}
	//--------------------------------------------------------------------------
	function gpt_GetDFPTestId() {
		//Get any request for a test id from querystring and set custom targeting parameter
		var gptDFPTestId = gpt_GetQuerystring('dfptestid', '');
		if (gptDFPTestId !== '') {
			$('#gpt-Variables').append('<input type="hidden" id="gptDFPTestId">');
			$('#gptDFPTestId').val(gptDFPTestId);
			gpt_Target("DFPTestId");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Target(targetName) {
		//Set page level target if value is found
		if ($('#gpt' + targetName).length > 0) {
			var targetValue = $('#gpt' + targetName).val();

			if (targetValue !== '') {
				targetValue = targetValue.replace(/[^-a-z0-9]/ig, '');	//Only Allow a-z, 0-9
				googletag.pubads().setTargeting(targetName.toLowerCase(), targetValue.toLowerCase());
				gptCustomTargeting_Debug = gptCustomTargeting_Debug + targetName.toLowerCase() + ' = ' + targetValue.toLowerCase() + '<br>';
			}
		}
	}
	//--------------------------------------------------------------------------
	function gpt_TargetAccessType() {
		var currentAccessType = $('#gptAccessType').val();
		if (typeof currentAccessType == "undefined") {
			currentAccessType = "";
		}
		if (currentAccessType.indexOf('ANON_IP') >= 0) {
			googletag.pubads().setTargeting("loggedin", "yes");
		}
		else {
			gpt_Target("LoggedIn");
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_PreTearsheet(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		//Remove Elsevier Cookie Policy Notice
		if ($("#onetrust-consent-sdk").length > 0) {
			$("#onetrust-consent-sdk").remove();
		}

        //Mobile Nav
        $('#skip').remove();
        $('skipNavigationLink').remove();

		//JBS Modals
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.usabilla__overlay').length > 0) {
			$('.usabilla__overlay').remove();
		}

		//Pendo
		if ($('._pendo-step-container').length > 0) {
			$('._pendo-step-container').remove();
		}
		if ($('._pendo-guide-tt_').length > 0) {
			$('._pendo-guide-tt_').remove();
		}
		if ($('._pendo-image').length > 0) {
			$('._pendo-image').remove();
		}
		if ($('._pendo-badge-image').length > 0) {
			$('._pendo-badge-image').remove();
		}

		switch (gpt_AdFile) {
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Mobile Bug Fix on Cell
				if (parseInt(adTypeId) == 5) {
					$('.widget-horizontalAd').css('position', 'static');
					$('.body-horizontalAd').css('display', 'block');
				}
				break;
			case "JBS":
			case "LANCET":
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 3: //MPU
					case 4: //SkyScraper
						//BUGFIX: Show Sidebar ad for JBS
						//skyscraper & mpu
						if ($('.widget-verticalAd').length > 0) {
							$('.widget-verticalAd').css('display', 'block');
						}
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
					case 6:     //Prestitial
						$('#backgroundLayer').css('display', 'block');
						break;
					default:
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Sleep(ms) {
		return new Promise(resolve => setTimeout(resolve, ms));
	}
	//--------------------------------------------------------------------------
	async function gpt_ScrollToAd(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		var adId = "";
		var offset = 0;
		var objLeaderboard = "";
		var gpt_ScrollToAd = true;

		switch (gpt_AdFile) {
			case "PU": //PracticeUpdate
				var hideOtherAds = true;
				$('#modalPrestitial').modal('hide');
				$('.jumbotron-welcome').hide();
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 2:
						//LeaderBoard, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 3:
						//MPU
						adId = "adSlot2";
						break;
					case 4:
						//SkyScraper
						adId = "adSlot3";
						$('.most-read').hide();
						break;
					case 5:
						//Mobile, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 6:
						//Interstitial
						gpt_ScrollToAd = false;
						adId = "adSlot15";
						await gpt_Sleep(1000);
						$(objLeaderboard).hide();
						$('#modalPrestitial').unbind();
						$('#modalPrestitial').modal();
						break;
					case 7:
						//Native Ad
						break;
					case 10:
						//Master Companion
						hideOtherAds = false;
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
				}
				if (hideOtherAds) {
					//Hide all other ads
					$('.ad-container').each(function (i, obj) {
						if (this.id !== adId) {
							var tempParent = this.id;
							tempParent = tempParent.replace("adSlot", "adParent");
							$("#" + tempParent).addClass('hide');
						}
					});
				}
				break;
			case "JBS":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$(".widget-verticalAd").hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="sidebar"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					case 13:	    //Phone - Portrait
					case 14:        //Phone - Landscape
						$(objLeaderboard).hide();
						offset = 60;
						adId = 'gpt-Interscroller';
						gpt_ScrollToAd = true;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
			case "CELLJOURNAL":
			case "CELLBUCKET":
				objLeaderboard = ".js__adToHide";
				offset = 260;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="boombox"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				//Hide the second ad if found
				var tCount = 0;
				$(".widget.literatumAd.none.GPT-ad-placeholder.widget-horizontalAd.widget-compact-all").each(function (index) {
					tCount += 1;
					if (tCount !== 1) {
						$(this).hide();
					}
				});
				break;
			case "LANCET":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="skyscraper"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
		}

		//Scroll to Top
		var gpt_container = $("html,body");
		gpt_container.animate({ scrollTop: 0, scrollLeft: 0 });

		if (gpt_ScrollToAd) {
			//If Adexists, scroll to it
			var gpt_scrollTo = $('#' + adId);
			if (gpt_scrollTo.length > 0) {
				//Scroll to the Ad
				var gpt_topPosition = gpt_scrollTo.offset().top - gpt_container.offset().top + gpt_container.scrollTop();
				if (gpt_topPosition > 0) {
					gpt_container.animate({ scrollTop: gpt_topPosition, scrollLeft: 0 });
					if (gpt_topPosition - offset > 0 && offset > 0) {
						gpt_container.animate({ scrollTop: gpt_topPosition - offset, scrollLeft: 0 });
					}
				}
			}
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForCookiePolicy() {
		var returnVal = false;
		if ($('#onetrust-accept-btn-handler').length > 0) {
			$('#onetrust-accept-btn-handler').click();
			returnVal = true;
		}
		return returnVal;
	}
	//--------------------------------------------------------------------------
	function gpt_InitAds() {
		var gpt_ResponsiveHomepage = false;

		switch (gpt_AdFile) {
			case "JBS":
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Responsive Check
				if ($('#hdrHomeBrand').length > 0) {
					gpt_ResponsiveHomepage = true;
				}
				break;
		}

		//InterScroller Check
		if (gpt_AdFile === "JBS") {
			var gpt_InterScrollerEnabled = false;
			var gpt_InterScrollerInsertObj;

			if ($("#articleHeader").length > 0) {
				//It's an article Page
				if ($('.article__sections > section').length > 0) {
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".article__sections > section");
				}
			}
			else {
				if ($('.toc__section').length > 0) {
					//It's a TOC Page
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".toc__section").first();
				}
			}

			//Add the Interscroller
			if (gpt_InterScrollerEnabled) {
				gpt_InterScrollerInsertObj.first().append($("#gpt-Interscroller").clone());
				$("#gpt-Interscroller").remove();
				$(".gpt-adinterscroller").addClass("gpt-ad");
			}
		}

		googletag.cmd.push(function () {
			var gptBoomBoxSizeMapping;
			var gptFluidMapping;
			var gptHomePageSidebarMapping;
			var gptCellHomePageSidebarMapping;
			var gptInterscrollerMapping;
			var gptLeaderboardSizeMapping;
			var gptMobileSizeMapping;
			var gptPrestitialMapping;
			var gptRectangleShortSizeMapping;
			var gptRectangleSizeMapping;
			var gptSideBarSizeMapping;
			var gptTallSizeMapping;
			var gptWideSizeMapping;
			var gptWideRectangleSizeMapping;

			//***********************************************
			//Start Define Size mapping based on client Viewport
			//***********************************************
			if (gpt_AdFile === 'PU') {
				gptTallSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 600], [160, 600], [120, 600]]).
					addSize([0, 0], []).
					build();

				gptRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250]]).
					addSize([0, 0], []).
					build();

				gptRectangleShortSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250], [320, 50], [300, 50]]).
					addSize([0, 0], [[300, 250], [320, 50], [300, 50]]).
					build();

				gptWideSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([760, 0], [[728, 90], [320, 50], [300, 50]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptWideRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], []).
					addSize([760, 0], [[320, 50], [300, 50], [300, 250]]).
					addSize([0, 0], [[320, 50], [300, 50], [300, 250]]).
					build();

				gptMobileSizeMapping = googletag.sizeMapping().
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([760, 0], [[1, 1]]).
					build();
			}
			else {
				//JBS-CELL-LANCET
				gptLeaderboardSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([768, 0], [[728, 90]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptHomePageSidebarMapping = googletag.sizeMapping().
					addSize([2090, 795], [[300, 600], [300, 250], [160, 600], [120, 600]]).
					addSize([1910, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptCellHomePageSidebarMapping = googletag.sizeMapping().
                    addSize([2180, 795], [[300, 600], [160, 600], [120, 600], [300, 250], [336, 280]]).
					addSize([2180, 445], [[336, 280]]).
                    addSize([2090, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
                    addSize([2090, 445], [[300, 250]]).
					addSize([1830, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptSideBarSizeMapping = googletag.sizeMapping().
					addSize([1140, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
					addSize([1140, 445], [[300, 250]]).
					addSize([0, 0], []). 				
					build();

				gptBoomBoxSizeMapping = googletag.sizeMapping().
					addSize([768, 0], [[300, 250], [336, 280]]).
					addSize([0, 0], []). 						
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([600, 700], [[1, 1]]).
					addSize([0, 0], []).
					build();

				gptInterscrollerMapping = googletag.sizeMapping().
					addSize([1140, 445], []).
					addSize([1024, 768], [[1024, 768]]).
					addSize([768, 1024], [[768, 1024]]).
					addSize([480, 320], [[480, 320]]).
					addSize([320, 480], [[320, 480]]).
					build();
			}
			//***********************************************
			//End Define Size mapping based on client Viewport
			//***********************************************

			//***********************************************
			//Start detection for ad slots on page
			//***********************************************
			var gptMasterPage = gpt_CheckForNULL($('#gptPage').val());
			var gptMasterSite;

			if (gpt_AdFile === 'PU') {
				gptMasterSite = $('#gptSite').val();
			}
			else {
				//JBS-CELL-LANCET
				gptMasterSite = "dev";

				if (gpt_IsProd) {
					gptMasterSite = gpt_CheckForNULL($('#gptSite').val());

					//If there is no master site, check for a defaultsite
					if (gptMasterSite == null) {
						gptMasterSite = gpt_CheckForNULL($('#gptDefaultSite').val());
					}
				}
				else {
					//Dev ENV
					//If the page has no gptSite Value, assume no value which will disable ads
					if (gpt_CheckForNULL($('#gptSite').val()) === null) {
						gptMasterSite = null;
					}
				}

				//If there is no master Page, check for a Page using the URL
				if (gptMasterPage === null) {
					gptMasterPage = GPT_GetPageByURL();
				}
			}

			$(".gpt-ad").each(function (index) {
				var gptPage = '';
				var adSizeMapping = '';
				var gptPOS;
				var gptTC;
				var gptNative;
				var adId;
				var gptSite;
				var tempSlot = null;


                if (gpt_IsProd) {
					if (gpt_AdFile !== "CELLJOURNAL") {
						//Check if the ad slot has it's own site defined
						if (typeof $(this).data('site') === 'undefined') {
							gptSite = gptMasterSite;
						}
						else {
							gptSite = gpt_CheckForNULL($(this).data('site'));
						}
					}
					else {
						gptSite = gptMasterSite;
					}
                }
                else {
					gptSite = gptMasterSite;
                }



				if (gpt_AdFile === 'PU') {
					adId = $(this).attr('id');
				}
				else {
					//JBS-CELL-LANCET
					adId = 'gpt-ad-' + index + 1;
				}

				if (gpt_CheckForNULL(gptSite) !== null) {
					gptSite_Debug = gptSite;

					gptPOS = parseInt($(this).data('pos')) || -1;
					if (gptPOS === -1) {
						gptPOS = index + 1;
					}

					//Check if the ad slot has it's own page defined
					gptPage = $(this).data('page');
					if (gpt_CheckForNULL(gptPage) == null) {
						//Use the Master Page
						gptPage = gptMasterPage;
					}

					//If the page is not null, preceed it with a slash
					if (gptPage !== null) {
						gptPage = '/' + gptPage;
					}
					else {
						gptPage = '';
					}
					gptPage_Debug = gptPage;


					gptTC = $(this).data('tc');
					if (typeof gptTC === "undefined") {
						gptTC = '';
					}

					gptNative = $(this).data('native');
					if (typeof gptNative === "undefined") {
						gptNative = '';
					}

					//Determine sizemapping based on data-adsize
					if (gpt_AdFile === 'PU') {
						switch ($(this).data('adsize')) {
							case 'tall':
								adSizeMapping = gptTallSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600]], adId);
								break;
							case 'rectangle':
								adSizeMapping = gptRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								break;
							case 'rectangleshort':
								adSizeMapping = gptRectangleShortSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [320, 50], [300, 50]], adId);
								break;
							case 'wide':
								adSizeMapping = gptWideSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'widerectangle':
								adSizeMapping = gptWideRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50], [300, 250]], adId);
								break;
							case 'mobile':
								adSizeMapping = gptMobileSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50]], adId);
								break;
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[1, 1]], adId);
								break;
						}
					}
					else {
						//JBS-CELL-LANCET
						switch ($(this).data('adsize')) {
							case 'cell-leaderboard':
							case 'leaderboard':
								adSizeMapping = gptLeaderboardSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'bottom':
								if (gpt_ResponsiveHomepage) {
									adSizeMapping = gptHomePageSidebarMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'boombox':
								if (gpt_AdFile === "CELLJOURNAL" || gpt_AdFile == "CELLBUCKET") {
									if (gpt_ResponsiveHomepage) {
										adSizeMapping = gptCellHomePageSidebarMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250], [336, 280]], adId);
									}
									else {
										adSizeMapping = gptBoomBoxSizeMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [336, 280]], adId);
									}
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'interscroller':
								adSizeMapping = gptInterscrollerMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 480], [480, 320], [768, 1024], [1024, 768]], adId);
								break;
							case 'sidebar':
							case 'skyscraper':
								adSizeMapping = gptSideBarSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								break;
							case 'native':
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
						}
					}
				}

				//Ignore any invalid adsizes that could be on the page
				if (adSizeMapping !== '') {
					$(this).addClass('gpt-ad-defined');
					if (gpt_AdFile !== 'PU') {
						$(this).attr('id', adId);
					}
					tempSlot.defineSizeMapping(adSizeMapping).addService(googletag.pubads()).setTargeting("pos", gptPOS);

					if (gptTC !== '') {
						tempSlot.setTargeting("tc", gptTC);
					}
					if (gptNative !== '') {
						tempSlot.setTargeting("native", gptNative);
					}
					gptEvent_Debug = gptEvent_Debug + $(this).data('adsize') + ' Requested<br>';
				}
				else {
					gptInvalidAdSize_Debug = gptInvalidAdSize_Debug + "Invalid Size Found, Id: " + $(this).prop('id') + ', adSize: ' + $(this).data('adsize') + '<br>';
					$(this).remove();
				}
			});
			if (gpt_CheckForNULL(gptInvalidAdSize_Debug) === null) {
				gptInvalidAdSize_Debug = "None Detected";
			}
			//***********************************************
			//End detection for ad slots on page
			//***********************************************

			//***********************************************
			//Start page level targeting
			//***********************************************
			if (gpt_AdFile !== 'PU') {
				//Logged in or IP Access
				gpt_TargetAccessType();

				//Check for Screenshot Client
				gpt_CheckSSC();
			}

			//Check for DFP Test
			gpt_GetDFPTestId();

			//Check for Additional Targeting
			gpt_GetAdditionalTargeting();

			if (gpt_IsProd && gptContextualEnabled) {
				var gpt_ContextualRetry = false;
				//Check for Contextual Targeting
				if (gs_channels !== "DEFAULT") {
					var gpt_ContextualCategories = Array.from(gs_channels);
					for (var i = 0; i < gpt_ContextualCategories.length; i++) {
						if (gpt_ContextualCategories[i] == 'gx_retry') {
							gpt_ContextualRetry = true;
						}
						if (!gpt_ContextualCategories[i].startsWith("custom_")) {
							//Remove any tag that is not custom
							gpt_ContextualCategories.splice(i, 1);
							i--;
						}
						else {
							//Strip the 'custom_' from the tag
							gpt_ContextualCategories[i] = gpt_ContextualCategories[i].replace("custom_", "")
						}
					}
					if (gpt_ContextualCategories.length > 0) {
						googletag.pubads().setTargeting("gs_cat", gpt_ContextualCategories);
					}
					else {
						gpt_ContextualCategories = 'none';
					}
					if (gpt_ContextualRetry) {
						gpt_ContextualCategories = "*Indexing*";
					}
					gptContextualResult_Debug = gpt_ContextualCategories;
				}
				else {
					gptContextualResult_Debug = 'No segments found';
				}
			}
			else {
				//Not Prod || Contextual not enabled
				gptContextualResult_Debug = 'Not enabled';
				
				if (!gpt_IsProd) {
                    var gpt_DevSite = gpt_CheckForNULL($('#gptSite').val(), "dev");
                    $('#gpt-Variables').append('<input type="hidden" id="gptEnvironment" value="' + gpt_DevSite + '">');
                    gpt_Target("Environment");
                }

			}
			//***********************************************
			//End page level targeting
			//***********************************************

			//Enable google dfp services
			if (parseInt($('#gptLazyLoading').val()) === 1) {
				googletag.pubads().enableLazyLoad({
					fetchMarginPercent: 200,
					renderMarginPercent: 0,
					mobileScaling: 2.0
				});
			}
			else {
				googletag.pubads().enableSingleRequest();
			}

			//Add Listener for RenderEnded
			googletag.pubads().addEventListener('slotRenderEnded', function (event) {
				if (!event.isEmpty) {
					if (typeof LocalAdLoaded === "function") {
						LocalAdLoaded(event);
					}
					if (gpt_ResponsiveHomepage) {
						if (typeof positionAd === "function") {
							positionAd();
						}
					}
					if (event.size[0] == "480" || event.size[1] == "480") {
						$('.gpt-InScrollBox').css('display', 'block');
						gptEvent_Debug = gptEvent_Debug + 'Interscroller ' + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}
					else {
						gptEvent_Debug = gptEvent_Debug + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}

				}
			});

			if (gpt_AdFile !== 'PU') {
				googletag.pubads().collapseEmptyDivs();
			}
			googletag.enableServices();

			//Populate Defined Ad Slots
			$(".gpt-ad-defined").each(function (index) {
				var adId = $(this).attr('id');
				googletag.cmd.push(function () { googletag.display(adId); });
			});

			gptStatus_Debug = 'GPT Complete';
		});
	}
	//--------------------------------------------------------------------------
	function gpt_DisplayDebug() {
		//Clone the template and append to Body
		$(document.body).append($('#gpt-DebugDiv').clone());
		$('#gpt-DebugDiv').remove();

		//Populate the Values
		gpt_LoadDebugValues();

		//Display and scroll to debug section
		$('.gpt-DebugDiv').css('display', 'block');
		window.scrollTo(0, document.body.scrollHeight);
	}
	//--------------------------------------------------------------------------
	function gpt_LoadDebugValues() {
		$('.gpt-DebugBtn').blur();
		$('.gptVersion_Debug').text(gpt_Version);
		$('.gptAdFile_Debug').html(gpt_AdFile);
		$('.gptEvent_Debug').html(gptEvent_Debug);
		$('.gptCustomTargeting_Debug').html(gptCustomTargeting_Debug);
		$('.gptSite_Debug').text(gptSite_Debug);
		$('.gptContextualResult_Debug').text(gptContextualResult_Debug);
		$('.gptContextualInit_Debug').text(gptContextualInit_Debug);
		$('.gptContextualURL_Debug').text(gptContextualURL_Debug);
		$('.gptContextualReady_Debug').text(gptContextualReady_Debug);
		$('.gptMoatReady_Debug').text(gptMoatReady_Debug);
		$('.gptMoatInit_Debug').text(gptMoatInit_Debug);
		$('.gptTestENV_Debug').text(gptTestENV_Debug);
		$('.gptDisableAds_Debug').text(gptDisableAds_Debug);
		$('.gptStatus_Debug').text(gptStatus_Debug);
		$('.gptPage_Debug').text(gptPage_Debug);
		$('.gptInvalidAdSize_Debug').html(gptInvalidAdSize_Debug);
	}
	//--------------------------------------------------------------------------
	function gpt_GrapeShotDebug() {
		$('.gpt-DebugBtn').blur();
		window.open("http://admin-elsevier.grapeshot.co.uk/custom/bookmarklet.cgi?blocking=1&vn=2&url=" + encodeURIComponent(document.location), "GRAPESHOT_POPUP", "width=650,height=600,scrollbars=yes,screenX=40,screenY=50,menubar=no,toolbar=no,resizable=yes", "Custom").focus();
	}
	//--------------------------------------------------------------------------
	function gpt_ShowConsole() {
		$('.gpt-DebugBtn').blur();
		googletag.openConsole();
	}
	//--------------------------------------------------------------------------
</script>
        </div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="912135d6-7135-4d45-b457-b503cacc3c8b" data-widget-name="ux3-layout-widget"><header class="header base fixed">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header js__adToHide widget-horizontalAd" id="9d6062d7-fad6-4e64-81cc-7dd25d99b23d">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 1 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="1"></div>
<!-- End AdSlot 1 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" class="header__wrapper clearfix" data-db-parent-of="quickSearch"><div id="brandingRow"><a href="/" data-aa-name="science that inspires" data-aa-region="cp global header" title="Visit Cell.com">Science that inspires</a><p id="brandingRowRight"><a href="/" data-aa-name="cell press endorsement" data-aa-region="cp global header" title="Visit Cell.com">A Cell Press journal</a></p></div>
        
    

        


    

            

            

            <div data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" data-widget-name="ux3-layout-widget"><div class="col-xs-6 header__left-side">
    

        


    

            

            
                <a href="/home" id="cpIconLnk" data-aa-name="cell press logo" data-aa-region="cp global header" title="Cell Press" target="_blank"><svg id="cp_logo" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 100 98.1" style="enable-background:new 0 0 100 98.1;" xml:space="preserve" height="100" width="98.1"><path style="fill:#FFFFFF;" d="M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z"></path></svg></a><div class="journal-logos">
            

            <span data-widget-id="35d8d734-3aa0-4ec8-9e2d-14babe803594" data-widget-name="ux3-general-image"><a href="/cell/home" title="Cell"><img alt="Cell" src="/pb-assets/ux3/logos/cell/Cell_white-1532516611593.svg"></a></span>

            
                </div>
            

        

    

        


    

            

            
                <div class="journal-logos">
            

            <span data-widget-id="3ffcbf1f-79fd-4ba3-85b5-bef10a63475f" data-widget-name="ux3-general-image"><a href="https://www.cell.com/open-access?utm_source=oa-label&amp;__hstc=109691226.e4e812b53ff324eccbdbdb2e4fb9a6ab.1644503737405.1644524234622.1644587109507.4&amp;__hssc=109691226.7.1644587109507&amp;__hsfp=3253153019" title="This journal offers authors two options (open access or subscription) to publish research"><img alt="This journal offers authors two options (open access or subscription) to publish research" src="/pb-assets/ux3/logos/cell/Supports_open_access_border-1645554937897.svg"></a></span>

            
                </div>
            

        
</div><div class="col-xs-6">
    

        


    

            

            

            <div data-widget-id="2555f6db-b333-4edb-8b15-ef9213f1f0a5" data-widget-name="ux3-layout-widget"><div class="header__nav row">
    

        


    

            

            

            <ul data-widget-id="52432d24-0331-4c9d-85f3-2033edc7208b" data-widget-name="UX3ProfileLinksWidget" class="rlist rlist--inline profile-links"><li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login-dropdown"><div class="profile-links__user-list__wrapper"><button data-db-target-for="loginmenu-527289" aria-expanded="false" aria-controls="login-links-527289" title="Log in links dropdown" class="profile-links__username"><span>Log in</span></button><div data-db-target-of="loginmenu-527289" id="login-links--527289" class="profile-links__user-list__holder dropBlock__holder"><ul class="rlist profile-links__list"><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900002-7" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900002-7" target="_self" data-profile-link="true">Get Institutional Access</a></li></ul></div></div></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900002-7" target="_self" data-profile-link="true">Register</a></li><li class="hidden-lg"> <div class="profile-links__controls"> <button aria-expanded="false" aria-controls="links-dialog-527289" data-opens="#links-dialog-527289" class="profile-links__btn--open"><span class="sr-only">open links dialog</span><i aria-hidden="true" class="icon-gizmo-person"></i></button></div><dialog id="links-dialog-527289" aria-modal="true"><button data-closes="#links-dialog-527289" class="profile-links__btn--close"><span class="sr-only">close links dialog</span><i aria-hidden="true" class="icon-close-solid"></i></button><ul>   <li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900002-7" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900002-7" target="_self" data-profile-link="true">Get Institutional Access</a></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900002-7" target="_self" data-profile-link="true">Register</a></li></ul></dialog></li></ul>

            

        
</div></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasInstitutionBanner none  widget-none" id="51b7fa33-2137-4f58-9e98-9746c4400513" style="display: none;">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><div class="ui-state-highlight ui-corner-all csas-institution-banner hidden" data-doi="10.1016/j.cell.2021.01.002">
    <span class="ui-icon ui-icon-close banner-close"></span>
    <p>
        Access provided by <span class="accountName"></span>
    </p>
</div>

<style>
    .csas-institution-banner {
        padding: 10px 0 0 10px;
        margin: 5px;
    }

    .csas-institution-banner.ui-state-highlight .ui-icon {
        background-image: url("/templates/jsp/css/jquery-ui-1.10.2/base/images/ui-icons_454545_256x240.png");
        margin-right: 5px;
        margin-top: -4px;
    }

    .csas-institution-banner .banner-close {
        float: right;
    }
</style>

<script>

    function resetBanner(doi) {
        $.get('/action/getAccount?doi=' + doi, function(data) {
            if (data) {
                $(".csas-institution-banner p .accountName").html(data);
                $(".csasInstitutionBanner").fadeIn();
                $(".csas-institution-banner").fadeIn();
            }
        });
    }

    var flag = 0;
    $(document).ready(function() {
        if(!$(".csas-institution-banner").is(":visible")){
            $(".csasInstitutionBanner").hide();
        }

        $(".banner-close").click(function() {
            $.get("/action/dismissBanner", function(data) {
                $(".csasInstitutionBanner").fadeOut(function () {
                    if(typeof UX !== 'undefined') {
                        UX.pageBody.init();
                    }
                });
            });
        });

        $(".articleContent .tabs li[role='tab'].showFullText").click(function() {
           flag = 1;
        });

        $(document).on("reloadTabsContent", function() {
            var isSelected = $(".articleContent .tabs li[role='tab'].showFullText").hasClass("active");
            if (isSelected) {
                var isHidden =  $(".csas-institution-banner").is(".hidden");
                if (!isHidden) {
                    resetBanner($(".csas-institution-banner").data("doi"));
                    console.log("fadeIn");
                }
            } else {
                $(".csas-institution-banner").fadeOut();
                console.log("fadeOut");
            }
            flag = 0;
        });

        $(document).on("click", ".articleContent .tabs li[role='tab']", function() {

        });
    });
</script></div>
                </div>
                </div>

        
</header></div>

            

        










        <div data-widget-def="graphQueryWidget" data-widget-id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" class="ux3">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget graphQueryWidget none top-padding-handler noMargin axel-mega-menu widget-none widget-compact-all fonts-loaded" id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" style="padding-top: 115.594px;">
                
                
                    
                

                <div class="wrapped " id="CP TOP LEVEL NAV MENU">
                    
                    <div class="widget-body body body-none  body-compact-all"><nav id="mega-menu-nav" role="navigation" class="mega-menu-nav">
  <!--.skip//a(href='#searchText' aria-label='Skip menu') Skip menu
  -->
  <div class="mega-menu-nav__wrapper">
    <button class="mega-menu__toggle"><span class="sr-only">Main menu</span><i aria-hidden="true" class="icon-gizmo-hamburger"></i></button>
    <ul role="menubar" class="mega-menu rlist">
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-1" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-1" data-item-link="main-menu-link-1" data-index="0" class="mega-menu__item-link menu-link"><span>This journal</span></a>
        <div id="main-menu-panel-1" aria-labelledby="main-menu-link-1" data-item-wrapper="main-menu-link-1" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <div aria-label="Menu dropzone section" tabindex="-1" class="listDropZone">
    

        


    

            

            

            <div class="cover-image"><div class="cover-image__thumb"><a href="/issue/S0092-8674(24)X0012-4" class="menu-link"><img src="/cms/asset/atypon:cms:attachment:img:d5e6:rev:1748270185670-389:pii:S0092867424X00124/cover.tif.jpg" alt="Cover Image - Cell, Volume 188, Issue 11"></a></div><div class="cover-image__meta"></div></div>

            

        
</div>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-2" class="sub-menu__heading">Read
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/newarticles" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Online now</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/current" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Current issue</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/archive" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Archive</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/action/showPreferences?menuTab=Alerts" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Publication alerts</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sneakpeek" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Sneak Peek - preprints</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-3" class="sub-menu__heading">About
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-2">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/advisory-board" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Advisory board</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/aims" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Aims and scope</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/contact" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/editors-and-staff" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Editors and staff</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/editorial-ethics" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Ethics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/permissions" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Permissions</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Reviewer instructions</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-2" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-2" data-item-link="main-menu-link-2" data-index="1" class="mega-menu__item-link menu-link"><span>Journals</span></a>
        <div id="main-menu-panel-2" aria-labelledby="main-menu-link-2" data-item-wrapper="main-menu-link-2" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-1" class="sub-menu__heading">Life &amp; medical sciences
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-4">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cancer-cell/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cancer Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-chemical-biology" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Chemical Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-genomics/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Genomics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-host-microbe/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Host &amp; Microbe</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-metabolism/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-medicine/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-stem-cell/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Stem Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-systems/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Systems</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/current-biology/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Current Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/developmental-cell/home" data-index="11" role="menuitem" class="sub-menu__item-link menu-link"><span>Developmental Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/immunity/home" data-index="12" role="menuitem" class="sub-menu__item-link menu-link"><span>Immunity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/med/home" data-index="13" role="menuitem" class="sub-menu__item-link menu-link"><span>Med</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-cell/home" data-index="14" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/neuron/home" data-index="15" role="menuitem" class="sub-menu__item-link menu-link"><span>Neuron</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/structure/home" data-index="16" role="menuitem" class="sub-menu__item-link menu-link"><span>Structure</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/ajhg/home" data-index="17" role="menuitem" class="sub-menu__item-link menu-link"><span>American Journal of Human Genetics (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysj/home" data-index="18" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Journal (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysreports/home" data-index="19" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/hgg-advances/home" data-index="20" role="menuitem" class="sub-menu__item-link menu-link"><span>Human Genetics and Genomics Advances (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-plant/home" data-index="21" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Plant (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/molecular-therapy/home" data-index="22" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/methods/home" data-index="23" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Methods &amp; Clinical Development (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/nucleic-acids/home" data-index="24" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Nucleic Acids (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/oncology/home" data-index="25" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Oncology (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/plant-communications/home" data-index="26" role="menuitem" class="sub-menu__item-link menu-link"><span>Plant Communications (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/stem-cell-reports/home" data-index="27" role="menuitem" class="sub-menu__item-link menu-link"><span>Stem Cell Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biochemical-sciences/home" data-index="28" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biochemical Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cancer/home" data-index="29" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cancer</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cell-biology/home" data-index="30" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cell Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/ecology-evolution/home" data-index="31" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Ecology &amp; Evolution</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/endocrinology-metabolism/home" data-index="32" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Endocrinology &amp; Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/genetics/home" data-index="33" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Genetics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/immunology/home" data-index="34" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Immunology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/microbiology/home" data-index="35" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Microbiology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/molecular-medicine/home" data-index="36" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Molecular Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/neurosciences/home" data-index="37" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Neurosciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/parasitology/home" data-index="38" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Parasitology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/pharmacological-sciences/home" data-index="39" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Pharmacological Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/plant-science/home" data-index="40" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Plant Science</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 5/6" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-2" class="sub-menu__heading">Physical sciences &amp; engineering
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-biomaterials/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Biomaterials</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-physical-science/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Physical Science</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem-catalysis/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem Catalysis</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/device/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Device</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/joule/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Joule</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/matter/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Matter</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/newton/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Newton</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/chemistry/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Chemistry</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 6/7" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-3" class="sub-menu__heading">Multidisciplinary
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-methods/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Methods</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-sustainability/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Sustainability</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/heliyon/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Heliyon</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/iscience/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>iScience</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/one-earth/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>One Earth</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/patterns/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Patterns</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/star-protocols/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Protocols</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/nexus/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Nexus (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/the-innovation/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>The Innovation (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biotechnology/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biotechnology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cognitive-sciences/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cognitive Sciences</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-3" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-3" data-item-link="main-menu-link-3" data-index="2" class="mega-menu__item-link menu-link"><span>Publish</span></a>
        <div id="main-menu-panel-3" aria-labelledby="main-menu-link-3" data-item-wrapper="main-menu-link-3" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-1" class="sub-menu__heading">Authors
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://www.editorialmanager.com/cell?__hstc=25856994.7201670a4397fa03148684920d4a8d38.1672762013831.1694716659709.1694718909620.146&amp;__hssc=25856994.15.1694718909620&amp;__hsfp=1366844671" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Submit article
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/information-for-authors" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for authors</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/multi-journal-submission" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Multi-Journal Submission</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/star-authors-guide" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Methods</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-2" class="sub-menu__heading">Reviewers
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for reviewers</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-4" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-4" data-item-link="main-menu-link-4" data-index="3" class="mega-menu__item-link menu-link"><span>News &amp; events</span></a>
        <div id="main-menu-panel-4" aria-labelledby="main-menu-link-4" data-item-wrapper="main-menu-link-4" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/newsroom" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Newsroom</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/events" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Events</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/symposia" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Symposia</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/webinars" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Webinars</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/consortia" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Consortia Hub</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-5" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-5" data-item-link="main-menu-link-5" data-index="4" class="mega-menu__item-link menu-link"><span>About Cell Press</span></a>
        <div id="main-menu-panel-5" aria-labelledby="main-menu-link-5" data-item-wrapper="main-menu-link-5" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-1" class="sub-menu__heading">Cell Press
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/about" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>About Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/contact" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact us</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="https://service.elsevier.com/app/overview/cell-press/" data-index="2" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Help &amp; support
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access at Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/diversity" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Inclusion and diversity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-50" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>50th anniversary</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-2" class="sub-menu__heading">Hubs
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/biotechnology-bioengineering" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Biotechnology and bioengineering</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-chemistry" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Chemistry</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/clinical-translational" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Clinical and translational</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/covid-19" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>COVID-19</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/fundamental-biology" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Fundamental biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sustainability" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Sustainability</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/4" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-3" class="sub-menu__heading">Careers
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Press careers
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
    </ul>
    <div class="mega-menu-nav__quick-search">
    

        


    

            

            

            <div data-widget-id="a1f05748-166f-41e0-b01a-ca8ac1cc95d4" data-widget-name="UX3QuickSearchWidget" class="quick-search"><div class="dropBlock"><form action="https://www.cell.com/action/doSearch?journalCode=cell" name="quickSearchBar" method="get" title="Quick Search"><input id="type" type="hidden" value="quicksearch" name="type"><div class="quick-search__toggle autoCompleteWrapper"><input id="searchText" type="text" name="text1" placeholder="Search for..." enterkeyhint="search" autocomplete="off" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" data-group-titles-conf="3" data-publication-items-conf="3" aria-label="Enter a search term" class="searchText searchText-autocomplete ui-autocomplete-input"><button type="submit" title="Search" aria-label="Submit the search form" class="btn quick-search__button icon-search"><span>Go search</span></button><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" unselectable="on" style="display: none;"></ul></div><div class="quick-search__box"><div class="quick-search__box-inner"><div class="quick-search__box-wrapper"><select name="field1" aria-label="Select a search area"><option value="AllField">All content</option><option value="Title">Article title</option><option value="Contrib">Authors</option><option value="Keyword">Keywords</option><option value="Abstract">Abstract</option><option value="AbstractTitleKeywordFilterField">Article title, abstract, keywords</option></select><input type="hidden" name="journalCode" value="cell"><div class="quick-search__scope-options"><span>Search within:</span><label title="This journal" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeSeries-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" title="This journal" value="cell" checked="checked" aria-label="Search within current journal"><span>This journal</span></label><label title="Full site" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeFullSite-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" value="" title="Full site" aria-label="Search within full site"><span>Full site</span></label></div><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a></div><a href="javascript:void(0)" aria-label="Close search options" title="Close search options" class="quick-search__box-close"><i aria-hidden="true" class="icon-tools_close"></i></a></div></div><div class="quick-search__alert hidden"><p>Please enter a term before submitting your search.</p><a href="#" class="quick-search__alert--close"> Ok</a></div></form></div></div>

            

        
</div>
  </div>
</nav>
<div id="page-body-id" class="page-body-flag"></div></div>
                </div>
                </div>

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="f8c6daf9-9df1-4fd9-ba3a-7f5d7b3d4466" data-widget-name="UX3HTMLWidget"><style>
.journal-logos:nth-of-type(2) img {
max-height: 30px !important;
}
.journal-logos:nth-of-type(3) img {
max-height: 30px !important;
}
.ux3 .journal-logos + .journal-logos {
margin-left: 30px;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 55%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 45%;
}
@media screen and (max-width: 1000px) {
.ux3 .journal-logos + .journal-logos {
display: none;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 50%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 50%;
}
}

.ux3 .journal-logos:first-of-type {
   max-width: 500px;
}

.profile-links {
   white-space: nowrap;
}

@media only screen and (min-width: 740px) and (max-width: 1600px) {
   .journal-logos:nth-of-type(2) img {
      max-width: 250px !important;
   }
}

@media only screen and (min-width: 1024px) and (max-width: 1600px) {
   .header__wrapper.clearfix .col-xs-6:first-of-type {
      width: 60% !important;
   }
   .header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
      width: 40% !important;
   }
}

@media only screen and (max-width: 1240px) {
   .ux3 .journal-logos + .journal-logos {
      display: none !important;
   }
}

</style></div>

            

        
</div></div>

            
                </div>
            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget axelPublicationContent none  widget-none" id="cadc9b41-a542-448a-9de4-8d0803320174">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/marlin/cell/releasedAssets/css/build-article-b26f3342b722959c7931.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" vocab="http://schema.org/" typeof="ScholarlyArticle" data-pii="S0092-8674(21)00002-7" lang="en" dir="ltr"><div data-core-wrapper="header"><header data-extent="frontmatter"><div class="core-container"><div data-article-access="full" data-article-access-type="open" class="meta-panel"><span class="meta-panel__left-content"><span class="meta-panel__type"><span>Article</span></span></span><span class="meta-panel__middle-content"><span class="meta-panel__volumeIssue"><a href="/cell/issue?pii=S0092-8674(20)X0004-3"><span>Volume 184</span>, <span>Issue 3</span></a></span><span class="meta-panel__pages"><span>p596-614.e14</span></span><span class="meta-panel__onlineDate">February 04, 2021</span></span><span class="meta-panel__right-content"><span class="meta-panel__access meta-panel__access--open"><span>Open access</span></span></span><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=184&amp;issue=3&amp;pii=S0092-8674%2820%29X0004-3" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div><h1 property="name">Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition</h1><div class="contributors"><span class="authors"><span role="list"><span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au1" aria-controls="axel_author_au1"><span property="givenName">Kevin</span> <span property="familyName">Litchfield</span></a><div id="au1" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Kevin</span> <span property="familyName">Litchfield</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">13</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Litchfield/Kevin" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a role="doc-noteref">13</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au2" aria-controls="axel_author_au2"><span property="givenName">James L.</span> <span property="familyName">Reading</span></a><div id="au2" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">James L.</span> <span property="familyName">Reading</span> <a class="orcid-id" href="https://orcid.org/0000-0001-5381-978X" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-5381-978X</a></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">13</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Reading/James+L" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a role="doc-noteref">13</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au3" aria-controls="axel_author_au3"><span property="givenName">Clare</span> <span property="familyName">Puttick</span></a><div id="au3" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Clare</span> <span property="familyName">Puttick</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">13</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Puttick/Clare" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">13</a></sup></span><span data-displayed-on="all"> ∙ … </span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au4" aria-controls="axel_author_au4"><span property="givenName">Krupa</span> <span property="familyName">Thakkar</span></a><div id="au4" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Krupa</span> <span property="familyName">Thakkar</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Thakkar/Krupa" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au5" aria-controls="axel_author_au5"><span property="givenName">Chris</span> <span property="familyName">Abbosh</span></a><div id="au5" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Chris</span> <span property="familyName">Abbosh</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Abbosh/Chris" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au6" aria-controls="axel_author_au6"><span property="givenName">Robert</span> <span property="familyName">Bentham</span></a><div id="au6" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Robert</span> <span property="familyName">Bentham</span> <a class="orcid-id" href="https://orcid.org/0000-0003-0487-8980" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0003-0487-8980</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Bentham/Robert" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au7" aria-controls="axel_author_au7"><span property="givenName">Thomas B.K.</span> <span property="familyName">Watkins</span></a><div id="au7" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Thomas B.K.</span> <span property="familyName">Watkins</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Watkins/Thomas+B+K" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au8" aria-controls="axel_author_au8"><span property="givenName">Rachel</span> <span property="familyName">Rosenthal</span></a><div id="au8" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Rachel</span> <span property="familyName">Rosenthal</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Rosenthal/Rachel" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au9" aria-controls="axel_author_au9"><span property="givenName">Dhruva</span> <span property="familyName">Biswas</span></a><div id="au9" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Dhruva</span> <span property="familyName">Biswas</span> <a class="orcid-id" href="https://orcid.org/0000-0001-9141-5188" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-9141-5188</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Biswas/Dhruva" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au10" aria-controls="axel_author_au10"><span property="givenName">Andrew</span> <span property="familyName">Rowan</span></a><div id="au10" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Andrew</span> <span property="familyName">Rowan</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Rowan/Andrew" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au11" aria-controls="axel_author_au11"><span property="givenName">Emilia</span> <span property="familyName">Lim</span></a><div id="au11" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Emilia</span> <span property="familyName">Lim</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Lim/Emilia" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au12" aria-controls="axel_author_au12"><span property="givenName">Maise</span> <span property="familyName">Al Bakir</span></a><div id="au12" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Maise</span> <span property="familyName">Al Bakir</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Al+Bakir/Maise" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au13" aria-controls="axel_author_au13"><span property="givenName">Virginia</span> <span property="familyName">Turati</span></a><div id="au13" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Virginia</span> <span property="familyName">Turati</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Stem Cell Group, Cancer Institute, University College London, London WC1E 6DD, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Turati/Virginia" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au14" aria-controls="axel_author_au14"><span property="givenName">José Afonso</span> <span property="familyName">Guerra-Assunção</span></a><div id="au14" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">José Afonso</span> <span property="familyName">Guerra-Assunção</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Bill Lyons Informatics Centre, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Guerra-Assun%C3%A7%C3%A3o/Jos%C3%A9+Afonso" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au15" aria-controls="axel_author_au15"><span property="givenName">Lucia</span> <span property="familyName">Conde</span></a><div id="au15" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Lucia</span> <span property="familyName">Conde</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Bill Lyons Informatics Centre, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Conde/Lucia" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au16" aria-controls="axel_author_au16"><span property="givenName">Andrew J.S.</span> <span property="familyName">Furness</span></a><div id="au16" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Andrew J.S.</span> <span property="familyName">Furness</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Furness/Andrew+J+S" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">6</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au17" aria-controls="axel_author_au17"><span property="givenName">Sunil Kumar</span> <span property="familyName">Saini</span></a><div id="au17" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Sunil Kumar</span> <span property="familyName">Saini</span> <a class="orcid-id" href="https://orcid.org/0000-0003-3382-9432" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0003-3382-9432</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Health Technology, Technical University of Denmark, Copenhagen, Denmark</span></div></div><div class="core-author-link"><a href="/authored-by/Saini/Sunil+Kumar" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au18" aria-controls="axel_author_au18"><span property="givenName">Sine R.</span> <span property="familyName">Hadrup</span></a><div id="au18" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Sine R.</span> <span property="familyName">Hadrup</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Health Technology, Technical University of Denmark, Copenhagen, Denmark</span></div></div><div class="core-author-link"><a href="/authored-by/Hadrup/Sine+R" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au19" aria-controls="axel_author_au19"><span property="givenName">Javier</span> <span property="familyName">Herrero</span></a><div id="au19" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Javier</span> <span property="familyName">Herrero</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Bill Lyons Informatics Centre, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Herrero/Javier" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au20" aria-controls="axel_author_au20"><span property="givenName">Se-Hoon</span> <span property="familyName">Lee</span></a><div id="au20" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au20"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Se-Hoon</span> <span property="familyName">Lee</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Health Sciences and Technology, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea</span></div><div property="affiliation" typeof="Organization"><span property="name">Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea</span></div></div><div class="core-author-link"><a href="/authored-by/Lee/Se-Hoon" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">8</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au21" aria-controls="axel_author_au21"><span property="givenName">Peter</span> <span property="familyName">Van Loo</span></a><div id="au21" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au21"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Peter</span> <span property="familyName">Van Loo</span> <a class="orcid-id" href="https://orcid.org/0000-0003-0292-1949" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0003-0292-1949</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Genomics Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Van+Loo/Peter" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">10</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au22" aria-controls="axel_author_au22"><span property="givenName">Tariq</span> <span property="familyName">Enver</span></a><div id="au22" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au22"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Tariq</span> <span property="familyName">Enver</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Stem Cell Group, Cancer Institute, University College London, London WC1E 6DD, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Enver/Tariq" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au23" aria-controls="axel_author_au23"><span property="givenName">James</span> <span property="familyName">Larkin</span></a><div id="au23" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au23"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">James</span> <span property="familyName">Larkin</span> <a class="orcid-id" href="https://orcid.org/0000-0001-5569-9523" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-5569-9523</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Larkin/James" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">6</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au24" aria-controls="axel_author_au24"><span property="givenName">Matthew D.</span> <span property="familyName">Hellmann</span></a><div id="au24" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au24"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Matthew D.</span> <span property="familyName">Hellmann</span> <a class="orcid-id" href="https://orcid.org/0000-0002-2670-9777" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-2670-9777</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, and Parker Center for Cancer Immunotherapy, 885 2nd Avenue, New York, NY 10017, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Hellmann/Matthew+D" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">11</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au25" aria-controls="axel_author_au25"><span property="givenName">Samra</span> <span property="familyName">Turajlic</span></a><div id="au25" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au25"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Samra</span> <span property="familyName">Turajlic</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Dynamics Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Turajlic/Samra" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">6</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">12</a></sup></span></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au26" aria-controls="axel_author_au26"><span property="givenName">Sergio A.</span> <span property="familyName">Quezada</span>, <span property="honorificSuffix">PhD</span></a><div id="au26" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au26"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Sergio A.</span> <span property="familyName">Quezada</span>, <span property="honorificSuffix">PhD</span> <a class="orcid-id" href="https://orcid.org/0000-0002-9763-1700" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-9763-1700</a></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0010" href="mailto:s.quezada@ucl.ac.uk" property="email" title="Send email to Sergio A. Quezada">s.quezada@ucl.ac.uk</a></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Quezada/Sergio+A" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup> <a id="eadd0010" href="mailto:s.quezada@ucl.ac.uk" property="email" title="Send email to Sergio A. Quezada">s.quezada@ucl.ac.uk</a></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au27" aria-controls="axel_author_au27"><span property="givenName">Nicholas</span> <span property="familyName">McGranahan</span></a><div id="au27" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au27"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Nicholas</span> <span property="familyName">McGranahan</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0015" href="mailto:nicholas.mcgranahan.10@ucl.ac.uk" property="email" title="Send email to Nicholas McGranahan">nicholas.mcgranahan.10@ucl.ac.uk</a></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/McGranahan/Nicholas" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup> <a id="eadd0015" href="mailto:nicholas.mcgranahan.10@ucl.ac.uk" property="email" title="Send email to Nicholas McGranahan">nicholas.mcgranahan.10@ucl.ac.uk</a></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au28" aria-controls="axel_author_au28"><span property="givenName">Charles</span> <span property="familyName">Swanton</span></a><div id="au28" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au28"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Charles</span> <span property="familyName">Swanton</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0020" href="mailto:charles.swanton@crick.ac.uk" property="email" title="Send email to Charles Swanton">charles.swanton@crick.ac.uk</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">14</div><div id="fn2"><div id="ntpara0015" role="paragraph">Lead contact</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Swanton/Charles" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a role="doc-noteref">14</a></sup> <a id="eadd0020" href="mailto:charles.swanton@crick.ac.uk" property="email" title="Send email to Charles Swanton">charles.swanton@crick.ac.uk</a></span><span data-displayed-on="all"> … <span><span data-action="reveal" tabindex="0" role="listitem">Show more</span></span> </span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">Show less</span></span></span></span></div><div class="core-self-citation"><div class="expandable-triggers"><button aria-controls="core-affiliations-notes" aria-expanded="false" tabindex="0" role="button"><span>Affiliations &amp; Notes</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button><button aria-controls="core-content-info" aria-expanded="false" tabindex="0" role="button"><span>Article Info</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button></div><div id="core-linked-content">
    

        

</div><div class="expandable-content"><div id="core-affiliations-notes" role="region" data-expandable="item" style="display: none;"><div class="affiliations"><div property="affiliation" typeof="Organization"><span class="label">1</span><span id="aff1" property="name">Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">2</span><span id="aff2" property="name">Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">3</span><span id="aff3" property="name">Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">4</span><span id="aff4" property="name">Stem Cell Group, Cancer Institute, University College London, London WC1E 6DD, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">5</span><span id="aff5" property="name">Bill Lyons Informatics Centre, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">6</span><span id="aff6" property="name">Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">7</span><span id="aff7" property="name">Department of Health Technology, Technical University of Denmark, Copenhagen, Denmark</span></div><div property="affiliation" typeof="Organization"><span class="label">8</span><span id="aff8" property="name">Department of Health Sciences and Technology, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea</span></div><div property="affiliation" typeof="Organization"><span class="label">9</span><span id="aff9" property="name">Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea</span></div><div property="affiliation" typeof="Organization"><span class="label">10</span><span id="aff10" property="name">Cancer Genomics Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">11</span><span id="aff11" property="name">Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, and Parker Center for Cancer Immunotherapy, 885 2nd Avenue, New York, NY 10017, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">12</span><span id="aff12" property="name">Cancer Dynamics Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK</span></div></div><div class="core-authors-notes"><div role="doc-footnote" data-has="label"><div class="label">13</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div><div role="doc-footnote" data-has="label"><div class="label">14</div><div id="fn2"><div id="ntpara0015" role="paragraph">Lead contact</div></div></div></div></div><div id="core-content-info" role="region" data-expandable="item" style="display: none;"><div class="history"><div>Publication History:</div><div><span>Received February 18, 2020</span>; <span>Revised June 26, 2020</span>; <span>Accepted January 4, 2021</span>; <span>Published online January 27, 2021</span></div></div><div class="core-links"><span class="doi">DOI: <a href="https://doi.org/10.1016/j.cell.2021.01.002" property="sameAs" target="_blank">10.1016/j.cell.2021.01.002 <span class="sr-only">External Link</span></a></span><span class="science-direct">Also available on <a href="https://www.sciencedirect.com/science/article/pii/S0092867421000027" target="_blank">ScienceDirect <span class="sr-only">External Link</span></a></span></div><div role="paragraph">Copyright: © 2021 The Authors. Published by Elsevier Inc.</div><div class="core-links"><span>User License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution (CC BY 4.0)</a> | <a href="https://www.elsevier.com/open-access" target="_blank">Elsevier's open access license policy</a></span></div><div class="core-crossmark-badge"><a data-target="crossmark" href="#" title="Check for updates on crossmark" data-doi="10.1016/j.cell.2021.01.002" data-id="article-info-crossmark" class="crossmark__link" style="cursor: pointer;"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 290 58" height="22px" role="presentation"><path fill="url(#horizontal_crossmark)" stroke="#948F8F" stroke-miterlimit="10" stroke-width=".75" d="M287 1H3a2 2 0 0 0-2 2v52a2 2 0 0 0 2 2h284a2 2 0 0 0 2-2V3a2 2 0 0 0-2-2Z"></path><path fill="#535353" d="M80.3 23.58a6.395 6.395 0 0 0-.55-1.43 3.92 3.92 0 0 0-2.19-1.86 5.099 5.099 0 0 0-1.71-.29 5 5 0 0 0-2.46.58 4.831 4.831 0 0 0-1.69 1.54 6.921 6.921 0 0 0-1 2.19 10.16 10.16 0 0 0 0 5 6.921 6.921 0 0 0 1 2.19 4.83 4.83 0 0 0 1.69 1.5 5 5 0 0 0 2.46.58 4.44 4.44 0 0 0 1.85-.36 4.12 4.12 0 0 0 1.38-1c.39-.436.695-.942.9-1.49A7.094 7.094 0 0 0 80.4 29h3a8.46 8.46 0 0 1-.69 2.92 7.179 7.179 0 0 1-1.59 2.29 7 7 0 0 1-2.35 1.49 8.14 8.14 0 0 1-3 .52 8.43 8.43 0 0 1-3.59-.74 7.88 7.88 0 0 1-2.69-2 9.001 9.001 0 0 1-1.69-3 11.41 11.41 0 0 1 0-7.23 9.001 9.001 0 0 1 1.69-3 8.001 8.001 0 0 1 2.69-2 8.3 8.3 0 0 1 3.59-.75 9.44 9.44 0 0 1 2.83.41c.866.242 1.68.642 2.4 1.18A6.229 6.229 0 0 1 82.65 21a6.66 6.66 0 0 1 .78 2.58H80.3ZM85.9 17.9h2.85v6.63h.05a4.15 4.15 0 0 1 1.56-1.46 4.61 4.61 0 0 1 2.31-.59 4.83 4.83 0 0 1 3.33 1.1 4.21 4.21 0 0 1 1.22 3.3v8.88H94.4v-8.13a3.51 3.51 0 0 0-.65-2.21 2.36 2.36 0 0 0-1.87-.69 3.1 3.1 0 0 0-1.3.26 2.821 2.821 0 0 0-1 .73A3.41 3.41 0 0 0 89 26.8a3.88 3.88 0 0 0-.23 1.33v7.63H85.9V17.9ZM102.47 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7A5.349 5.349 0 0 1 109.7 35a5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4A5.953 5.953 0 0 1 100 32a8.748 8.748 0 0 1-.41-2.75 7.768 7.768 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.264.905.352 1.852.26 2.79h-9.53Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.594 3.594 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM122.88 27.15a2.666 2.666 0 0 0-1-1.81 3.14 3.14 0 0 0-2-.61c-.4.005-.798.07-1.18.19-.435.136-.83.376-1.15.7a3.92 3.92 0 0 0-.87 1.43 6.783 6.783 0 0 0-.35 2.39c.002.539.065 1.076.19 1.6.113.509.316.993.6 1.43.273.41.635.752 1.06 1a3 3 0 0 0 1.58.39 2.872 2.872 0 0 0 2.06-.77 3.596 3.596 0 0 0 1-2.18h2.85a6.26 6.26 0 0 1-1.91 3.86 5.83 5.83 0 0 1-4 1.34 6.61 6.61 0 0 1-2.69-.51 5.695 5.695 0 0 1-2-1.4 6.001 6.001 0 0 1-1.21-2.11 8.279 8.279 0 0 1-.41-2.65 8.987 8.987 0 0 1 .4-2.72 6.237 6.237 0 0 1 1.2-2.21 5.614 5.614 0 0 1 2-1.47 6.7 6.7 0 0 1 2.79-.54 7.801 7.801 0 0 1 2.14.29 5.634 5.634 0 0 1 1.8.86c.529.386.969.88 1.29 1.45a5 5 0 0 1 .6 2.07h-2.85l.06-.02ZM128.13 17.9H131V28l5.15-5.22h3.5l-5 4.75 5.42 8.17h-3.47l-4-6.27-1.6 1.7v4.63h-2.85V17.9h-.02ZM147.15 22.83h2.13v-1.08a5.505 5.505 0 0 1 .3-2c.161-.456.436-.862.8-1.18.33-.273.721-.462 1.14-.55.44-.094.89-.141 1.34-.14a8.158 8.158 0 0 1 2 .18v2.24a4.113 4.113 0 0 0-.59-.11 6.343 6.343 0 0 0-.74 0 1.74 1.74 0 0 0-1 .27 1.204 1.204 0 0 0-.41 1.08v1.33h2.42V25h-2.42v10.8h-2.85V25h-2.12v-2.17ZM162.23 36.1a6.999 6.999 0 0 1-2.76-.51 5.877 5.877 0 0 1-2-1.41 5.998 5.998 0 0 1-1.33-2.18 8.775 8.775 0 0 1 0-5.48 6.008 6.008 0 0 1 1.27-2.15 5.894 5.894 0 0 1 2-1.41A7.71 7.71 0 0 1 165 23a5.894 5.894 0 0 1 2 1.41 6.003 6.003 0 0 1 1.28 2.15c.585 1.78.585 3.7 0 5.48a5.99 5.99 0 0 1-3.28 3.54 7.002 7.002 0 0 1-2.77.52Zm0-2.25a3.268 3.268 0 0 0 1.65-.4c.447-.262.83-.621 1.12-1.05.304-.444.528-.938.66-1.46a6.581 6.581 0 0 0 0-3.31 4.416 4.416 0 0 0-.66-1.46 3.526 3.526 0 0 0-1.15-1 3.6 3.6 0 0 0-3.3 0 3.526 3.526 0 0 0-1.15 1 4.414 4.414 0 0 0-.66 1.46 6.558 6.558 0 0 0 0 3.31c.132.522.356 1.016.66 1.46a3.47 3.47 0 0 0 1.15 1.05 3.26 3.26 0 0 0 1.68.4ZM171.13 22.83h2.67v2.5c.097-.362.264-.701.49-1 .251-.341.547-.647.88-.91a4.404 4.404 0 0 1 1.14-.66 3.41 3.41 0 0 1 1.28-.25c.23-.013.46-.013.69 0h.39v2.79l-.61-.09a5.173 5.173 0 0 0-.61 0 3.278 3.278 0 0 0-1.36.29 3.131 3.131 0 0 0-1.11.85 4.171 4.171 0 0 0-.75 1.39 6 6 0 0 0-.28 1.9v6.15h-2.85V22.83h.03ZM198.22 35.75h-2.8V34a3.907 3.907 0 0 1-1.56 1.56 4.25 4.25 0 0 1-2.11.59 4.742 4.742 0 0 1-3.75-1.31 5.537 5.537 0 0 1-1.12-3.84v-8.2h2.85v7.92a3.503 3.503 0 0 0 .65 2.4 2.38 2.38 0 0 0 1.83.7 3.599 3.599 0 0 0 1.5-.27 2.66 2.66 0 0 0 1-.74c.259-.326.444-.705.54-1.11a5.79 5.79 0 0 0 .16-1.4v-7.5h2.85v12.95h-.04ZM201.3 22.83h2.7v1.75a3.523 3.523 0 0 1 1.72-1.58 5.568 5.568 0 0 1 2.33-.49 6.17 6.17 0 0 1 2.66.54 5.246 5.246 0 0 1 1.89 1.47c.515.65.899 1.394 1.13 2.19.257.87.385 1.773.38 2.68.001.851-.114 1.7-.34 2.52a6.568 6.568 0 0 1-1 2.16 5.002 5.002 0 0 1-4.21 2.06c-.419 0-.837-.036-1.25-.11a5.39 5.39 0 0 1-1.2-.36A4.737 4.737 0 0 1 205 35a3.567 3.567 0 0 1-.81-.91v6.45h-2.89V22.83Zm10 6.47c0-.574-.078-1.146-.23-1.7a4.606 4.606 0 0 0-.67-1.46 3.475 3.475 0 0 0-1.12-1 3.06 3.06 0 0 0-1.55-.39A3.141 3.141 0 0 0 205 26a5.518 5.518 0 0 0-1 3.3c-.004.611.077 1.22.24 1.81.138.523.38 1.012.71 1.44a3.55 3.55 0 0 0 1.14 1 3.242 3.242 0 0 0 1.54.35 3.18 3.18 0 0 0 1.65-.4c.438-.25.817-.59 1.11-1 .299-.44.513-.931.63-1.45a7.38 7.38 0 0 0 .23-1.75h.05ZM228.67 35.75H226V34a3.38 3.38 0 0 1-1.67 1.61 5.668 5.668 0 0 1-2.33.49 6.17 6.17 0 0 1-2.66-.54 5.307 5.307 0 0 1-1.89-1.46 6.254 6.254 0 0 1-1.12-2.19 9.48 9.48 0 0 1-.37-2.71 8.67 8.67 0 0 1 .47-3 6.058 6.058 0 0 1 1.26-2.1 4.89 4.89 0 0 1 1.8-1.21 5.738 5.738 0 0 1 2.06-.39c.412 0 .824.037 1.23.11.413.073.815.194 1.2.36.38.166.736.381 1.06.64.32.255.594.562.81.91V17.9h2.85v17.85h-.03Zm-10-6.33c-.001.55.069 1.098.21 1.63.13.511.35.996.65 1.43.288.414.668.757 1.11 1a3.241 3.241 0 0 0 1.6.38 3.199 3.199 0 0 0 1.64-.4 3.398 3.398 0 0 0 1.13-1.05c.297-.447.517-.94.65-1.46.14-.542.211-1.1.21-1.66a5.227 5.227 0 0 0-1-3.35 3.175 3.175 0 0 0-2.61-1.2 3.23 3.23 0 0 0-1.69.41 3.478 3.478 0 0 0-1.12 1.07 4.494 4.494 0 0 0-.62 1.5 7.871 7.871 0 0 0-.11 1.7h-.05ZM242.6 32.88c-.018.258.03.516.14.75a.577.577 0 0 0 .54.23h.3c.135-.002.269-.019.4-.05v2l-.39.11-.49.08-.5.08h-.42a2.75 2.75 0 0 1-1.45-.35 1.731 1.731 0 0 1-.75-1.23 4.998 4.998 0 0 1-2.09 1.2 8.224 8.224 0 0 1-2.39.38 5.861 5.861 0 0 1-1.67-.24 4.394 4.394 0 0 1-1.41-.7 3.35 3.35 0 0 1-1-1.18 3.624 3.624 0 0 1-.36-1.66 3.84 3.84 0 0 1 .44-2 3.246 3.246 0 0 1 1.15-1.17 5.195 5.195 0 0 1 1.6-.61c.593-.127 1.19-.223 1.79-.29a14.77 14.77 0 0 1 1.47-.21 6.896 6.896 0 0 0 1.24-.21c.318-.077.611-.236.85-.46a1.286 1.286 0 0 0 .31-.94 1.458 1.458 0 0 0-.26-.9A1.759 1.759 0 0 0 239 25a2.807 2.807 0 0 0-.86-.25 6.941 6.941 0 0 0-.9-.06 3.58 3.58 0 0 0-2 .5 2 2 0 0 0-.87 1.55h-2.85c.021-.73.227-1.442.6-2.07.338-.54.797-.996 1.34-1.33a5.475 5.475 0 0 1 1.84-.7c.692-.134 1.395-.2 2.1-.2.632 0 1.262.067 1.88.2a5.337 5.337 0 0 1 1.66.65 3.6 3.6 0 0 1 1.19 1.16c.314.525.47 1.129.45 1.74v6.65l.02.04Zm-2.85-3.6a3.45 3.45 0 0 1-1.6.51c-.667.06-1.3.147-1.9.26a6.137 6.137 0 0 0-.87.21 2.64 2.64 0 0 0-.75.38c-.22.164-.395.38-.51.63a2.129 2.129 0 0 0-.19.94c-.011.29.085.575.27.8.182.215.407.388.66.51.269.128.555.216.85.26.277.05.558.076.84.08a4.63 4.63 0 0 0 1-.12 3.418 3.418 0 0 0 1-.43 2.73 2.73 0 0 0 .81-.76 1.93 1.93 0 0 0 .32-1.14v-2.14l.07.01ZM244.37 22.83h2.15V19h2.85v3.88h2.58V25h-2.58v6.9a7.064 7.064 0 0 0 0 .77c.016.194.074.381.17.55a.84.84 0 0 0 .41.34 2 2 0 0 0 .75.11h.6c.203-.01.404-.04.6-.09v2.2l-.93.1a8.403 8.403 0 0 1-.92 0 6.33 6.33 0 0 1-1.81-.21 2.421 2.421 0 0 1-1.08-.62 2.15 2.15 0 0 1-.52-1 7.791 7.791 0 0 1-.16-1.42V25h-2.15v-2.17h.04ZM256.22 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7a5.352 5.352 0 0 1-2.1 3.26 5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4 5.947 5.947 0 0 1-1.21-2.18 8.754 8.754 0 0 1-.41-2.75 7.758 7.758 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.243.916.308 1.87.19 2.81h-9.5V30Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.575 3.575 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM270 31.6a2.154 2.154 0 0 0 .95 1.75c.607.35 1.3.524 2 .5.304-.002.608-.022.91-.06a3.943 3.943 0 0 0 1-.24c.286-.105.54-.28.74-.51a1.23 1.23 0 0 0 .26-.89 1.261 1.261 0 0 0-.4-.9 2.779 2.779 0 0 0-1-.56 9.315 9.315 0 0 0-1.34-.36l-1.5-.33a14.219 14.219 0 0 1-1.54-.42 4.937 4.937 0 0 1-1.33-.68 3.12 3.12 0 0 1-.94-1.09 3.472 3.472 0 0 1-.35-1.64 2.94 2.94 0 0 1 .51-1.76 3.913 3.913 0 0 1 1.3-1.15 5.66 5.66 0 0 1 1.75-.61 10.316 10.316 0 0 1 1.84-.17 8.418 8.418 0 0 1 1.91.21 5.19 5.19 0 0 1 1.65.69c.496.318.916.741 1.23 1.24.341.559.55 1.188.61 1.84h-3a1.783 1.783 0 0 0-.94-1.37 3.892 3.892 0 0 0-1.69-.35 6.093 6.093 0 0 0-.71 0 3.327 3.327 0 0 0-.78.19 1.642 1.642 0 0 0-.61.4 1 1 0 0 0-.25.69 1.093 1.093 0 0 0 .36.85c.294.245.634.428 1 .54.437.153.885.274 1.34.36l1.55.33a20.9 20.9 0 0 1 1.53.42c.479.157.931.386 1.34.68.41.277.751.643 1 1.07.255.494.379 1.045.36 1.6a3.48 3.48 0 0 1-.52 2 4.15 4.15 0 0 1-1.36 1.3 6.19 6.19 0 0 1-1.86.73 9.435 9.435 0 0 1-2 .23 8.823 8.823 0 0 1-2.26-.27 5.265 5.265 0 0 1-1.8-.84 4 4 0 0 1-1.2-1.4 4.445 4.445 0 0 1-.46-2h2.7v-.02Z"></path><path fill="#C72914" d="m21.94 38.74 18.12-12.08v-14.5H21.94v26.58Z"></path><path fill="#EF3340" d="M40.06 38.74 21.94 26.66v-14.5h18.12v26.58Z"></path><path fill="#3EB1C8" d="M31 9a20 20 0 1 0 0 40 20 20 0 0 0 0-40Zm0 35.1a15.1 15.1 0 1 1 0-30.2 15.1 15.1 0 0 1 0 30.2Z"></path><path fill="#FFC72C" d="M42.09 39.23A15.09 15.09 0 0 1 17 23.38l-4.2-2.64a20 20 0 0 0 33.49 21.14l-4.2-2.65Z"></path><defs><linearGradient id="horizontal_crossmark" x1="145" x2="145" y1="7.33" y2="56.82" gradientUnits="userSpaceOnUse"><stop stop-color="#fff"></stop><stop offset="1" stop-color="#c4c4c4"></stop></linearGradient></defs></svg></a></div><div class="core-content-info"></div></div></div></div></div></header><div class="core-header-aside">
    

        


    

            

            

            <div class="cover-image cover-image--axel"><div class="cover-image__thumb"><a href="https://www.cell.com/cell/issue?pii=S0092-8674(20)X0004-3"><img src="/cms/asset/c22743ff-7b25-4b26-aaca-7f1760300f13/cov200h.gif" alt="Cover Image - Cell, Volume 184, Issue 3"></a></div></div>

            

        
</div></div><div data-core-wrapper="content"><div id="dummy-sticky-observer"></div><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="navigation-menu-pdf">
    

        


    

            

            

            <div data-widget-id="ecff07e8-0bc4-4533-b1f1-49365e2ead20" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><a href="/action/showPdf?pii=S0092-8674%2821%2900002-7" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" role="menuitem" class="article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></div>

            

        
</div><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Outline</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><div class="heading">Outline<button aria-haspopup="true" aria-controls="article_sections_menu" title="Close outline menu"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical Abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental information (2)</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div><div class="navigation-menu-share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="5f978446-c80a-450c-a185-94d633df2db2" data-widget-name="UX3share" aria-hidden="false" role="group" class="article-tools__dropblock article-tools__share"><button aria-label="Toggle share menu" aria-expanded="false" aria-haspopup="true" role="menuitem" aria-controls="navigation_menu_share_block" aria-labelledby="share-label" class="article-tools__item__share"><i aria-hidden="true" class="icon-article-share"></i><span id="share-label">Share</span></button><div id="navigation_menu_share_block" role="menu" class="share__block axel-share article-tools__dropblock__holder"><h4 class="axel-share__title heading">Share<button title="Close share menu" aria-expanded="false" aria-haspopup="true" aria-controls="navigation_menu_share_block"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2821%2900002-7" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="f1a208d3-ac5e-4db2-9c3a-40ef97ddfa10" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2021.01.002">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</div><div><button data-id="article-nav-menubar-more" aria-controls="article_more_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle more menu"><i aria-hidden="true" class="icon-more-mobile"></i><span>More</span></button><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__article_tools info-panel__item"><div id="article_more_menu" aria-label="More menu" data-core-nav="more"><div class="heading">More<button title="Close more menu" aria-controls="article_more_menu" aria-haspopup="true"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div>
    

        


    

            

            

            <ul data-widget-id="183a17a2-87b5-4e6f-bb85-6b5cda068c89" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><li class="article-tools__item article-tools__pdf"><a href="/action/showPdf?pii=S0092-8674%2821%2900002-7" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" class="article-tools__ctrl article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></li><li><a href="https://www.cell.com/action/showCitFormats?doi=10.1016%2Fj.cell.2021.01.002&amp;pii=S0092-8674%2821%2900002-7" title="Cite" target="_blank" aria-label="Open Cite in new tab" class="article-tools__item__displayExportCitation"><i aria-hidden="true" class="icon-export-Citation"></i><span>Cite</span></a></li><li id="article_tools_share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" data-widget-name="UX3share" class="dropBlock article-tools__dropblock article-tools__share"><button data-db-target-for="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" aria-expanded="false" title="open Share menu" class="article-tools__ctrl share__ctrl"><i aria-hidden="true" class="icon-article-share"></i><span>Share</span></button><div data-db-target-of="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da_Pop" class="share__block axel-share dropBlock__holder article-tools__dropblock__holder"><h4 class="axel-share__title">Share</h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2821%2900002-7" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>Bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="ae9bf5c5-a2ee-4f5c-8e41-9b21638b1a9f" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2021.01.002">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</li><li><a href="https://www.cell.com/action/addCitationAlert?doi=10.1016%2Fj.cell.2021.01.002" title="Set Alert" target="_blank" aria-label="Open Set Alert in new tab" class="article-tools__item__displayCreateCitationAlert"><i aria-hidden="true" class="icon-set-alert"></i><span>Set Alert</span></a></li><li><a href="https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&amp;contentID=S0092867421000027&amp;orderBeanReset=true&amp;orderSource=Phoenix" title="Get Rights" target="_blank" aria-label="Open Get Rights in new tab" class="article-tools__item__request"><i aria-hidden="true" class="icon-get-rights"></i><span>Get Rights</span></a></li><li><a href="https://www.contentednet.com/salesforce-form/?pii=S0092867421000027&amp;issn=00928674&amp;source=jbs" title="Reprints" target="_blank" aria-label="Open Reprints in new tab" class="article-tools__item__reprints"><i aria-hidden="true" class="icon-article-reprints"></i><span>Reprints</span></a></li></ul>

            

        
</div></div><div class="info-panel__download-issue info-panel__item"><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=184&amp;issue=3&amp;pii=S0092-8674%2820%29X0004-3" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div></div><div class="info-panel__right-content"><div class="info-panel__navigation info-panel__item"><div class="content-navigation"><a href="/cell/fulltext/S0092-8674(20)31756-6" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><i aria-hidden="true" class="icon-arrow_l"></i><span>Previous article</span></a><a href="/cell/fulltext/S0092-8674(20)31681-0" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><span>Next article</span><i aria-hidden="true" class="icon-arrow_r"></i></a></div></div></div></div></div></div></div><div class="core-sections-menu-outer"><div class="core-sections-menu"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-show-outline" aria-hidden="true"></i><span>Show Outline</span></button><nav id="article_sections_menu-desktop" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-hide-outline" aria-hidden="true"></i><span>Hide Outline</span></button><ul><li><a href="#author-highlights-abstract" aria-current="true">Highlights</a></li><li><a href="#author-abstract" aria-current="false">Summary</a></li><li><a href="#graphical-abstract" aria-current="false">Graphical Abstract</a></li><li><a href="#keywords" aria-current="false">Keywords</a></li><li><a href="#sec-1" aria-current="false">Introduction</a></li><li><a href="#sec-2" aria-current="false">Results</a></li><li><a href="#sec-3" aria-current="false">Discussion</a></li><li><a href="#sec-4" aria-current="false">STAR★methods</a></li><li><a href="#acknowledgments" aria-current="false">Acknowledgments</a></li><li><a href="#supplementary-material" aria-current="false">Supplemental information (2)</a></li><li><a href="#references" aria-current="false">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div></div><div><div class="core-content-inner"><div class="core-linked-content"></div><div id="abstracts" data-extent="frontmatter"><div class="core-container"><section id="author-highlights-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Highlights</h2><div id="abspara0020" role="paragraph"><div id="ulist0010" role="list"><div id="u0010" role="listitem"><div class="label">•</div><div class="content"><div id="p0010" role="paragraph">Large-scale meta-analysis of &gt;1,000 CPI-treated cases with exome/transcriptome data</div></div></div><div id="u0015" role="listitem"><div class="label">•</div><div class="content"><div id="p0015" role="paragraph">Clonal TMB and <i>CXCL9/CXCL13</i> expression are the strongest predictors of CPI response</div></div></div><div id="u0020" role="listitem"><div class="label">•</div><div class="content"><div id="p0020" role="paragraph">A multivariable predictor of CPI response significantly outperforms TMB</div></div></div><div id="u0025" role="listitem"><div class="label">•</div><div class="content"><div id="p0025" role="paragraph">9q34 loss and <i>CCND1</i> amplification are additional determinants of CPI response</div></div></div></div></div></section><section id="author-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Summary</h2><div id="abspara0010" role="paragraph">Checkpoint inhibitors (CPIs) augment adaptive immunity. Systematic pan-tumor analyses may reveal the relative importance of tumor-cell-intrinsic and microenvironmental features underpinning CPI sensitization. Here, we collated whole-exome and transcriptomic data for &gt;1,000 CPI-treated patients across seven tumor types, utilizing standardized bioinformatics workflows and clinical outcome criteria to validate multivariable predictors of CPI sensitization. Clonal tumor mutation burden (TMB) was the strongest predictor of CPI response, followed by total TMB and <i>CXCL9</i> expression. Subclonal TMB, somatic copy alteration burden, and histocompatibility leukocyte antigen (HLA) evolutionary divergence failed to attain pan-cancer significance. Dinucleotide variants were identified as a source of immunogenic epitopes associated with radical amino acid substitutions and enhanced peptide hydrophobicity/immunogenicity. Copy-number analysis revealed two additional determinants of CPI outcome supported by prior functional evidence: 9q34 (<i>TRAF2</i>) loss associated with response and <i>CCND1</i> amplification associated with resistance. Finally, single-cell RNA sequencing (RNA-seq) of clonal neoantigen-reactive CD8 tumor-infiltrating lymphocytes (TILs), combined with bulk RNA-seq analysis of CPI-responding tumors, identified <i>CCR5</i> and <i>CXCL13</i> as T-cell-intrinsic markers of CPI sensitivity.</div></section><section id="graphical-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Graphical Abstract</h2><div id="abspara0015" role="paragraph"><div class="figure-wrap"><figure id="undfig1" class="graphic" data-figureviewer-ignore="true"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.002/asset/76daf7fe-6ff4-443c-9b66-abd34f6d766d/main.assets/fx1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx1" alt="Graphical abstract undfig1" src="/cms/10.1016/j.cell.2021.01.002/asset/2d13c384-f548-49d4-ac18-ae25c1766315/main.assets/fx1.jpg" height="375" width="375" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/76daf7fe-6ff4-443c-9b66-abd34f6d766d/main.assets/fx1_lrg.jpg" loading="lazy"></a></figure></div></div></section></div></div><div class="core-linked-content"></div><section id="keywords" property="keywords"><h2>Keywords</h2><ol><li><a href="/action/doSearch?AllField=&quot;neoantigen&quot;" alt="Search on this keyword" rel="nofollow">neoantigen</a></li><li><a href="/action/doSearch?AllField=&quot;mutation&quot;" alt="Search on this keyword" rel="nofollow">mutation</a></li><li><a href="/action/doSearch?AllField=&quot;immunogenicity&quot;" alt="Search on this keyword" rel="nofollow">immunogenicity</a></li><li><a href="/action/doSearch?AllField=&quot;checkpoint+inhibitors&quot;" alt="Search on this keyword" rel="nofollow">checkpoint inhibitors</a></li><li><a href="/action/doSearch?AllField=&quot;immunotherapy&quot;" alt="Search on this keyword" rel="nofollow">immunotherapy</a></li><li><a href="/action/doSearch?AllField=&quot;biomarkers&quot;" alt="Search on this keyword" rel="nofollow">biomarkers</a></li><li><a href="/action/doSearch?AllField=&quot;CXCL9&quot;" alt="Search on this keyword" rel="nofollow">CXCL9</a></li><li><a href="/action/doSearch?AllField=&quot;clonal+TMB&quot;" alt="Search on this keyword" rel="nofollow">clonal TMB</a></li><li><a href="/action/doSearch?AllField=&quot;meta-analysis&quot;" alt="Search on this keyword" rel="nofollow">meta-analysis</a></li></ol></section><div class="core-linked-content"></div><div class="core-linked-content"></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text"><div class="core-container"><section id="sec-1"><h2>Introduction</h2><div id="p0030" role="paragraph">To date, multiple biomarkers have been associated with immune checkpoint inhibitor (CPI) response, which can be broadly grouped into four categories: (1) sources of antigen that elicit T&nbsp;cell responses, (2) mechanisms of immune evasion that drive resistance, (3) host factors, and (4) markers of immune infiltration. Despite these promising insights, large-scale studies of CPI response in patients with in-depth whole-exome and transcriptome data have been lacking. Furthermore, given that CPIs activate the immune system rather than target cancer-cell-intrinsic pathways, we hypothesized that a systematic pan-tumor analysis could help elucidate the critical features underpinning CPI response and enable appropriately powered biomarker discovery. Accordingly, we collated raw exome/transcriptome data across multiple studies and cancer types, totaling n&nbsp;= 1,008 CPI-treated patients (termed the “CPI1000+ cohort”; <a id="crosref0220" href="#fig1">Figure&nbsp;1</a>) from 12 individual cohorts (see <a id="crosref0225" href="#sec-4">STAR methods</a>), and reprocessed these data through a uniform bioinformatics pipeline to maximize comparability across cohorts. Furthermore, we harmonized radiological clinical response definitions across the 12 studies to ensure strict consistency in outcome measurement (“responder” is defined as a RECIST-criteria-based radiological response with complete response [CR] or partial response [PR], and “nonresponder” is defined as stable disease [SD] or progressive disease [PD]). We note this is a conservative definition of response, and patients with SD and extended survival can be considered as experiencing clinical benefit from treatment; however, the “CR/PR versus SD/PD” definition allows the clearest response interpretation and is consistent with the most recent literature (<span class="dropBlock reference-citations"><a id="body-ref-sref26-1" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-1" aria-controls="sref26-1">Cristescu et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref26-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Cristescu, R. ∙ Mogg, R. ∙ Ayers, M. ...</div><div><strong>Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:362</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aar3593" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85054777584" target="_blank" aria-label="Open Scopus in new tab">Scopus (403)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aar3593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref62-1" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-1" aria-controls="sref62-1">Mariathasan et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref62-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Mariathasan, S. ∙ Turley, S.J. ∙ Nickles, D. ...</div><div><strong>TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T&nbsp;cells</strong></div><div><em>Nature.</em> 2018; <strong>554</strong>:544-548</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85042495633" target="_blank" aria-label="Open Scopus in new tab">Scopus (833)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29443960/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25501&amp;pmid=29443960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Furthermore, in a subset of patients with both radiological response and overall survival data, we found a strong relationship in biomarker effect sizes for response and survival (<a id="crosref0240" href="#figs1">Figure&nbsp;S1</a>A; p&nbsp;= 0.001). The CPI1000+ cohort comprises data from seven tumor types (metastatic urothelial cancer [n&nbsp;= 387], malignant melanoma [n&nbsp;= 353], head and neck cancer [n&nbsp;= 107], non-small cell lung cancer [n&nbsp;= 76], renal cell carcinoma [RCC] [n&nbsp;= 51], colorectal cancer [n&nbsp;= 20], and breast cancer [n&nbsp;= 14]), treated with three classes of CPIs (anti-CTLA-4 [n&nbsp;= 155], anti-PD-1 [n&nbsp;= 432], and anti-PD-L1 [n&nbsp;= 421]) (<a id="crosref0245" href="#mmc2">Table S1</a>). Samples predominantly represented baseline pretreatment specimens, treated with single agent CPI, with a small number of exceptions (n&nbsp;= 55, 5.5%) in which the patient had either undergone prior lines of anti-CTLA-4 treatment or the biopsy was taken on treatment (see <a id="crosref0250" href="#mmc2">Table S1</a>). As a validation cohort, we obtained processed copy-number segment and overall survival data from n&nbsp;= 1,600 cases from CPI-treated patients profiled using the MSK-IMPACT panel (<span class="dropBlock reference-citations"><a id="body-ref-sref24" href="#" role="doc-biblioref" data-xml-rid="bib24" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref24" aria-controls="sref24">Consortium, 2017</a><div class="dropBlock__holder" data-db-target-of="sref24"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Consortium, A.P.G., AACR Project GENIE Consortium</div><div><strong>AACR Project GENIE: powering precision medicine through an international consortium</strong></div><div><em>Cancer Discov.</em> 2017; <strong>7</strong>:818-831</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-17-0151" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85026862883" target="_blank" aria-label="Open Scopus in new tab">Scopus (308)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28572459/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-17-0151&amp;pmid=28572459" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref86-1" href="#" role="doc-biblioref" data-xml-rid="bib86" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref86-1" aria-controls="sref86-1">Samstein et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref86-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Samstein, R.M. ∙ Lee, C.H. ∙ Shoushtari, A.N. ...</div><div><strong>Tumor mutational load predicts survival after immunotherapy across multiple cancer types</strong></div><div><em>Nat. Genet.</em> 2019; <strong>51</strong>:202-206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41588-018-0312-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85059965982" target="_blank" aria-label="Open Scopus in new tab">Scopus (669)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30643254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41588-018-0312-8&amp;pmid=30643254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (referred to hereafter as the MSK1600 cohort; RECIST response outcome data were not available for this cohort).</div><div class="figure-wrap"><figure id="fig1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.002/asset/f3909e55-ed7b-4e4c-af08-8cb8ce61728d/main.assets/gr1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr1" src="/cms/10.1016/j.cell.2021.01.002/asset/b8d55f60-ef3f-43f1-9a39-1822e2a7331f/main.assets/gr1.jpg" height="788" width="762" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/f3909e55-ed7b-4e4c-af08-8cb8ce61728d/main.assets/gr1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;1</span> <span class="figure__title__text">Design of the meta-analysis study</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0015" role="paragraph">Input studies to the meta-analysis (<a id="crosref1655" href="#fig2">Figure&nbsp;2</a>) results (top) and validation cohorts for the multivariable predictive modeling (<a id="crosref1660" href="#fig3">Figure&nbsp;3</a>) (bottom).</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.002/asset/21e33d05-21ac-44ba-b730-1ab71e258f69/main.assets/figs1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs1" src="/cms/10.1016/j.cell.2021.01.002/asset/9bd58c95-f198-4332-ba56-953ce923fa97/main.assets/figs1.jpg" height="622" width="678" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/21e33d05-21ac-44ba-b730-1ab71e258f69/main.assets/figs1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S1</span> <span class="figure__title__text">Supplementary meta-analysis data, related to <a id="crosref1665" href="#fig2">Figure&nbsp;2</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0200" role="paragraph">Panel A shows the correlation in biomarker effect sizes for radiological response and overall survival clinical endpoints (Spearman's correlation). Panel B shows response rate by number of NMD-escape mutations for all available samples. Panel C shows results from previously published histology specific biomarkers, or metrics that could not be calculated in &gt; 75% of the cohort samples.</div></div></div></div></figcaption></figure></div></section><section id="sec-2"><h2>Results</h2><section id="sec-2-1"><h3>Benchmarking of previously reported biomarkers of CPI response</h3><div id="p0035" role="paragraph">Samples were processed from raw sequencing reads, and standardized processing/quality control procedures were executed as described in <a id="crosref0265" href="#sec-4">STAR methods</a>. We began the analysis by benchmarking previously published predictors of CPI response using a literature search to systematically identify relevant biomarkers. We reviewed 723 articles that matched the search terms (see <a id="crosref0270" href="#sec-4">STAR methods</a>), yielding a panel of 55 unique biomarkers (methods). To allow biomarkers with varying measurement scales (e.g., mutation counts versus gene expression values) to be compared equivalently based on effect size rather than p value (<span class="dropBlock reference-citations"><a id="body-ref-sref110-1" href="#" role="doc-biblioref" data-xml-rid="bib110" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref110-1" aria-controls="sref110-1">Wasserstein et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref110-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">110.</div><div>Wasserstein, R.L. ∙ Schirm, A.L. ∙ Lazar, N.A.</div><div><strong>Moving to a world beyond “p &lt; 0.05”</strong></div><div><em>Am. Stat.</em> 2019; <strong>73</strong>:1-19</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/00031305.2019.1583913" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_110_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85063216937" target="_blank" aria-label="Open Scopus in new tab">Scopus (597)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F00031305.2019.1583913" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), all biomarker values were converted to standard <i>Z</i> scores. We note <i>Z</i> score conversion has been similarly applied in other large-scale tumor mutation burden (TMB) projects (<span class="dropBlock reference-citations"><a id="body-ref-sref105" href="#" role="doc-biblioref" data-xml-rid="bib105" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref105" aria-controls="sref105">Vokes et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref105"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">105.</div><div>Vokes, N.I. ∙ Liu, D. ∙ Ricciuti, B. ...</div><div><strong>Harmonization of tumor mutational burden quantification and association with response to immune checkpoint blockade in non-small-cell lung cancer</strong></div><div><em>JCO Precis. Oncol.</em> 2019; <strong>3</strong></div><div>PO.19.00171</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31832578/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=31832578" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and as a control all analyses were repeated without <i>Z</i> score conversion, with the top-ranked biomarkers found to be the same (data not shown). Finally, to avoid data pooling (<span class="dropBlock reference-citations"><a id="body-ref-sref11" href="#" role="doc-biblioref" data-xml-rid="bib11" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref11" aria-controls="sref11">Bravata and Olkin, 2001</a><div class="dropBlock__holder" data-db-target-of="sref11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Bravata, D.M. ∙ Olkin, I.</div><div><strong>Simple pooling versus combining in meta-analysis</strong></div><div><em>Eval. Health Prof.</em> 2001; <strong>24</strong>:218-230</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1177/01632780122034885" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-0035182332" target="_blank" aria-label="Open Scopus in new tab">Scopus (80)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11523387/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1177%2F01632780122034885&amp;pmid=11523387" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), each biomarker in each study was analyzed individually, and then the effect sizes/standard errors were combined through meta-analysis (<a id="crosref0290" href="#fig2">Figure&nbsp;2</a>A).</div><div class="figure-wrap"><figure id="fig2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.002/asset/db282d46-1ab1-43e2-a3a8-b6d905326489/main.assets/gr2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr2" src="/cms/10.1016/j.cell.2021.01.002/asset/4d182840-6f06-4171-baf3-38b5c235c468/main.assets/gr2.jpg" height="941" width="655" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/db282d46-1ab1-43e2-a3a8-b6d905326489/main.assets/gr2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;2</span> <span class="figure__title__text">The biomarker landscape of CPI response</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0025" role="paragraph">(A) Previously published biomarkers are shown as rows and individual cohorts within the CPI1000+ cohort as columns. The heatmap indicates the effect size of each biomarker in each cohort, measured as the log2 odds ratio (OR) for response “CR/PR” versus no response “SD/PD/NE” derived from logistic regression. Blue denotes association with response, red association with no response. Drug class and cohort sizes are annotated, and the right-hand forest plot shows the overall effect size and significance of each biomarker in meta-analysis across all studies, based on effect sizes and standard errors from each individual cohort. p values are shown from meta-analysis (random effects, on account of the different tumor types), with the first set of p-values including all samples (p-meta all cohorts) and last set (p-meta validation cohorts) including validation cohorts only (i.e., when a biomarker was originally discovered in a cohort, this cohort was excluded from the meta-analysis). For clarity of plotting, outlier OR values were capped between OR&nbsp;= 0.1 and OR&nbsp;= 10 (all outlier values were nonsignificant results skewed by rare event counts, and raw (uncapped) values were still used in the meta-analysis).</div><div id="fspara0030" role="paragraph">(B) The CPI1000+ cohort broken into cancer/drug subgroups for combinations with two or more independent cohorts. OR effect sizes are shown on the y axis, and biomarkers that are either significant in the pan-cancer 2A analysis or within an individual subgroup are shown. Colors are arbitrary and are used only to distinguish the groups.</div><div id="fspara0035" role="paragraph">(C) Correlation between biomarkers that are measured on a continuous scale.</div><div id="fspara0040" role="paragraph">(D) Proportion of variance explained for each category of biomarker, for each study, calculated using logistic regression pseudo-<i>R</i><sup><i>2</i></sup>.</div></div></div></div></figcaption></figure></div><div id="p0040" role="paragraph">The biomarker with strongest effect size across all 12 studies in the CPI1000+ cohort was clonal TMB (i.e., the number of nonsynonymous mutations estimated to be present in every cancer cell) (odds ratio [OR] for “CR/PR” versus “SD/PD”&nbsp;= 1.74; 95% confidence interval [CI], [1.41–2.15], p&nbsp;= 2.9&nbsp;× 10<sup>−7</sup>), closely followed by total TMB (OR&nbsp;= 1.70 [1.33–2.17], p&nbsp;= 1.9&nbsp;× 10<sup>−5</sup>). Subclonal mutation burden (subclonal TMB) was not significantly associated with CPI response (OR&nbsp;= 1.18 [0.99–1.41], p&nbsp;= 0.07), indicating that the dominant biomarker associated with CPI response is clonal mutational burden specifically. We note, however, that the single-region nature of this study, combined with tumor purity and modest sequencing depths, means we are underpowered to detect the full subclonal mutation burden of each tumor. Within the sources of antigen category, other biomarkers such as frameshift insertion/deletion burden (indel TMB) (OR&nbsp;= 1.34 [1.12–1.62], p&nbsp;= 1.6&nbsp;× 10<sup>−3</sup>), nonsense-mediated decay (NMD) escaping (NMD-escape) fs-indel burden (OR&nbsp;= 1.38 [1.15–1.66], p&nbsp;= 5.6&nbsp;× 10<sup>−4</sup>), proportion of mutations fitting tobacco (OR&nbsp;= 1.39 [1.02–1.88], p&nbsp;= 3.5&nbsp;× 10<sup>−2</sup>), UV (OR&nbsp;= 1.34 [1.12–1.60], p&nbsp;= 1.2&nbsp;× 10<sup>−3</sup>), and APOBEC (OR&nbsp;= 1.39 [1.09–1.76], p&nbsp;= 8.1&nbsp;× 10<sup>−3</sup>) mutation signatures, as well as <i>SERPINB3</i> mutations (OR&nbsp;= 1.33 [1.12–1.59], p&nbsp;= 1.2&nbsp;× 10<sup>−3</sup>), were all significantly associated with CPI response. Regarding nonsense mediated decay, we note CPI response rates are particularly elevated (∼50%–70% CR/PR) in patients with ≥5 fs-indel NMD-escaping mutations (<a id="crosref0300" href="#figs1">Figure&nbsp;S1</a>B). Within the sources of antigen category, DNA damage response pathway mutations were not associated with CPI response (OR&nbsp;= 1.14 [0.95–1.36, p&nbsp;= 0.17]), nor was the differential agretopicity index (OR&nbsp;= 1.03 [0.81–1.32, p&nbsp;= 0.79]), <i>MUC16</i> neoantigen count (OR&nbsp;= 1.15 [0.98–1.35, p&nbsp;= 0.08]), or AxR neoantigen fitness model (OR&nbsp;= 1.12 [0.95–1.32, p&nbsp;= 0.18]). With regard to drivers of immune escape, we observed no significant association between the level of somatic copy-number alteration (SCNA), measured using the weighted genome instability index (wGII) (<span class="dropBlock reference-citations"><a id="body-ref-sref30-1" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref30-1" aria-controls="sref30-1">Endesfelder et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref30-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Endesfelder, D. ∙ Burrell, R. ∙ Kanu, N. ...</div><div><strong>Chromosomal instability selects gene copy-number variants encoding core regulators of proliferation in ER+ breast cancer</strong></div><div><em>Cancer Res.</em> 2014; <strong>74</strong>:4853-4863</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-13-2664" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84907053818" target="_blank" aria-label="Open Scopus in new tab">Scopus (32)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24970479/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-13-2664&amp;pmid=24970479" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and CPI response (OR&nbsp;= 1.05 [0.87–1.25], p&nbsp;= 0.62), or copy-number loss burden (OR&nbsp;= 1.09 [0.93–1.28], p&nbsp;= 0.27). <i>B2M</i>, <i>PTEN</i>, <i>JAK1/JAK2</i>, <i>KRAS</i>, <i>TP53</i>, and receptor tyrosine kinase (RTK) mutations did not reach overall significance, despite showing strong effect sizes in some individual cohorts (see <a id="crosref0310" href="#fig2">Figure&nbsp;2</a>A), nor did the ITH Shannon diversity index (<span class="dropBlock reference-citations"><a id="body-ref-sref112-1" href="#" role="doc-biblioref" data-xml-rid="bib112" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref112-1" aria-controls="sref112-1">Wolf et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref112-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">112.</div><div>Wolf, Y. ∙ Bartok, O. ∙ Patkar, S. ...</div><div><strong>UVB-induced tumor heterogeneity diminishes immune response in melanoma</strong></div><div><em>Cell.</em> 2019; <strong>179</strong>:219-235.e21</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_112_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2019.08.032&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_112_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2019.08.032&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_112_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85072208317" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31522890/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.08.032&amp;pmid=31522890" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Intriguingly, loss of heterozygosity (LOH) at the human leukocyte antigen (HLA) locus (LOHHLA) (<span class="dropBlock reference-citations"><a id="body-ref-sref65-1" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65-1" aria-controls="sref65-1">McGranahan et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref65-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>McGranahan, N. ∙ Rosenthal, R. ∙ Hiley, C.T. ..., TRACERx Consortium</div><div><strong>Allele-specific HLA loss and immune escape in lung cancer evolution</strong></div><div><em>Cell.</em> 2017; <strong>171</strong>:1259-1271.e11</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2017.10.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2017.10.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85032583704" target="_blank" aria-label="Open Scopus in new tab">Scopus (343)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29107330/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.10.001&amp;pmid=29107330" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) had a non-significant OR in the direction of improved chances of CPI response (OR&nbsp;= 1.14, [0.95–1.36, p&nbsp;= 0.16), the opposite of what may be expected, and possibly reflecting the fact that LOHHLA is found at higher frequency later in tumor evolution and is enriched in hot versus cold tumors (<span class="dropBlock reference-citations"><a id="body-ref-sref84-1" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84-1" aria-controls="sref84-1">Rosenthal et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref84-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Rosenthal, R. ∙ Cadieux, E.L. ∙ Salgado, R. ..., TRACERx consortium</div><div><strong>Neoantigen-directed immune escape in lung cancer evolution</strong></div><div><em>Nature.</em> 2019; <strong>567</strong>:479-485</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1032-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85063265508" target="_blank" aria-label="Open Scopus in new tab">Scopus (180)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30894752/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1032-7&amp;pmid=30894752" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). As a technical validation LOHHLA analysis was repeated using: (1) the ASCAT tool (<span class="dropBlock reference-citations"><a id="body-ref-sref103-1" href="#" role="doc-biblioref" data-xml-rid="bib103" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref103-1" aria-controls="sref103-1">Van Loo et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref103-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Van Loo, P. ∙ Nordgard, S.H. ∙ Lingjærde, O.C. ...</div><div><strong>Allele-specific copy number analysis of tumors</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2010; <strong>107</strong>:16910-16915</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1009843107" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-78049248432" target="_blank" aria-label="Open Scopus in new tab">Scopus (524)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20837533/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1009843107&amp;pmid=20837533" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) to call LOH, and (2) only calls concordant between ASCAT and LOHHLA tools. Both of these additional analyses yielded the same result (i.e., non-significant OR numerically &gt; 1). Regarding host factors, we did not observe a significant association between the level of germline HLA-I evolutionary divergence (<span class="dropBlock reference-citations"><a id="body-ref-sref19-1" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19-1" aria-controls="sref19-1">Chowell et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref19-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Chowell, D. ∙ Krishna, C. ∙ Pierini, F. ...</div><div><strong>Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:1715-1720</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-019-0639-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85074822630" target="_blank" aria-label="Open Scopus in new tab">Scopus (27)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31700181/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-019-0639-4&amp;pmid=31700181" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (OR&nbsp;= 1.01 [0.80–1.28], p&nbsp;= 0.94) in the combined meta-analysis, nor for maximal HLA heterozygosity (OR&nbsp;= 0.97 [0.83–1.14], p&nbsp;= 0.70), HLA B62 supertype (OR&nbsp;= 0.93 [0.78–1.11], p&nbsp;= 0.45), HLA B1501 type (OR&nbsp;= 0.97 [0.81–1.16], p&nbsp;= 0.75) (<span class="dropBlock reference-citations"><a id="body-ref-sref18-1" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18-1" aria-controls="sref18-1">Chowell et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref18-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>Chowell, D. ∙ Morris, L.G.T. ∙ Grigg, C.M. ...</div><div><strong>Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>359</strong>:582-587</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aao4572" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85037700703" target="_blank" aria-label="Open Scopus in new tab">Scopus (318)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29217585/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aao4572&amp;pmid=29217585" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), or germline variants in the <i>KIR3DS1</i> gene (OR&nbsp;= 1.16 [0.99–1.37], p&nbsp;= 0.067). HLA B44 supertype was found to be marginally nonsignificant (OR&nbsp;= 1.17 [1.00–1.37], p&nbsp;= 0.053), and sex was found to have a significant association (OR&nbsp;= 1.22 [1.03–1.43, p&nbsp;= 1.9&nbsp;× 10<sup>−2</sup>), with male patients experiencing better response rates as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref23-1" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23-1" aria-controls="sref23-1">Conforti et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref23-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Conforti, F. ∙ Pala, L. ∙ Bagnardi, V. ...</div><div><strong>Cancer immunotherapy efficacy and patients’ sex: a systematic review and meta-analysis</strong></div><div><em>Lancet Oncol.</em> 2018; <strong>19</strong>:737-746</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS1470-2045%2818%2930261-4&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS1470-2045%2818%2930261-4&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85047095751" target="_blank" aria-label="Open Scopus in new tab">Scopus (227)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29778737/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1470-2045%2818%2930261-4&amp;pmid=29778737" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In the markers of immune infiltration category, we observed <i>CXCL9</i> expression (<span class="dropBlock reference-citations"><a id="body-ref-sref43" href="#" role="doc-biblioref" data-xml-rid="bib43" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref43" aria-controls="sref43">House et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref43"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>House, I.G. ∙ Savas, P. ∙ Lai, J. ...</div><div><strong>Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade</strong></div><div><em>Clin. Cancer Res.</em> 2020; <strong>26</strong>:487-504</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-19-1868" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85075037247" target="_blank" aria-label="Open Scopus in new tab">Scopus (40)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31636098/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-19-1868&amp;pmid=31636098" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) as the predictor with strongest effect size (OR&nbsp;=&nbsp;1.67 [1.38–2.03], p&nbsp;= 1.3&nbsp;× 10<sup>−7</sup>), followed by significant associations for <i>CD8A</i> expression (OR&nbsp;= 1.45 [1.20–1.74], p&nbsp;= 1.0&nbsp;× 10<sup>−4</sup>), the T&nbsp;cell inflamed gene expression signature (<span class="dropBlock reference-citations"><a id="body-ref-sref6-1" href="#" role="doc-biblioref" data-xml-rid="bib6" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref6-1" aria-controls="sref6-1">Ayers et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref6-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Ayers, M. ∙ Lunceford, J. ∙ Nebozhyn, M. ...</div><div><strong>IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2017; <strong>127</strong>:2930-2940</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI91190" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85026675148" target="_blank" aria-label="Open Scopus in new tab">Scopus (834)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28650338/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI91190&amp;pmid=28650338" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (OR&nbsp;= 1.43 [1.05–1.96], p&nbsp;= 2.5&nbsp;× 10<sup>−2</sup>), and <i>CD274 (</i>PD-L1) expression level (OR&nbsp;= 1.32 [1.10–1.58], p&nbsp;= 3.0&nbsp;× 10<sup>−3</sup>). CXCL9 is a critical chemokine that binds CXCR3 on T&nbsp;cells, enhancing recruitment of cytotoxic CD8<sup>+</sup> T&nbsp;cells into the tumor (<span class="dropBlock reference-citations"><a id="body-ref-sref38" href="#" role="doc-biblioref" data-xml-rid="bib38" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref38" aria-controls="sref38">Gorbachev et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref38"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Gorbachev, A.V. ∙ Kobayashi, H. ∙ Kudo, D. ...</div><div><strong>CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T&nbsp;cell-mediated suppression of cutaneous tumors</strong></div><div><em>J.&nbsp;Immunol.</em> 2007; <strong>178</strong>:2278-2286</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.178.4.2278" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17277133/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.178.4.2278&amp;pmid=17277133" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and promoting the differentiation of inflammatory T helper type 1 (Th1) and Th17 CD4 T&nbsp;cells (<span class="dropBlock reference-citations"><a id="body-ref-sref48" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48" aria-controls="sref48">Karin et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref48"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Karin, N. ∙ Wildbaum, G. ∙ Thelen, M.</div><div><strong>Biased signaling pathways via CXCR3 control the development and function of CD4+ T&nbsp;cell subsets</strong></div><div><em>J.&nbsp;Leukoc. Biol.</em> 2016; <strong>99</strong>:857-862</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1189/jlb.2MR0915-441R" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84971373567" target="_blank" aria-label="Open Scopus in new tab">Scopus (38)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26657511/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1189%2Fjlb.2MR0915-441R&amp;pmid=26657511" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Additional biomarkers identified in the literature review that are either histology specific or could not be measured&nbsp;in &gt;75% of samples are included in <a id="crosref0365" href="#figs1">Figure&nbsp;S1</a>C. Of these, the following were significant: <i>CD38</i> expression (OR&nbsp;= 1.29 [1.03–1.61, p&nbsp;= 2.6&nbsp;× 10<sup>−2</sup>), <i>CXCL13</i> expression (OR&nbsp;= 1.38 [1.11–1.73, p&nbsp;= 3.8&nbsp;× 10<sup>−3</sup>), IMPRES (OR&nbsp;= 1.31 [1.05–1.65, p&nbsp;= 1.8&nbsp;× 10<sup>−2</sup>), T effector signature from the POPLAR trial (OR&nbsp;= 1.38 [1.13–1.70, p&nbsp;= 1.9&nbsp;× 10<sup>−3</sup>), and cytolytic score (OR&nbsp;= 1.22 [1.00–1.51, p&nbsp;= 4.9&nbsp;× 10<sup>−2</sup>). Three signatures (stroma-EMT/pan-fibroblast transforming growth factor β (TGF-β)/T effector score from IMmotion150 trial), while nonsignificant, had p&nbsp;&lt; 0.1 (<a id="crosref0370" href="#figs1">Figure&nbsp;S1</a>C).</div><div id="p0045" role="paragraph">We note that the lack of a statistically significant association for any of these biomarkers does not rule out an important underlying biological role for these processes in determining CPI response. Instead, these data provide insights into the universal predictors of CPI response, with evidence of predictive utility across multiple tumor types. Furthermore, for rarer mutational events, this analysis is underpowered (e.g., <i>B2M</i> mutations/deletions were found only in 1.4% of cases), meaning larger sample sizes are likely required to confirm the role of these events in influencing CPI response. We next analyzed the CPI1000+ data split by cancer/drug type, assessing four groupings where we had two or more independent cohorts available: melanoma anti-PD-1/L1, melanoma anti-CTLA-4, urothelial carcinoma anti-PD-1/L1, and non-small cell lung cancer anti-PD-1/L1. The majority of biomarkers significant in individual subgroups were the same as those attaining significance in the pan-cancer meta-analysis, with the exception of HLA B44 supertype (<span class="dropBlock reference-citations"><a id="body-ref-sref18-2" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18-2" aria-controls="sref18-2">Chowell et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref18-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>Chowell, D. ∙ Morris, L.G.T. ∙ Grigg, C.M. ...</div><div><strong>Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>359</strong>:582-587</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aao4572" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85037700703" target="_blank" aria-label="Open Scopus in new tab">Scopus (318)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29217585/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aao4572&amp;pmid=29217585" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and germline HLA-I evolutionary divergence (<span class="dropBlock reference-citations"><a id="body-ref-sref19-2" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19-2" aria-controls="sref19-2">Chowell et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref19-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Chowell, D. ∙ Krishna, C. ∙ Pierini, F. ...</div><div><strong>Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:1715-1720</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-019-0639-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85074822630" target="_blank" aria-label="Open Scopus in new tab">Scopus (27)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31700181/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-019-0639-4&amp;pmid=31700181" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), which, while not significant overall, were significant in the melanoma anti-CTLA-4 cohorts (OR&nbsp;= 1.65 [1.11–2.46], p&nbsp;= 1.3&nbsp;× 10<sup>−2</sup> and OR&nbsp;= 1.71 [1.07–2.75], p&nbsp;= 2.5&nbsp;× 10<sup>−2</sup>, respectively). This latter association is potentially consistent with the increase in T&nbsp;cell receptor (TCR) diversity observed in anti-CTLA-4-treated patients (<span class="dropBlock reference-citations"><a id="body-ref-sref12" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12" aria-controls="sref12">Cha et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Cha, E. ∙ Klinger, M. ∙ Hou, Y. ...</div><div><strong>Improved survival with T&nbsp;cell clonotype stability after anti-CTLA-4 treatment in cancer patients</strong></div><div><em>Sci. Transl. Med.</em> 2014; <strong>6</strong>:238ra70</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.3008211" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84902825664" target="_blank" aria-label="Open Scopus in new tab">Scopus (232)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24871131/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.3008211&amp;pmid=24871131" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and hence, a broader set of HLA presented peptides may facilitate improved response; however, other explanations are possible. The only other exceptions were differential agretopicity index (significant only in lung cancer anti-PD-1/L1 cohorts [OR&nbsp;= 1.90 (1.05–3.44), p&nbsp;= 3.5&nbsp;× 10<sup>−2</sup>]) and subclonal TMB (significant only in urothelial anti-PD-1/L1 cohorts [OR&nbsp;= 1.28 (1.01–1.62), p&nbsp;= 4.2&nbsp;× 10<sup>−2</sup>]) (<a id="crosref0390" href="#fig2">Figure&nbsp;2</a>B). Other cancer/drug histology differences reflected expected patterns; for example, <i>CD274</i> (PD-L1) was significant in melanoma anti-PD-1 cohorts, but not anti-CTLA-4 (<a id="crosref0395" href="#fig2">Figure&nbsp;2</a>B). To formally test for histology/drug-specific biomarker differences, we also conducted interaction tests and found three significant interactions (<a id="crosref0400" href="#figs2">Figure&nbsp;S2</a>A), the first being between histology and TMB/clonal TMB, with the predictive effect size of TMB being significantly lower in melanoma as compared to urothelial carcinoma (p&nbsp;= 4.8&nbsp;× 10<sup>−3</sup>) (<a id="crosref0405" href="#figs2">Figure&nbsp;S2</a>A). Similarly, we also observed a significantly lower OR effect size for <i>CXCL9</i> expression in melanoma as compared to urothelial cancer (p&nbsp;= 3.3&nbsp;× 10<sup>−2</sup>) (<a id="crosref0410" href="#figs2">Figure&nbsp;S2</a>A). Third, <i>SERPINB3</i> mutations were found to have significantly higher effect size in anti-CTLA-4 versus anti-PD-1/L1 cohorts (p&nbsp;= 3.9&nbsp;× 10<sup>−2</sup>) (<a id="crosref0415" href="#figs2">Figure&nbsp;S2</a>A). We next assessed the level of correlation between continuous biomarkers, observing a high level of correlation between metrics within each category (e.g., mutational metrics like TMB and clonal TMB were strongly correlated with each other). Similarly, markers of immune infiltration like <i>CD8A</i> and <i>CXCL9</i> were correlated with each other (<a id="crosref0420" href="#fig2">Figure&nbsp;2</a>C). However, the correlation between separate biomarker categories was generally low (e.g., sources of antigen biomarkers were largely not correlated with markers of immune infiltration), suggesting potential nonredundant utility in combining multiple markers together into a multivariable test. Finally, we quantified the total proportion of variance in CPI response that could be explained by all biomarkers measured in <a id="crosref0425" href="#fig2">Figure&nbsp;2</a>A, which for most studies gave a value of ∼0.6, suggesting that up to 40% of the factors determining CPI outcome are either still to be discovered or lie outside of the exome/transcriptome (<a id="crosref0430" href="#fig2">Figure&nbsp;2</a>D; values calculated using logistic regression pseudo-<i>R</i><sup><i>2</i></sup>).</div><div class="figure-wrap"><figure id="figs2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.002/asset/2e2234f8-aaf8-416c-bc86-0233384c6826/main.assets/figs2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs2" src="/cms/10.1016/j.cell.2021.01.002/asset/fbbf0c63-a020-4f32-8717-d6c0e2435a0a/main.assets/figs2.jpg" height="559" width="506" aria-labelledby="figs2-title" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/2e2234f8-aaf8-416c-bc86-0233384c6826/main.assets/figs2_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div><figcaption class="figure__caption__body"><div id="figs2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S2</span> <span class="figure__title__text">(A) shows significant histology or drug-specific biomarker interactions identified in the CPI1000+ cohort (using histology*biomarker and drug*biomarker interaction terms in logistic regression), and (B) shows dinucleotide variant associations with CPI response, related to <a id="crosref1670" href="#fig2">Figures 2</a> and <a id="crosref1675" href="#fig4">4</a></span></div></figcaption></figure></div></section><section id="sec-2-2"><h3>A multivariable predictor of CPI response</h3><div id="p0050" role="paragraph">Given the complexity of the CPI biomarker landscape, we next explored if biomarkers could be combined and converted into a single score predicting the overall likelihood of CPI response with improved accuracy. For this analysis, we started by exploring the importance of predictive features in the largest training cohort of matched exome and transcriptome data for each tumor type: urothelial (n&nbsp;= 215; <span class="dropBlock reference-citations"><a id="body-ref-sref62-2" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-2" aria-controls="sref62-2">Mariathasan et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref62-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Mariathasan, S. ∙ Turley, S.J. ∙ Nickles, D. ...</div><div><strong>TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T&nbsp;cells</strong></div><div><em>Nature.</em> 2018; <strong>554</strong>:544-548</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85042495633" target="_blank" aria-label="Open Scopus in new tab">Scopus (833)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29443960/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25501&amp;pmid=29443960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), head and neck (n&nbsp;= 106; <span class="dropBlock reference-citations"><a id="body-ref-sref26-2" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-2" aria-controls="sref26-2">Cristescu et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref26-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Cristescu, R. ∙ Mogg, R. ∙ Ayers, M. ...</div><div><strong>Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:362</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aar3593" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85054777584" target="_blank" aria-label="Open Scopus in new tab">Scopus (403)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aar3593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), melanoma (n&nbsp;= 89; <span class="dropBlock reference-citations"><a id="body-ref-sref26-3" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-3" aria-controls="sref26-3">Cristescu et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref26-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Cristescu, R. ∙ Mogg, R. ∙ Ayers, M. ...</div><div><strong>Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:362</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aar3593" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85054777584" target="_blank" aria-label="Open Scopus in new tab">Scopus (403)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aar3593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and renal (n&nbsp;= 44; <span class="dropBlock reference-citations"><a id="body-ref-sref63-1" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63-1" aria-controls="sref63-1">McDermott et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref63-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>McDermott, D.F. ∙ Huseni, M.A. ∙ Atkins, M.B. ...</div><div><strong>Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:749-757</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0053-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85048001150" target="_blank" aria-label="Open Scopus in new tab">Scopus (334)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29867230/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0053-3&amp;pmid=29867230" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (total across these four cohorts, n&nbsp;= 454). The multivariable model was trained using all biomarkers achieving overall significance in the <a id="crosref0455" href="#fig2">Figure&nbsp;2</a>A meta-analysis (final column [11 total]), validation cohort results), namely clonal TMB, indel TMB, NMD-escape TMB, tobacco signature, UV signature, APOBEC signature, sex, T&nbsp;cell inflamed GEP signature, and gene expression values for <i>CD274</i> (PD-L1), <i>CD8A</i>, and <i>CXCL9</i>. TMB was used as a univariable benchmark comparison measure, due to it's US Food and Drug Administration (FDA) approval. We utilized a machine learning algorithm, XGBoost (see <a id="crosref0460" href="#sec-4">STAR methods</a>), to construct a multivariable predictive model for each cancer type (using the 11 features described above), which demonstrated some subtle differences by cancer type (e.g., the APOBEC signature proportion was highly ranked in urothelial carcinoma and the UV signature proportion in melanoma) (<a id="crosref0465" href="#fig3">Figure&nbsp;3</a>A). However, the models also displayed strong evidence of similarity. For example, clonal TMB and <i>CXCL9</i> expression were both ranked as the top two in multiple models (<a id="crosref0470" href="#fig3">Figure&nbsp;3</a>A). Hence, a final combined pan-cancer model was trained using all CPI1000+ samples (n&nbsp;= 1,008) based on the set of 11 biomarkers listed above (<a id="crosref0475" href="#fig3">Figure&nbsp;3</a>B), with feature importance scores as displayed in (<a id="crosref0480" href="#fig3">Figure&nbsp;3</a>C).</div><div class="figure-wrap"><figure id="fig3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.002/asset/32526d0c-7386-401b-bfa8-65dcc5432989/main.assets/gr3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr3" src="/cms/10.1016/j.cell.2021.01.002/asset/1d610540-f0ab-4625-8097-2a1a1f80beda/main.assets/gr3.jpg" height="941" width="698" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/32526d0c-7386-401b-bfa8-65dcc5432989/main.assets/gr3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;3</span> <span class="figure__title__text">A multivariable predictor of CPI response outperforms TMB</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0050" role="paragraph">(A) Feature importance scores from XGBoost for the multivariable model, corresponding to 1,000 Monte Carlo sampling rounds.</div><div id="fspara0055" role="paragraph">(B) Design, samples included, and features utilized in the final model training.</div><div id="fspara0060" role="paragraph">(C) The top five feature importance scores from the final pan-cancer model.</div><div id="fspara0065" role="paragraph">(D) ROC curves and AUC values for the multivariable predictor benchmarked to TMB, as a univariable comparator, in the three independent test cohorts (not used in any of the model training steps). p values report the significance of improved performance for the multivariable versus TMB model using DeLong’s test.</div></div></div></div></figcaption></figure></div><div id="p0055" role="paragraph">In accordance with diagnostic accuracy best-practice standards, we tested the final parameterized multivariable predictor in three independent cohorts of test samples not used in the model training steps and not in the CPI1000+ cohort (test cohorts were selected based on defined criteria; see <a id="crosref0490" href="#sec-4">STAR methods</a>). We calculated area under the receiver operating characteristic curve (AUC) values for the multivariable predictive model and benchmarked these to a TMB-only model for comparison purposes. Test cohort 1 was taken from KEYNOTE-028, a set of samples from <span class="dropBlock reference-citations"><a id="body-ref-sref26-4" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-4" aria-controls="sref26-4">Cristescu et&nbsp;al. (2018)</a><div class="dropBlock__holder" data-db-target-of="sref26-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Cristescu, R. ∙ Mogg, R. ∙ Ayers, M. ...</div><div><strong>Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:362</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aar3593" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85054777584" target="_blank" aria-label="Open Scopus in new tab">Scopus (403)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aar3593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span> (n&nbsp;= 76), which was selected as a test cohort due to its set of pan-cancer “other tumor type” mix of patients. The multivariable predictor attained an AUC value of 0.86, significantly better than the TMB AUC of 0.68 (p&nbsp;= 0.0049, DeLong’s test for comparison of AUCs; <a id="crosref0500" href="#fig3">Figure&nbsp;3</a>D). Test cohort 2 was obtained from a recently published cohort from University Hospital Essen of melanoma samples (<span class="dropBlock reference-citations"><a id="body-ref-sref59-1" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-1" aria-controls="sref59-1">Liu et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref59-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Liu, D. ∙ Schilling, B. ∙ Liu, D. ...</div><div><strong>Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:1916-1927</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-019-0654-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85075928991" target="_blank" aria-label="Open Scopus in new tab">Scopus (60)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31792460/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-019-0654-5&amp;pmid=31792460" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (n&nbsp;= 121), and similarly, a significantly better performance was observed for the multivariable model (AUC&nbsp;= 0.66) compared to the TMB AUC of 0.58 (p&nbsp;= 0.025, DeLong’s test; <a id="crosref0510" href="#fig3">Figure&nbsp;3</a>D). Finally, test cohort 3 consisted of non-small cell lung cancer (NSCLC) samples (n&nbsp;= 144; obtained from <span class="dropBlock reference-citations"><a id="body-ref-sref88-1" href="#" role="doc-biblioref" data-xml-rid="bib88" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref88-1" aria-controls="sref88-1">Shim et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref88-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">87.</div><div>Shim, J.H. ∙ Kim, H.S. ∙ Cha, H. ...</div><div><strong>HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients</strong></div><div><em>Ann. Oncol.</em> 2020; <strong>31</strong>:902-911</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.annonc.2020.04.004&amp;cf=fulltext&amp;site=annonc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.annonc.2020.04.004&amp;cf=pdf&amp;site=annonc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85085291189" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32320754/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.annonc.2020.04.004&amp;pmid=32320754" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and again, a significantly better performance was observed for the multivariable model (AUC&nbsp;= 0.70) compared to TMB (AUC&nbsp;= 0.62) (p&nbsp;= 0.047, DeLong’s test; <a id="crosref0520" href="#fig3">Figure&nbsp;3</a>D) in the NSCLC samples. Thus, in summary, a pan-cancer multivariable model trained on n&nbsp;= 1,008 samples was found to significantly outperform TMB as a predictor of CPI response across three independent test cohorts, totaling ∼350 samples. Lastly, we assessed how a simpler two-parameter biomarker would perform utilizing the top biomarker from the sources of antigen and immune infiltration categories, namely clonal TMB and <i>CXCL9</i> expression. The two-parameter biomarker attained the following AUC values in each test cohort: test cohort 1 AUC&nbsp;= 0.79 (for reference, TMB AUC&nbsp;= 0.68 and full multivariable model AUC&nbsp;= 0.86), test cohort 2 AUC&nbsp;= 0.63 (for reference, TMB AUC&nbsp;= 0.58 and full multivariable model AUC&nbsp;= 0.66), and test cohort 3 AUC&nbsp;= 0.72 (for reference, TMB AUC&nbsp;= 0.62 and full multivariable model AUC&nbsp;= 0.70) (<a id="crosref0525" href="#mmc2">Table S2</a>). Overall, while not scoring as highly as the full 11-marker model, we note that a two-marker model may have potential utility as a simplifed alternative, which is superior to TMB alone.</div></section><section id="sec-2-3"><h3>Mutational processes associated with CPI response</h3><div id="p0060" role="paragraph">Acknowledging that the current set of published biomarkers provides only a partial explanation of CPI response, we next undertook discovery analysis to search for additional predictors of response in the CPI1000+ cohort. Given the importance of TMB from the literature search, we started by assessing for evidence of mutational processes associated with treatment outcome. All samples in the CPI1000+ cohort with ≥50 somatic mutations (n&nbsp;= 774) were analyzed to calculate the proportion of mutations in a given sample attributable to each signature. The complete set of COSMIC mutational signatures (v2) (<span class="dropBlock reference-citations"><a id="body-ref-sref1-1" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-1" aria-controls="sref1-1">Alexandrov et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref1-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Alexandrov, L.B. ∙ Jones, P.H. ∙ Wedge, D.C. ...</div><div><strong>Clock-like mutational processes in human somatic cells</strong></div><div><em>Nat. Genet.</em> 2015; <strong>47</strong>:1402-1407</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ng.3441" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84949104081" target="_blank" aria-label="Open Scopus in new tab">Scopus (350)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26551669/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fng.3441&amp;pmid=26551669" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) was utilized. For each signature, we tested for association between the proportion of mutations fitting that signature and CPI response. To avoid any confounding bias due to different response rates across cancer types, all cohorts were analyzed individually. For example, UV signature mutations were compared within each melanoma cohort (comparing more or less sun damage within melanoma patients), and then study-level results were combined only via meta-analysis. Five out of 20 mutational processes were found to be significant: signature 1A (aging, OR&nbsp;= 0.65 [0.53–0.80], p&nbsp;= 4.5&nbsp;× 10<sup>−5</sup>), signature 4 (tobacco, OR&nbsp;= 1.39 [1.02–1.88], p&nbsp;= 3.5&nbsp;× 10<sup>−2</sup>), signature 7 (UV, OR&nbsp;= 1.34 [1.12–1.60], p&nbsp;= 1.2&nbsp;× 10<sup>−3</sup>), signature 10 (POLE, OR&nbsp;= 1.35 [1.11–1.66], p&nbsp;= 3.4&nbsp;× 10<sup>−3</sup>), and signature 2+13 (APOBEC, OR&nbsp;= 1.39 [1.09–1.76], p&nbsp;= 8.1&nbsp;× 10<sup>−3</sup>) (<a id="crosref0535" href="#fig4">Figure&nbsp;4</a>A). These associations remained significant after correction for total mutation count (i.e., TMB), suggesting that clonality and mutation quality characteristics are important. Several of these associations have also been reported by others, including tobacco (<span class="dropBlock reference-citations"><a id="body-ref-sref2-1" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2-1" aria-controls="sref2-1">Anagnostou et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref2-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Anagnostou, V. ∙ Niknafs, N. ∙ Marrone, K. ...</div><div><strong>Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer</strong></div><div><em>Nat. Can.</em> 2020; <strong>1</strong>:99-111</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s43018-019-0008-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32984843/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs43018-019-0008-8&amp;pmid=32984843" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), APOBEC (<span class="dropBlock reference-citations"><a id="body-ref-sref13-1" href="#" role="doc-biblioref" data-xml-rid="bib13" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref13-1" aria-controls="sref13-1">Chapuy et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref13-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Chapuy, B. ∙ Stewart, C. ∙ Dunford, A.J. ...</div><div><strong>Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade</strong></div><div><em>Blood.</em> 2019; <strong>134</strong>:2369-2382</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood.2019002067" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85076370169" target="_blank" aria-label="Open Scopus in new tab">Scopus (10)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31697821/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood.2019002067&amp;pmid=31697821" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and UV (<span class="dropBlock reference-citations"><a id="body-ref-sref69-1" href="#" role="doc-biblioref" data-xml-rid="bib69" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref69-1" aria-controls="sref69-1">Miao et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref69-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">68.</div><div>Miao, D. ∙ Margolis, C.A. ∙ Vokes, N.I. ...</div><div><strong>Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors</strong></div><div><em>Nat. Genet.</em> 2018; <strong>50</strong>:1271-1281</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41588-018-0200-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85052712350" target="_blank" aria-label="Open Scopus in new tab">Scopus (121)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30150660/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41588-018-0200-2&amp;pmid=30150660" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref98" href="#" role="doc-biblioref" data-xml-rid="bib98" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref98" aria-controls="sref98">Trucco et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref98"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">98.</div><div>Trucco, L.D. ∙ Mundra, P.A. ∙ Hogan, K. ...</div><div><strong>Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanoma</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:221-224</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0265-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_98_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85058061858" target="_blank" aria-label="Open Scopus in new tab">Scopus (27)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30510256/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0265-6&amp;pmid=30510256" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). All of the signatures (except 1A, aging) were associated with a significantly improved chance of CPI response (<a id="crosref0560" href="#fig4">Figure&nbsp;4</a>A). Next, we sought to identify properties of these mutational processes that may lead to more immunogenic epitopes. Interestingly, we noted a strong association between signature 4 (tobacco)/signature 7 (UV) mutations and dinucleotide variant (DNV) count. DNVs were particularly enriched in melanoma, correlating strongly with signature 7 (UV) mutation proportion (rho&nbsp;= 0.65, p&nbsp;&lt; 2.2&nbsp;× 10<sup>−16</sup>, <a id="crosref0565" href="#fig4">Figure&nbsp;4</a>B) and significantly associated with CPI response (<a id="crosref0570" href="#figs2">Figure&nbsp;S2</a>B). Up to 10% of UV mutations are known to be CC &gt; TT changes (<span class="dropBlock reference-citations"><a id="body-ref-sref9" href="#" role="doc-biblioref" data-xml-rid="bib9" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref9" aria-controls="sref9">Brash, 2015</a><div class="dropBlock__holder" data-db-target-of="sref9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Brash, D.E.</div><div><strong>UV signature mutations</strong></div><div><em>Photochem. Photobiol.</em> 2015; <strong>91</strong>:15-26</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/php.12377" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84921519652" target="_blank" aria-label="Open Scopus in new tab">Scopus (185)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25354245/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fphp.12377&amp;pmid=25354245" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Dinucleotide changes have two unique properties compared to single-nucleotide variants (SNVs): (1) where they straddle two codons, a double amino acid change can occur; and (2) in cases where both nucleotide changes are in the same codon, a more radical change in amino acid properties can result. While the first property is of obvious immunogenic relevance, we note only a small minority of DNVs produce a 2-amino-acid mutation (3.5% [95% CI, 3.1%–4.0%]), which in absolute number equates on average to ∼0.2 such mutations per tumor. However, the second property is of likely broader relevance, with DNVs being associated with a wider repertoire of amino acid change. Specifically, for SNV mutations, a total of only 150 unique reference to alternative amino acid change combinations were observed, whereas DNVs generated 250 different unique reference to alternative change combinations (p&nbsp;= 4.7&nbsp;× 10<sup>−13</sup>, <a id="crosref0580" href="#fig4">Figure&nbsp;4</a>C). Many of the amino acid changes observed in the DNV group, such as CCT codon (p&nbsp;= proline) change to TTT codon (F&nbsp;= phenylalanine), are impossible with only a single nucleotide change (<a id="crosref0585" href="#fig4">Figure&nbsp;4</a>C). As such, DNVs were found to associate with a higher proportion of radical versus conservative amino acid substitutions (p&nbsp;&lt; 2.2&nbsp;× 10<sup>−16</sup>, <a id="crosref0590" href="#fig4">Figure&nbsp;4</a>C), as well as a greater change in Grantham distance (p&nbsp;&lt; 2.2&nbsp;× 10<sup>−16</sup>, <a id="crosref0595" href="#fig4">Figure&nbsp;4</a>D). Importantly, DNV changes were also associated with a larger increase in hydrophobicity compared to SNVs (p&nbsp;&lt; 2.2&nbsp;× 10<sup>−16</sup>, <a id="crosref0600" href="#fig4">Figure&nbsp;4</a>D), a feature known to enhance peptide immunogenicity (<span class="dropBlock reference-citations"><a id="body-ref-sref17" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17" aria-controls="sref17">Chowell et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Chowell, D. ∙ Krishna, S. ∙ Becker, P.D. ...</div><div><strong>TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T&nbsp;cell epitopes</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2015; <strong>112</strong>:E1754-E1762</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1500973112" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84929659335" target="_blank" aria-label="Open Scopus in new tab">Scopus (81)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25831525/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1500973112&amp;pmid=25831525" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Indeed, we obtained functional data from melanoma/gastric cancer patient tumor-infiltrating lymphocyte (TIL) samples, which were screened for reactivity against neoantigen peptides (<span class="dropBlock reference-citations"><a id="body-ref-sref20-1" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20-1" aria-controls="sref20-1">Chudley et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref20-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Chudley, L. ∙ McCann, K.J. ∙ Coleman, A. ...</div><div><strong>Harmonisation of short-term in&nbsp;vitro culture for the expansion of antigen-specific CD8(+) T&nbsp;cells with detection by ELISPOT and HLA-multimer staining</strong></div><div><em>Cancer Immunol. Immunother.</em> 2014; <strong>63</strong>:1199-1211</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s00262-014-1593-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84939876111" target="_blank" aria-label="Open Scopus in new tab">Scopus (16)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25134947/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs00262-014-1593-0&amp;pmid=25134947" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref40-1" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-1" aria-controls="sref40-1">Gros et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref40-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Gros, A. ∙ Parkhurst, M.R. ∙ Tran, E. ...</div><div><strong>Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients</strong></div><div><em>Nat. Med.</em> 2016; <strong>22</strong>:433-438</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4051" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84959152038" target="_blank" aria-label="Open Scopus in new tab">Scopus (398)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26901407/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4051&amp;pmid=26901407" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref96-1" href="#" role="doc-biblioref" data-xml-rid="bib96" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref96-1" aria-controls="sref96-1">Tran et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref96-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">96.</div><div>Tran, E. ∙ Ahmadzadeh, M. ∙ Lu, Y.C. ...</div><div><strong>Immunogenicity of somatic mutations in human gastrointestinal cancers</strong></div><div><em>Science.</em> 2015; <strong>350</strong>:1387-1390</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad1253" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84949730499" target="_blank" aria-label="Open Scopus in new tab">Scopus (363)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26516200/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad1253&amp;pmid=26516200" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and found that T&nbsp;cell reactive epitopes had a significantly higher hydrophobicity score compared to nonreactive epitopes (p&nbsp;= 0.04; <a id="crosref0625" href="#fig4">Figure&nbsp;4</a>E). We note the nature of this analysis is hypothesis generating, and further functional investigation of DNVs will be of significant interest.</div><div class="figure-wrap"><figure id="fig4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.002/asset/882422eb-4eb6-4f61-a351-87d6a14109ab/main.assets/gr4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr4" src="/cms/10.1016/j.cell.2021.01.002/asset/54f2a675-d8b3-4162-98dc-0d49f38b8a66/main.assets/gr4.jpg" height="959" width="683" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/882422eb-4eb6-4f61-a351-87d6a14109ab/main.assets/gr4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;4</span> <span class="figure__title__text">Mutational processes associated with CPI response</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0075" role="paragraph">(A) Forest plot of each mutation signature and its association with CPI response, with odds ratio values shown on the y-axis, and p-values derived from meta-analysis (hence the results are not biased by mixing histology types).</div><div id="fspara0080" role="paragraph">(B) Proportion of signature 7 (UV) mutations (left) and the number of dinucleotide variants (DNVs) per tumor (middle), split by histology type. The panel on the right shows the correlation between signature 7 proportion and DNV count. p value and correlation coefficient are from Spearman’s rank test.</div><div id="fspara0085" role="paragraph">(C) Grid of substitutions from the reference amino acid (rows) to the mutated amino acid (columns). The heatmap is colored from low to high, based on the simple count of each observed ref &gt; alt change in the cohort, shown on a log10 scale. The first grid (left) shows the data for SNVs, and the second grid (middle) shows data for DNVs. The first barplot (middle) then quantifies the number of unique changes observed for SNVs and DNVs, and the second barplot shows the proportion of amino acid changes resulting in a radical amino acid change (i.e., Grantham distance ≥ 100) compared to those resulting in a conservative change (Grantham distance&nbsp;&lt; 100), with p-values derived from Fisher's exact test.</div><div id="fspara0090" role="paragraph">(D) Grantham distances for SNV and DNV changes (left boxplot), and change in hydrophobicity score in the ridge plot (right), with p-value derived from Mann-Whitney U test.</div><div id="fspara0095" role="paragraph">(E) Hydrophobicity scores of neoantigen epitopes undergoing T&nbsp;cell reactivity screening, with p-value derived from Mann-Whitney U test.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-4"><h3>Loss of 9q34.3 sensitizes tumors to CPI response</h3><div id="p0065" role="paragraph">Next, we undertook a genome-wide somatic copy-number analysis in the CPI1000+ sample set to search for genomic loci associated with CPI response. The reasoning for this is that although the total burden of SCNAs was not found to predict response (<a id="crosref0630" href="#fig2">Figure&nbsp;2</a>A), changes to specific loci may drive resistance or sensitization to therapy. The frequency of somatic copy-number gains and losses was traced across the genome for CPI responders (CR/PR) (n&nbsp;= 257) and nonresponders (SD/PD) (n&nbsp;= 731), using all samples with available QC validated exome copy-number alteration data (<a id="crosref0635" href="#fig5">Figure&nbsp;5</a>A) (CPI1000+ samples, test cohort 1 and other available samples; see <a id="crosref0640" href="#sec-4">STAR methods</a>), and frequency differences were compared per cytoband (<a id="crosref0645" href="#fig5">Figure&nbsp;5</a>B). The most significantly differential cytoband was 9q34, which was lost in responders with a frequency of 44.4% compared to nonresponders with 30.5% (p&nbsp;= 6.9&nbsp;× 10<sup>−5</sup>, q&nbsp;= 0.02, CPI1000+ cohort) (<a id="crosref0650" href="#fig5">Figure&nbsp;5</a>B). Hence, loss of 9q34 was associated with sensitization to CPI therapy. Fine mapping of this locus revealed a sharp peak in the frequency difference at 9q34.3, directly overlapping the gene <i>TRAF2</i> (<a id="crosref0655" href="#fig5">Figure&nbsp;5</a>C). <i>TRAF2</i> has been independently identified in recent functional work (<span class="dropBlock reference-citations"><a id="body-ref-sref106-1" href="#" role="doc-biblioref" data-xml-rid="bib106" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref106-1" aria-controls="sref106-1">Vredevoogd et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref106-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">106.</div><div>Vredevoogd, D.W. ∙ Kuilman, T. ∙ Ligtenberg, M.A. ...</div><div><strong>Augmenting immunotherapy impact by lowering tumor TNF cytotoxicity threshold</strong></div><div><em>Cell.</em> 2019; <strong>178</strong>:585-599.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_106_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2019.06.014&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_106_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2019.06.014&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_106_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85069738521" target="_blank" aria-label="Open Scopus in new tab">Scopus (34)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31303383/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.06.014&amp;pmid=31303383" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) as the top hit in a genome-wide CRISPR screen for genes, that when knocked out, sensitize tumor cells to T cell-mediated elimination. Mechanistically, <i>TRAF2</i> loss was shown to enhance CPI efficacy by lowering the tumor necrosis factor (TNF) cytotoxicity threshold and increasing T cell-mediated tumor cell apoptosis (<span class="dropBlock reference-citations"><a id="body-ref-sref106-2" href="#" role="doc-biblioref" data-xml-rid="bib106" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref106-2" aria-controls="sref106-2">Vredevoogd et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref106-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">106.</div><div>Vredevoogd, D.W. ∙ Kuilman, T. ∙ Ligtenberg, M.A. ...</div><div><strong>Augmenting immunotherapy impact by lowering tumor TNF cytotoxicity threshold</strong></div><div><em>Cell.</em> 2019; <strong>178</strong>:585-599.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_106_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2019.06.014&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_106_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2019.06.014&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_106_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85069738521" target="_blank" aria-label="Open Scopus in new tab">Scopus (34)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31303383/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.06.014&amp;pmid=31303383" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). <i>TRAF2</i> loss was found to be significantly enriched in responders in the overall pan-cancer cohort (p&nbsp;= 1.8&nbsp;× 10<sup>−4</sup>), as well as urothelial cancer (p&nbsp;= 8.0&nbsp;× 10<sup>−3</sup>), melanoma (p&nbsp;= 3.2&nbsp;× 10<sup>−2</sup>), and borderline nonsignificance in the “other tumor types” cohort (p&nbsp;= 7.0&nbsp;× 10<sup>−2</sup>) as individual cohorts (<a id="crosref0670" href="#fig5">Figure&nbsp;5</a>D). We note the majority of 9q34 losses were found to be single-allele events (i.e., not homozygous deletions); however, supporting a potential functional impact from single-allele loss, we analyzed human germline data on n&nbsp;= 125,748 individuals from the gnomAD study (<span class="dropBlock reference-citations"><a id="body-ref-sref47" href="#" role="doc-biblioref" data-xml-rid="bib47" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref47" aria-controls="sref47">Karczewski et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref47"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Karczewski, K.J. ∙ Francioli, L.C. ∙ Tiao, G. ..., Genome Aggregation Database Consortium</div><div><strong>The mutational constraint spectrum quantified from variation in 141,456 humans</strong></div><div><em>Nature.</em> 2020; <strong>581</strong>:434-443</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-020-2308-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85085542423" target="_blank" aria-label="Open Scopus in new tab">Scopus (564)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32461654/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-020-2308-7&amp;pmid=32461654" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and found <i>TRAF2</i> to have a very high probability of being haploinsufficient (p&nbsp;= 0.99979, probability of haploinsufficiency [pLI] score) (<a id="crosref0680" href="#fig5">Figure&nbsp;5</a>E). In addition, we obtained drug screen data from the “Genomics of Drug Sensitivity in Cancer” database (<span class="dropBlock reference-citations"><a id="body-ref-sref113" href="#" role="doc-biblioref" data-xml-rid="bib113" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref113" aria-controls="sref113">Yang et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref113"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">113.</div><div>Yang, W. ∙ Soares, J. ∙ Greninger, P. ...</div><div><strong>Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells</strong></div><div><em>Nucleic Acids Res.</em> 2013; <strong>41</strong>:D955-D961</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gks1111" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_113_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84876563391" target="_blank" aria-label="Open Scopus in new tab">Scopus (714)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23180760/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgks1111&amp;pmid=23180760" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) for two TNF pathway compounds that inhibit TRAF2 binding partners, BIRC2/BIRC3 (IAP-5620) and BIRC2 (AZD5582). Cell lines with heterozygous TRAF2 mutation (n&nbsp;= 32) were significantly more sensitive to IAP-5620 treatment than wild-type (n&nbsp;= 685) cell lines (<a id="crosref0690" href="#figs3">Figure&nbsp;S3</a>A; p&nbsp;= 2.5&nbsp;× 10<sup>−2</sup>). Within the CPI1000+ cohort, we also observe higher rates of antigen-presentation-pathway defects, (as defined in <span class="dropBlock reference-citations"><a id="body-ref-sref84-2" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84-2" aria-controls="sref84-2">Rosenthal et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref84-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Rosenthal, R. ∙ Cadieux, E.L. ∙ Salgado, R. ..., TRACERx consortium</div><div><strong>Neoantigen-directed immune escape in lung cancer evolution</strong></div><div><em>Nature.</em> 2019; <strong>567</strong>:479-485</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1032-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85063265508" target="_blank" aria-label="Open Scopus in new tab">Scopus (180)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30894752/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1032-7&amp;pmid=30894752" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) in 9q34 (TRAF2)-loss tumors compared to wild-type, suggesting heightened immune pressure in TRAF2-loss samples (<a id="crosref0700" href="#figs3">Figure&nbsp;S3</a>B; p&nbsp;= 1.2&nbsp;× 10<sup>−8</sup>).</div><div class="figure-wrap"><figure id="fig5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.002/asset/63e92e88-a0e0-4a4a-988e-7c3114189d74/main.assets/gr5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr5" src="/cms/10.1016/j.cell.2021.01.002/asset/41b78baf-6cfa-4bfb-9052-fe3197331db9/main.assets/gr5.jpg" height="698" width="753" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/63e92e88-a0e0-4a4a-988e-7c3114189d74/main.assets/gr5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;5</span> <span class="figure__title__text">Somatic copy-number alteration (SCNA) profile of CPI responders versus nonresponders</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0105" role="paragraph">(A) Frequency of somatic copy-number gain (top) and loss (bottom) across the genome for CPI responders (“CR/PR”) versus nonresponders (“SD/PD”).</div><div id="fspara0110" role="paragraph">(B) Cytobands with significantly different loss or gain frequencies in responders versus nonresponders,with p-value derived from Fisher's exact test, and q values from FDR correction.</div><div id="fspara0115" role="paragraph">(C) Fine mapping of the 9q34 locus to identify the peak of differential loss frequency between groups.</div><div id="fspara0120" role="paragraph">(D) <i>TRAF2</i>-loss percentage frequencies for cohorts with a significant difference between responders and nonresponders, with p-value derived from Fisher's exact test.</div><div id="fspara0125" role="paragraph">(E) Probability of haploinsufficiency (pLI) scores from the gnomAD/ExAC consortium data (n&nbsp;= 125,748 germline human samples).</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.002/asset/45fdef0a-9e38-48e3-b8c0-1827a1ca8e08/main.assets/figs3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs3" src="/cms/10.1016/j.cell.2021.01.002/asset/998b51dd-d076-4075-bc1e-3d79183bc1c7/main.assets/figs3.jpg" height="515" width="504" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/45fdef0a-9e38-48e3-b8c0-1827a1ca8e08/main.assets/figs3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S3</span> <span class="figure__title__text">9q34 (TRAF2) analysis and immune evasion data, related to <a id="crosref1680" href="#fig5">Figure&nbsp;5</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0215" role="paragraph">Panel A shows drug sensitivity screening data for two compounds, for <i>TRAF2</i> heterozygously mutated versus <i>TRAF2</i> wild-type cell lines. Panel B shows immune evasion analysis, measuring as the % of patients with an antigen presentation pathway defect between tumors with 9q34 wild-type (i.e., no loss) compared to 9q34 loss tumors. The left barplot includes either a somatic copy number loss, or a non-synonymous mutation, in an antigen presentation pathway gene. The right plot includes non-synonymous mutations only. Antigen presentation pathway genes were defined as per (<span class="dropBlock reference-citations"><a id="body-ref-sref84-3" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84-3" aria-controls="sref84-3">Rosenthal et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref84-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Rosenthal, R. ∙ Cadieux, E.L. ∙ Salgado, R. ..., TRACERx consortium</div><div><strong>Neoantigen-directed immune escape in lung cancer evolution</strong></div><div><em>Nature.</em> 2019; <strong>567</strong>:479-485</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1032-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85063265508" target="_blank" aria-label="Open Scopus in new tab">Scopus (180)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30894752/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1032-7&amp;pmid=30894752" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), also see methods. Panel C shows the frequency of whole chromosome loss in TCGA for the set of cancer types included in the CPI1000+ study.</div></div></div></div></figcaption></figure></div><div id="p0070" role="paragraph">The high frequency of 9q34 loss raises an important evolutionary question as to why tumors would be selected with a potentially disadvantageous event. Detailed inspection of the 9q34-loss events revealed that the majority of cases were in fact whole-chromosome 9 losses, and analysis of independent TCGA data for the same seven histologies considered in the CPI1000+ cohort revealed that loss of chromosome 9 is the most frequent whole-chromosome (p+q)-loss event (<a id="crosref0705" href="#figs3">Figure&nbsp;S3</a>C). Chromosome 9 contains a number of tumor suppressor genes, with loss of <i>CDKN2A</i> (9p21.3) in particular being under strong positive selection and associated with aggressive tumor growth in multiple tumor types (<span class="dropBlock reference-citations"><a id="body-ref-sref92-1" href="#" role="doc-biblioref" data-xml-rid="bib92" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref92-1" aria-controls="sref92-1">Smith and Sheltzer, 2018</a><div class="dropBlock__holder" data-db-target-of="sref92-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">91.</div><div>Smith, J.C. ∙ Sheltzer, J.M.</div><div><strong>Systematic identification of mutations and copy number alterations associated with cancer patient prognosis</strong></div><div><em>eLife.</em> 2018; <strong>7</strong>:e39217</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.39217" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_91_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85058605162" target="_blank" aria-label="Open Scopus in new tab">Scopus (28)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30526857/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.39217&amp;pmid=30526857" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref101" href="#" role="doc-biblioref" data-xml-rid="bib101" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref101" aria-controls="sref101">Turajlic et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref101"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">101.</div><div>Turajlic, S. ∙ Xu, H. ∙ Litchfield, K. ..., PEACE, TRACERx Renal Consortium</div><div><strong>Tracking cancer evolution reveals constrained routes to metastases: TRACERx Renal</strong></div><div><em>Cell.</em> 2018; <strong>173</strong>:581-594.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_101_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2018.03.057&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_101_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2018.03.057&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_101_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85045083551" target="_blank" aria-label="Open Scopus in new tab">Scopus (215)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29656895/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.03.057&amp;pmid=29656895" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref111-1" href="#" role="doc-biblioref" data-xml-rid="bib111" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref111-1" aria-controls="sref111-1">Watkins et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref111-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">111.</div><div>Watkins, T.B.K. ∙ Lim, E.L. ∙ Petkovic, M. ...</div><div><strong>Pervasive chromosomal instability and karyotype order in tumour evolution</strong></div><div><em>Nature.</em> 2020; <strong>587</strong>:126-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-020-2698-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_111_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85090112455" target="_blank" aria-label="Open Scopus in new tab">Scopus (2)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32879494/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-020-2698-6&amp;pmid=32879494" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). By contrast, loss of <i>TRAF2</i> is not documented as a cancer-driver event (e.g., not listed in the Cancer Gene Census; <a id="intref0010" href="https://cancer.sanger.ac.uk/census" target="_blank">https://cancer.sanger.ac.uk/census</a>), and hence, loss of this gene may be a passenger event. Following CPI treatment, the potentially deleterious impact of <i>TRAF2</i> loss on tumor cell fitness is revealed, where it has potential to enhance anti-tumor T&nbsp;cell activity (<span class="dropBlock reference-citations"><a id="body-ref-sref106-3" href="#" role="doc-biblioref" data-xml-rid="bib106" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref106-3" aria-controls="sref106-3">Vredevoogd et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref106-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">106.</div><div>Vredevoogd, D.W. ∙ Kuilman, T. ∙ Ligtenberg, M.A. ...</div><div><strong>Augmenting immunotherapy impact by lowering tumor TNF cytotoxicity threshold</strong></div><div><em>Cell.</em> 2019; <strong>178</strong>:585-599.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_106_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2019.06.014&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_106_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2019.06.014&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_106_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85069738521" target="_blank" aria-label="Open Scopus in new tab">Scopus (34)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31303383/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.06.014&amp;pmid=31303383" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Hence, these data suggest an evolutionary model where loss of whole chromosome 9 is selected as a driver event early in tumor evolution (e.g., due to <i>CDKN2A</i>), but then later leads to collateral sensitivity (<span class="dropBlock reference-citations"><a id="body-ref-sref115-1" href="#" role="doc-biblioref" data-xml-rid="bib115" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref115-1" aria-controls="sref115-1">Zhao et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref115-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">115.</div><div>Zhao, B. ∙ Sedlak, J.C. ∙ Srinivas, R. ...</div><div><strong>Exploiting temporal collateral sensitivity in tumor clonal evolution</strong></div><div><em>Cell.</em> 2016; <strong>165</strong>:234-246</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_115_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2016.01.045&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_115_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2016.01.045&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_115_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84961654807" target="_blank" aria-label="Open Scopus in new tab">Scopus (56)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26924578/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2016.01.045&amp;pmid=26924578" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) to immunotherapy, possibly due to 9q34 (<i>TRAF2</i>) loss. We note chromosome 9q34 loss was also identified in a recent RCC anti-PD-1 study (<span class="dropBlock reference-citations"><a id="body-ref-sref10" href="#" role="doc-biblioref" data-xml-rid="bib10" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref10" aria-controls="sref10">Braun et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Braun, D.A. ∙ Hou, Y. ∙ Bakouny, Z. ...</div><div><strong>Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma</strong></div><div><em>Nat. Med.</em> 2020; <strong>26</strong>:909-918</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-020-0839-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85085556126" target="_blank" aria-label="Open Scopus in new tab">Scopus (25)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32472114/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-020-0839-y&amp;pmid=32472114" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), as associated with increased immune cell infiltration. However, the histology differences between RCC and the pan-cancer cohort presented here should be noted, and hence, these findings may not be linked to a common biological cause. We acknowledge our findings here of 9q34 (<i>TRAF2</i>) loss being associated with CPI sensitization are exploratory in nature and have not been externally validated. Lastly, while primarily powered for pan-cancer copy-number analysis, we also repeated the above copy-number analysis per tumor/drug type (as per <a id="crosref0740" href="#fig2">Figure&nbsp;2</a>B) and identified a number of candidate cytobands significantly associated with CPI response in individual subcohorts (q&nbsp;&lt; 0.1; <a id="crosref0745" href="#figs4">Figure&nbsp;S4</a>).</div><div class="figure-wrap"><figure id="figs4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.002/asset/221e6402-6246-40b5-a3c0-f1c14d7c14f6/main.assets/figs4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs4" src="/cms/10.1016/j.cell.2021.01.002/asset/58796cb1-a5ba-42af-89e2-b5d1c4df233f/main.assets/figs4.jpg" height="462" width="762" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/221e6402-6246-40b5-a3c0-f1c14d7c14f6/main.assets/figs4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S4</span> <span class="figure__title__text">Cytobands with significantly different copy-number loss or gain frequencies in responders versus nonresponders, related to <a id="crosref1690" href="#fig5">Figure&nbsp;5</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0225" role="paragraph">Analysis is split by 4 tumor/drug types.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-5"><h3>Focal amplification of <i>CCND1</i> associates with CPI resistance</h3><div id="p0075" role="paragraph">Next, we considered focal (&lt;3 Mb) (<span class="dropBlock reference-citations"><a id="body-ref-sref52" href="#" role="doc-biblioref" data-xml-rid="bib52" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref52" aria-controls="sref52">Krijgsman et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref52"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>Krijgsman, O. ∙ Carvalho, B. ∙ Meijer, G.A. ...</div><div><strong>Focal chromosomal copy number aberrations in cancer-Needles in a genome haystack</strong></div><div><em>Biochim. Biophys. Acta.</em> 2014; <strong>1843</strong>:2698-2704</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.bbamcr.2014.08.001" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84905962250" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25110350/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bbamcr.2014.08.001&amp;pmid=25110350" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) amplifications (defined as copy number ≥ 5) (<span class="dropBlock reference-citations"><a id="body-ref-sref33" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33" aria-controls="sref33">Fontanilles et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref33"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">32.</div><div>Fontanilles, M. ∙ Marguet, F. ∙ Ruminy, P. ...</div><div><strong>Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma</strong></div><div><em>Acta Neuropathol. Commun.</em> 2020; <strong>8</strong>:52</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s40478-020-00917-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85083451351" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32303258/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs40478-020-00917-6&amp;pmid=32303258" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and homozygous deletions (copy number&nbsp;= 0) in oncogenes and tumor suppressor genes respectively, to understand if these events are associated with CPI response. The most significant association was found to be significantly lower rates of CPI response in tumors with <i>CCND1</i> amplification (response rate&nbsp;= 16.3%) compared to wild-type (26.6%) (p&nbsp;= 4.8&nbsp;× 10<sup>−2</sup>; <a id="crosref0760" href="#fig6">Figure&nbsp;6</a>A). Similarly to <i>TRAF2</i>, prior functional evidence supports a role for <i>CCND1</i> in determining CPI response (<span class="dropBlock reference-citations"><a id="body-ref-sref114-1" href="#" role="doc-biblioref" data-xml-rid="bib114" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref114-1" aria-controls="sref114-1">Zhang et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref114-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">114.</div><div>Zhang, J. ∙ Bu, X. ∙ Wang, H. ...</div><div><strong>Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance</strong></div><div><em>Nature.</em> 2018; <strong>553</strong>:91-95</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_114_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85040189345" target="_blank" aria-label="Open Scopus in new tab">Scopus (229)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29160310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25015&amp;pmid=29160310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Specifically, <span class="dropBlock reference-citations"><a id="body-ref-sref114-2" href="#" role="doc-biblioref" data-xml-rid="bib114" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref114-2" aria-controls="sref114-2">Zhang et&nbsp;al. (2018)</a><div class="dropBlock__holder" data-db-target-of="sref114-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">114.</div><div>Zhang, J. ∙ Bu, X. ∙ Wang, H. ...</div><div><strong>Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance</strong></div><div><em>Nature.</em> 2018; <strong>553</strong>:91-95</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_114_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85040189345" target="_blank" aria-label="Open Scopus in new tab">Scopus (229)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29160310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25015&amp;pmid=29160310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span> demonstrated that PD-L1 protein abundance fluctuates during cell-cycle progression and that Cyclin D-CDK4 negatively regulates PD-L1 protein stability. Urothelial carcinoma had the highest number of <i>CCND1</i> amplified tumors (<a id="crosref0775" href="#fig6">Figure&nbsp;6</a>B); accordingly we assessed mRNA levels in this histology type and observed significantly higher levels of <i>CCND1</i> expression in urothelial cancer nonresponders (SD/PD) versus responders (PR/CR) (p&nbsp;= 1.5&nbsp;× 10<sup>−2</sup>) (<a id="crosref0780" href="#fig6">Figure&nbsp;6</a>C). To validate the effect of <i>CCND1</i> amplification in an independent cohort, we conducted overall survival analysis in n&nbsp;= 214 urothelial cancer patients treated with CPI in the MSK1600 cohort and observed a strong effect size whereby <i>CCND1</i> amplification was associated with significantly shorter overall survival (hazard ratio [HR]&nbsp;= 3.6 [1.9–7.0], p&nbsp;= 1.3&nbsp;× 10<sup>−4</sup>)(<a id="crosref0785" href="#fig6">Figure&nbsp;6</a>D). As negative control, we observed no overall survival difference in MSK-IMPACT urothelial cancer patients not treated with CPI, controlling for the possibility that <i>CCND1</i>-amplified tumors have a generally poorer prognosis irrespective of CPI treatment (<a id="crosref0790" href="#fig6">Figure&nbsp;6</a>E). Finally, we assessed the role of <i>CCND1</i> amplification in a pan-cancer context in MSK1600 and found a significant association with reduced overall survival in CPI-treated patients (HR&nbsp;= 2.0 [1.4–2.9], p&nbsp;= 3.3&nbsp;× 10<sup>−4</sup>) (<a id="crosref0795" href="#fig6">Figure&nbsp;6</a>F), but not the non-CPI-treated MSK cohort (p&nbsp;= n.s., which is a larger cohort with arguably greater power) (<a id="crosref0800" href="#fig6">Figure&nbsp;6</a>G). The data suggest a predictive association between <i>CCND1</i> amplification and CPI resistance, rather than prognostic; however, formal treatment × genotype interaction analysis will be required to confirm this (we note the two MSK cohorts, CPI and non-CPI, had considerably different follow-up times and could not be reliably combined together for interaction analysis; we further note the sensitivity to call single-allele SCNA events was found to be reduced in the MSK panel data, which was not encountered for validation of <i>CCND1</i> amplification events which have multiple copy gains; therefore, we could not reliably address 9q34 (<i>TRAF2</i>) losses in this cohort).</div><div class="figure-wrap"><figure id="fig6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.002/asset/3d9c572f-e9f2-497e-aa97-87d5ad60858e/main.assets/gr6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr6" src="/cms/10.1016/j.cell.2021.01.002/asset/8f25b0df-a056-454a-b593-ec92abd5fb99/main.assets/gr6.jpg" height="422" width="753" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/3d9c572f-e9f2-497e-aa97-87d5ad60858e/main.assets/gr6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;6</span> <span class="figure__title__text">Focal amplification and deletion profile of CPI responders versus nonresponders</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0135" role="paragraph">(A) CPI response rate (% “CR/PR”) in patients with focal amplification (defined as copy number ≥ 5) or homozygous deletion (copy number&nbsp;= 0) compared to wild-type (nonamplified/deleted) tumors. The analysis was conducted for all oncogenes/tumor suppressor genes with greater than 5% amplification/deletion frequency, and p-values were derived from Fisher's exact test.</div><div id="fspara0140" role="paragraph">(B) Counts of <i>CCND1</i> amplification by histology.</div><div id="fspara0145" role="paragraph">(C) mRNA expression for <i>CCND1</i> in responders versus nonresponders from the Mariathasan et&nbsp;al. urothelial cancer cohort, with p-value derived from Mann-Whitney U test.</div><div id="fspara0150" role="paragraph">(D) Overall survival analysis in MSK-IMPACT urothelial cancer CPI-treated patients for <i>CCND1</i>-amplified versus wild-type tumor groups.</div><div id="fspara0155" role="paragraph">(E) Overall survival analysis in MSK-IMPACT urothelial cancer non-CPI-treated patients for <i>CCND1</i>-amplified versus wild-type tumor groups.</div><div id="fspara0160" role="paragraph">(F) Overall survival analysis in MSK-IMPACT pan-cancer CPI-treated patients for <i>CCND1</i>-amplified versus wild-type tumor groups.</div><div id="fspara0165" role="paragraph">(G) Overall survival analysis in MSK-IMPACT pan-cancer non-CPI-treated patients for <i>CCND1</i>-amplified versus wild-type tumor groups.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-6"><h3>Single-cell RNA-seq identifies <i>CXCL13</i> and <i>CCR5</i></h3><div id="p0080" role="paragraph">The identification of clonal mutation burden as the biomarker with strongest effect size in the CPI1000+ cohort implicates a central role for T&nbsp;cell responses targeting clonal neoantigens during immunotherapy. To examine whether genes expressed by clonal neoantigen-reactive T&nbsp;cells could help further elucidate the drivers of CPI response, we performed single-cell RNA sequencing (RNA-seq) on <i>ex&nbsp;vivo</i> CD8 TILs from a treatment-naive NSCLC patient (L011) sorted according to positivity for a clonal neoantigen (<i>MTFR2</i>) multimer (as previously described; <span class="dropBlock reference-citations"><a id="body-ref-sref64-1" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-1" aria-controls="sref64-1">McGranahan et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref64-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>McGranahan, N. ∙ Furness, A.J. ∙ Rosenthal, R. ...</div><div><strong>Clonal neoantigens elicit T&nbsp;cell immunoreactivity and sensitivity to immune checkpoint blockade</strong></div><div><em>Science.</em> 2016; <strong>351</strong>:1463-1469</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaf1490" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84962301577" target="_blank" aria-label="Open Scopus in new tab">Scopus (1319)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26940869/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaf1490&amp;pmid=26940869" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). 846 genes were significantly upregulated in multimer-positive (Mult<sup>+</sup>) cells relative to multimer-negative (Mult<sup>−</sup>) cells from the same region (q&nbsp;&lt; 0.05; <a id="crosref0810" href="#fig7">Figure&nbsp;7</a>A), including major histocompatibility complex class II (MHC class II) presentation machinery (e.g., <i>HLA-DOA</i> and <i>HLA-DMB</i>) and glycoprotein enzymes upregulated during T&nbsp;cell activation (e.g., <i>CD38</i>), trafficking (<i>CCR5</i>), and T&nbsp;cell dysfunction (<i>CXCL13</i>, <i>IL-10</i>, <i>IL27RA</i>, <i>FAS</i>, and <i>MYO7A</i>) (<a id="crosref0815" href="#fig7">Figure&nbsp;7</a>A). Of the genes significantly enriched in Mult<sup>+</sup> cells (&gt;2-fold upregulation and q&nbsp;&lt; 0.05), 101 were also significantly more highly expressed in responders (“CR/PR”) versus nonresponders (“SD/PD”) in the CPI1000+ cohort dataset (p&nbsp;&lt; 0.05) (<a id="crosref0820" href="#fig7">Figure&nbsp;7</a>B). <i>CXCL13</i> exhibited the most marked selective expressions in CPI responders (<a id="crosref0825" href="#fig7">Figure&nbsp;7</a>B) and was the second highest differentially expressed gene in Mult<sup>+</sup> cells (log2 fold change [FC]&nbsp;= 13.4 versus Mult<sup>−</sup>, q&nbsp;= 0.0047) (<a id="crosref0830" href="#fig7">Figures 7</a>A–7C). We note this result validates recent work from <span class="dropBlock reference-citations"><a id="body-ref-sref95-1" href="#" role="doc-biblioref" data-xml-rid="bib95" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref95-1" aria-controls="sref95-1">Thommen et&nbsp;al. (2018)</a><div class="dropBlock__holder" data-db-target-of="sref95-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">94.</div><div>Thommen, D.S. ∙ Koelzer, V.H. ∙ Herzig, P. ...</div><div><strong>A transcriptionally and functionally distinct PD-1<sup>+</sup> CD8<sup>+</sup> T&nbsp;cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:994-1004</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0057-z" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_94_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85048343664" target="_blank" aria-label="Open Scopus in new tab">Scopus (233)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29892065/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0057-z&amp;pmid=29892065" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, and taken together, highlights that <i>CXCL13</i> expression may be a feature of clonal neoantigen-reactive CD8 TILs that associates with CPI outcome in a pan-cancer cohort. The gene next most highly expressed in responders was <i>CCR5</i>, a chemokine receptor central to T&nbsp;cell migration within draining lymph nodes and tumor tissues, which was also significantly higher in Mult<sup>+</sup> cells (log2 FC&nbsp;= 8.9 versus Mult<sup>−</sup>, q&nbsp;= 0.002) (<a id="crosref0840" href="#fig7">Figures 7</a>A–7C). To control for the possibility that in the CPI1000+ patient data high <i>CXCL13/CCR5</i> expression merely reflects higher <i>CD8</i> infiltration, we tested a logistic regression model with <i>CD8</i> only compared to <i>CD8&nbsp;+ CXCL13&nbsp;+ CCR5</i> and found the latter model to be significantly better (p&nbsp;= 0.05, likelihood ratio test). Other notable genes significantly upregulated in Mult<sup>+</sup> cells and selectively expressed by responders in the CPI1000+ cohort included co-stimulatory molecules targeted by immunotherapeutic antibodies under clinical investigation (<i>ICOS</i>), negative regulators of TCR signaling or cytokine production&nbsp;(<i>SLA2, IKZF3</i>), loci associated with IFN activity and predisposition to autoimmunity (<i>NCF1</i>, <i>EPSTI1</i>, and <i>PARP9</i>) or allograft rejection (<i>GBP4</i>), and regulators of type I IFN signaling (<i>FBX06</i>) (<a id="crosref0845" href="#fig7">Figure&nbsp;7</a>B). These data suggest that expression of molecular circuits related to chemotaxis, T cell activation, IFN signaling, and T&nbsp;cell exhaustion may help to identify patients that will benefit from CPI and allude to potential immunological networks involving neoantigen reactive T cells that may confer sensitivity of tumors to immunotherapy.</div><div class="figure-wrap"><figure id="fig7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.002/asset/ffa3d189-d19e-4e86-b24e-7f1aaf4fbbdc/main.assets/gr7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr7" src="/cms/10.1016/j.cell.2021.01.002/asset/c97c1a9e-e9f2-4d18-9b64-63d1f8518dd2/main.assets/gr7.jpg" height="601" width="753" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/ffa3d189-d19e-4e86-b24e-7f1aaf4fbbdc/main.assets/gr7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;7</span> <span class="figure__title__text">CD8<sup>+</sup> neoantigen-reactive single-cell RNA-seq and CPI1000+ cohort analysis</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0175" role="paragraph">(A) Single-cell RNA sequencing (RNA-seq) data from neoantigen multimer negative versus positive CD8<sup>+</sup> TILs. The top plot shows the sorting of multimer positive versus negative T&nbsp;cells, and the bottom plot shows differential gene expression analysis between multimer-positive versus multimer-negative cells, with log2 fold change (FC) shown on the x axis and −log10&nbsp;value on the y axis. Significant genes with &gt; 2 FC upregulation (log2(FC) &gt; 1) and false discovery rate (FDR)&nbsp;&lt; 0.05 are shown blue.</div><div id="fspara0180" role="paragraph">(B) The same FC upregulation values from (A) on the y axis and then overlaid on the x axis is upregulation scores from the CPI1000+ cohort (log2[FC] values for responders “PR/CR” versus nonresponders “SD/PD”). The panel only shows genes significantly upregulated in both experiments.</div><div id="fspara0185" role="paragraph">(C) Patient-level mRNA data for the two most strongly unregulated genes (<i>CXCL13</i> and <i>CCR5</i>) from (B) from the CPI1000+ cohort, with p-value derived from Mann-Whitney U test.</div></div></div></div></figcaption></figure></div></section></section><section id="sec-3"><h2>Discussion</h2><div id="p0085" role="paragraph">Here, we present meta-analysis of data across &gt;1,000 patients to assess the reproducibility of CPI response predictors across seven different tumor types. Our combined pan-cancer approach is supported by the common role for tumor antigen recognition and consequent initiation of T&nbsp;cell effector responses that underlie the activity of CPI in a breadth of clinical and experimental models, irrespective of tumor type (<span class="dropBlock reference-citations"><a id="body-ref-sref41" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41" aria-controls="sref41">Havel et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref41"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Havel, J.J. ∙ Chowell, D. ∙ Chan, T.A.</div><div><strong>The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy</strong></div><div><em>Nat. Rev. Cancer.</em> 2019; <strong>19</strong>:133-150</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41568-019-0116-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85061498033" target="_blank" aria-label="Open Scopus in new tab">Scopus (507)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30755690/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41568-019-0116-x&amp;pmid=30755690" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Although clonal TMB and TMB were strongly correlated, clonal TMB emerged as the predictor with strongest effect size and subclonal TMB being nonsignificant. In terms of markers of immune infiltration, <i>CXCL9</i> expression had the highest ranking effect size, outperforming CD8 effector and T&nbsp;cell inflamed signatures. In addition to subclonal TMB, a number of other putative predictors also failed to show consistent evidence of association with response. It is important to note the failure of individual markers to reach statistical significance across all seven tumor types does not rule out their importance in specific histology or drug contexts, nor does it undermine their potential biological relevance. A notable observation from this study is the relative homogeneity in CPI biomarker associations across histologies, as &gt;80% of the biomarkers significant in individual histologies (<a id="crosref0855" href="#fig2">Figure&nbsp;2</a>B) were also significant at the pan-cancer level. Indeed, histology-specific biomarkers were rare (less than five examples identified). However, we note the statistical power in individual histologies is reduced, and as sample sizes increase, additional histology-specific associations may emerge. Adding further complexity, we identified significant differences in effect size between histologies, with TMB, for example, having significantly weaker predictive utility in melanoma as compared to urothelial carcinoma.</div><div id="p0090" role="paragraph">To improve the clinical utility of biomarker stratification in immunotherapy-treated patients, progress is required in two areas: (1) the array of biomarkers identified in a research context needs to be validated and simplified into a single clinical grade test, and (2) evidence is needed to validate that sufficiently high AUC values can be attained with such a test and that this provides useful information to support clinical decision-making. In this context, we propose a multivariable model trained on &gt;1,000 samples and validated in three independent test cohorts, which attains an AUC value of 0.86 in a pan-tumor independent test cohort, superior to TMB alone (0.68). In the short term, the most promising translational strategy is likely to be a panel or exome sequencing approach combined with a targeted gene expression quantification assay. Such a combination would allow the critical measures of antigenicity (e.g., TMB, clonal TMB, and indel TMB) and immune infiltration (e.g., <i>CXCL9</i>, <i>CD8A</i>, <i>CD274</i>, and <i>CXCL13</i>) to be captured in a cost-effective scalable manner. Regarding antigenicity, our data would support the utility of exome sequencing over panel-based approaches, given the importance of mutational signatures such as APOBEC, Tobacco, and UV. Hence, a beneficial path forward would be for a standardized assay to be established, combining exome sequencing and targeted gene expression data (e.g., NanoString) to give a multivariable predictive score of CPI response. An important question is whether predictive models will need to be customized for each cancer/treatment type or if a pan-cancer approach is sufficient. We note that with current sample sizes, the vast majority of biomarkers that were significant in one cancer type also achieved pan-cancer significance. Also, without multiple well-powered cohorts in each specific histology/drug combination, it is difficult to differentiate between study-specific phenomena and genuine tumor/drug-type-specific biology. Thus, until datasets mature in size to thousands of samples per specific combination, a pan-cancer predictive model may provide the most reliable utility. Clearly, any predictive test would require further validation in either a prospective study or additional large-scale retrospective cohorts to assess if the negative and positive predictive values can indeed exceed the threshold of clinical utility. One final observation from this study is the distinction between associations of biological/mechanistic relevance, compared to reproducible clinical grade biomarkers. Hence, caution should be applied in translating research findings into clinical practice too rapidly.</div><div id="p0095" role="paragraph">In the longer term, further discovery work is required to build a more complete understanding of CPI response, and in this context, our analysis shows that previously published biomarkers explain only ∼0.6 of the variance in CPI outcome. To address this gap, we conducted additional discovery analysis, identifying a number of other pan-cancer factors influencing CPI response, namely 9q34.3 (<i>TRAF2</i>) loss, <i>CCND1</i> amplification, DNV count, and expression of <i>CXCL13</i>. 9q34.3 (<i>TRAF2</i>) loss was found to occur via the evolutionary phenomenon of collateral sensitivity (<span class="dropBlock reference-citations"><a id="body-ref-sref115-2" href="#" role="doc-biblioref" data-xml-rid="bib115" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref115-2" aria-controls="sref115-2">Zhao et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref115-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">115.</div><div>Zhao, B. ∙ Sedlak, J.C. ∙ Srinivas, R. ...</div><div><strong>Exploiting temporal collateral sensitivity in tumor clonal evolution</strong></div><div><em>Cell.</em> 2016; <strong>165</strong>:234-246</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_115_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2016.01.045&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_115_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2016.01.045&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_115_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84961654807" target="_blank" aria-label="Open Scopus in new tab">Scopus (56)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26924578/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2016.01.045&amp;pmid=26924578" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), where whole-chromosome 9 loss creates a strong pro-tumor driver effect in untreated patients, which then switches to vulnerability under CPI therapy. From a clinical perspective, the observation of <i>CCND1</i> amplification as a cause of CPI resistance may offer potential therapeutic relevance, either as genetically defined subgroup unlikely to benefit from anti-PD-1/PD-L1 treatment or as a population suitable for combined CPI/anti-CDK4/6 therapy. We note the prognostic role of <i>CCND1</i> outside of immunotherapy response is complex and well studied (<span class="dropBlock reference-citations"><a id="body-ref-sref111-2" href="#" role="doc-biblioref" data-xml-rid="bib111" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref111-2" aria-controls="sref111-2">Watkins et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref111-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">111.</div><div>Watkins, T.B.K. ∙ Lim, E.L. ∙ Petkovic, M. ...</div><div><strong>Pervasive chromosomal instability and karyotype order in tumour evolution</strong></div><div><em>Nature.</em> 2020; <strong>587</strong>:126-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-020-2698-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_111_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85090112455" target="_blank" aria-label="Open Scopus in new tab">Scopus (2)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32879494/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-020-2698-6&amp;pmid=32879494" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), with some reports highlighting reduced survival in <i>CCND1</i>-amplified tumors (<span class="dropBlock reference-citations"><a id="body-ref-sref61" href="#" role="doc-biblioref" data-xml-rid="bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61" aria-controls="sref61">Mahdey et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref61"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>Mahdey, H.M. ∙ Ramanathan, A. ∙ Ismail, S.M. ...</div><div><strong>Cyclin D1 amplification in tongue and cheek squamous cell carcinoma</strong></div><div><em>Asian Pac. J. Cancer Prev.</em> 2011; <strong>12</strong>:2199-2204</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22296356/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=22296356" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref87" href="#" role="doc-biblioref" data-xml-rid="bib87" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref87" aria-controls="sref87">Seiler et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref87"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">86.</div><div>Seiler, R. ∙ Thalmann, G.N. ∙ Rotzer, D. ...</div><div><strong>CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response</strong></div><div><em>Mod. Pathol.</em> 2014; <strong>27</strong>:87-95</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/modpathol.2013.125" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84891741522" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23887292/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fmodpathol.2013.125&amp;pmid=23887292" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref104" href="#" role="doc-biblioref" data-xml-rid="bib104" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref104" aria-controls="sref104">Vízkeleti et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref104"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">104.</div><div>Vízkeleti, L. ∙ Ecsedi, S. ∙ Rákosy, Z. ...</div><div><strong>The role of CCND1 alterations during the progression of cutaneous malignant melanoma</strong></div><div><em>Tumour Biol.</em> 2012; <strong>33</strong>:2189-2199</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s13277-012-0480-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_104_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84866484497" target="_blank" aria-label="Open Scopus in new tab">Scopus (33)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23001925/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs13277-012-0480-6&amp;pmid=23001925" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref108" href="#" role="doc-biblioref" data-xml-rid="bib108" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref108" aria-controls="sref108">Wang et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref108"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">108.</div><div>Wang, M.T. ∙ Chen, G. ∙ An, S.J. ...</div><div><strong>Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma</strong></div><div><em>Dis. Esophagus.</em> 2012; <strong>25</strong>:664-670</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/j.1442-2050.2011.01291.x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_108_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84866294247" target="_blank" aria-label="Open Scopus in new tab">Scopus (24)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22150974/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fj.1442-2050.2011.01291.x&amp;pmid=22150974" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), others reporting the opposite (<span class="dropBlock reference-citations"><a id="body-ref-sref57" href="#" role="doc-biblioref" data-xml-rid="bib57" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref57" aria-controls="sref57">Li et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref57"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Li, Z. ∙ Liu, J. ∙ Zhang, X. ...</div><div><strong>Prognostic significance of cyclin D1 expression in renal cell carcinoma: a systematic review and meta-analysis</strong></div><div><em>Pathol. Oncol. Res.</em> 2020; <strong>26</strong>:1401-1409</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s12253-019-00776-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85075345705" target="_blank" aria-label="Open Scopus in new tab">Scopus (2)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31748879/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs12253-019-00776-0&amp;pmid=31748879" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref75" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75" aria-controls="sref75">Ren et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref75"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Ren, B. ∙ Li, W. ∙ Yang, Y. ...</div><div><strong>The impact of cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis</strong></div><div><em>World J. Surg. Oncol.</em> 2014; <strong>12</strong>:55</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1477-7819-12-55" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84897438497" target="_blank" aria-label="Open Scopus in new tab">Scopus (20)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24602161/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1477-7819-12-55&amp;pmid=24602161" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and a recent large study finding no association (<span class="dropBlock reference-citations"><a id="body-ref-sref92-2" href="#" role="doc-biblioref" data-xml-rid="bib92" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref92-2" aria-controls="sref92-2">Smith and Sheltzer, 2018</a><div class="dropBlock__holder" data-db-target-of="sref92-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">91.</div><div>Smith, J.C. ∙ Sheltzer, J.M.</div><div><strong>Systematic identification of mutations and copy number alterations associated with cancer patient prognosis</strong></div><div><em>eLife.</em> 2018; <strong>7</strong>:e39217</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.39217" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_91_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85058605162" target="_blank" aria-label="Open Scopus in new tab">Scopus (28)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30526857/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.39217&amp;pmid=30526857" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Analysis of mutational processes revealed a potential immunogenic role for DNVs through generation of more radical amino acid substitutions and a shift toward more hydrophobic epitopes, a known driver of immune response. Lastly, we show with single-cell RNA-seq that <i>CXCL13</i>, a marker of exhausted T&nbsp;cells in multiple human cancers, is preferntially expressed in both T&nbsp;cells reactive to a clonal neoantigen and responders in the CPI1000+ cohort. This provides independent validation of prior work by <span class="dropBlock reference-citations"><a id="body-ref-sref95-2" href="#" role="doc-biblioref" data-xml-rid="bib95" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref95-2" aria-controls="sref95-2">Thommen et&nbsp;al. (2018)</a><div class="dropBlock__holder" data-db-target-of="sref95-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">94.</div><div>Thommen, D.S. ∙ Koelzer, V.H. ∙ Herzig, P. ...</div><div><strong>A transcriptionally and functionally distinct PD-1<sup>+</sup> CD8<sup>+</sup> T&nbsp;cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:994-1004</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0057-z" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_94_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85048343664" target="_blank" aria-label="Open Scopus in new tab">Scopus (233)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29892065/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0057-z&amp;pmid=29892065" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span> and suggests that neoantigen reactivity is coupled to a <i>CXCL13</i>-secreting “exhausted” phenotype, possibly induced by chronic TCR signaling, as we have recently proposed occurs in NSCLC (<span class="dropBlock reference-citations"><a id="body-ref-sref36" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36" aria-controls="sref36">Ghorani et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref36"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Ghorani, E. ∙ Reading, J.L. ∙ Henry, J.Y. ...</div><div><strong>The T&nbsp;cell differentiation landscape is shaped by tumour mutations in lung cancer</strong></div><div><em>Nat. Can.</em> 2020; <strong>1</strong>:546-561</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s43018-020-0066-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32803172/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs43018-020-0066-y&amp;pmid=32803172" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). If we combine the insights from published biomarker analysis with discovery results, a number of summary observations emerge. Starting within the tumor genome, we find CPI response to be underpinned by a high burden of clonal mutations enriched for immunogenic characteristics such as APOBEC or dinucleotide signatures. Armed with this rich baseline level of antigenicity, elevated <i>CXCL9</i> expression then supports ongoing recruitment of cytotoxic CD8<sup>+</sup> T&nbsp;cells. The selective expression of <i>CCR5</i> and <i>CXCL13</i> in neoantigen-specific T&nbsp;cells further suggests that a key feature of CPI-responsiveness is the ability to sustain ongoing priming and recruitment of tumour reactive T&nbsp;cells supported by CXCR5+ lymphocytes, which may include T and B cells (<span class="dropBlock reference-citations"><a id="body-ref-sref42" href="#" role="doc-biblioref" data-xml-rid="bib42" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref42" aria-controls="sref42">Helmink et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref42"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Helmink, B.A. ∙ Reddy, S.M. ∙ Gao, J. ...</div><div><strong>B cells and tertiary lymphoid structures promote immunotherapy response</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:549-555</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1922-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85078126241" target="_blank" aria-label="Open Scopus in new tab">Scopus (229)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31942075/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1922-8&amp;pmid=31942075" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This model can then be perturbed by tumor-intrinsic alterations, promoting either resistance (e.g., <i>CCND1</i> amplification) or sensitization (e.g., 9q34 [<i>TRAF2</i>] loss) to treatment. While simplified in nature, these results serve to highlight recurrent features of CPI response across multiple cancer types.</div><div id="p0100" role="paragraph">Regarding study limitations, we acknowledge that the CPI1000+ cohort is made up from a diverse set of underlying previously published studies; however, the bioinformatics processing and clinical classifications have been fully harmonized. Second, we note that IHC PD-L1 data are only available in a minority of cohorts, and hence, we have estimated expression at the mRNA rather than protein level in the CPI1000+ cohort. Lastly, we note the single-tumor-region nature of the CPI1000+ dataset means that subclonal mutation counts are underestimated, impairing our ability to observe an association (or lack thereof) between subclonal mutation burden and response. In summary, here, we build and utilize a large cohort of CPI-treated patients that can be extended as new data emerge, with whole-exome sequencing and transcriptomic data, to enable a greater understanding of the determinants of treatment response. As biomarker datasets continue to grow in size, there is tangible opportunity to build a more complete understanding of CPI response, which holds the promise of augmenting immune surveillance and disease control in molecularly defined patient cohorts.</div></section><section id="sec-4"><h2>STAR★methods</h2><section id="sec-4-1"><h3>KEY RESOURCES TABLE</h3><div id="p0105" role="paragraph"><div class="figure-wrap"><figure id="undtbl1" class="table" data-figureviewer-ignore="true"><div class="table-wrap"><table data-figureviewer-ignore="true" tabindex="0"><thead><tr class="rowsep"><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr class="rowsep"><td colspan="3"><b>Antibodies</b></td></tr><tr><td>Mouse anti-human CD3 BV711</td><td>Biolegend</td><td>300464; RRID: <a id="interref110" href="https://antibodyregistry.org/AB_2566036" target="_blank">AB_2566036</a></td></tr><tr><td>Mouse anti-human CD4 AF700</td><td>Biolegend</td><td>344622; RRID: <a id="interref105" href="https://antibodyregistry.org/AB_2563150" target="_blank">AB_2563150</a></td></tr><tr><td>Mouse anti-human CD8 BV510</td><td>Biolegend</td><td>301048; RRID: <a id="interref115" href="https://antibodyregistry.org/AB_2561942" target="_blank">AB_2561942</a></td></tr><tr><td>Live/dead exclusion Alexa Fluor-ef780</td><td>ThermoFisher Scientific</td><td>65-0865-18</td></tr><tr><td>Streptavidin PE</td><td>Biolegend</td><td>405203</td></tr><tr class="rowsep"><td>Streptavidin APC</td><td>Biolegend</td><td>405207</td></tr><tr class="rowsep"><td colspan="3"><b>Chemicals, peptides, and recombinant proteins</b></td></tr><tr><td>BD FACS Aria Fusion</td><td>Becton Dickinson</td><td>cat # 656700</td></tr><tr><td>C1 Single cell autoprep capture instrument</td><td>Fluidigm</td><td>N/A</td></tr><tr><td>EVOS FL Auto Imaging System</td><td>Thermo Fisher Scientific</td><td>N/A</td></tr><tr><td>Bovine serum albumin</td><td>Sigma-aldrich</td><td>9048468</td></tr><tr class="rowsep"><td>phosphate buffered saline</td><td>Fisher Scientific</td><td>cat # 14190</td></tr><tr class="rowsep"><td colspan="3"><b>Critical commercial assays</b></td></tr><tr><td>HiSeq 2500 Sequencing System</td><td>Illumina</td><td>SY-401-2501</td></tr><tr><td>SMARTer v4&nbsp;Ultra Low RNA Kit</td><td>Takara Clontech</td><td>634892</td></tr><tr><td>Qubit dsDNA HS</td><td>Thermo Fisher Scientific</td><td>Q32851</td></tr><tr><td>C1 Single cell IFC 10-17um diameter</td><td>Fluidigm</td><td>1006041</td></tr><tr><td>Nextera XT DNA Sample Preparation kit</td><td>Illumina</td><td>FC-121-1030</td></tr><tr class="rowsep"><td>NextSeq 500 (150bp paired end kits)</td><td>Illumina</td><td>SY-415-1001</td></tr><tr class="rowsep"><td colspan="3"><b>Software and algorithms</b></td></tr><tr><td>Flowjo for MAC v10.6.2</td><td>Becton Dickinson</td><td>N/A</td></tr><tr><td>FacsDIVAv9.0</td><td>Becton Dickinson</td><td>N/A</td></tr><tr><td>Burrows-Wheeler Aligner (BWA) v0.7.15</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref56-1" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56-1" aria-controls="sref56-1">Li and Durbin, 2009</a><div class="dropBlock__holder" data-db-target-of="sref56-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Li, H. ∙ Durbin, R.</div><div><strong>Fast and accurate short read alignment with Burrows-Wheeler transform</strong></div><div><em>Bioinformatics.</em> 2009; <strong>25</strong>:1754-1760</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btp324" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-67649884743" target="_blank" aria-label="Open Scopus in new tab">Scopus (19329)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19451168/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtp324&amp;pmid=19451168" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0015" href="http://bio-bwa.sourceforge.net/" target="_blank">http://bio-bwa.sourceforge.net/</a></td></tr><tr><td>Samtools v1.3.1</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref56-2" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56-2" aria-controls="sref56-2">Li and Durbin, 2009</a><div class="dropBlock__holder" data-db-target-of="sref56-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Li, H. ∙ Durbin, R.</div><div><strong>Fast and accurate short read alignment with Burrows-Wheeler transform</strong></div><div><em>Bioinformatics.</em> 2009; <strong>25</strong>:1754-1760</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btp324" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-67649884743" target="_blank" aria-label="Open Scopus in new tab">Scopus (19329)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19451168/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtp324&amp;pmid=19451168" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0020" href="http://samtools.sourceforge.net/" target="_blank">http://samtools.sourceforge.net/</a></td></tr><tr><td>Picard 1.81</td><td>N/A</td><td><a id="intref0025" href="http://broadinstitute.github.io/picard/" target="_blank">http://broadinstitute.github.io/picard/</a></td></tr><tr><td>Mutect v1.1.7</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref21-1" href="#" role="doc-biblioref" data-xml-rid="bib21" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref21-1" aria-controls="sref21-1">Cibulskis et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref21-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Cibulskis, K. ∙ Lawrence, M.S. ∙ Carter, S.L. ...</div><div><strong>Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples</strong></div><div><em>Nat. Biotechnol.</em> 2013; <strong>31</strong>:213-219</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nbt.2514" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84874025843" target="_blank" aria-label="Open Scopus in new tab">Scopus (2145)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23396013/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnbt.2514&amp;pmid=23396013" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0030" href="https://software.broadinstitute.org/cancer/cga/mutect" target="_blank">https://software.broadinstitute.org/cancer/cga/mutect</a></td></tr><tr><td>VarScan v2.4.1</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref50-1" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50-1" aria-controls="sref50-1">Koboldt et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref50-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Koboldt, D.C. ∙ Zhang, Q. ∙ Larson, D.E. ...</div><div><strong>VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing</strong></div><div><em>Genome Res.</em> 2012; <strong>22</strong>:568-576</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gr.129684.111" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84863229597" target="_blank" aria-label="Open Scopus in new tab">Scopus (2189)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22300766/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgr.129684.111&amp;pmid=22300766" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0035" href="http://varscan.sourceforge.net/" target="_blank">http://varscan.sourceforge.net/</a></td></tr><tr><td>Annovar</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref107-1" href="#" role="doc-biblioref" data-xml-rid="bib107" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref107-1" aria-controls="sref107-1">Wang et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref107-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">107.</div><div>Wang, K. ∙ Li, M. ∙ Hakonarson, H.</div><div><strong>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</strong></div><div><em>Nucleic Acids Res.</em> 2010; <strong>38</strong>:e164</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkq603" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_107_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-77956534324" target="_blank" aria-label="Open Scopus in new tab">Scopus (5569)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20601685/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkq603&amp;pmid=20601685" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0040" href="http://annovar.openbioinformatics.org/en/latest/" target="_blank">http://annovar.openbioinformatics.org/en/latest/</a></td></tr><tr><td>R package ‘Copynumber’</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref70-1" href="#" role="doc-biblioref" data-xml-rid="bib70" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref70-1" aria-controls="sref70-1">Nilsen et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref70-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Nilsen, G. ∙ Liestøl, K. ∙ Van Loo, P. ...</div><div><strong>Copynumber: efficient algorithms for single- and multi-track copy number segmentation</strong></div><div><em>BMC Genomics.</em> 2012; <strong>13</strong>:591</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1471-2164-13-591" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84873813238" target="_blank" aria-label="Open Scopus in new tab">Scopus (126)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23442169/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1471-2164-13-591&amp;pmid=23442169" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0045" href="http://bioconductor.org/packages/release/bioc/html/copynumber.html" target="_blank">http://bioconductor.org/packages/release/bioc/html/copynumber.html</a></td></tr><tr><td>ASCAT</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref103-2" href="#" role="doc-biblioref" data-xml-rid="bib103" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref103-2" aria-controls="sref103-2">Van Loo et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref103-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Van Loo, P. ∙ Nordgard, S.H. ∙ Lingjærde, O.C. ...</div><div><strong>Allele-specific copy number analysis of tumors</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2010; <strong>107</strong>:16910-16915</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1009843107" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-78049248432" target="_blank" aria-label="Open Scopus in new tab">Scopus (524)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20837533/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1009843107&amp;pmid=20837533" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0050" href="https://github.com/Crick-CancerGenomics/ascat" target="_blank">https://github.com/Crick-CancerGenomics/ascat</a></td></tr></tbody></table></div><figcaption><div class="core-table-tools"><ul><li><a class="core-table-show-action" href="/action/showFullTableHTML?isHtml=true&amp;tableId=undtbl1&amp;pii=S0092-8674%2821%2900002-7" target="_blank">Open table in a new tab</a></li></ul></div></figcaption></figure></div></div></section><section id="sec-4-2"><h3>Resource availability</h3><section id="sec-4-2-1"><h4>Lead contact</h4><div id="p0110" role="paragraph">Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Charles Swanton (<a id="intref0055" href="mailto:Charles.Swanton@crick.ac.uk">Charles.Swanton@crick.ac.uk</a>).</div></section><section id="sec-4-2-2"><h4>Materials availability</h4><div id="p0115" role="paragraph">This&nbsp;study did not generate new unique reagents.</div></section><section id="sec-4-2-3"><h4>Data and code availability</h4><div id="p0120" role="paragraph">The code used for this manuscript is available at: <a id="intref0060" href="https://github.com/kevlitchfield1/CPI1000_paper" target="_blank">https://github.com/kevlitchfield1/CPI1000_paper</a>.</div></section></section><section id="sec-4-3"><h3>Experimental model and subject details</h3><section id="sec-4-3-1"><h4>Human clinical datasets</h4><div id="p0125" role="paragraph">The CPI1000+ cohort utilizes raw whole exome and RNA sequencing data from the following studies:<div id="olist0010" role="list"><div id="o0010" role="listitem"><div class="label">1.</div><div class="content"><div id="p0130" role="paragraph">Snyder et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref93-1" href="#" role="doc-biblioref" data-xml-rid="bib93" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref93-1" aria-controls="sref93-1">Snyder et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref93-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">92.</div><div>Snyder, A. ∙ Makarov, V. ∙ Merghoub, T. ...</div><div><strong>Genetic basis for clinical response to CTLA-4 blockade in melanoma</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2014; <strong>371</strong>:2189-2199</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1406498" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_92_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84918828514" target="_blank" aria-label="Open Scopus in new tab">Scopus (2353)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25409260/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1406498&amp;pmid=25409260" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), an advanced melanoma anti-CTLA-4 treated cohort.</div></div></div><div id="o0015" role="listitem"><div class="label">2.</div><div class="content"><div id="p0135" role="paragraph">Van Allen et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref102-1" href="#" role="doc-biblioref" data-xml-rid="bib102" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref102-1" aria-controls="sref102-1">Van Allen et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref102-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Van Allen, E.M. ∙ Miao, D. ∙ Schilling, B. ...</div><div><strong>Genomic correlates of response to CTLA-4 blockade in metastatic melanoma</strong></div><div><em>Science.</em> 2015; <strong>350</strong>:207-211</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad0095" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84943516465" target="_blank" aria-label="Open Scopus in new tab">Scopus (1192)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26359337/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad0095&amp;pmid=26359337" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), an advanced melanoma anti-CTLA-4 treated cohort.</div></div></div><div id="o0020" role="listitem"><div class="label">3.</div><div class="content"><div id="p0140" role="paragraph">Hugo et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref45-1" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45-1" aria-controls="sref45-1">Hugo et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref45-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Hugo, W. ∙ Zaretsky, J.M. ∙ Sun, L. ...</div><div><strong>Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma</strong></div><div><em>Cell.</em> 2016; <strong>165</strong>:35-44</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2016.02.065&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2016.02.065&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84961221351" target="_blank" aria-label="Open Scopus in new tab">Scopus (1043)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26997480/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2016.02.065&amp;pmid=26997480" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), an advanced melanoma anti-PD-1 treated cohort.</div></div></div><div id="o0025" role="listitem"><div class="label">4.</div><div class="content"><div id="p0145" role="paragraph">Riaz et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref77" href="#" role="doc-biblioref" data-xml-rid="bib77" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref77" aria-controls="sref77">Riaz et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref77"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">76.</div><div>Riaz, N. ∙ Havel, J.J. ∙ Makarov, V. ...</div><div><strong>Tumor and microenvironment evolution during immunotherapy with nivolumab</strong></div><div><em>Cell.</em> 2017; <strong>171</strong>:934-949.e16</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2017.09.028&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2017.09.028&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85031295254" target="_blank" aria-label="Open Scopus in new tab">Scopus (453)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29033130/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.09.028&amp;pmid=29033130" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), an advanced melanoma anti-PD-1 treated cohort.</div></div></div><div id="o0030" role="listitem"><div class="label">5.</div><div class="content"><div id="p0150" role="paragraph">Cristescu et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref26-5" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-5" aria-controls="sref26-5">Cristescu et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref26-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Cristescu, R. ∙ Mogg, R. ∙ Ayers, M. ...</div><div><strong>Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:362</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aar3593" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85054777584" target="_blank" aria-label="Open Scopus in new tab">Scopus (403)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aar3593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) an advanced melanoma anti-PD-1 treated cohort.</div></div></div><div id="o0035" role="listitem"><div class="label">6.</div><div class="content"><div id="p0155" role="paragraph">Cristescu et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref26-6" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-6" aria-controls="sref26-6">Cristescu et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref26-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Cristescu, R. ∙ Mogg, R. ∙ Ayers, M. ...</div><div><strong>Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:362</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aar3593" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85054777584" target="_blank" aria-label="Open Scopus in new tab">Scopus (403)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aar3593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) an advanced head and neck cancer anti-PD-1 treated cohort.</div></div></div><div id="o0040" role="listitem"><div class="label">7.</div><div class="content"><div id="p0160" role="paragraph">Snyder et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref94-1" href="#" role="doc-biblioref" data-xml-rid="bib94" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref94-1" aria-controls="sref94-1">Snyder et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref94-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">93.</div><div>Snyder, A. ∙ Nathanson, T. ∙ Funt, S.A. ...</div><div><strong>Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: an exploratory multi-omic analysis</strong></div><div><em>PLoS Med.</em> 2017; <strong>14</strong>:e1002309</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pmed.1002309" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_93_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85020087828" target="_blank" aria-label="Open Scopus in new tab">Scopus (115)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28552987/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pmed.1002309&amp;pmid=28552987" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), a metastatic urothelial cancer anti-PD-L1 treated cohort.</div></div></div><div id="o0045" role="listitem"><div class="label">8.</div><div class="content"><div id="p0165" role="paragraph">Mariathasan et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref62-3" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-3" aria-controls="sref62-3">Mariathasan et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref62-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Mariathasan, S. ∙ Turley, S.J. ∙ Nickles, D. ...</div><div><strong>TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T&nbsp;cells</strong></div><div><em>Nature.</em> 2018; <strong>554</strong>:544-548</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85042495633" target="_blank" aria-label="Open Scopus in new tab">Scopus (833)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29443960/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25501&amp;pmid=29443960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), a metastatic urothelial cancer anti-PD-L1 treated cohort.</div></div></div><div id="o0050" role="listitem"><div class="label">9.</div><div class="content"><div id="p0170" role="paragraph">McDermott et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref63-2" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63-2" aria-controls="sref63-2">McDermott et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref63-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>McDermott, D.F. ∙ Huseni, M.A. ∙ Atkins, M.B. ...</div><div><strong>Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:749-757</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0053-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85048001150" target="_blank" aria-label="Open Scopus in new tab">Scopus (334)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29867230/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0053-3&amp;pmid=29867230" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), a metastatic renal cell carcinoma anti-PD-L1 treated cohort.</div></div></div><div id="o0055" role="listitem"><div class="label">10.</div><div class="content"><div id="p0175" role="paragraph">Rizvi et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref79-1" href="#" role="doc-biblioref" data-xml-rid="bib79" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref79-1" aria-controls="sref79-1">Rizvi et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref79-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Rizvi, N.A. ∙ Hellmann, M.D. ∙ Snyder, A. ...</div><div><strong>Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer</strong></div><div><em>Science.</em> 2015; <strong>348</strong>:124-128</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaa1348" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84928761118" target="_blank" aria-label="Open Scopus in new tab">Scopus (4018)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25765070/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaa1348&amp;pmid=25765070" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), a non-small cell lung cancer anti-PD-1 treated cohort.</div></div></div><div id="o0060" role="listitem"><div class="label">11.</div><div class="content"><div id="p0180" role="paragraph">Hellman et&nbsp;al., an unpublished cohort of non-small cell lung cancer samples treated with anti-PD-1.</div></div></div><div id="o0065" role="listitem"><div class="label">12.</div><div class="content"><div id="p0185" role="paragraph">Le et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref54" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54" aria-controls="sref54">Le et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref54"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Le, D.T. ∙ Uram, J.N. ∙ Wang, H. ...</div><div><strong>PD-1 blockade in tumors with mismatch-repair deficiency</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2015; <strong>372</strong>:2509-2520</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1500596" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84932628341" target="_blank" aria-label="Open Scopus in new tab">Scopus (4297)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26028255/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1500596&amp;pmid=26028255" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), a colorectal cancer cohort treated with anti-PD-1 therapy.</div></div></div></div></div><div id="p0190" role="paragraph">In order to allow studies to be grouped by histology, additional patients from the KEYNOTE-028 and KEYNOTE-012 cohorts from Cristescu et&nbsp;al. were utilized to create two additional cohorts, cohort 13: Cristescu et&nbsp;al. urothelial cancer and cohort 14: Cristescu et&nbsp;al. breast cancer. For cohort 2, in line with the original authors separate categorization (<span class="dropBlock reference-citations"><a id="body-ref-sref102-2" href="#" role="doc-biblioref" data-xml-rid="bib102" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref102-2" aria-controls="sref102-2">Van Allen et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref102-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Van Allen, E.M. ∙ Miao, D. ∙ Schilling, B. ...</div><div><strong>Genomic correlates of response to CTLA-4 blockade in metastatic melanoma</strong></div><div><em>Science.</em> 2015; <strong>350</strong>:207-211</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad0095" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84943516465" target="_blank" aria-label="Open Scopus in new tab">Scopus (1192)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26359337/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad0095&amp;pmid=26359337" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), the additional cohort of n&nbsp;= 10 patients who achieved long-term survival but with early tumor progression were excluded. For cohort 1, in line with previous treatment by (<span class="dropBlock reference-citations"><a id="body-ref-sref69-2" href="#" role="doc-biblioref" data-xml-rid="bib69" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref69-2" aria-controls="sref69-2">Miao et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref69-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">68.</div><div>Miao, D. ∙ Margolis, C.A. ∙ Vokes, N.I. ...</div><div><strong>Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors</strong></div><div><em>Nat. Genet.</em> 2018; <strong>50</strong>:1271-1281</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41588-018-0200-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85052712350" target="_blank" aria-label="Open Scopus in new tab">Scopus (121)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30150660/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41588-018-0200-2&amp;pmid=30150660" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), tumor samples from non-responding lesions from patients who otherwise had clinical benefit from immune checkpoint therapy were excluded (n&nbsp;= 8). Samples with truncated raw fastq file downloads, which remained truncated after multiple download attempts were also excluded. A breakdown of sample numbers for each study/histology is contained in <a id="crosref1020" href="#mmc2">Table S1</a>. For validation purposes the following cohort was utilized: Cristescu et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref26-7" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-7" aria-controls="sref26-7">Cristescu et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref26-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Cristescu, R. ∙ Mogg, R. ∙ Ayers, M. ...</div><div><strong>Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:362</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aar3593" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85054777584" target="_blank" aria-label="Open Scopus in new tab">Scopus (403)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aar3593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) “all other tumor types” (n&nbsp;= 76) cohort (from KEYNOTE-028 and KEYNOTE-012 studies), treated with anti-PD-1. This was reserved as a test validation cohort for the <a id="crosref1030" href="#fig3">Figure&nbsp;3</a> multivariable model analysis (i.e., not included in the <a id="crosref1035" href="#fig2">Figure&nbsp;2</a> meta-analysis), on account of its set of pan-cancer “other tumour type” mix of patients, which was selected as suitable for validation of a pan-cancer predictive model. Two additional test validation cohorts were utilized from recently published papers (<span class="dropBlock reference-citations"><a id="body-ref-sref59-2" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-2" aria-controls="sref59-2">Liu et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref59-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Liu, D. ∙ Schilling, B. ∙ Liu, D. ...</div><div><strong>Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:1916-1927</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-019-0654-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85075928991" target="_blank" aria-label="Open Scopus in new tab">Scopus (60)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31792460/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-019-0654-5&amp;pmid=31792460" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and (<span class="dropBlock reference-citations"><a id="body-ref-sref88-2" href="#" role="doc-biblioref" data-xml-rid="bib88" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref88-2" aria-controls="sref88-2">Shim et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref88-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">87.</div><div>Shim, J.H. ∙ Kim, H.S. ∙ Cha, H. ...</div><div><strong>HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients</strong></div><div><em>Ann. Oncol.</em> 2020; <strong>31</strong>:902-911</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.annonc.2020.04.004&amp;cf=fulltext&amp;site=annonc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.annonc.2020.04.004&amp;cf=pdf&amp;site=annonc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85085291189" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32320754/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.annonc.2020.04.004&amp;pmid=32320754" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) as additional test samples for the multivariable model (<a id="crosref1050" href="#fig3">Figure&nbsp;3</a>), with data being taken from supplementary tables of these papers. Cohort 9 (<span class="dropBlock reference-citations"><a id="body-ref-sref63-3" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63-3" aria-controls="sref63-3">McDermott et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref63-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>McDermott, D.F. ∙ Huseni, M.A. ∙ Atkins, M.B. ...</div><div><strong>Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:749-757</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0053-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85048001150" target="_blank" aria-label="Open Scopus in new tab">Scopus (334)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29867230/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0053-3&amp;pmid=29867230" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) comprised a treatment arm with anti-PD-L1 and anti-VEGF treatment, these samples were excluded from the meta-analysis of previously published biomarkers (<a id="crosref1060" href="#fig2">Figure&nbsp;2</a>) and multivariable AUC analysis (<a id="crosref1065" href="#fig3">Figure&nbsp;3</a>) but retained for the discovery analysis (<a id="crosref1070" href="#fig5">Figure&nbsp;5</a> and <a id="crosref1075" href="#fig6">Figure&nbsp;6</a>) to maximize discovery power. Similarly, the “all other tumor types” (n&nbsp;= 76) set was also used in (<a id="crosref1080" href="#fig5">Figure&nbsp;5</a> and <a id="crosref1085" href="#fig6">Figure&nbsp;6</a>) discovery analysis. Regarding prior lines of treatment, we note (n&nbsp;= 55, 5.5% of patients) had either undergone prior line of anti-CTLA-4 treatment or the biopsy was taken on treatment (see <a id="crosref1090" href="#mmc2">Table S1</a>). Age and gender information of each cohort is available in the corresponding references. To assess if sex affected the results of the <a id="crosref1095" href="#fig2">Figure&nbsp;2</a> meta-analysis, the analysis was repeated including sex as an additional term in the model, and no difference was observed in the top ranked biomarkers. Validation data for copy number analysis was reused from Samstein et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref86-2" href="#" role="doc-biblioref" data-xml-rid="bib86" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref86-2" aria-controls="sref86-2">Samstein et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref86-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Samstein, R.M. ∙ Lee, C.H. ∙ Shoushtari, A.N. ...</div><div><strong>Tumor mutational load predicts survival after immunotherapy across multiple cancer types</strong></div><div><em>Nat. Genet.</em> 2019; <strong>51</strong>:202-206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41588-018-0312-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85059965982" target="_blank" aria-label="Open Scopus in new tab">Scopus (669)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30643254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41588-018-0312-8&amp;pmid=30643254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), a cohort of 1662 patients treated with CPI and profiled using the MSK-IMPACT gene panel (referred to as the MSK1600 cohort). Segment copy number data for these samples was downloaded from the GENIE Synapse portal (syn7222066), <a id="intref0065" href="https://www.synapse.org/" target="_blank">https://www.synapse.org/</a>, and clinical data were utilized from the Samstein et&nbsp;al. paper. In addition, a cohort of MSK-IMPACT sequenced, but non-CPI treated patients was utilized for negative control analyses, to distinguish CPI predictive from generally prognostic biomarkers. Copy number segment data for this non-CPI cohort were similarly obtained from the GENIE Synapse portal (syn7222066), <a id="intref0070" href="https://www.synapse.org/" target="_blank">https://www.synapse.org/</a>, and clinical response data were reused from Bielski et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref8" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8" aria-controls="sref8">Bielski et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Bielski, C.M. ∙ Zehir, A. ∙ Penson, A.V. ...</div><div><strong>Genome doubling shapes the evolution and prognosis of advanced cancers</strong></div><div><em>Nat. Genet.</em> 2018; <strong>50</strong>:1189-1195</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41588-018-0165-1" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85049987702" target="_blank" aria-label="Open Scopus in new tab">Scopus (97)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30013179/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41588-018-0165-1&amp;pmid=30013179" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and patients overlapping with the Samstein et&nbsp;al. were removed. Lastly, single cell RNA sequencing was conducted on CD8 TILs from patient L011, a patient diagnosed with non-small cell lung cancer who underwent definitive surgical resection prior to receiving any adjuvant therapy. Patient L011 was a 49 year old female smoker (45 pack years). Informed consent was obtained under study UCLHRTB 10/H1306/42.</div></section></section><section id="sec-4-4"><h3>Method details</h3><section id="sec-4-4-1"><h4>Clinical end points</h4><div id="p0195" role="paragraph">In the CPI1000+ cohort, a uniform clinical end-point of response was defined across all the 15 studies based on radiological response as per the RECIST criteria, with “CR/PR” being classified as a responder and “SD/PD,” as well as any “NE” cases, being classed as a non-responder. We note this is a definition of response that may undercount the number of patients who derive clinical benefit, as patients with SD and extended survival have in some previous studies been considered as experiencing clinical benefit from treatment. Conversely, a radiological complete or partial response does not always equate to extended survival, and subtle distinctions between these measures should be recognized. However the “CR/PR” versus “SD/PD” definition used here allows for uniform consistency across cohorts, clearest interpretation and is consistent with the most recent literature (<span class="dropBlock reference-citations"><a id="body-ref-sref26-8" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-8" aria-controls="sref26-8">Cristescu et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref26-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Cristescu, R. ∙ Mogg, R. ∙ Ayers, M. ...</div><div><strong>Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:362</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aar3593" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85054777584" target="_blank" aria-label="Open Scopus in new tab">Scopus (403)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aar3593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref62-4" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-4" aria-controls="sref62-4">Mariathasan et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref62-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Mariathasan, S. ∙ Turley, S.J. ∙ Nickles, D. ...</div><div><strong>TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T&nbsp;cells</strong></div><div><em>Nature.</em> 2018; <strong>554</strong>:544-548</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85042495633" target="_blank" aria-label="Open Scopus in new tab">Scopus (833)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29443960/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25501&amp;pmid=29443960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For RECIST response evaluations we utilized the clinical data provided by the original authors, which in &gt; 90% of cases was best response time point. In a minority of cases the time point of RECIST evaluation was not directly specified. For the (<span class="dropBlock reference-citations"><a id="body-ref-sref26-9" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-9" aria-controls="sref26-9">Cristescu et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref26-9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Cristescu, R. ∙ Mogg, R. ∙ Ayers, M. ...</div><div><strong>Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:362</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aar3593" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85054777584" target="_blank" aria-label="Open Scopus in new tab">Scopus (403)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aar3593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) cohort response labels were not available as a supplementary file, however they could be inferred from cross-reference of <a id="crosref1125" href="#mmc1">Table S2</a> and <a id="crosref1130" href="#figs3">Figure&nbsp;S3</a> of that paper, and validated by re-computing p values from the paper to ensure exact match (e.g., <a id="crosref1135" href="#fig2">Figure&nbsp;2</a> multivariable model p values stated in the paper, we were able to match to the 4 decimal places accuracy provided in the paper). In addition, the inferred labels were further validated when we checked the numbers of responders per detailed histology in Table S3 of (<span class="dropBlock reference-citations"><a id="body-ref-sref26-10" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-10" aria-controls="sref26-10">Cristescu et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref26-10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Cristescu, R. ∙ Mogg, R. ∙ Ayers, M. ...</div><div><strong>Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:362</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aar3593" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85054777584" target="_blank" aria-label="Open Scopus in new tab">Scopus (403)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aar3593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and found the inferred data matched exactly the reported results. RECIST response data was not available for the MSK1600 cohort, so instead overall survival was used as the clinical end-point, combined with negative control analysis in MSK-IMPACT profiled samples not treated with CPI, to distinguish predictive from prognostic biomarkers.</div></section><section id="sec-4-4-2"><h4>Multimer sorting of neoantigen reactive T&nbsp;cells</h4><div id="p0200" role="paragraph">We have previously identified CD8+ neoantigen reactive T&nbsp;cells (NARTs) targeted against a clonal neoantigen (arising from the mutated <i>MTFR2</i> gene) in NSCLC tumor regions derived from patient L011 (<span class="dropBlock reference-citations"><a id="body-ref-sref64-2" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-2" aria-controls="sref64-2">McGranahan et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref64-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>McGranahan, N. ∙ Furness, A.J. ∙ Rosenthal, R. ...</div><div><strong>Clonal neoantigens elicit T&nbsp;cell immunoreactivity and sensitivity to immune checkpoint blockade</strong></div><div><em>Science.</em> 2016; <strong>351</strong>:1463-1469</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaf1490" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84962301577" target="_blank" aria-label="Open Scopus in new tab">Scopus (1319)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26940869/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaf1490&amp;pmid=26940869" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, neoantigen-specific CD8 T&nbsp;cells were identified using high throughput MHC multimer screening of candidate mutant peptides generated from patient-specific neoantigens of predicted&nbsp;&lt; 500nM affinity for cognate HLA as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref64-3" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-3" aria-controls="sref64-3">McGranahan et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref64-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>McGranahan, N. ∙ Furness, A.J. ∙ Rosenthal, R. ...</div><div><strong>Clonal neoantigens elicit T&nbsp;cell immunoreactivity and sensitivity to immune checkpoint blockade</strong></div><div><em>Science.</em> 2016; <strong>351</strong>:1463-1469</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaf1490" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84962301577" target="_blank" aria-label="Open Scopus in new tab">Scopus (1319)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26940869/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaf1490&amp;pmid=26940869" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). 288 candidate mutant peptides (with predicted HLA binding affinity&nbsp;&lt; 500nM, including multiple potential peptide variations from the same missense mutation) were synthesized and used to screen expanded L011 TILs. In patient L011, TILs were found to recognize the HLA-B<sup>∗</sup>3501 restricted, MTFR2D326Y-derived mutated sequence FAFQEYDSF (netMHC binding score: 22nM), but not the wild-type sequence FAFQEDDSF (netMHC binding score: 10nM). No responses were found against overlapping peptides AFQEYDSFEK and KFAFQEYDSF. Neoantigen-specific CD8+ T&nbsp;cells were tracked with peptide-MHC multimers conjugated with either streptavidin PE (Biolegend, cat#405203), APC (Biolegend, cat#405207) BV650 (Biolegend, cat#405231) or PE-Cy-7 (Biolegend, cat#405206) and gated as double positive cells among live, single CD8+ cells. Phenotypic characterization of neoantigen-specific CD8 T&nbsp;cells in L011 was performed as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref64-4" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-4" aria-controls="sref64-4">McGranahan et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref64-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>McGranahan, N. ∙ Furness, A.J. ∙ Rosenthal, R. ...</div><div><strong>Clonal neoantigens elicit T&nbsp;cell immunoreactivity and sensitivity to immune checkpoint blockade</strong></div><div><em>Science.</em> 2016; <strong>351</strong>:1463-1469</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaf1490" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84962301577" target="_blank" aria-label="Open Scopus in new tab">Scopus (1319)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26940869/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaf1490&amp;pmid=26940869" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-3"><h4>Single-cell RNA sequencing of neoantigen reactive T&nbsp;cells</h4><div id="p0205" role="paragraph">Multimer-positive and negative single CD8+ T&nbsp;cells from NSCLC specimens were sorted directly into the C1 Integrated Fluidic Circuit (IFC; Fluidigm). Cell lysing, reverse transcription, and cDNA amplification were performed as specified by the manufacturer. Briefly, 1000 single, multimer positive or negative CD8 T&nbsp;cells were flow sorted directly into a 10- to 17-μm-diameter C1 Integrated Fluidic Circuit (IFC; Fluidigm). Ahead of sorting, the cell inlet well was preloaded with 3.5&nbsp;μL of PBS 0.5% BSA. Post-sorting the total well volume was measured and brought to 5&nbsp;μL with PBS 0.5% BSA. 1&nbsp;μL of C1 Cell Suspension Reagent (Fluidigm) was added and the final solution was mixed by pipetting. Each C1 IFC capture site was carefully examined under an EVOS FL Auto Imaging System (Thermo Fisher Scientific) in bright field, for empty wells and cell doublets. An automated scan of all capture sites was also obtained for reference. Cell lysing, reverse transcription, and cDNA amplification were performed on the C1 Single-Cell Auto Prep IFC, as specified by the manufacturer. The SMARTer v4&nbsp;Ultra Low RNA Kit (Takara Clontech) was used for cDNA synthesis from the single cells. cDNA was quantified with Qubit dsDNA HS (Molecular Probes) and checked on an Agilent Bioanalyzer high sensitivity DNA chip. Illumina NGS libraries were constructed with Nextera XT DNA Sample Preparation kit (Illumina), according to the Fluidigm Single-Cell cDNA Libraries for mRNA sequencing protocol. Sequencing was performed on Illumina® NextSeq 500 using 150bp paired end kits.</div></section></section><section id="sec-4-5"><h3>Quantification and statistical analysis</h3><section id="sec-4-5-1"><h4>Sample quality control</h4><div id="p0210" role="paragraph">First, samples were clustered using a panel of common germline SNPs, to ensure no duplicate participants were included (<a id="crosref1160" href="#figs5">Figure&nbsp;S5</a>). Next, we assessed for any technical correlations between mutation counts and purity or sequencing coverage (<a id="crosref1165" href="#figs6">Figure&nbsp;S6</a>A). While at the combined CPI1000+ cohort level we did not observe any significant relationships (<a id="crosref1170" href="#figs6">Figure&nbsp;S6</a>A), we note in a minority of individual studies (3 out of 15) there was a significant relationship between TMB and purity (<a id="optuB6ZkCK3Ap" href="#figs7">Figure S7</a>). This technical correlation is linked to low sequencing coverage, for example the Snyder et&nbsp;al. NEJM 2014 cohort has the strongest correlation and is also the cohort with lowest average depth per tumor sample. These findings are consistent with recent results published by Anagnostou et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref2-2" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2-2" aria-controls="sref2-2">Anagnostou et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref2-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Anagnostou, V. ∙ Niknafs, N. ∙ Marrone, K. ...</div><div><strong>Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer</strong></div><div><em>Nat. Can.</em> 2020; <strong>1</strong>:99-111</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s43018-019-0008-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32984843/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs43018-019-0008-8&amp;pmid=32984843" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), who demonstrate a relationship between purity and TMB, which is mitigated with higher coverage. Finally, we assessed for any evidence of different exome capture kits across the cohorts impacting results, and found no significant difference in TMB scores based on exome capture kits utilized (<a id="optNShhYvwZew" href="#figs6">Figure S6</a>B). We note however that Agilent SureSelect kits were used in nearly all studies, except for one cohort, Snyder et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref94-2" href="#" role="doc-biblioref" data-xml-rid="bib94" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref94-2" aria-controls="sref94-2">Snyder et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref94-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">93.</div><div>Snyder, A. ∙ Nathanson, T. ∙ Funt, S.A. ...</div><div><strong>Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: an exploratory multi-omic analysis</strong></div><div><em>PLoS Med.</em> 2017; <strong>14</strong>:e1002309</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pmed.1002309" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_93_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85020087828" target="_blank" aria-label="Open Scopus in new tab">Scopus (115)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28552987/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pmed.1002309&amp;pmid=28552987" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), which used IDT xGen WES capture, and in addition we found no specification of the capture kit used in the Hugo et&nbsp;al. manuscript (<span class="dropBlock reference-citations"><a id="body-ref-sref45-2" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45-2" aria-controls="sref45-2">Hugo et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref45-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Hugo, W. ∙ Zaretsky, J.M. ∙ Sun, L. ...</div><div><strong>Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma</strong></div><div><em>Cell.</em> 2016; <strong>165</strong>:35-44</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2016.02.065&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2016.02.065&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84961221351" target="_blank" aria-label="Open Scopus in new tab">Scopus (1043)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26997480/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2016.02.065&amp;pmid=26997480" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div class="figure-wrap"><figure id="figs5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.002/asset/fc3e57a5-64be-4d3d-9b0f-a08fcd2e0695/main.assets/figs5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs5" src="/cms/10.1016/j.cell.2021.01.002/asset/58d6ed1e-6b32-49b9-ae04-55ea33c19d0a/main.assets/figs5.jpg" height="365" width="759" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/fc3e57a5-64be-4d3d-9b0f-a08fcd2e0695/main.assets/figs5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S5</span> <span class="figure__title__text">Clustering by common germline SNP panel to ensure no duplicate participants were recorded in the CPI1000+ cohort, related to <a id="crosref1695" href="#sec-4">STAR methods</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0235" role="paragraph">Columns are patients, rows are SNPs.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.002/asset/f7402d01-cb2c-4179-8297-825b9ac1defd/main.assets/figs6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs6" src="/cms/10.1016/j.cell.2021.01.002/asset/7533e529-f376-4ab3-8e21-8656c871a966/main.assets/figs6.jpg" height="581" width="502" aria-labelledby="figs6-title" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/f7402d01-cb2c-4179-8297-825b9ac1defd/main.assets/figs6_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div><figcaption class="figure__caption__body"><div id="figs6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S6</span> <span class="figure__title__text">Purity, sequencing coverage, and choice of exome capture kits do not correlate with TMB scores in the CPI1000+ cohort, related to <a id="crosref1700" href="#sec-4">STAR methods</a></span></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.002/asset/0a0074c7-9fa1-4f19-a836-516a9db59e02/main.assets/figs7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs7" src="/cms/10.1016/j.cell.2021.01.002/asset/4795cc03-259e-4659-8c47-304dca40c7df/main.assets/figs7.jpg" height="364" width="762" aria-labelledby="figs7-title" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/0a0074c7-9fa1-4f19-a836-516a9db59e02/main.assets/figs7_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div><figcaption class="figure__caption__body"><div id="figs7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S7</span> <span class="figure__title__text">Purity vs TMB correlations by study, related to <a id="crosref1705" href="#sec-4">STAR methods</a></span></div></figcaption></figure></div></section><section id="sec-4-5-2"><h4>Whole exome sequencing (DNA) pipeline–variant calling</h4><div id="p0215" role="paragraph">For all studies we obtained germline/tumor whole exome sequencing data in either BAM, SRA or FASTQ format, from the relevant sequencing repository or directly from the original authors, and where applicable reverted these files back to FASTQ format using Picard tools (version 1.107) SamToFastq. Raw paired-end reads in FASTQ format were aligned to hg19 obtained from the GATK bundle (v2.8) using bwa mem (bwa v0.7.15) (<span class="dropBlock reference-citations"><a id="body-ref-sref56-3" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56-3" aria-controls="sref56-3">Li and Durbin, 2009</a><div class="dropBlock__holder" data-db-target-of="sref56-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Li, H. ∙ Durbin, R.</div><div><strong>Fast and accurate short read alignment with Burrows-Wheeler transform</strong></div><div><em>Bioinformatics.</em> 2009; <strong>25</strong>:1754-1760</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btp324" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-67649884743" target="_blank" aria-label="Open Scopus in new tab">Scopus (19329)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19451168/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtp324&amp;pmid=19451168" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref66" href="#" role="doc-biblioref" data-xml-rid="bib66" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref66" aria-controls="sref66">McKenna et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref66"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>McKenna, A. ∙ Hanna, M. ∙ Banks, E. ...</div><div><strong>The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</strong></div><div><em>Genome Res.</em> 2010; <strong>20</strong>:1297-1303</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gr.107524.110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-77956295988" target="_blank" aria-label="Open Scopus in new tab">Scopus (10719)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20644199/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgr.107524.110&amp;pmid=20644199" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Picard tools (picard v1.107) was used to remove duplicates (<a id="intref0075" href="http://broadinstitute.github.io/picard" target="_blank">http://broadinstitute.github.io/picard</a>), and GATK was additionally used for local indel realignment. Quality control metrics were produced with picard tools (v1.107), FastQC (v0.11.5 - <a id="intref0080" href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/" target="_blank">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</a>) and GATK(v3.9). Platypus v0.8.1 was used to call homozygous and heterozygous germline SNPs (<span class="dropBlock reference-citations"><a id="body-ref-sref78" href="#" role="doc-biblioref" data-xml-rid="bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78" aria-controls="sref78">Rimmer et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref78"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">77.</div><div>Rimmer, A. ∙ Phan, H. ∙ Mathieson, I. ..., WGS500 Consortium</div><div><strong>Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications</strong></div><div><em>Nat. Genet.</em> 2014; <strong>46</strong>:912-918</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ng.3036" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_77_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84905576523" target="_blank" aria-label="Open Scopus in new tab">Scopus (456)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25017105/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fng.3036&amp;pmid=25017105" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The default parameters were used, but the genIndels flag was set to FALSE. Only SNPs with a minimum depth of coverage of 20x were taken forward. Somatic variants were detected using two tools (MuTect v1.1.7 &amp; VarScan2 v2.4.1) (<span class="dropBlock reference-citations"><a id="body-ref-sref21-2" href="#" role="doc-biblioref" data-xml-rid="bib21" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref21-2" aria-controls="sref21-2">Cibulskis et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref21-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Cibulskis, K. ∙ Lawrence, M.S. ∙ Carter, S.L. ...</div><div><strong>Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples</strong></div><div><em>Nat. Biotechnol.</em> 2013; <strong>31</strong>:213-219</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nbt.2514" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84874025843" target="_blank" aria-label="Open Scopus in new tab">Scopus (2145)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23396013/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnbt.2514&amp;pmid=23396013" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref50-2" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50-2" aria-controls="sref50-2">Koboldt et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref50-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Koboldt, D.C. ∙ Zhang, Q. ∙ Larson, D.E. ...</div><div><strong>VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing</strong></div><div><em>Genome Res.</em> 2012; <strong>22</strong>:568-576</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gr.129684.111" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84863229597" target="_blank" aria-label="Open Scopus in new tab">Scopus (2189)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22300766/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgr.129684.111&amp;pmid=22300766" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), using the following method: SAMtools mpileup (version 0.1.19) was used to locate non-reference positions in tumor and germline samples. Bases with a Phred score of less than 20 or reads with a mapping quality less than 20 were omitted. The Base alignment quality (BAQ) calculation option was deactivated and a threshold of 50 was set for the coefficient of downgrading mapping quality. VarScan2 somatic (version 2.3.6) used output from SAMtools mpileup to identify somatic variants between tumor and matched germline samples. VarScan2 processSomatic was used to extract the somatic variants. Single nucleotide variant (SNV) calls were filtered for false positives with the associated fpfilter.pl script in Varscan2, initially with default settings then repeated with min-var-frac&nbsp;= 0·02, having first run the data through bam-readcount (version 0.5.1). MuTect (version 1.1.4) was also used to detect SNVs, and results were filtered according to the filter parameter PASS. Default parameters were used in both tools with the exception of: i) minimum coverage for the germline sample was set to 10, ii) minimum coverage for the tumor sample was set to 30 and minimum alternative allele read depth of 3, iii) minimum somatic variant allele frequency (VAF) was set to 0.01 and minimum alternative read coverage set to 5, iv) alternative reads in the germline had to be ≤ 5 and germline VAF ≤ 1%, v) variant had to be not present in EXAC03 database at 5% or higher frequency. In final QC filtering, an SNV was considered a true positive if the variant allele frequency (VAF) was greater than 1% and the mutation was called by both VarScan2, with a somatic p value ≤ 0.01, and MuTect. Alternatively, a frequency of 5% was required if only called in VarScan2, again with a somatic p value ≤ 0.01. For small scale insertion/deletions (INDELs), the same filters above were applied, and only calls classified as high confidence by VarScan2 processSomatic were kept for further analysis, with somatic_p_value scores less than 1.0&nbsp;× 10<sup>−</sup><sup>3</sup>. Variant annotation was performed using ANNOVAR (version 2016Feb01) (<span class="dropBlock reference-citations"><a id="body-ref-sref107-2" href="#" role="doc-biblioref" data-xml-rid="bib107" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref107-2" aria-controls="sref107-2">Wang et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref107-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">107.</div><div>Wang, K. ∙ Li, M. ∙ Hakonarson, H.</div><div><strong>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</strong></div><div><em>Nucleic Acids Res.</em> 2010; <strong>38</strong>:e164</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkq603" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_107_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-77956534324" target="_blank" aria-label="Open Scopus in new tab">Scopus (5569)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20601685/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkq603&amp;pmid=20601685" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-5-3"><h4>Whole exome sequencing (DNA) pipeline–copy number calling</h4><div id="p0220" role="paragraph">VarScan2(v2.4.1) was used to generate logR depth ratios from paired tumor region/germline samples. These values were subsequently GC corrected (<span class="dropBlock reference-citations"><a id="body-ref-sref15" href="#" role="doc-biblioref" data-xml-rid="bib15" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref15" aria-controls="sref15">Cheng et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Cheng, J. ∙ Vanneste, E. ∙ Konings, P. ...</div><div><strong>Single-cell copy number variation detection</strong></div><div><em>Genome Biol.</em> 2011; <strong>12</strong>:R80</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/gb-2011-12-8-r80" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-80051786597" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21854607/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fgb-2011-12-8-r80&amp;pmid=21854607" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Default parameters were used to generate this data with the exception of: min-coverage&nbsp;= 8 and min-segment-size&nbsp;= 50. B-Allele Frequencies (BAFs)–the proportion of reads with a SNP variant relative to the total read depth–were calculated using the SNPs called in the germline by platypus. The GC-corrected logR values and BAF values are then used by ASCAT (v2.3) (<span class="dropBlock reference-citations"><a id="body-ref-sref103-3" href="#" role="doc-biblioref" data-xml-rid="bib103" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref103-3" aria-controls="sref103-3">Van Loo et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref103-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Van Loo, P. ∙ Nordgard, S.H. ∙ Lingjærde, O.C. ...</div><div><strong>Allele-specific copy number analysis of tumors</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2010; <strong>107</strong>:16910-16915</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1009843107" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-78049248432" target="_blank" aria-label="Open Scopus in new tab">Scopus (524)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20837533/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1009843107&amp;pmid=20837533" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) to generate segmented allele-specific copy number data, including estimates of tumor ploidy and cellularity. Sequenza (<span class="dropBlock reference-citations"><a id="body-ref-sref31" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31" aria-controls="sref31">Favero et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref31"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Favero, F. ∙ Joshi, T. ∙ Marquard, A.M. ...</div><div><strong>Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data</strong></div><div><em>Ann. Oncol.</em> 2015; <strong>26</strong>:64-70</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1093%2Fannonc%2Fmdu479&amp;cf=fulltext&amp;site=annonc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1093%2Fannonc%2Fmdu479&amp;cf=pdf&amp;site=annonc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84922572688" target="_blank" aria-label="Open Scopus in new tab">Scopus (214)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25319062/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fannonc%2Fmdu479&amp;pmid=25319062" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) was additionally run on all samples in parallel. To ensure accuracy, default ASCAT copy number solutions were quality control checked, and where a sample failed any of the following quality flags it then underwent manual review: i) unexpectedly high purity, defined as tumor cellularity &gt; 80%, ii) unexpectedly low levels of loss of heterozygosity, defined as fraction of the genome LOH of&nbsp;&lt; 0.1, iii) unexpectedly high level of the genome with both alleles at even copy number, defined as the fraction of the genome with alleles A and B both even as &gt; 0.7, iv) unexpectedly high level of the genome with copy number&nbsp;= 0, defined as ≥ 4Mb with copy number&nbsp;= 0. In addition, an orthogonal measure of tumor purity was derived based on mutation variant allele fraction, as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref46-1" href="#" role="doc-biblioref" data-xml-rid="bib46" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref46-1" aria-controls="sref46-1">Jamal-Hanjani et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref46-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Jamal-Hanjani, M. ∙ Wilson, G.A. ∙ McGranahan, N. ..., TRACERx Consortium</div><div><strong>Tracking the evolution of non-small-cell lung cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2017; <strong>376</strong>:2109-2121</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1616288" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85019668203" target="_blank" aria-label="Open Scopus in new tab">Scopus (822)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28445112/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1616288&amp;pmid=28445112" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and samples with a mismatch in purity between ASCAT and orthogonal measurements of greater than 1 standard deviation were additionally flagged for manual review. Samples that had been flagged for manual review underwent dual analyst inspection, which involved review of the default and alternative copy number solutions from ASCAT and Sequenza tools. Where a better fitting solution was available (based on the rules above, as well as obtaining consistency in solutions between ASCAT and Sequenza) this was utilized rather than the ASCAT default.</div></section><section id="sec-4-5-4"><h4>RNA sequencing pipeline</h4><div id="p0225" role="paragraph">RNAseq data was obtained in BAM/SRA/FASTQ format for all studies, and reverted back to FASTQ format using bam2fastq (v1.1.0). FASTQ data underwent quality control and were aligned to the hg19 genome using STAR (<span class="dropBlock reference-citations"><a id="body-ref-sref29" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29" aria-controls="sref29">Dobin et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref29"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>Dobin, A. ∙ Davis, C.A. ∙ Schlesinger, F. ...</div><div><strong>STAR: ultrafast universal RNA-seq aligner</strong></div><div><em>Bioinformatics.</em> 2013; <strong>29</strong>:15-21</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/bts635" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84871809302" target="_blank" aria-label="Open Scopus in new tab">Scopus (10402)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23104886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbts635&amp;pmid=23104886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Expression counts were normalized using DESeq2 variance stabilizing transformation (vst) function and transcripts per kilobase million (TPM) values calculated using RSEM with default parameters (<span class="dropBlock reference-citations"><a id="body-ref-sref55" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55" aria-controls="sref55">Li and Dewey, 2011</a><div class="dropBlock__holder" data-db-target-of="sref55"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Li, B. ∙ Dewey, C.N.</div><div><strong>RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome</strong></div><div><em>BMC Bioinformatics.</em> 2011; <strong>12</strong>:323</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1471-2105-12-323" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-79961123152" target="_blank" aria-label="Open Scopus in new tab">Scopus (6920)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21816040/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1471-2105-12-323&amp;pmid=21816040" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Within the meta-analysis and multivariable modelling sections (<a id="optijiGcVWEs5" href="#fig2">Figures 2</a> and <a id="crosref8255" href="#fig3">3</a>), individual gene expression analyses across samples were conducted using vst normalized expression counts, and for signatures involving multiple genes, TPM values were used (to give consistency with the majority of original authors methodologies). For other RNAseq analyses the relevant measure used is indicated in the axis labels.</div></section><section id="sec-4-5-5"><h4>Mutation clonality analysis</h4><div id="p0230" role="paragraph">PyClone (<span class="dropBlock reference-citations"><a id="body-ref-sref85" href="#" role="doc-biblioref" data-xml-rid="bib85" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref85" aria-controls="sref85">Roth et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref85"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">84.</div><div>Roth, A. ∙ Khattra, J. ∙ Yap, D. ...</div><div><strong>PyClone: statistical inference of clonal population structure in cancer</strong></div><div><em>Nat. Methods.</em> 2014; <strong>11</strong>:396-398</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.2883" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84897954204" target="_blank" aria-label="Open Scopus in new tab">Scopus (402)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24633410/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.2883&amp;pmid=24633410" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) version 0.12.7 was used to determine the clonal status of mutations. For each sample variant calls were integrated with local allele specific copy number (obtained from ASCAT), tumor purity (also obtained from ASCAT), and variant allele frequency data. All mutations were then clustered using the PyClone Dirichlet process clustering. This enables mutations to be grouped together based on likely co-occurrence in the same set of cancer cells (clones), from which the founding (truncal) clone can be identified. We ran PyClone with 10,000 iterations and a burn-in of 1000, and using parameters as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref46-2" href="#" role="doc-biblioref" data-xml-rid="bib46" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref46-2" aria-controls="sref46-2">Jamal-Hanjani et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref46-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Jamal-Hanjani, M. ∙ Wilson, G.A. ∙ McGranahan, N. ..., TRACERx Consortium</div><div><strong>Tracking the evolution of non-small-cell lung cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2017; <strong>376</strong>:2109-2121</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1616288" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85019668203" target="_blank" aria-label="Open Scopus in new tab">Scopus (822)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28445112/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1616288&amp;pmid=28445112" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-5-6"><h4>HLA and neoantigen analysis</h4><div id="p0235" role="paragraph">Neoantigen predictions were derived by first determining the 4-digit HLA type for each patient, along with mutations in class I HLA genes, using POLYSOLVER (<span class="dropBlock reference-citations"><a id="body-ref-sref91" href="#" role="doc-biblioref" data-xml-rid="bib91" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref91" aria-controls="sref91">Shukla et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref91"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">90.</div><div>Shukla, S.A. ∙ Rooney, M.S. ∙ Rajasagi, M. ...</div><div><strong>Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes</strong></div><div><em>Nat. Biotechnol.</em> 2015; <strong>33</strong>:1152-1158</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nbt.3344" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_90_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84946565788" target="_blank" aria-label="Open Scopus in new tab">Scopus (256)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26372948/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnbt.3344&amp;pmid=26372948" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Next, all possible 9, 10 and 11-mer mutant peptides were computed, based on the detected somatic non-synonymous SNV and INDEL mutations in each sample. Binding affinities of mutant and corresponding wild-type peptides, relevant to the corresponding POLYSOLVER-inferred HLA alleles, were predicted using NetMHCpan (v3.0) and NetMHC (v4.0) (<span class="dropBlock reference-citations"><a id="body-ref-sref3" href="#" role="doc-biblioref" data-xml-rid="bib3" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref3" aria-controls="sref3">Andreatta and Nielsen, 2016</a><div class="dropBlock__holder" data-db-target-of="sref3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Andreatta, M. ∙ Nielsen, M.</div><div><strong>Gapped sequence alignment using artificial neural networks: application to the MHC class I system</strong></div><div><em>Bioinformatics.</em> 2016; <strong>32</strong>:511-517</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btv639" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84959881509" target="_blank" aria-label="Open Scopus in new tab">Scopus (370)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26515819/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtv639&amp;pmid=26515819" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Neoantigen binders were defined as IC<sub>50</sub>0&nbsp;&lt; 500&nbsp;nM or rank&nbsp;&lt; 2.0. Grantham distances between HLA gene allele pairs were calculated using the same procedure described in Pierini et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref74-1" href="#" role="doc-biblioref" data-xml-rid="bib74" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref74-1" aria-controls="sref74-1">Pierini and Lenz, 2018</a><div class="dropBlock__holder" data-db-target-of="sref74-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Pierini, F. ∙ Lenz, T.L.</div><div><strong>Divergent allele advantage at human MHC genes: signatures of past and ongoing selection</strong></div><div><em>Mol. Biol. Evol.</em> 2018; <strong>35</strong>:2145-2158</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/molbev/msy116" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85053713496" target="_blank" aria-label="Open Scopus in new tab">Scopus (31)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29893875/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fmolbev%2Fmsy116&amp;pmid=29893875" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), utilizing the Grantham distance metric originally designed for investigating protein evolution from physiochemical differences in amino acid sequences (<span class="dropBlock reference-citations"><a id="body-ref-sref39-1" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-1" aria-controls="sref39-1">Grantham, 1974</a><div class="dropBlock__holder" data-db-target-of="sref39-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">38.</div><div>Grantham, R.</div><div><strong>Amino acid difference formula to help explain protein evolution</strong></div><div><em>Science.</em> 1974; <strong>185</strong>:862-864</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.185.4154.862" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/4843792/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.185.4154.862&amp;pmid=4843792" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Aligned protein sequences for HLA alleles were obtained from the IMGT database (<span class="dropBlock reference-citations"><a id="body-ref-sref80" href="#" role="doc-biblioref" data-xml-rid="bib80" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref80" aria-controls="sref80">Robinson et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref80"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">79.</div><div>Robinson, J. ∙ Soormally, A.R. ∙ Hayhurst, J.D. ...</div><div><strong>The IPD-IMGT/HLA database: new developments in reporting HLA variation</strong></div><div><em>Hum. Immunol.</em> 2016; <strong>77</strong>:233-237</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.humimm.2016.01.020" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84956609076" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26826444/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.humimm.2016.01.020&amp;pmid=26826444" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) for the different HLA alleles as called by Polysolver from the raw germline data files for the HLA-A, B and C genes. A custom R script was created to calculate the Grantham distance at each position on exons 2 and 3 of two aligned HLA alleles (exon 2 and 3 being the peptide binding region of the HLA protein). The final Grantham distance score between two HLA alleles was calculated as the sum of the scores at each position divided by length of the amino acid sequence. The average Grantham score for an individual patient was then calculated by taking the mean of the separate Grantham scores for HLA-A, B and C. It should be noted that to be consistent with the approach used in Pierini et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref74-2" href="#" role="doc-biblioref" data-xml-rid="bib74" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref74-2" aria-controls="sref74-2">Pierini and Lenz, 2018</a><div class="dropBlock__holder" data-db-target-of="sref74-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Pierini, F. ∙ Lenz, T.L.</div><div><strong>Divergent allele advantage at human MHC genes: signatures of past and ongoing selection</strong></div><div><em>Mol. Biol. Evol.</em> 2018; <strong>35</strong>:2145-2158</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/molbev/msy116" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85053713496" target="_blank" aria-label="Open Scopus in new tab">Scopus (31)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29893875/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fmolbev%2Fmsy116&amp;pmid=29893875" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), these scores do not correct for possible loss of heterozygosity of the HLA alleles (LOHHLA) that frequently occur somatically during cancer evolution but instead reflect the germline HLA divergence of a patient pre-cancers. HLA loss of heterozygosity analysis was performed using the LOHHLA tool as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref65-2" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65-2" aria-controls="sref65-2">McGranahan et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref65-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>McGranahan, N. ∙ Rosenthal, R. ∙ Hiley, C.T. ..., TRACERx Consortium</div><div><strong>Allele-specific HLA loss and immune escape in lung cancer evolution</strong></div><div><em>Cell.</em> 2017; <strong>171</strong>:1259-1271.e11</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2017.10.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2017.10.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85032583704" target="_blank" aria-label="Open Scopus in new tab">Scopus (343)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29107330/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.10.001&amp;pmid=29107330" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We implemented two additional filters to the HLA LOH calls. The first is based on the expected depth of the HLA allele in the tumor. This is calculated as the depth of the allele in the germline divided by the tumor purity and multiplied by the ratio of the number of unique reads in the tumor to the germline bam, where the allele depth in the germline sample is the median depth across the mismatches. We filtered out calls for genes that had at least one allele with an expected depth in the tumor of less than 10. We also filtered out HLA LOH calls for genes that had a minor copy number less than −0.5.</div></section><section id="sec-4-5-7"><h4>Literature search</h4><div id="p0240" role="paragraph">PubMed abstract/title fields were searched for the following sets of keywords:</div><div id="p0245" role="paragraph">“Predictive biomarker AND immunotherapy,” “Associated AND checkpoint inhibitor response,” “Sensitivity AND PD-1 blockade,” “Sensitivity AND CTLA-4 blockade,” “Sensitivity AND PD-L1 blockade,” “Resistance AND PD-1 blockade,” “Resistance AND CTLA-4 blockade,” “Resistance and PD-L1 blockade,” “Immunotherapeutic AND escape mechanism,” “Predictors AND immune checkpoint blockade,” “Immune checkpoint blockade AND determinants,” “Immune checkpoint blockade AND markers,” “Cancer immunotherapy AND determinant,” “Effectiveness AND immune checkpoint inhibitors,” “Prediction AND immune checkpoint blockade,” “Predict AND cancer immunotherapy,” “Predictive biomarkers AND checkpoint blockade therapies,” “Response AND checkpoint blockade immunotherapy,” “Predicts AND checkpoint blockade immunotherapies,” “Prediction AND immunotherapies.” Articles matching human species and date range [2015-2020] were selected, yielding a total of 723 unique manuscripts. The final search was conducted on 12<sup>th</sup> August 2020. Each paper was reviewed, and where human data was presented to support a biomarker associated with checkpoint inhibitor response, this was added to the analysis. Case reports were excluded, along with review papers, and biomarkers that could not be calculated with exome or transcriptome data. In total 55 unique biomarkers were identified and included in the study for analysis.</div></section><section id="sec-4-5-8"><h4>Derivation of published biomarkers</h4><div id="p0250" role="paragraph">The following previously published biomarkers were tested for association with response to CPI therapy: tumor mutation burden (TMB) (<span class="dropBlock reference-citations"><a id="body-ref-sref79-2" href="#" role="doc-biblioref" data-xml-rid="bib79" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref79-2" aria-controls="sref79-2">Rizvi et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref79-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Rizvi, N.A. ∙ Hellmann, M.D. ∙ Snyder, A. ...</div><div><strong>Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer</strong></div><div><em>Science.</em> 2015; <strong>348</strong>:124-128</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaa1348" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84928761118" target="_blank" aria-label="Open Scopus in new tab">Scopus (4018)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25765070/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaa1348&amp;pmid=25765070" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref93-2" href="#" role="doc-biblioref" data-xml-rid="bib93" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref93-2" aria-controls="sref93-2">Snyder et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref93-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">92.</div><div>Snyder, A. ∙ Makarov, V. ∙ Merghoub, T. ...</div><div><strong>Genetic basis for clinical response to CTLA-4 blockade in melanoma</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2014; <strong>371</strong>:2189-2199</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1406498" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_92_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84918828514" target="_blank" aria-label="Open Scopus in new tab">Scopus (2353)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25409260/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1406498&amp;pmid=25409260" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref102-3" href="#" role="doc-biblioref" data-xml-rid="bib102" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref102-3" aria-controls="sref102-3">Van Allen et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref102-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Van Allen, E.M. ∙ Miao, D. ∙ Schilling, B. ...</div><div><strong>Genomic correlates of response to CTLA-4 blockade in metastatic melanoma</strong></div><div><em>Science.</em> 2015; <strong>350</strong>:207-211</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad0095" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84943516465" target="_blank" aria-label="Open Scopus in new tab">Scopus (1192)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26359337/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad0095&amp;pmid=26359337" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (also split out into Clonal (<span class="dropBlock reference-citations"><a id="body-ref-sref64-5" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-5" aria-controls="sref64-5">McGranahan et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref64-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>McGranahan, N. ∙ Furness, A.J. ∙ Rosenthal, R. ...</div><div><strong>Clonal neoantigens elicit T&nbsp;cell immunoreactivity and sensitivity to immune checkpoint blockade</strong></div><div><em>Science.</em> 2016; <strong>351</strong>:1463-1469</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaf1490" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84962301577" target="_blank" aria-label="Open Scopus in new tab">Scopus (1319)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26940869/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaf1490&amp;pmid=26940869" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and Subclonal TMB), frameshift insertion/deletion (indel) mutation burden (<span class="dropBlock reference-citations"><a id="body-ref-sref100" href="#" role="doc-biblioref" data-xml-rid="bib100" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref100" aria-controls="sref100">Turajlic et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref100"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">100.</div><div>Turajlic, S. ∙ Litchfield, K. ∙ Xu, H. ...</div><div><strong>Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis</strong></div><div><em>Lancet Oncol.</em> 2017; <strong>18</strong>:1009-1021</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_100_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS1470-2045%2817%2930516-8&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_100_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS1470-2045%2817%2930516-8&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_100_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85022069589" target="_blank" aria-label="Open Scopus in new tab">Scopus (324)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28694034/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1470-2045%2817%2930516-8&amp;pmid=28694034" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), burden of indels escaping nonsense mediated decay (<span class="dropBlock reference-citations"><a id="body-ref-sref58" href="#" role="doc-biblioref" data-xml-rid="bib58" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58" aria-controls="sref58">Lindeboom et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref58"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Lindeboom, R.G.H. ∙ Vermeulen, M. ∙ Lehner, B. ...</div><div><strong>The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy</strong></div><div><em>Nat. Genet.</em> 2019; <strong>51</strong>:1645-1651</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41588-019-0517-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85074666705" target="_blank" aria-label="Open Scopus in new tab">Scopus (25)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31659324/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41588-019-0517-5&amp;pmid=31659324" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), Tobacco mutation signature (<span class="dropBlock reference-citations"><a id="body-ref-sref2-3" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2-3" aria-controls="sref2-3">Anagnostou et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref2-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Anagnostou, V. ∙ Niknafs, N. ∙ Marrone, K. ...</div><div><strong>Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer</strong></div><div><em>Nat. Can.</em> 2020; <strong>1</strong>:99-111</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s43018-019-0008-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32984843/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs43018-019-0008-8&amp;pmid=32984843" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), UV signature (<span class="dropBlock reference-citations"><a id="body-ref-sref49" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49" aria-controls="sref49">Knepper et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref49"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Knepper, T.C. ∙ Montesion, M. ∙ Russell, J.S. ...</div><div><strong>The genomic landscape of Merkel cell carcinoma and clinicogenomic biomarkers of response to immune checkpoint inhibitor therapy</strong></div><div><em>Clin. Cancer Res.</em> 2019; <strong>25</strong>:5961-5971</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-18-4159" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85072820707" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31399473/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-18-4159&amp;pmid=31399473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), APOBEC signature (<span class="dropBlock reference-citations"><a id="body-ref-sref13-2" href="#" role="doc-biblioref" data-xml-rid="bib13" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref13-2" aria-controls="sref13-2">Chapuy et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref13-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Chapuy, B. ∙ Stewart, C. ∙ Dunford, A.J. ...</div><div><strong>Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade</strong></div><div><em>Blood.</em> 2019; <strong>134</strong>:2369-2382</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood.2019002067" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85076370169" target="_blank" aria-label="Open Scopus in new tab">Scopus (10)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31697821/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood.2019002067&amp;pmid=31697821" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), Differential Agretopicity Index (<span class="dropBlock reference-citations"><a id="body-ref-sref35" href="#" role="doc-biblioref" data-xml-rid="bib35" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref35" aria-controls="sref35">Ghorani et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref35"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Ghorani, E. ∙ Rosenthal, R. ∙ McGranahan, N. ...</div><div><strong>Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma</strong></div><div><em>Ann. Oncol.</em> 2018; <strong>29</strong>:271-279</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1093%2Fannonc%2Fmdx687&amp;cf=fulltext&amp;site=annonc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1093%2Fannonc%2Fmdx687&amp;cf=pdf&amp;site=annonc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85041219991" target="_blank" aria-label="Open Scopus in new tab">Scopus (38)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29361136/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fannonc%2Fmdx687&amp;pmid=29361136" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), <i>MUC16</i> neoantigens (<span class="dropBlock reference-citations"><a id="body-ref-sref7" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7" aria-controls="sref7">Balachandran et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Balachandran, V.P. ∙ Łuksza, M. ∙ Zhao, J.N. ..., Australian Pancreatic Cancer Genome Initiative, Garvan Institute of Medical Research, Prince of Wales Hospital, Royal North Shore Hospital, University of Glasgow, St Vincent’s Hospital, QIMR Berghofer Medical Research Institute, University of Melbourne, Centre for Cancer Research, University of Queensland, Institute for Molecular Bioscience, Bankstown Hospital, Liverpool Hospital, Royal Prince Alfred Hospital, Chris O’Brien Lifehouse, Westmead Hospital, Fremantle Hospital, St John of God Healthcare, Royal Adelaide Hospital, Flinders Medical Centre, Envoi Pathology, Princess Alexandria Hospital, Austin Hospital, Johns Hopkins Medical Institutes, ARC-Net Centre for Applied Research on Cancer</div><div><strong>Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer</strong></div><div><em>Nature.</em> 2017; <strong>551</strong>:512-516</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature24462" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85034815842" target="_blank" aria-label="Open Scopus in new tab">Scopus (359)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29132146/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature24462&amp;pmid=29132146" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), Neoantigen fitness model (<span class="dropBlock reference-citations"><a id="body-ref-sref60" href="#" role="doc-biblioref" data-xml-rid="bib60" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref60" aria-controls="sref60">Łuksza et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref60"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Łuksza, M. ∙ Riaz, N. ∙ Makarov, V. ...</div><div><strong>A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy</strong></div><div><em>Nature.</em> 2017; <strong>551</strong>:517-520</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature24473" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85034865728" target="_blank" aria-label="Open Scopus in new tab">Scopus (229)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29132144/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature24473&amp;pmid=29132144" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), <i>SERPINB3/SERPINB4</i> mutations (<span class="dropBlock reference-citations"><a id="body-ref-sref76" href="#" role="doc-biblioref" data-xml-rid="bib76" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref76" aria-controls="sref76">Riaz et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref76"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">75.</div><div>Riaz, N. ∙ Havel, J.J. ∙ Kendall, S.M. ...</div><div><strong>Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy</strong></div><div><em>Nat. Genet.</em> 2016; <strong>48</strong>:1327-1329</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ng.3677" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84988734918" target="_blank" aria-label="Open Scopus in new tab">Scopus (57)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27668655/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fng.3677&amp;pmid=27668655" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), DNA damage response pathway mutations (<span class="dropBlock reference-citations"><a id="body-ref-sref25-1" href="#" role="doc-biblioref" data-xml-rid="bib25" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref25-1" aria-controls="sref25-1">Conway et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref25-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Conway, J.R. ∙ Kofman, E. ∙ Mo, S.S. ...</div><div><strong>Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine</strong></div><div><em>Genome Med.</em> 2018; <strong>10</strong>:93</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s13073-018-0605-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85057436952" target="_blank" aria-label="Open Scopus in new tab">Scopus (43)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30497521/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs13073-018-0605-7&amp;pmid=30497521" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), Shannon diversity index for intratumor heterogeneity (SDI-ITH) (<span class="dropBlock reference-citations"><a id="body-ref-sref112-2" href="#" role="doc-biblioref" data-xml-rid="bib112" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref112-2" aria-controls="sref112-2">Wolf et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref112-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">112.</div><div>Wolf, Y. ∙ Bartok, O. ∙ Patkar, S. ...</div><div><strong>UVB-induced tumor heterogeneity diminishes immune response in melanoma</strong></div><div><em>Cell.</em> 2019; <strong>179</strong>:219-235.e21</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_112_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2019.08.032&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_112_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2019.08.032&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_112_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85072208317" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31522890/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.08.032&amp;pmid=31522890" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), burden of somatic copy number alterations (<span class="dropBlock reference-citations"><a id="body-ref-sref28" href="#" role="doc-biblioref" data-xml-rid="bib28" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref28" aria-controls="sref28">Davoli et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref28"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Davoli, T. ∙ Uno, H. ∙ Wooten, E.C. ...</div><div><strong>Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy</strong></div><div><em>Science.</em> 2017; <strong>355</strong>:eaaf8399</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaf8399" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85010652953" target="_blank" aria-label="Open Scopus in new tab">Scopus (364)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28104840/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaf8399&amp;pmid=28104840" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), burden of somatic copy number losses (<span class="dropBlock reference-citations"><a id="body-ref-sref81" href="#" role="doc-biblioref" data-xml-rid="bib81" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref81" aria-controls="sref81">Roh et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref81"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>Roh, W. ∙ Chen, P.L. ∙ Reuben, A. ...</div><div><strong>Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance</strong></div><div><em>Sci. Transl. Med.</em> 2017; <strong>9</strong>:eaah3560</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aah3560" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85014681380" target="_blank" aria-label="Open Scopus in new tab">Scopus (234)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28251903/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aah3560&amp;pmid=28251903" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), HLA-I evolutionary divergence (<span class="dropBlock reference-citations"><a id="body-ref-sref19-3" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19-3" aria-controls="sref19-3">Chowell et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref19-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Chowell, D. ∙ Krishna, C. ∙ Pierini, F. ...</div><div><strong>Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:1715-1720</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-019-0639-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85074822630" target="_blank" aria-label="Open Scopus in new tab">Scopus (27)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31700181/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-019-0639-4&amp;pmid=31700181" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), maximal HLA heterozygosity, HLA B44/B62 supertypes, HLA B1501 type (<span class="dropBlock reference-citations"><a id="body-ref-sref18-3" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18-3" aria-controls="sref18-3">Chowell et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref18-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>Chowell, D. ∙ Morris, L.G.T. ∙ Grigg, C.M. ...</div><div><strong>Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>359</strong>:582-587</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aao4572" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85037700703" target="_blank" aria-label="Open Scopus in new tab">Scopus (318)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29217585/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aao4572&amp;pmid=29217585" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), <i>KIR3DS1</i> germline variants (<span class="dropBlock reference-citations"><a id="body-ref-sref97" href="#" role="doc-biblioref" data-xml-rid="bib97" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref97" aria-controls="sref97">Trefny et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref97"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">97.</div><div>Trefny, M.P. ∙ Rothschild, S.I. ∙ Uhlenbrock, F. ...</div><div><strong>A variant of a killer cell immunoglobulin-like receptor is associated with resistance to PD-1 blockade in lung cancer</strong></div><div><em>Clin. Cancer Res.</em> 2019; <strong>25</strong>:3026-3034</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-18-3041" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85065774404" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30765392/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-18-3041&amp;pmid=30765392" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), loss of heterozygosity at the HLA locus (<span class="dropBlock reference-citations"><a id="body-ref-sref65-3" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65-3" aria-controls="sref65-3">McGranahan et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref65-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>McGranahan, N. ∙ Rosenthal, R. ∙ Hiley, C.T. ..., TRACERx Consortium</div><div><strong>Allele-specific HLA loss and immune escape in lung cancer evolution</strong></div><div><em>Cell.</em> 2017; <strong>171</strong>:1259-1271.e11</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2017.10.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2017.10.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85032583704" target="_blank" aria-label="Open Scopus in new tab">Scopus (343)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29107330/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.10.001&amp;pmid=29107330" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), sex (<span class="dropBlock reference-citations"><a id="body-ref-sref23-2" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23-2" aria-controls="sref23-2">Conforti et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref23-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Conforti, F. ∙ Pala, L. ∙ Bagnardi, V. ...</div><div><strong>Cancer immunotherapy efficacy and patients’ sex: a systematic review and meta-analysis</strong></div><div><em>Lancet Oncol.</em> 2018; <strong>19</strong>:737-746</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS1470-2045%2818%2930261-4&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS1470-2045%2818%2930261-4&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85047095751" target="_blank" aria-label="Open Scopus in new tab">Scopus (227)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29778737/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1470-2045%2818%2930261-4&amp;pmid=29778737" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), <i>B2M</i> mutations (<span class="dropBlock reference-citations"><a id="body-ref-sref34" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34" aria-controls="sref34">Gettinger et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref34"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Gettinger, S. ∙ Choi, J. ∙ Hastings, K. ...</div><div><strong>Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer</strong></div><div><em>Cancer Discov.</em> 2017; <strong>7</strong>:1420-1435</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-17-0593" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85037334618" target="_blank" aria-label="Open Scopus in new tab">Scopus (184)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29025772/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-17-0593&amp;pmid=29025772" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), JAK1/JAK2 mutations (<span class="dropBlock reference-citations"><a id="body-ref-sref89" href="#" role="doc-biblioref" data-xml-rid="bib89" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref89" aria-controls="sref89">Shin et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref89"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">88.</div><div>Shin, D.S. ∙ Zaretsky, J.M. ∙ Escuin-Ordinas, H. ...</div><div><strong>Primary resistance to PD-1 blockade mediated by JAK1/2 mutations</strong></div><div><em>Cancer Discov.</em> 2017; <strong>7</strong>:188-201</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-16-1223" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85011827059" target="_blank" aria-label="Open Scopus in new tab">Scopus (490)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27903500/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-16-1223&amp;pmid=27903500" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), <i>KRAS</i> and <i>TP53</i> mutations (<span class="dropBlock reference-citations"><a id="body-ref-sref4-1" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4-1" aria-controls="sref4-1">Aredo et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref4-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Aredo, J.V. ∙ Padda, S.K. ∙ Kunder, C.A. ...</div><div><strong>Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes</strong></div><div><em>Lung Cancer.</em> 2019; <strong>133</strong>:144-150</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.lungcan.2019.05.015&amp;cf=fulltext&amp;site=lung-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.lungcan.2019.05.015&amp;cf=pdf&amp;site=lung-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85066077498" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31200821/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.lungcan.2019.05.015&amp;pmid=31200821" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), <i>PTEN</i> mutations (<span class="dropBlock reference-citations"><a id="body-ref-sref73" href="#" role="doc-biblioref" data-xml-rid="bib73" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref73" aria-controls="sref73">Peng et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref73"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">72.</div><div>Peng, W. ∙ Chen, J.Q. ∙ Liu, C. ...</div><div><strong>Loss of PTEN promotes resistance to T&nbsp;cell-mediated immunotherapy</strong></div><div><em>Cancer Discov.</em> 2016; <strong>6</strong>:202-216</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-15-0283" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84957093642" target="_blank" aria-label="Open Scopus in new tab">Scopus (595)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26645196/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-15-0283&amp;pmid=26645196" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), <i>RTK</i> mutations (<span class="dropBlock reference-citations"><a id="body-ref-sref2-4" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2-4" aria-controls="sref2-4">Anagnostou et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref2-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Anagnostou, V. ∙ Niknafs, N. ∙ Marrone, K. ...</div><div><strong>Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer</strong></div><div><em>Nat. Can.</em> 2020; <strong>1</strong>:99-111</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s43018-019-0008-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32984843/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs43018-019-0008-8&amp;pmid=32984843" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), <i>STK11</i> mutations (<span class="dropBlock reference-citations"><a id="body-ref-sref4-2" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4-2" aria-controls="sref4-2">Aredo et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref4-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Aredo, J.V. ∙ Padda, S.K. ∙ Kunder, C.A. ...</div><div><strong>Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes</strong></div><div><em>Lung Cancer.</em> 2019; <strong>133</strong>:144-150</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.lungcan.2019.05.015&amp;cf=fulltext&amp;site=lung-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.lungcan.2019.05.015&amp;cf=pdf&amp;site=lung-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85066077498" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31200821/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.lungcan.2019.05.015&amp;pmid=31200821" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), <i>BAP1</i> mutations (<span class="dropBlock reference-citations"><a id="body-ref-sref90" href="#" role="doc-biblioref" data-xml-rid="bib90" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref90" aria-controls="sref90">Shrestha et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref90"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">89.</div><div>Shrestha, R. ∙ Nabavi, N. ∙ Lin, Y.Y. ...</div><div><strong>BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma</strong></div><div><em>Genome Med.</em> 2019; <strong>11</strong>:8</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s13073-019-0620-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_89_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85061874412" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30777124/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs13073-019-0620-3&amp;pmid=30777124" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), <i>CD8A</i> (<span class="dropBlock reference-citations"><a id="body-ref-sref99" href="#" role="doc-biblioref" data-xml-rid="bib99" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref99" aria-controls="sref99">Tumeh et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref99"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">99.</div><div>Tumeh, P.C. ∙ Harview, C.L. ∙ Yearley, J.H. ...</div><div><strong>PD-1 blockade induces responses by inhibiting adaptive immune resistance</strong></div><div><em>Nature.</em> 2014; <strong>515</strong>:568-571</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature13954" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_99_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84920956732" target="_blank" aria-label="Open Scopus in new tab">Scopus (3130)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25428505/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature13954&amp;pmid=25428505" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), <i>CD274 (</i>PD-L1) (<span class="dropBlock reference-citations"><a id="body-ref-sref37" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37" aria-controls="sref37">Gibney et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref37"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>Gibney, G.T. ∙ Weiner, L.M. ∙ Atkins, M.B.</div><div><strong>Predictive biomarkers for checkpoint inhibitor-based immunotherapy</strong></div><div><em>Lancet Oncol.</em> 2016; <strong>17</strong>:e542-e551</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS1470-2045%2816%2930406-5&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS1470-2045%2816%2930406-5&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85003475383" target="_blank" aria-label="Open Scopus in new tab">Scopus (555)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27924752/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1470-2045%2816%2930406-5&amp;pmid=27924752" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), <i>CD38</i> (<span class="dropBlock reference-citations"><a id="body-ref-sref14" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14" aria-controls="sref14">Chen et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Chen, L. ∙ Diao, L. ∙ Yang, Y. ...</div><div><strong>CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade</strong></div><div><em>Cancer Discov.</em> 2018; <strong>8</strong>:1156-1175</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-17-1033" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85053178618" target="_blank" aria-label="Open Scopus in new tab">Scopus (115)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30012853/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-17-1033&amp;pmid=30012853" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), <i>HAVCR2</i> (TIM3)/<i>LGALS9</i> (<span class="dropBlock reference-citations"><a id="body-ref-sref51" href="#" role="doc-biblioref" data-xml-rid="bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51" aria-controls="sref51">Koyama et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref51"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Koyama, S. ∙ Akbay, E.A. ∙ Li, Y.Y. ...</div><div><strong>Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints</strong></div><div><em>Nat. Commun.</em> 2016; <strong>7</strong>:10501</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms10501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84958555198" target="_blank" aria-label="Open Scopus in new tab">Scopus (622)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26883990/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms10501&amp;pmid=26883990" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), <i>MEX3B</i> (<span class="dropBlock reference-citations"><a id="body-ref-sref44" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44" aria-controls="sref44">Huang et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref44"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Huang, L. ∙ Malu, S. ∙ McKenzie, J.A. ...</div><div><strong>The RNA-binding protein MEX3B mediates resistance to cancer immunotherapy by downregulating HLA-A expression</strong></div><div><em>Clin. Cancer Res.</em> 2018; <strong>24</strong>:3366-3376</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-17-2483" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85050116970" target="_blank" aria-label="Open Scopus in new tab">Scopus (24)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29496759/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-17-2483&amp;pmid=29496759" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and <i>CXCL9</i> expression (<span class="dropBlock reference-citations"><a id="body-ref-sref16" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16" aria-controls="sref16">Chow et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Chow, M.T. ∙ Ozga, A.J. ∙ Servis, R.L. ...</div><div><strong>Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy</strong></div><div><em>Immunity.</em> 2019; <strong>50</strong>:1498-1512.e5</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.immuni.2019.04.010&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.immuni.2019.04.010&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85066303170" target="_blank" aria-label="Open Scopus in new tab">Scopus (103)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31097342/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2019.04.010&amp;pmid=31097342" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), as well as the CD8 T&nbsp;cell effector (<span class="dropBlock reference-citations"><a id="body-ref-sref63-4" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63-4" aria-controls="sref63-4">McDermott et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref63-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>McDermott, D.F. ∙ Huseni, M.A. ∙ Atkins, M.B. ...</div><div><strong>Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:749-757</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0053-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85048001150" target="_blank" aria-label="Open Scopus in new tab">Scopus (334)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29867230/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0053-3&amp;pmid=29867230" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), proliferation (<span class="dropBlock reference-citations"><a id="body-ref-sref71" href="#" role="doc-biblioref" data-xml-rid="bib71" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref71" aria-controls="sref71">Pabla et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref71"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">70.</div><div>Pabla, S. ∙ Conroy, J.M. ∙ Nesline, M.K. ...</div><div><strong>Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients</strong></div><div><em>J.&nbsp;Immunother. Cancer.</em> 2019; <strong>7</strong>:27</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s40425-019-0506-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85060929943" target="_blank" aria-label="Open Scopus in new tab">Scopus (7)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30709424/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs40425-019-0506-3&amp;pmid=30709424" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), cytolytic (<span class="dropBlock reference-citations"><a id="body-ref-sref82" href="#" role="doc-biblioref" data-xml-rid="bib82" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref82" aria-controls="sref82">Rooney et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref82"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">81.</div><div>Rooney, M.S. ∙ Shukla, S.A. ∙ Wu, C.J. ...</div><div><strong>Molecular and genetic properties of tumors associated with local immune cytolytic activity</strong></div><div><em>Cell.</em> 2015; <strong>160</strong>:48-61</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2014.12.033&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2014.12.033&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84920962202" target="_blank" aria-label="Open Scopus in new tab">Scopus (1188)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25594174/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2014.12.033&amp;pmid=25594174" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), stroma-EMT (<span class="dropBlock reference-citations"><a id="body-ref-sref109" href="#" role="doc-biblioref" data-xml-rid="bib109" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref109" aria-controls="sref109">Wang et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref109"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">109.</div><div>Wang, L. ∙ Saci, A. ∙ Szabo, P.M. ...</div><div><strong>EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:3503</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-018-05992-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_109_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85052691158" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30158554/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-018-05992-x&amp;pmid=30158554" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), TGF beta pan fibroblast (<span class="dropBlock reference-citations"><a id="body-ref-sref62-5" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-5" aria-controls="sref62-5">Mariathasan et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref62-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Mariathasan, S. ∙ Turley, S.J. ∙ Nickles, D. ...</div><div><strong>TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T&nbsp;cells</strong></div><div><em>Nature.</em> 2018; <strong>554</strong>:544-548</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85042495633" target="_blank" aria-label="Open Scopus in new tab">Scopus (833)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29443960/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25501&amp;pmid=29443960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), IMPRES (<span class="dropBlock reference-citations"><a id="body-ref-sref5" href="#" role="doc-biblioref" data-xml-rid="bib5" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref5" aria-controls="sref5">Auslander et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Auslander, N. ∙ Zhang, G. ∙ Lee, J.S. ...</div><div><strong>Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1545-1549</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0157-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85052285340" target="_blank" aria-label="Open Scopus in new tab">Scopus (111)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30127394/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0157-9&amp;pmid=30127394" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), CD8&nbsp;T effector from the POPLAR trial (<span class="dropBlock reference-citations"><a id="body-ref-sref32" href="#" role="doc-biblioref" data-xml-rid="bib32" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref32" aria-controls="sref32">Fehrenbacher et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref32"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Fehrenbacher, L. ∙ Spira, A. ∙ Ballinger, M. ..., POPLAR Study Group</div><div><strong>Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial</strong></div><div><em>Lancet.</em> 2016; <strong>387</strong>:1837-1846</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS0140-6736%2816%2900587-0&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS0140-6736%2816%2900587-0&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26970723/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0140-6736%2816%2900587-0&amp;pmid=26970723" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), 12-cheomokine (<span class="dropBlock reference-citations"><a id="body-ref-sref68" href="#" role="doc-biblioref" data-xml-rid="bib68" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref68" aria-controls="sref68">Messina et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref68"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Messina, J.L. ∙ Fenstermacher, D.A. ∙ Eschrich, S. ...</div><div><strong>12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?</strong></div><div><em>Sci. Rep.</em> 2012; <strong>2</strong>:765</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/srep00765" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84868277668" target="_blank" aria-label="Open Scopus in new tab">Scopus (184)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23097687/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fsrep00765&amp;pmid=23097687" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref116" href="#" role="doc-biblioref" data-xml-rid="bib116" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref116" aria-controls="sref116">Tokunaga et al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref116"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">95.</div><div>Tokunaga, R. ∙ Nakagawa, S. ∙ Sakamoto, Y. ...</div><div><strong>12-Chemokine signature, a predictor of tumor recurrence in colorectal cancer</strong></div><div><em>International Journal of Cancer.</em> 2020; <strong>147</strong>:532-541</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/ijc.32982" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_95_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85084047731" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32191346/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fijc.32982&amp;pmid=32191346" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), HERV-3 family expression (<span class="dropBlock reference-citations"><a id="body-ref-sref72" href="#" role="doc-biblioref" data-xml-rid="bib72" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref72" aria-controls="sref72">Panda et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref72"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">71.</div><div>Panda, A. ∙ de Cubas, A.A. ∙ Stein, M. ...</div><div><strong>Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma</strong></div><div><em>JCI Insight.</em> 2018; <strong>3</strong>:e121522</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/jci.insight.121522" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85062245416" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30135306/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2Fjci.insight.121522&amp;pmid=30135306" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and T&nbsp;cell inflamed gene expression signatures (<span class="dropBlock reference-citations"><a id="body-ref-sref6-2" href="#" role="doc-biblioref" data-xml-rid="bib6" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref6-2" aria-controls="sref6-2">Ayers et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref6-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Ayers, M. ∙ Lunceford, J. ∙ Nebozhyn, M. ...</div><div><strong>IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2017; <strong>127</strong>:2930-2940</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI91190" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85026675148" target="_blank" aria-label="Open Scopus in new tab">Scopus (834)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28650338/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI91190&amp;pmid=28650338" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). TMB was measured on a per megabase basis using the Friends of Cancer Research TMB Harmonization Project phase I guidelines (<span class="dropBlock reference-citations"><a id="body-ref-sref67" href="#" role="doc-biblioref" data-xml-rid="bib67" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref67" aria-controls="sref67">Merino et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref67"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Merino, D.M. ∙ McShane, L.M. ∙ Fabrizio, D. ..., TMB Harmonization Consortium</div><div><strong>Establishing guidelines to harmonize tumor mutational burden (TMB): in&nbsp;silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project</strong></div><div><em>J.&nbsp;Immunother. Cancer.</em> 2020; <strong>8</strong>:e000147</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/jitc-2019-000147" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85082561754" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32217756/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1136%2Fjitc-2019-000147&amp;pmid=32217756" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), clonal TMB was measured as per (<span class="dropBlock reference-citations"><a id="body-ref-sref64-6" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-6" aria-controls="sref64-6">McGranahan et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref64-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>McGranahan, N. ∙ Furness, A.J. ∙ Rosenthal, R. ...</div><div><strong>Clonal neoantigens elicit T&nbsp;cell immunoreactivity and sensitivity to immune checkpoint blockade</strong></div><div><em>Science.</em> 2016; <strong>351</strong>:1463-1469</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaf1490" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84962301577" target="_blank" aria-label="Open Scopus in new tab">Scopus (1319)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26940869/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaf1490&amp;pmid=26940869" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) with samples which failed pyclone clustering assumed that all mutations were clonal, SCNA load was defined using the weighted genome instability index (wGII) (<span class="dropBlock reference-citations"><a id="body-ref-sref30-2" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref30-2" aria-controls="sref30-2">Endesfelder et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref30-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Endesfelder, D. ∙ Burrell, R. ∙ Kanu, N. ...</div><div><strong>Chromosomal instability selects gene copy-number variants encoding core regulators of proliferation in ER+ breast cancer</strong></div><div><em>Cancer Res.</em> 2014; <strong>74</strong>:4853-4863</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-13-2664" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84907053818" target="_blank" aria-label="Open Scopus in new tab">Scopus (32)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24970479/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-13-2664&amp;pmid=24970479" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), expression of individual genes was measured using varianceStabilizingTransformation (vst) normalized expression count from DESeq2 (for datasets with RNaseq) or normalized nanostring expression values for the Cristescu et&nbsp;al. cohort. In the Cristescu et&nbsp;al. cohort, where transcriptome data is only available for a subset of genes, gene expression signatures were calculated with as many genes as were available. For inactivating pathway mutations (i.e., <i>B2M</i>, <i>PTEN, JAK1/JAK2</i>, DNA damage response) loss of function mutations (i.e., those causing a premature stop codon) and homozygous deletions were included. DNA damage response pathway genes were defined as: <i>BRCA1, BRCA2, ATM, POLE, ERCC2, FANCA, MSH2, MLH1, POLD1</i> and <i>MSH6</i> based on (<span class="dropBlock reference-citations"><a id="body-ref-sref25-2" href="#" role="doc-biblioref" data-xml-rid="bib25" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref25-2" aria-controls="sref25-2">Conway et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref25-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Conway, J.R. ∙ Kofman, E. ∙ Mo, S.S. ...</div><div><strong>Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine</strong></div><div><em>Genome Med.</em> 2018; <strong>10</strong>:93</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s13073-018-0605-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85057436952" target="_blank" aria-label="Open Scopus in new tab">Scopus (43)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30497521/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs13073-018-0605-7&amp;pmid=30497521" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). All other biomarkers were defined as per the method outlined in the original underlying publication as referenced above. Associations with response were tested using logistic regression. To allow biomarkers with varying measurement scales (e.g., mutation counts versus gene expression values) to be compared equivalently based on effect size rather than p value (<span class="dropBlock reference-citations"><a id="body-ref-sref110-2" href="#" role="doc-biblioref" data-xml-rid="bib110" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref110-2" aria-controls="sref110-2">Wasserstein et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref110-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">110.</div><div>Wasserstein, R.L. ∙ Schirm, A.L. ∙ Lazar, N.A.</div><div><strong>Moving to a world beyond “p &lt; 0.05”</strong></div><div><em>Am. Stat.</em> 2019; <strong>73</strong>:1-19</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/00031305.2019.1583913" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_110_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85063216937" target="_blank" aria-label="Open Scopus in new tab">Scopus (597)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F00031305.2019.1583913" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), all biomarker values (continuous and binary) were converted to standard z-scores (i.e., mean normalized to equal zero, and standard deviation normalized to one). To avoid data pooling, each biomarker was tested individually in each sub-study, and then the effect sizes and standard errors were combined through random effects meta-analysis to derive a final p value per biomarker. Meta-analysis was conducted using R package ‘meta’. Proportion of variance explained analysis. The total proportion of variance explained by all biomarkers was calculated by logistic regression pseudo-<i>R</i><sup>2</sup>, using R function ‘PseudoR2′.</div></section><section id="sec-4-5-9"><h4>Fitting a multivariable model of CPI response</h4><div id="p0255" role="paragraph">The predicative utility of a multivariable model was benchmarked against TMB as a univariable comparator. The multivariable model was made up of all biomarkers attaining significance in the <a id="opt1gM5S8wcwI" href="#fig2">Figure 2</a>A meta-analysis (final column, p-meta validation cohorts only), comprising 11 measures in total: Clonal TMB, Indel TMB, NMD-escape TMB, UV signature, Tobacco signature, APOBEC signature, sex, T&nbsp;cell inflamed GEP signature, and gene expression values for CD274 (PD-L1), CD8A and CXCL9. All 11 biomarkers were inputted into the gradient boosted tree algorithm XGBoost (R package ‘xgboost’), a widely used machine learning algorithm effective for classification tasks. The variation in feature importance scores across tumor types was demonstrated using the largest cohort of matched exome and transcriptome data for each tumor type: urothelial: (<span class="dropBlock reference-citations"><a id="body-ref-sref62-6" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-6" aria-controls="sref62-6">Mariathasan et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref62-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Mariathasan, S. ∙ Turley, S.J. ∙ Nickles, D. ...</div><div><strong>TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T&nbsp;cells</strong></div><div><em>Nature.</em> 2018; <strong>554</strong>:544-548</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85042495633" target="_blank" aria-label="Open Scopus in new tab">Scopus (833)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29443960/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25501&amp;pmid=29443960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), head and neck: (<span class="dropBlock reference-citations"><a id="body-ref-sref26-11" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-11" aria-controls="sref26-11">Cristescu et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref26-11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Cristescu, R. ∙ Mogg, R. ∙ Ayers, M. ...</div><div><strong>Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:362</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aar3593" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85054777584" target="_blank" aria-label="Open Scopus in new tab">Scopus (403)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aar3593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), melanoma: (<span class="dropBlock reference-citations"><a id="body-ref-sref26-12" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-12" aria-controls="sref26-12">Cristescu et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref26-12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Cristescu, R. ∙ Mogg, R. ∙ Ayers, M. ...</div><div><strong>Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:362</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aar3593" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85054777584" target="_blank" aria-label="Open Scopus in new tab">Scopus (403)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aar3593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and renal: (<span class="dropBlock reference-citations"><a id="body-ref-sref63-5" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63-5" aria-controls="sref63-5">McDermott et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref63-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>McDermott, D.F. ∙ Huseni, M.A. ∙ Atkins, M.B. ...</div><div><strong>Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:749-757</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0053-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85048001150" target="_blank" aria-label="Open Scopus in new tab">Scopus (334)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29867230/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0053-3&amp;pmid=29867230" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). All training samples (n&nbsp;= 1008) were then utilized to build a final predictive model with the 11 biomarkers, with maximum tree depth of 2, nrounds set as 15 and eta set 0.2—these values were derived using grid search in ‘caret’ R package with 5-fold cross validation using (n&nbsp;= 1008) training cohort samples. All other parameters were kept as default values. TMB predictions were made using an identical model desgin. R package ‘ROCR’ was used for the ROC curve analysis. Three cohorts were utilized as independent test/validation sets (not used in model training process): 1) the KEYNOTE-028 “other tumour type” cohort from (<span class="dropBlock reference-citations"><a id="body-ref-sref26-13" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-13" aria-controls="sref26-13">Cristescu et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref26-13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Cristescu, R. ∙ Mogg, R. ∙ Ayers, M. ...</div><div><strong>Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:362</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aar3593" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85054777584" target="_blank" aria-label="Open Scopus in new tab">Scopus (403)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aar3593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), 2) Liu, Schilling et&nbsp;al., 2019 melanoma cohort (<span class="dropBlock reference-citations"><a id="body-ref-sref59-3" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-3" aria-controls="sref59-3">Liu et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref59-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Liu, D. ∙ Schilling, B. ∙ Liu, D. ...</div><div><strong>Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:1916-1927</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-019-0654-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85075928991" target="_blank" aria-label="Open Scopus in new tab">Scopus (60)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31792460/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-019-0654-5&amp;pmid=31792460" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and 3) Shim et&nbsp;al., 2020 lung cancer cohort (<span class="dropBlock reference-citations"><a id="body-ref-sref88-3" href="#" role="doc-biblioref" data-xml-rid="bib88" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref88-3" aria-controls="sref88-3">Shim et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref88-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">87.</div><div>Shim, J.H. ∙ Kim, H.S. ∙ Cha, H. ...</div><div><strong>HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients</strong></div><div><em>Ann. Oncol.</em> 2020; <strong>31</strong>:902-911</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.annonc.2020.04.004&amp;cf=fulltext&amp;site=annonc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.annonc.2020.04.004&amp;cf=pdf&amp;site=annonc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85085291189" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32320754/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.annonc.2020.04.004&amp;pmid=32320754" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Test set 1) was selected as this consists of “other tumour type” samples, and the final model from Figure&nbsp;3b/c is trained on a combined set of pan-cancer samples, hence this mixed tumor type cohort was selected as an appropriate validation set. Test sets 2) and 3) were selected as test datasets based on their publication timing, i.e., they are the most recently published datasets, which became available after model training was completed. Data for test cohort 1) was obtained as raw data, and data for test cohorts 2) &amp; 3) was obtained from supplementary published tables on account of the recent publication of these studies. We note that for test cohort 3) (<span class="dropBlock reference-citations"><a id="body-ref-sref88-4" href="#" role="doc-biblioref" data-xml-rid="bib88" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref88-4" aria-controls="sref88-4">Shim et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref88-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">87.</div><div>Shim, J.H. ∙ Kim, H.S. ∙ Cha, H. ...</div><div><strong>HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients</strong></div><div><em>Ann. Oncol.</em> 2020; <strong>31</strong>:902-911</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.annonc.2020.04.004&amp;cf=fulltext&amp;site=annonc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.annonc.2020.04.004&amp;cf=pdf&amp;site=annonc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85085291189" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32320754/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.annonc.2020.04.004&amp;pmid=32320754" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) only TMB, PD-L1, smoking signature (inferred from smoking history) and sex data was available, and hence only these four variables were used in the multivariable model, and PD-L1 was used in place of <i>CXCL9</i> expression in the two-parameter model.</div></section><section id="sec-4-5-10"><h4>Mutation signature analysis</h4><div id="p0260" role="paragraph">DeconstructSigs (<span class="dropBlock reference-citations"><a id="body-ref-sref83" href="#" role="doc-biblioref" data-xml-rid="bib83" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref83" aria-controls="sref83">Rosenthal et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref83"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">82.</div><div>Rosenthal, R. ∙ McGranahan, N. ∙ Herrero, J. ...</div><div><strong>DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution</strong></div><div><em>Genome Biol.</em> 2016; <strong>17</strong>:31</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s13059-016-0893-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84959467752" target="_blank" aria-label="Open Scopus in new tab">Scopus (369)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26899170/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs13059-016-0893-4&amp;pmid=26899170" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) was used to derive COSMIC mutational signatures (v2) (<span class="dropBlock reference-citations"><a id="body-ref-sref1-2" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-2" aria-controls="sref1-2">Alexandrov et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref1-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Alexandrov, L.B. ∙ Jones, P.H. ∙ Wedge, D.C. ...</div><div><strong>Clock-like mutational processes in human somatic cells</strong></div><div><em>Nat. Genet.</em> 2015; <strong>47</strong>:1402-1407</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ng.3441" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84949104081" target="_blank" aria-label="Open Scopus in new tab">Scopus (350)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26551669/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fng.3441&amp;pmid=26551669" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) for each tumor samples with ≥ 50 somatic mutations (n&nbsp;= 872 patients). Grantham distance, which considers three properties: composition, polarity and molecular volume, was used to measure difference in amino acid properties (<span class="dropBlock reference-citations"><a id="body-ref-sref39-2" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-2" aria-controls="sref39-2">Grantham, 1974</a><div class="dropBlock__holder" data-db-target-of="sref39-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">38.</div><div>Grantham, R.</div><div><strong>Amino acid difference formula to help explain protein evolution</strong></div><div><em>Science.</em> 1974; <strong>185</strong>:862-864</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.185.4154.862" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/4843792/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.185.4154.862&amp;pmid=4843792" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). A Grantham distance change of ≥ 100 was considered radical, or less than 100 conservative (<span class="dropBlock reference-citations"><a id="body-ref-sref27" href="#" role="doc-biblioref" data-xml-rid="bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27" aria-controls="sref27">Dagan et&nbsp;al., 2002</a><div class="dropBlock__holder" data-db-target-of="sref27"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Dagan, T. ∙ Talmor, Y. ∙ Graur, D.</div><div><strong>Ratios of radical to conservative amino acid replacement are affected by mutational and compositional factors and may not be indicative of positive Darwinian selection</strong></div><div><em>Mol. Biol. Evol.</em> 2002; <strong>19</strong>:1022-1025</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/oxfordjournals.molbev.a004161" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12082122/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Foxfordjournals.molbev.a004161&amp;pmid=12082122" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Hydrophobicity scores per amino acid were derived using the scale from Kyte &amp; Doolittle (<span class="dropBlock reference-citations"><a id="body-ref-sref53" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53" aria-controls="sref53">Kyte and Doolittle, 1982</a><div class="dropBlock__holder" data-db-target-of="sref53"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Kyte, J. ∙ Doolittle, R.F.</div><div><strong>A simple method for displaying the hydropathic character of a protein</strong></div><div><em>J.&nbsp;Mol. Biol.</em> 1982; <strong>157</strong>:105-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/0022-2836(82)90515-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-0020475449" target="_blank" aria-label="Open Scopus in new tab">Scopus (16210)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7108955/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2F0022-2836%2882%2990515-0&amp;pmid=7108955" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Data from melanoma/gastric cancer patient tumor infiltrating lymphocyte (TIL) samples, which were screened for reactivity against neoantigen peptides, was taken from (<span class="dropBlock reference-citations"><a id="body-ref-sref20-2" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20-2" aria-controls="sref20-2">Chudley et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref20-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Chudley, L. ∙ McCann, K.J. ∙ Coleman, A. ...</div><div><strong>Harmonisation of short-term in&nbsp;vitro culture for the expansion of antigen-specific CD8(+) T&nbsp;cells with detection by ELISPOT and HLA-multimer staining</strong></div><div><em>Cancer Immunol. Immunother.</em> 2014; <strong>63</strong>:1199-1211</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s00262-014-1593-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84939876111" target="_blank" aria-label="Open Scopus in new tab">Scopus (16)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25134947/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs00262-014-1593-0&amp;pmid=25134947" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref40-2" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-2" aria-controls="sref40-2">Gros et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref40-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Gros, A. ∙ Parkhurst, M.R. ∙ Tran, E. ...</div><div><strong>Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients</strong></div><div><em>Nat. Med.</em> 2016; <strong>22</strong>:433-438</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4051" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84959152038" target="_blank" aria-label="Open Scopus in new tab">Scopus (398)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26901407/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4051&amp;pmid=26901407" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref96-2" href="#" role="doc-biblioref" data-xml-rid="bib96" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref96-2" aria-controls="sref96-2">Tran et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref96-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">96.</div><div>Tran, E. ∙ Ahmadzadeh, M. ∙ Lu, Y.C. ...</div><div><strong>Immunogenicity of somatic mutations in human gastrointestinal cancers</strong></div><div><em>Science.</em> 2015; <strong>350</strong>:1387-1390</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad1253" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84949730499" target="_blank" aria-label="Open Scopus in new tab">Scopus (363)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26516200/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad1253&amp;pmid=26516200" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-5-11"><h4>Pan-cancer analysis of copy number losses and gains</h4><div id="p0265" role="paragraph">Copy number segment data from ASCAT for all responders and non-responders were inputted to the R package ‘copynumber’ (<span class="dropBlock reference-citations"><a id="body-ref-sref70-2" href="#" role="doc-biblioref" data-xml-rid="bib70" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref70-2" aria-controls="sref70-2">Nilsen et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref70-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Nilsen, G. ∙ Liestøl, K. ∙ Van Loo, P. ...</div><div><strong>Copynumber: efficient algorithms for single- and multi-track copy number segmentation</strong></div><div><em>BMC Genomics.</em> 2012; <strong>13</strong>:591</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1471-2164-13-591" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84873813238" target="_blank" aria-label="Open Scopus in new tab">Scopus (126)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23442169/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1471-2164-13-591&amp;pmid=23442169" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) to derive the gain and loss frequency across the genome for each group (i.e., for responders and non-responders separately). Region level cytoband coordinates were obtained from the UCSC Table Browser, with 286 autosomal chromosomes cytobands defined. For gains and losses (separately) the frequency per cytoband was converted back to absolute patient counts and the difference between responders and non-responders was compared using a 2x2 Fisher’s exact test. Results were corrected for multiple testing using the p.adjust function in R, with the FDR method. The frequency of whole chromosomal losses was analyzed using genome-wide SNP6 segmented data per sample from the TCGA GDAC Firehose repository (<a id="intref0085" href="http://firebrowse.org/" target="_blank">http://firebrowse.org/</a>), for histology types overlapping with the CPI1000+ cohort, i.e., TCGA cohorts: BLCA, BRCA, COADREAD, HNSC, KIRC, LUAD, LUSC and SKCM. The immune evasion alteration analysis (<a id="optSoD3Td2g5I" href="#figs3">Figure S3</a>B) was conducted as per previously published method by Rosenthal et&nbsp;al., 2019 (<span class="dropBlock reference-citations"><a id="body-ref-sref84-4" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84-4" aria-controls="sref84-4">Rosenthal et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref84-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Rosenthal, R. ∙ Cadieux, E.L. ∙ Salgado, R. ..., TRACERx consortium</div><div><strong>Neoantigen-directed immune escape in lung cancer evolution</strong></div><div><em>Nature.</em> 2019; <strong>567</strong>:479-485</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1032-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85063265508" target="_blank" aria-label="Open Scopus in new tab">Scopus (180)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30894752/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1032-7&amp;pmid=30894752" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), which defines antigen-presentation-pathway genes as components of the HLA enhanceosome, peptide generation, chaperones or the MHC complex itself. In the analysis we included disruptive events (non-synonymous mutations or copy-number loss defined relative to ploidy) of the following genes: <i>CIITA, IRF1, PSME1, PSME2, PSME3, ERAP1, ERAP2, HSPA, HSPC, TAP1, TAP2, TAPBP, CALR, CNX, PDIA3</i> and <i>B2M</i>. The analysis was also repeated for non-synonymous mutations only (i.e., no copy number loss events). In addition, a multivariable logistic regression test was also performed, adjusting for wGII and cancer type, which also confirmed a significant association between 9q34 loss and a higher rate of immune evasion.</div></section><section id="sec-4-5-12"><h4>Pan-cancer analysis of focal amplifications and deep deletions</h4><div id="p0270" role="paragraph">Copy number segment data from ASCAT for all responders and non-responders were utilized to identify tumors with either focal amplification (copy number ≥ 5 and segment length&nbsp;&lt; 3Mb) or homozygous deletions (copy number&nbsp;= 0 and segment length&nbsp;&lt; 3Mb), in known oncogenes (for amplifications) or tumor suppressor genes (for deep deletions). Oncogenes and tumor suppressor genes were defined according to the Cancer Gene Census (<a id="intref0090" href="https://cancer.sanger.ac.uk/census" target="_blank">https://cancer.sanger.ac.uk/census</a>), accessed 23<sup>rd</sup> October 2019, and events with greater than 5% frequency in the CPI1000+ cohort were analyzed. The difference in Oncogene/TSG amplification/deletion frequency was compared between responders and non-responders using a one-sided 2x2 Fisher’s exact test (events were hypothesized to associate with resistance only, as they are not collateral passenger events that may cause sensitization).</div></section><section id="sec-4-5-13"><h4>Analysis of single cell RNA sequencing data</h4><div id="p0275" role="paragraph">All sequencing data was assessed to detect sequencing failures using FASTQC and lower quality reads were filtered or trimmed using TrimGalore. Outlier samples containing low sequencing coverage or high duplication rates were discarded. Analyses using the RNaseq data were performed in the R statistical computing framework, version 3.5 using packages from BioConductor version 3.7. The single cell RNAseq samples were mapped to the GRCh38 reference human genome, as included in Ensembl version 84, using the STAR algorithm and transcript and gene abundance were estimated using the RSEM algorithm. After quantification, the scater package was used to set filtering thresholds, based on using spike ins and mitochondrial genes to filter out bad quality cells, filtering by total number of genes and filtering by total number of sequenced reads. The remaining cells were used after normalizing using size-factors estimated by the SCRAN package. Downstream analyses used log2 transformed normalized count data. All count data, metadata and intermediate results were kept within a SummarizedExperiment/SingleCellExperiment R object. The data was processed using the edgeR BioConductor package that was used for outlier detection and differential gene expression analyses. Differentially expressed genes were assessed based on their protein coding status. The combined single cell and CPI1000+ bulk sequencing analysis was conducted as follows: i) genes discovered in single cell sequencing dataset were filtered for q&nbsp;&lt; 0.05 (FDR corrected p value), log10 fold-change &gt; 2 and T&nbsp;cell receptor variable genes (e.g., <i>TRAV19</i>) were removed, ii) filtering from the previous step yielded n&nbsp;= 846 genes, which were then each validated for an association with response in patients from the CPI1000+ cohort with full RNAseq data (n&nbsp;= 564). TPM expression values were used and tested for an association with response using logistic regression, with all samples combined together but corrected for study as a covariate, iii) the previous step yielded 110 genes with p&nbsp;&lt; 0.05, we note these p values were not corrected for multiple testing as this was a validation of the single cell identified hits. Of the 110 genes, 101 were upregulated in CPI responders, and this was utilized for figure plotting.</div></section><section id="sec-4-5-14"><h4>Statistical methods</h4><div id="p0280" role="paragraph">Unless otherwise stated (e.g., the section above “Derivation of published biomarkers”), odds ratios were calculated using Fisher’s exact test for count data, Kruskal-Wallis test was used to test for a difference in distribution between three or more independent groups, and Mann Whitney U test was used to assess for a difference in distributions between two population groups. Logistic regression was used to assess multiple variables jointly for independent association with binary outcomes. Overall survival analysis was conducted using a Cox proportional hazards model. Statistical analysis were carried out using R3.4.4 (<a id="intref0095" href="http://www.r-project.org/" target="_blank">http://www.r-project.org/</a>) or greater. We considered a p value of 0.05 as being statistically significant. Any discovery analysis with more than 20 comparisons was subject to multiple testing correction using the R p.adjust function, with FDR method.</div></section></section></section><section id="acknowledgments" role="doc-acknowledgments"><h2>Acknowledgments</h2><div id="p0285" role="paragraph">We greatly thank all investigators, funders, and industry partners that supported the generation of the data within this study, as well as patients for their participation. Specifically, we thank Merck &amp; Co, Genentech, and Bristol-Myers Squibb for generating the industry datasets used in this study, and Eli Van Allen, Luis Diaz, Timothy A Chan, Levi A Garraway, Roger S Lo, Dean F. Bajorin, Dirk Schadendorf, Thomas Powles, and Antoni&nbsp;Ribas for academic datasets. K.L. is funded by the UK Medical Research Council (MR/P014712/1), the Rosetrees Trust and Cotswold Trust (A2437), the Royal Marsden Cancer Charity (thanks to the Ross-Russell and Macfarlanes donations), Melanoma Research Alliance, and Cancer Research UK (C69256/A30194). K.T. is funded by the Rosetrees Trust and Cotswold Trust (A2437). S.T. is a Cancer Research UK clinician scientist and is funded by Cancer Research UK (grant C50947/A18176), the National Institute for Health Research (NIHR) Biomedical Research Centre at the Royal Marsden Hospital, the Institute of Cancer Research (grant A109), the Kidney and Melanoma Cancer Fund of Royal Marsden Cancer Charity (thanks to the Ross-Russell and Macfarlanes donations), the Rosetrees Trust (grant reference number A2204), Ventana Medical Systems (grant reference numbers 10467 and 10530), the National Institute of Health (Bethesda), and Melanoma Research Alliance. M.D.H. and this research are supported in part by the Damon Runyon Cancer Research Foundation (grant CI-98-18), the Memorial Sloan Kettering Cancer Center (support grant/core grant P30 CA008748, and a Stand Up to Cancer (SU2C)-American Cancer Society Lung Cancer Dream Team Translational research grant (SU2C-AACR-DT17-15). SU2C is a program of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C. M.D.H. is a member of the Parker Institute for Cancer Immunotherapy. This work was supported by the Post-Genome Technology Development Program (business model development driven by the clinico-genomic database for precision immuno-oncology) funded by the Ministry of Trade, Industry and Energy (MOTIE, Korea; grant 10067758). This work was supported by the National Research Foundation of Korea (NRF) grant&nbsp;funded by the Korea government (MSIT) (No. 2020R1A2C3006535). P.V.L. is supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001202), the UK Medical Research Council (FC001202), and the Wellcome Trust (FC001202). P.V.L. is a Winton Group Leader in recognition of the Winton Charitable Foundation’s support towards the establishment of The Francis Crick Institute. S.R.H is funded by the European Research Council (StG 677268 NextDART). D.B. is funded by the National Institute for Health Research Biomedical Research Centre and the Idea to Innovation (i2i) Crick translation scheme supported by the Medical Research Council, and was previously funded by the Jean Shanks Foundation and University College London. J.L. is supported by the&nbsp;National Institute for Health Research&nbsp;(NIHR) Biomedical Research Centre at the Royal Marsden Hospital, the&nbsp;Institute of Cancer Research&nbsp;(grant&nbsp;A109), and&nbsp;Royal Marsden Cancer Charity. N.M. is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (Grant Number 211179/Z/18/Z), and also receives funding from Cancer Research UK Lung Cancer Centre of Excellence, Rosetrees, and the NIHR BRC at University College London Hospitals. L.C. and J.A.G.-A. were funded by the Cancer Research UK-University College London (CRUK-UCL) Centre Award [C416/A25145]. T.E. and V.T. are supported by BloodCancer Research UK. C.S. is Royal Society Napier Research Professor. His work is supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001169), the UK Medical Research Council (FC001169), and the Wellcome Trust (FC001169). C.S. is funded by Cancer Research UK (TRACERx, PEACE, and CRUK Cancer Immunotherapy Catalyst Network), the Cancer Research UK Lung Cancer Centre of Excellence, the Rosetrees Trust, the Butterfield and Stoneygate Trusts, the Novo Nordisk Foundation (ID16584), a Royal Society Research Professorship Enhancement Award (RP/EA/180007), the National Institute for Health Research&nbsp;(NIHR) Biomedical Research Centre at University College London Hospitals, the CRUK-UCL Centre, Experimental Cancer Medicine Centre, and the Breast Cancer Research Foundation (BCRF). This research is supported by a SU2C-LUNGevity-American Lung Association Lung Cancer Interception Dream Team translational research grant (SU2C-AACR-DT23-17). Research grants are administered by the American Association for Cancer Research, the Scientific Partner of SU2C. C.S. also receives funding from the European Research Council (ERC) under the European Union’s Seventh Framework Programme (FP7/2007-2013) consolidator grant (FP7-THESEUS-617844), European Commission ITN (FP7-PloidyNet 607722), an ERC advanced grant (PROTEUS) under the European Union’s Horizon 2020 research and innovation program (835297), and Chromavision from the European Union’s Horizon 2020 research and innovation program (665233). S.A.Q. received a CRUK Senior Cancer Research Fellowship (C36463/A22246) and is funded by a CRUK Biotherapeutic Program Grant (C36463/A20764), the Rosetrees and Stoneygate trusts (A1388), and a donation from the Khoo Teck Puat UK Foundation via the UCL Cancer Institute Research Trust (539288) and is supported by the Cancer Immunotherapy Accelerator Award (CITA-CRUK) (C33499/A20265). The results published here are in whole or part based upon data generated by the TCGA Research Network:&nbsp;<a id="PC_linktdftTCv9DS" href="https://www.cancer.gov/tcga" target="_blank">https://www.cancer.gov/tcga</a>. Grahical abstract created with biorender.com. This research was funded in whole, or in part, by the Wellcome Trust [FC001169, FC001202, FC10988]. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.</div><section id="sec-5"><h3>Author contributions</h3><div id="p0290" role="paragraph">K.L., J.L.R., S.Q., N.M., and C.S. designed the study. J.L.R., V.T., and A.J.S.F. performed laboratory experiments. C.A., M.D.H., S.T., and J.L. performed clinical work. K.L., J.R., C.P., K.T., R.B., T.B.K.W., R.R., D.B., E.L., M.A.B., J.A.G.-A., and L.C. analyzed data. A.R., S.K.S., S.R.H., J.H., T.E., S.-H. L., and P.V.L. interpreted data. K.L., J.L.R., M.D.H., N.M., S.Q., and C.S. wrote the manuscript.</div></section><section id="sec-6"><h3>Declaration of interests</h3><div id="p0295" role="paragraph">K.L. has a patent on indel burden and CPI response pending and outside of the submitted work, speaker fees from Roche tissue diagnostics, research funding from CRUK TDL/Ono/LifeArc alliance, and a consulting role with Monopteros Therapeutics. S.T. has received speaking fees from Roche, AstraZeneca, Novartis, and Ipsen. S.T. has the following patents filed:&nbsp;Indel mutations as a therapeutic target and predictive biomarker PCTGB2018/051892 and PCTGB2018/051893 and Clear Cell Renal Cell Carcinoma Biomarkers P113326GB. S.Q. reports personal fees and employment with Achilles Therapeutics (where he is CSO) outside of the submitted work. J.L.R. consults for Achilles Therapeutics. N.M. has received consultancy fees and has stock options in Achilles Therapeutics. N.M. holds European patents relating to targeting neoantigens (PCT/EP2016/ 059401), identifying patient response to immune checkpoint blockade (PCT/ EP2016/071471), determining HLA LOH (PCT/GB2018/052004), and predicting survival rates of patients with cancer (PCT/GB2020/050221). C.A. receives research salary from AstraZeneca and is an AstraZeneca Fellow and acting study physician on the MERMAID-1 study. C.A. holds pending patents in methods to detect tumor recurrence (PCT/GB2017/053289). C.A. and C.S. declare patent PCT/US2017/028013 for methods to detect lung cancer. C.A. has received speaker fees from Novartis, Roche Diagnostics, Bristol Myers Squibb, and AstraZeneca and was an advisory board member for AstraZeneca. M.D.H. has stock and other ownership interests in Shattuck Labs, Immunai, and Arcus Biosciences; reports honoraria from AstraZeneca and Bristol-Myers Squibb; has a consulting or advisory role with Bristol-Myers Squibb, Merck, Genentech/Roche, AstraZeneca, Nektar, Syndax, Mirati Therapeutics, Shattuck Labs, Immunai, Blueprint Medicines, Achilles Therapeutics, and Arcus Biosciences; receives research funding from Bristol-Myers Squibb (Inst); has patents, royalties, and other intellectual property (a patent has been filed by Memorial Sloan Kettering [PCT/US2015/062208] for the use of TMB for prediction of immunotherapy efficacy, which is licensed to Personal Genome Diagnostics); and receives travel and accommodation expense reimbursement from AstraZeneca, Bristol-Myers Squibb, and Eli Lilly. J.L. reports personal fees from Eisai, GlaxoSmithKline, Kymab, Roche/Genentech, Secarna, Pierre Fabre, and EUSA Pharma and grants and personal fees from Bristol-Myers Squibb, Merck Sharp &amp; Dohme, Pfizer, and Novartis outside of the submitted work. C. Swanton acknowledges grant support from Pfizer, AstraZeneca, Bristol-Myers Squibb, Roche-Ventana, Boehringer-Ingelheim, Archer Dx (collaboration in minimal residual disease sequencing technologies), and Ono Pharmaceutical; is an AstraZeneca advisory board member and chief investigator for the MeRmaiD1 clinical trial; has consulted for Pfizer, Novartis, GlaxoSmithKline, MSD, Bristol-Myers Squibb, Celgene, Amgen, AstraZeneca, Illumina, Genentech, Roche-Ventana, GRAIL, Medicxi, Bicycle Therapeutics, and the Sarah Cannon Research Institute; has stock options in Apogen Biotechnologies, Epic Bioscience, and GRAIL; and has stock options and is co-founder of Achilles Therapeutics. C.S. holds European patents relating to assay technology to detect tumor recurrence (PCT/GB2017/053289), targeting neoantigens (PCT/EP2016/059401), identifying patient response to immune checkpoint blockade (PCT/EP2016/071471), determining HLA LOH (PCT/GB2018/052004), predicting survival rates of patients with cancer (PCT/GB2020/050221), and identifying patients who respond to cancer treatment (PCT/GB2018/051912), as well as a US patent relating to detecting tumor mutations (PCT/US2017/28013) and both a European and US patent related to identifying insertion/deletion mutation targets (PCT/GB2018/051892). S.R.H. is co-founder of Tetramershop and PokeAcell. D.B. reports personal fees from NanoString, outside this work, and he has a patent PCT/GB2020/050221 issued on methods for cancer prognostication.</div></section></section><section id="supplementary-material" data-type="supplementary-materials"><h2>Supplemental information (2)</h2><div id="p0305" role="paragraph"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div id="mmc1" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.01.002/attachment/2a586919-a898-4ded-89e3-9710295b2ea4/mmc1.pdf" download="mmc1.pdf" aria-labelledby="mmc1-heading mmc1-link"><span id="mmc1-link">PDF (167.89 KB)</span></a></div><div class="core-description"><div id="mmc1-heading" class="heading">Document S1. Clinical and sequencing assay data on the CPI1000+ cohort</div></div></div><div id="mmc2" class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.01.002/attachment/343f6766-a81b-4e96-ad7a-1ae07bb3a86c/mmc2.xlsx" download="mmc2.xlsx" aria-labelledby="mmc2-heading mmc2-link"><span id="mmc2-link">Spreadsheet (56.02 KB)</span></a></div><div class="core-description"><div id="mmc2-heading" class="heading">Table S2. Simplified two-paramter multivariable model, related to Figure&nbsp;3</div></div></div></div></section></div></section><div class="core-linked-content">
    

        

</div><section id="backmatter" data-extent="backmatter"><div class="core-container"><section id="references"><h2>References</h2><div id="bibliography" role="doc-bibliography"><div role="list"><div role="listitem" data-has="label"><div id="bib1" class="citations"><div id="sref1" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref1-1" title="View in article">1.</a></div><div>Alexandrov, L.B. ∙ Jones, P.H. ∙ Wedge, D.C. ...</div><div><strong>Clock-like mutational processes in human somatic cells</strong></div><div><em>Nat. Genet.</em> 2015; <strong>47</strong>:1402-1407</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ng.3441" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84949104081" target="_blank" aria-label="Open Scopus in new tab">Scopus (350)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26551669/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fng.3441&amp;pmid=26551669" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib2" class="citations"><div id="sref2" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref2-1" title="View in article">2.</a></div><div>Anagnostou, V. ∙ Niknafs, N. ∙ Marrone, K. ...</div><div><strong>Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer</strong></div><div><em>Nat. Can.</em> 2020; <strong>1</strong>:99-111</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s43018-019-0008-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32984843/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs43018-019-0008-8&amp;pmid=32984843" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib3" class="citations"><div id="sref3" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref3" title="View in article">3.</a></div><div>Andreatta, M. ∙ Nielsen, M.</div><div><strong>Gapped sequence alignment using artificial neural networks: application to the MHC class I system</strong></div><div><em>Bioinformatics.</em> 2016; <strong>32</strong>:511-517</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btv639" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84959881509" target="_blank" aria-label="Open Scopus in new tab">Scopus (370)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26515819/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtv639&amp;pmid=26515819" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib4" class="citations"><div id="sref4" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref4-1" title="View in article">4.</a></div><div>Aredo, J.V. ∙ Padda, S.K. ∙ Kunder, C.A. ...</div><div><strong>Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes</strong></div><div><em>Lung Cancer.</em> 2019; <strong>133</strong>:144-150</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.lungcan.2019.05.015&amp;cf=fulltext&amp;site=lung-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.lungcan.2019.05.015&amp;cf=pdf&amp;site=lung-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85066077498" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31200821/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.lungcan.2019.05.015&amp;pmid=31200821" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib5" class="citations"><div id="sref5" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref5" title="View in article">5.</a></div><div>Auslander, N. ∙ Zhang, G. ∙ Lee, J.S. ...</div><div><strong>Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1545-1549</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0157-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85052285340" target="_blank" aria-label="Open Scopus in new tab">Scopus (111)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30127394/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0157-9&amp;pmid=30127394" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib6" class="citations"><div id="sref6" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref6-1" title="View in article">6.</a></div><div>Ayers, M. ∙ Lunceford, J. ∙ Nebozhyn, M. ...</div><div><strong>IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2017; <strong>127</strong>:2930-2940</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI91190" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85026675148" target="_blank" aria-label="Open Scopus in new tab">Scopus (834)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28650338/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI91190&amp;pmid=28650338" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib7" class="citations"><div id="sref7" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref7" title="View in article">7.</a></div><div>Balachandran, V.P. ∙ Łuksza, M. ∙ Zhao, J.N. ..., Australian Pancreatic Cancer Genome Initiative, Garvan Institute of Medical Research, Prince of Wales Hospital, Royal North Shore Hospital, University of Glasgow, St Vincent’s Hospital, QIMR Berghofer Medical Research Institute, University of Melbourne, Centre for Cancer Research, University of Queensland, Institute for Molecular Bioscience, Bankstown Hospital, Liverpool Hospital, Royal Prince Alfred Hospital, Chris O’Brien Lifehouse, Westmead Hospital, Fremantle Hospital, St John of God Healthcare, Royal Adelaide Hospital, Flinders Medical Centre, Envoi Pathology, Princess Alexandria Hospital, Austin Hospital, Johns Hopkins Medical Institutes, ARC-Net Centre for Applied Research on Cancer</div><div><strong>Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer</strong></div><div><em>Nature.</em> 2017; <strong>551</strong>:512-516</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature24462" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85034815842" target="_blank" aria-label="Open Scopus in new tab">Scopus (359)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29132146/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature24462&amp;pmid=29132146" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib8" class="citations"><div id="sref8" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref8" title="View in article">8.</a></div><div>Bielski, C.M. ∙ Zehir, A. ∙ Penson, A.V. ...</div><div><strong>Genome doubling shapes the evolution and prognosis of advanced cancers</strong></div><div><em>Nat. Genet.</em> 2018; <strong>50</strong>:1189-1195</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41588-018-0165-1" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85049987702" target="_blank" aria-label="Open Scopus in new tab">Scopus (97)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30013179/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41588-018-0165-1&amp;pmid=30013179" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib9" class="citations"><div id="sref9" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref9" title="View in article">9.</a></div><div>Brash, D.E.</div><div><strong>UV signature mutations</strong></div><div><em>Photochem. Photobiol.</em> 2015; <strong>91</strong>:15-26</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/php.12377" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84921519652" target="_blank" aria-label="Open Scopus in new tab">Scopus (185)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25354245/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fphp.12377&amp;pmid=25354245" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib10" class="citations"><div id="sref10" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref10" title="View in article">10.</a></div><div>Braun, D.A. ∙ Hou, Y. ∙ Bakouny, Z. ...</div><div><strong>Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma</strong></div><div><em>Nat. Med.</em> 2020; <strong>26</strong>:909-918</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-020-0839-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85085556126" target="_blank" aria-label="Open Scopus in new tab">Scopus (25)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32472114/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-020-0839-y&amp;pmid=32472114" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib11" class="citations"><div id="sref11" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref11" title="View in article">11.</a></div><div>Bravata, D.M. ∙ Olkin, I.</div><div><strong>Simple pooling versus combining in meta-analysis</strong></div><div><em>Eval. Health Prof.</em> 2001; <strong>24</strong>:218-230</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1177/01632780122034885" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-0035182332" target="_blank" aria-label="Open Scopus in new tab">Scopus (80)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11523387/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1177%2F01632780122034885&amp;pmid=11523387" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib12" class="citations"><div id="sref12" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref12" title="View in article">12.</a></div><div>Cha, E. ∙ Klinger, M. ∙ Hou, Y. ...</div><div><strong>Improved survival with T&nbsp;cell clonotype stability after anti-CTLA-4 treatment in cancer patients</strong></div><div><em>Sci. Transl. Med.</em> 2014; <strong>6</strong>:238ra70</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.3008211" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84902825664" target="_blank" aria-label="Open Scopus in new tab">Scopus (232)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24871131/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.3008211&amp;pmid=24871131" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib13" class="citations"><div id="sref13" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref13-1" title="View in article">13.</a></div><div>Chapuy, B. ∙ Stewart, C. ∙ Dunford, A.J. ...</div><div><strong>Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade</strong></div><div><em>Blood.</em> 2019; <strong>134</strong>:2369-2382</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood.2019002067" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85076370169" target="_blank" aria-label="Open Scopus in new tab">Scopus (10)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31697821/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood.2019002067&amp;pmid=31697821" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib14" class="citations"><div id="sref14" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref14" title="View in article">14.</a></div><div>Chen, L. ∙ Diao, L. ∙ Yang, Y. ...</div><div><strong>CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade</strong></div><div><em>Cancer Discov.</em> 2018; <strong>8</strong>:1156-1175</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-17-1033" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85053178618" target="_blank" aria-label="Open Scopus in new tab">Scopus (115)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30012853/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-17-1033&amp;pmid=30012853" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib15" class="citations"><div id="sref15" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref15" title="View in article">15.</a></div><div>Cheng, J. ∙ Vanneste, E. ∙ Konings, P. ...</div><div><strong>Single-cell copy number variation detection</strong></div><div><em>Genome Biol.</em> 2011; <strong>12</strong>:R80</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/gb-2011-12-8-r80" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-80051786597" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21854607/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fgb-2011-12-8-r80&amp;pmid=21854607" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib16" class="citations"><div id="sref16" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref16" title="View in article">16.</a></div><div>Chow, M.T. ∙ Ozga, A.J. ∙ Servis, R.L. ...</div><div><strong>Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy</strong></div><div><em>Immunity.</em> 2019; <strong>50</strong>:1498-1512.e5</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.immuni.2019.04.010&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.immuni.2019.04.010&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85066303170" target="_blank" aria-label="Open Scopus in new tab">Scopus (103)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31097342/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2019.04.010&amp;pmid=31097342" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib17" class="citations"><div id="sref17" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref17" title="View in article">17.</a></div><div>Chowell, D. ∙ Krishna, S. ∙ Becker, P.D. ...</div><div><strong>TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T&nbsp;cell epitopes</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2015; <strong>112</strong>:E1754-E1762</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1500973112" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84929659335" target="_blank" aria-label="Open Scopus in new tab">Scopus (81)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25831525/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1500973112&amp;pmid=25831525" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib18" class="citations"><div id="sref18" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref18-1" title="View in article">18.</a></div><div>Chowell, D. ∙ Morris, L.G.T. ∙ Grigg, C.M. ...</div><div><strong>Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>359</strong>:582-587</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aao4572" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85037700703" target="_blank" aria-label="Open Scopus in new tab">Scopus (318)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29217585/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aao4572&amp;pmid=29217585" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib19" class="citations"><div id="sref19" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref19-1" title="View in article">19.</a></div><div>Chowell, D. ∙ Krishna, C. ∙ Pierini, F. ...</div><div><strong>Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:1715-1720</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-019-0639-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85074822630" target="_blank" aria-label="Open Scopus in new tab">Scopus (27)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31700181/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-019-0639-4&amp;pmid=31700181" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib20" class="citations"><div id="sref20" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref20-1" title="View in article">20.</a></div><div>Chudley, L. ∙ McCann, K.J. ∙ Coleman, A. ...</div><div><strong>Harmonisation of short-term in&nbsp;vitro culture for the expansion of antigen-specific CD8(+) T&nbsp;cells with detection by ELISPOT and HLA-multimer staining</strong></div><div><em>Cancer Immunol. Immunother.</em> 2014; <strong>63</strong>:1199-1211</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s00262-014-1593-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84939876111" target="_blank" aria-label="Open Scopus in new tab">Scopus (16)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25134947/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs00262-014-1593-0&amp;pmid=25134947" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib21" class="citations"><div id="sref21" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref21-1" title="View in article">21.</a></div><div>Cibulskis, K. ∙ Lawrence, M.S. ∙ Carter, S.L. ...</div><div><strong>Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples</strong></div><div><em>Nat. Biotechnol.</em> 2013; <strong>31</strong>:213-219</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nbt.2514" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84874025843" target="_blank" aria-label="Open Scopus in new tab">Scopus (2145)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23396013/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnbt.2514&amp;pmid=23396013" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib23" class="citations"><div id="sref23" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref23-1" title="View in article">22.</a></div><div>Conforti, F. ∙ Pala, L. ∙ Bagnardi, V. ...</div><div><strong>Cancer immunotherapy efficacy and patients’ sex: a systematic review and meta-analysis</strong></div><div><em>Lancet Oncol.</em> 2018; <strong>19</strong>:737-746</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS1470-2045%2818%2930261-4&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS1470-2045%2818%2930261-4&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85047095751" target="_blank" aria-label="Open Scopus in new tab">Scopus (227)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29778737/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1470-2045%2818%2930261-4&amp;pmid=29778737" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib24" class="citations"><div id="sref24" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref24" title="View in article">23.</a></div><div>Consortium, A.P.G., AACR Project GENIE Consortium</div><div><strong>AACR Project GENIE: powering precision medicine through an international consortium</strong></div><div><em>Cancer Discov.</em> 2017; <strong>7</strong>:818-831</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-17-0151" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85026862883" target="_blank" aria-label="Open Scopus in new tab">Scopus (308)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28572459/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-17-0151&amp;pmid=28572459" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib25" class="citations"><div id="sref25" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref25-1" title="View in article">24.</a></div><div>Conway, J.R. ∙ Kofman, E. ∙ Mo, S.S. ...</div><div><strong>Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine</strong></div><div><em>Genome Med.</em> 2018; <strong>10</strong>:93</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s13073-018-0605-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85057436952" target="_blank" aria-label="Open Scopus in new tab">Scopus (43)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30497521/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs13073-018-0605-7&amp;pmid=30497521" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib26" class="citations"><div id="sref26" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref26-1" title="View in article">25.</a></div><div>Cristescu, R. ∙ Mogg, R. ∙ Ayers, M. ...</div><div><strong>Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:362</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aar3593" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85054777584" target="_blank" aria-label="Open Scopus in new tab">Scopus (403)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aar3593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib27" class="citations"><div id="sref27" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref27" title="View in article">26.</a></div><div>Dagan, T. ∙ Talmor, Y. ∙ Graur, D.</div><div><strong>Ratios of radical to conservative amino acid replacement are affected by mutational and compositional factors and may not be indicative of positive Darwinian selection</strong></div><div><em>Mol. Biol. Evol.</em> 2002; <strong>19</strong>:1022-1025</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/oxfordjournals.molbev.a004161" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12082122/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Foxfordjournals.molbev.a004161&amp;pmid=12082122" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib28" class="citations"><div id="sref28" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref28" title="View in article">27.</a></div><div>Davoli, T. ∙ Uno, H. ∙ Wooten, E.C. ...</div><div><strong>Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy</strong></div><div><em>Science.</em> 2017; <strong>355</strong>:eaaf8399</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaf8399" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85010652953" target="_blank" aria-label="Open Scopus in new tab">Scopus (364)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28104840/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaf8399&amp;pmid=28104840" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib29" class="citations"><div id="sref29" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref29" title="View in article">28.</a></div><div>Dobin, A. ∙ Davis, C.A. ∙ Schlesinger, F. ...</div><div><strong>STAR: ultrafast universal RNA-seq aligner</strong></div><div><em>Bioinformatics.</em> 2013; <strong>29</strong>:15-21</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/bts635" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84871809302" target="_blank" aria-label="Open Scopus in new tab">Scopus (10402)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23104886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbts635&amp;pmid=23104886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib30" class="citations"><div id="sref30" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref30-1" title="View in article">29.</a></div><div>Endesfelder, D. ∙ Burrell, R. ∙ Kanu, N. ...</div><div><strong>Chromosomal instability selects gene copy-number variants encoding core regulators of proliferation in ER+ breast cancer</strong></div><div><em>Cancer Res.</em> 2014; <strong>74</strong>:4853-4863</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-13-2664" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84907053818" target="_blank" aria-label="Open Scopus in new tab">Scopus (32)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24970479/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-13-2664&amp;pmid=24970479" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib31" class="citations"><div id="sref31" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref31" title="View in article">30.</a></div><div>Favero, F. ∙ Joshi, T. ∙ Marquard, A.M. ...</div><div><strong>Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data</strong></div><div><em>Ann. Oncol.</em> 2015; <strong>26</strong>:64-70</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1093%2Fannonc%2Fmdu479&amp;cf=fulltext&amp;site=annonc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1093%2Fannonc%2Fmdu479&amp;cf=pdf&amp;site=annonc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84922572688" target="_blank" aria-label="Open Scopus in new tab">Scopus (214)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25319062/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fannonc%2Fmdu479&amp;pmid=25319062" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib32" class="citations"><div id="sref32" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref32" title="View in article">31.</a></div><div>Fehrenbacher, L. ∙ Spira, A. ∙ Ballinger, M. ..., POPLAR Study Group</div><div><strong>Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial</strong></div><div><em>Lancet.</em> 2016; <strong>387</strong>:1837-1846</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS0140-6736%2816%2900587-0&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS0140-6736%2816%2900587-0&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26970723/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0140-6736%2816%2900587-0&amp;pmid=26970723" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib33" class="citations"><div id="sref33" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref33" title="View in article">32.</a></div><div>Fontanilles, M. ∙ Marguet, F. ∙ Ruminy, P. ...</div><div><strong>Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma</strong></div><div><em>Acta Neuropathol. Commun.</em> 2020; <strong>8</strong>:52</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s40478-020-00917-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85083451351" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32303258/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs40478-020-00917-6&amp;pmid=32303258" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib34" class="citations"><div id="sref34" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref34" title="View in article">33.</a></div><div>Gettinger, S. ∙ Choi, J. ∙ Hastings, K. ...</div><div><strong>Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer</strong></div><div><em>Cancer Discov.</em> 2017; <strong>7</strong>:1420-1435</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-17-0593" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85037334618" target="_blank" aria-label="Open Scopus in new tab">Scopus (184)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29025772/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-17-0593&amp;pmid=29025772" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib35" class="citations"><div id="sref35" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref35" title="View in article">34.</a></div><div>Ghorani, E. ∙ Rosenthal, R. ∙ McGranahan, N. ...</div><div><strong>Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma</strong></div><div><em>Ann. Oncol.</em> 2018; <strong>29</strong>:271-279</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1093%2Fannonc%2Fmdx687&amp;cf=fulltext&amp;site=annonc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1093%2Fannonc%2Fmdx687&amp;cf=pdf&amp;site=annonc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85041219991" target="_blank" aria-label="Open Scopus in new tab">Scopus (38)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29361136/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fannonc%2Fmdx687&amp;pmid=29361136" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib36" class="citations"><div id="sref36" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref36" title="View in article">35.</a></div><div>Ghorani, E. ∙ Reading, J.L. ∙ Henry, J.Y. ...</div><div><strong>The T&nbsp;cell differentiation landscape is shaped by tumour mutations in lung cancer</strong></div><div><em>Nat. Can.</em> 2020; <strong>1</strong>:546-561</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s43018-020-0066-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32803172/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs43018-020-0066-y&amp;pmid=32803172" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib37" class="citations"><div id="sref37" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref37" title="View in article">36.</a></div><div>Gibney, G.T. ∙ Weiner, L.M. ∙ Atkins, M.B.</div><div><strong>Predictive biomarkers for checkpoint inhibitor-based immunotherapy</strong></div><div><em>Lancet Oncol.</em> 2016; <strong>17</strong>:e542-e551</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS1470-2045%2816%2930406-5&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS1470-2045%2816%2930406-5&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85003475383" target="_blank" aria-label="Open Scopus in new tab">Scopus (555)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27924752/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1470-2045%2816%2930406-5&amp;pmid=27924752" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib38" class="citations"><div id="sref38" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref38" title="View in article">37.</a></div><div>Gorbachev, A.V. ∙ Kobayashi, H. ∙ Kudo, D. ...</div><div><strong>CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T&nbsp;cell-mediated suppression of cutaneous tumors</strong></div><div><em>J.&nbsp;Immunol.</em> 2007; <strong>178</strong>:2278-2286</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.178.4.2278" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17277133/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.178.4.2278&amp;pmid=17277133" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib39" class="citations"><div id="sref39" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref39-1" title="View in article">38.</a></div><div>Grantham, R.</div><div><strong>Amino acid difference formula to help explain protein evolution</strong></div><div><em>Science.</em> 1974; <strong>185</strong>:862-864</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.185.4154.862" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/4843792/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.185.4154.862&amp;pmid=4843792" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib40" class="citations"><div id="sref40" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref40-1" title="View in article">39.</a></div><div>Gros, A. ∙ Parkhurst, M.R. ∙ Tran, E. ...</div><div><strong>Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients</strong></div><div><em>Nat. Med.</em> 2016; <strong>22</strong>:433-438</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4051" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84959152038" target="_blank" aria-label="Open Scopus in new tab">Scopus (398)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26901407/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4051&amp;pmid=26901407" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib41" class="citations"><div id="sref41" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref41" title="View in article">40.</a></div><div>Havel, J.J. ∙ Chowell, D. ∙ Chan, T.A.</div><div><strong>The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy</strong></div><div><em>Nat. Rev. Cancer.</em> 2019; <strong>19</strong>:133-150</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41568-019-0116-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85061498033" target="_blank" aria-label="Open Scopus in new tab">Scopus (507)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30755690/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41568-019-0116-x&amp;pmid=30755690" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib42" class="citations"><div id="sref42" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref42" title="View in article">41.</a></div><div>Helmink, B.A. ∙ Reddy, S.M. ∙ Gao, J. ...</div><div><strong>B cells and tertiary lymphoid structures promote immunotherapy response</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:549-555</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1922-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85078126241" target="_blank" aria-label="Open Scopus in new tab">Scopus (229)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31942075/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1922-8&amp;pmid=31942075" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib43" class="citations"><div id="sref43" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref43" title="View in article">42.</a></div><div>House, I.G. ∙ Savas, P. ∙ Lai, J. ...</div><div><strong>Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade</strong></div><div><em>Clin. Cancer Res.</em> 2020; <strong>26</strong>:487-504</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-19-1868" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85075037247" target="_blank" aria-label="Open Scopus in new tab">Scopus (40)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31636098/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-19-1868&amp;pmid=31636098" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib44" class="citations"><div id="sref44" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref44" title="View in article">43.</a></div><div>Huang, L. ∙ Malu, S. ∙ McKenzie, J.A. ...</div><div><strong>The RNA-binding protein MEX3B mediates resistance to cancer immunotherapy by downregulating HLA-A expression</strong></div><div><em>Clin. Cancer Res.</em> 2018; <strong>24</strong>:3366-3376</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-17-2483" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85050116970" target="_blank" aria-label="Open Scopus in new tab">Scopus (24)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29496759/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-17-2483&amp;pmid=29496759" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib45" class="citations"><div id="sref45" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref45-1" title="View in article">44.</a></div><div>Hugo, W. ∙ Zaretsky, J.M. ∙ Sun, L. ...</div><div><strong>Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma</strong></div><div><em>Cell.</em> 2016; <strong>165</strong>:35-44</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2016.02.065&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2016.02.065&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84961221351" target="_blank" aria-label="Open Scopus in new tab">Scopus (1043)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26997480/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2016.02.065&amp;pmid=26997480" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib46" class="citations"><div id="sref46" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref46-1" title="View in article">45.</a></div><div>Jamal-Hanjani, M. ∙ Wilson, G.A. ∙ McGranahan, N. ..., TRACERx Consortium</div><div><strong>Tracking the evolution of non-small-cell lung cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2017; <strong>376</strong>:2109-2121</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1616288" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85019668203" target="_blank" aria-label="Open Scopus in new tab">Scopus (822)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28445112/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1616288&amp;pmid=28445112" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib47" class="citations"><div id="sref47" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref47" title="View in article">46.</a></div><div>Karczewski, K.J. ∙ Francioli, L.C. ∙ Tiao, G. ..., Genome Aggregation Database Consortium</div><div><strong>The mutational constraint spectrum quantified from variation in 141,456 humans</strong></div><div><em>Nature.</em> 2020; <strong>581</strong>:434-443</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-020-2308-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85085542423" target="_blank" aria-label="Open Scopus in new tab">Scopus (564)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32461654/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-020-2308-7&amp;pmid=32461654" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib48" class="citations"><div id="sref48" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref48" title="View in article">47.</a></div><div>Karin, N. ∙ Wildbaum, G. ∙ Thelen, M.</div><div><strong>Biased signaling pathways via CXCR3 control the development and function of CD4+ T&nbsp;cell subsets</strong></div><div><em>J.&nbsp;Leukoc. Biol.</em> 2016; <strong>99</strong>:857-862</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1189/jlb.2MR0915-441R" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84971373567" target="_blank" aria-label="Open Scopus in new tab">Scopus (38)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26657511/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1189%2Fjlb.2MR0915-441R&amp;pmid=26657511" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib49" class="citations"><div id="sref49" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref49" title="View in article">48.</a></div><div>Knepper, T.C. ∙ Montesion, M. ∙ Russell, J.S. ...</div><div><strong>The genomic landscape of Merkel cell carcinoma and clinicogenomic biomarkers of response to immune checkpoint inhibitor therapy</strong></div><div><em>Clin. Cancer Res.</em> 2019; <strong>25</strong>:5961-5971</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-18-4159" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85072820707" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31399473/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-18-4159&amp;pmid=31399473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib50" class="citations"><div id="sref50" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref50-1" title="View in article">49.</a></div><div>Koboldt, D.C. ∙ Zhang, Q. ∙ Larson, D.E. ...</div><div><strong>VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing</strong></div><div><em>Genome Res.</em> 2012; <strong>22</strong>:568-576</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gr.129684.111" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84863229597" target="_blank" aria-label="Open Scopus in new tab">Scopus (2189)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22300766/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgr.129684.111&amp;pmid=22300766" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib51" class="citations"><div id="sref51" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref51" title="View in article">50.</a></div><div>Koyama, S. ∙ Akbay, E.A. ∙ Li, Y.Y. ...</div><div><strong>Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints</strong></div><div><em>Nat. Commun.</em> 2016; <strong>7</strong>:10501</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms10501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84958555198" target="_blank" aria-label="Open Scopus in new tab">Scopus (622)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26883990/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms10501&amp;pmid=26883990" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib52" class="citations"><div id="sref52" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref52" title="View in article">51.</a></div><div>Krijgsman, O. ∙ Carvalho, B. ∙ Meijer, G.A. ...</div><div><strong>Focal chromosomal copy number aberrations in cancer-Needles in a genome haystack</strong></div><div><em>Biochim. Biophys. Acta.</em> 2014; <strong>1843</strong>:2698-2704</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.bbamcr.2014.08.001" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84905962250" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25110350/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bbamcr.2014.08.001&amp;pmid=25110350" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib53" class="citations"><div id="sref53" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref53" title="View in article">52.</a></div><div>Kyte, J. ∙ Doolittle, R.F.</div><div><strong>A simple method for displaying the hydropathic character of a protein</strong></div><div><em>J.&nbsp;Mol. Biol.</em> 1982; <strong>157</strong>:105-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/0022-2836(82)90515-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-0020475449" target="_blank" aria-label="Open Scopus in new tab">Scopus (16210)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7108955/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2F0022-2836%2882%2990515-0&amp;pmid=7108955" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib54" class="citations"><div id="sref54" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref54" title="View in article">53.</a></div><div>Le, D.T. ∙ Uram, J.N. ∙ Wang, H. ...</div><div><strong>PD-1 blockade in tumors with mismatch-repair deficiency</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2015; <strong>372</strong>:2509-2520</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1500596" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84932628341" target="_blank" aria-label="Open Scopus in new tab">Scopus (4297)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26028255/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1500596&amp;pmid=26028255" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib55" class="citations"><div id="sref55" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref55" title="View in article">54.</a></div><div>Li, B. ∙ Dewey, C.N.</div><div><strong>RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome</strong></div><div><em>BMC Bioinformatics.</em> 2011; <strong>12</strong>:323</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1471-2105-12-323" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-79961123152" target="_blank" aria-label="Open Scopus in new tab">Scopus (6920)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21816040/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1471-2105-12-323&amp;pmid=21816040" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib56" class="citations"><div id="sref56" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref56-1" title="View in article">55.</a></div><div>Li, H. ∙ Durbin, R.</div><div><strong>Fast and accurate short read alignment with Burrows-Wheeler transform</strong></div><div><em>Bioinformatics.</em> 2009; <strong>25</strong>:1754-1760</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btp324" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-67649884743" target="_blank" aria-label="Open Scopus in new tab">Scopus (19329)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19451168/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtp324&amp;pmid=19451168" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib57" class="citations"><div id="sref57" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref57" title="View in article">56.</a></div><div>Li, Z. ∙ Liu, J. ∙ Zhang, X. ...</div><div><strong>Prognostic significance of cyclin D1 expression in renal cell carcinoma: a systematic review and meta-analysis</strong></div><div><em>Pathol. Oncol. Res.</em> 2020; <strong>26</strong>:1401-1409</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s12253-019-00776-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85075345705" target="_blank" aria-label="Open Scopus in new tab">Scopus (2)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31748879/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs12253-019-00776-0&amp;pmid=31748879" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib58" class="citations"><div id="sref58" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref58" title="View in article">57.</a></div><div>Lindeboom, R.G.H. ∙ Vermeulen, M. ∙ Lehner, B. ...</div><div><strong>The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy</strong></div><div><em>Nat. Genet.</em> 2019; <strong>51</strong>:1645-1651</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41588-019-0517-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85074666705" target="_blank" aria-label="Open Scopus in new tab">Scopus (25)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31659324/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41588-019-0517-5&amp;pmid=31659324" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib59" class="citations"><div id="sref59" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref59-1" title="View in article">58.</a></div><div>Liu, D. ∙ Schilling, B. ∙ Liu, D. ...</div><div><strong>Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:1916-1927</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-019-0654-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85075928991" target="_blank" aria-label="Open Scopus in new tab">Scopus (60)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31792460/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-019-0654-5&amp;pmid=31792460" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib60" class="citations"><div id="sref60" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref60" title="View in article">59.</a></div><div>Łuksza, M. ∙ Riaz, N. ∙ Makarov, V. ...</div><div><strong>A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy</strong></div><div><em>Nature.</em> 2017; <strong>551</strong>:517-520</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature24473" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85034865728" target="_blank" aria-label="Open Scopus in new tab">Scopus (229)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29132144/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature24473&amp;pmid=29132144" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib61" class="citations"><div id="sref61" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61" title="View in article">60.</a></div><div>Mahdey, H.M. ∙ Ramanathan, A. ∙ Ismail, S.M. ...</div><div><strong>Cyclin D1 amplification in tongue and cheek squamous cell carcinoma</strong></div><div><em>Asian Pac. J. Cancer Prev.</em> 2011; <strong>12</strong>:2199-2204</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22296356/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=22296356" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib62" class="citations"><div id="sref62" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref62-1" title="View in article">61.</a></div><div>Mariathasan, S. ∙ Turley, S.J. ∙ Nickles, D. ...</div><div><strong>TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T&nbsp;cells</strong></div><div><em>Nature.</em> 2018; <strong>554</strong>:544-548</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85042495633" target="_blank" aria-label="Open Scopus in new tab">Scopus (833)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29443960/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25501&amp;pmid=29443960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib63" class="citations"><div id="sref63" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref63-1" title="View in article">62.</a></div><div>McDermott, D.F. ∙ Huseni, M.A. ∙ Atkins, M.B. ...</div><div><strong>Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:749-757</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0053-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85048001150" target="_blank" aria-label="Open Scopus in new tab">Scopus (334)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29867230/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0053-3&amp;pmid=29867230" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib64" class="citations"><div id="sref64" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref64-1" title="View in article">63.</a></div><div>McGranahan, N. ∙ Furness, A.J. ∙ Rosenthal, R. ...</div><div><strong>Clonal neoantigens elicit T&nbsp;cell immunoreactivity and sensitivity to immune checkpoint blockade</strong></div><div><em>Science.</em> 2016; <strong>351</strong>:1463-1469</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaf1490" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84962301577" target="_blank" aria-label="Open Scopus in new tab">Scopus (1319)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26940869/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaf1490&amp;pmid=26940869" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib65" class="citations"><div id="sref65" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref65-1" title="View in article">64.</a></div><div>McGranahan, N. ∙ Rosenthal, R. ∙ Hiley, C.T. ..., TRACERx Consortium</div><div><strong>Allele-specific HLA loss and immune escape in lung cancer evolution</strong></div><div><em>Cell.</em> 2017; <strong>171</strong>:1259-1271.e11</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2017.10.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2017.10.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85032583704" target="_blank" aria-label="Open Scopus in new tab">Scopus (343)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29107330/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.10.001&amp;pmid=29107330" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib66" class="citations"><div id="sref66" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref66" title="View in article">65.</a></div><div>McKenna, A. ∙ Hanna, M. ∙ Banks, E. ...</div><div><strong>The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</strong></div><div><em>Genome Res.</em> 2010; <strong>20</strong>:1297-1303</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gr.107524.110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-77956295988" target="_blank" aria-label="Open Scopus in new tab">Scopus (10719)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20644199/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgr.107524.110&amp;pmid=20644199" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib67" class="citations"><div id="sref67" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref67" title="View in article">66.</a></div><div>Merino, D.M. ∙ McShane, L.M. ∙ Fabrizio, D. ..., TMB Harmonization Consortium</div><div><strong>Establishing guidelines to harmonize tumor mutational burden (TMB): in&nbsp;silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project</strong></div><div><em>J.&nbsp;Immunother. Cancer.</em> 2020; <strong>8</strong>:e000147</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/jitc-2019-000147" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85082561754" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32217756/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1136%2Fjitc-2019-000147&amp;pmid=32217756" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib68" class="citations"><div id="sref68" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref68" title="View in article">67.</a></div><div>Messina, J.L. ∙ Fenstermacher, D.A. ∙ Eschrich, S. ...</div><div><strong>12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?</strong></div><div><em>Sci. Rep.</em> 2012; <strong>2</strong>:765</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/srep00765" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84868277668" target="_blank" aria-label="Open Scopus in new tab">Scopus (184)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23097687/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fsrep00765&amp;pmid=23097687" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib69" class="citations"><div id="sref69" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref69-1" title="View in article">68.</a></div><div>Miao, D. ∙ Margolis, C.A. ∙ Vokes, N.I. ...</div><div><strong>Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors</strong></div><div><em>Nat. Genet.</em> 2018; <strong>50</strong>:1271-1281</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41588-018-0200-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85052712350" target="_blank" aria-label="Open Scopus in new tab">Scopus (121)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30150660/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41588-018-0200-2&amp;pmid=30150660" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib70" class="citations"><div id="sref70" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref70-1" title="View in article">69.</a></div><div>Nilsen, G. ∙ Liestøl, K. ∙ Van Loo, P. ...</div><div><strong>Copynumber: efficient algorithms for single- and multi-track copy number segmentation</strong></div><div><em>BMC Genomics.</em> 2012; <strong>13</strong>:591</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1471-2164-13-591" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84873813238" target="_blank" aria-label="Open Scopus in new tab">Scopus (126)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23442169/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1471-2164-13-591&amp;pmid=23442169" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib71" class="citations"><div id="sref71" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref71" title="View in article">70.</a></div><div>Pabla, S. ∙ Conroy, J.M. ∙ Nesline, M.K. ...</div><div><strong>Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients</strong></div><div><em>J.&nbsp;Immunother. Cancer.</em> 2019; <strong>7</strong>:27</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s40425-019-0506-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85060929943" target="_blank" aria-label="Open Scopus in new tab">Scopus (7)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30709424/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs40425-019-0506-3&amp;pmid=30709424" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib72" class="citations"><div id="sref72" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref72" title="View in article">71.</a></div><div>Panda, A. ∙ de Cubas, A.A. ∙ Stein, M. ...</div><div><strong>Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma</strong></div><div><em>JCI Insight.</em> 2018; <strong>3</strong>:e121522</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/jci.insight.121522" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85062245416" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30135306/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2Fjci.insight.121522&amp;pmid=30135306" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib73" class="citations"><div id="sref73" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73" title="View in article">72.</a></div><div>Peng, W. ∙ Chen, J.Q. ∙ Liu, C. ...</div><div><strong>Loss of PTEN promotes resistance to T&nbsp;cell-mediated immunotherapy</strong></div><div><em>Cancer Discov.</em> 2016; <strong>6</strong>:202-216</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-15-0283" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84957093642" target="_blank" aria-label="Open Scopus in new tab">Scopus (595)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26645196/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-15-0283&amp;pmid=26645196" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib74" class="citations"><div id="sref74" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref74-1" title="View in article">73.</a></div><div>Pierini, F. ∙ Lenz, T.L.</div><div><strong>Divergent allele advantage at human MHC genes: signatures of past and ongoing selection</strong></div><div><em>Mol. Biol. Evol.</em> 2018; <strong>35</strong>:2145-2158</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/molbev/msy116" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85053713496" target="_blank" aria-label="Open Scopus in new tab">Scopus (31)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29893875/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fmolbev%2Fmsy116&amp;pmid=29893875" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib75" class="citations"><div id="sref75" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref75" title="View in article">74.</a></div><div>Ren, B. ∙ Li, W. ∙ Yang, Y. ...</div><div><strong>The impact of cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis</strong></div><div><em>World J. Surg. Oncol.</em> 2014; <strong>12</strong>:55</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1477-7819-12-55" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84897438497" target="_blank" aria-label="Open Scopus in new tab">Scopus (20)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24602161/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1477-7819-12-55&amp;pmid=24602161" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib76" class="citations"><div id="sref76" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref76" title="View in article">75.</a></div><div>Riaz, N. ∙ Havel, J.J. ∙ Kendall, S.M. ...</div><div><strong>Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy</strong></div><div><em>Nat. Genet.</em> 2016; <strong>48</strong>:1327-1329</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ng.3677" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84988734918" target="_blank" aria-label="Open Scopus in new tab">Scopus (57)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27668655/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fng.3677&amp;pmid=27668655" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib77" class="citations"><div id="sref77" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref77" title="View in article">76.</a></div><div>Riaz, N. ∙ Havel, J.J. ∙ Makarov, V. ...</div><div><strong>Tumor and microenvironment evolution during immunotherapy with nivolumab</strong></div><div><em>Cell.</em> 2017; <strong>171</strong>:934-949.e16</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2017.09.028&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2017.09.028&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85031295254" target="_blank" aria-label="Open Scopus in new tab">Scopus (453)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29033130/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.09.028&amp;pmid=29033130" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib78" class="citations"><div id="sref78" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref78" title="View in article">77.</a></div><div>Rimmer, A. ∙ Phan, H. ∙ Mathieson, I. ..., WGS500 Consortium</div><div><strong>Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications</strong></div><div><em>Nat. Genet.</em> 2014; <strong>46</strong>:912-918</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ng.3036" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_77_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84905576523" target="_blank" aria-label="Open Scopus in new tab">Scopus (456)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25017105/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fng.3036&amp;pmid=25017105" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib79" class="citations"><div id="sref79" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref79-1" title="View in article">78.</a></div><div>Rizvi, N.A. ∙ Hellmann, M.D. ∙ Snyder, A. ...</div><div><strong>Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer</strong></div><div><em>Science.</em> 2015; <strong>348</strong>:124-128</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaa1348" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84928761118" target="_blank" aria-label="Open Scopus in new tab">Scopus (4018)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25765070/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaa1348&amp;pmid=25765070" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib80" class="citations"><div id="sref80" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref80" title="View in article">79.</a></div><div>Robinson, J. ∙ Soormally, A.R. ∙ Hayhurst, J.D. ...</div><div><strong>The IPD-IMGT/HLA database: new developments in reporting HLA variation</strong></div><div><em>Hum. Immunol.</em> 2016; <strong>77</strong>:233-237</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.humimm.2016.01.020" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84956609076" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26826444/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.humimm.2016.01.020&amp;pmid=26826444" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib81" class="citations"><div id="sref81" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref81" title="View in article">80.</a></div><div>Roh, W. ∙ Chen, P.L. ∙ Reuben, A. ...</div><div><strong>Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance</strong></div><div><em>Sci. Transl. Med.</em> 2017; <strong>9</strong>:eaah3560</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aah3560" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85014681380" target="_blank" aria-label="Open Scopus in new tab">Scopus (234)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28251903/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aah3560&amp;pmid=28251903" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib82" class="citations"><div id="sref82" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref82" title="View in article">81.</a></div><div>Rooney, M.S. ∙ Shukla, S.A. ∙ Wu, C.J. ...</div><div><strong>Molecular and genetic properties of tumors associated with local immune cytolytic activity</strong></div><div><em>Cell.</em> 2015; <strong>160</strong>:48-61</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2014.12.033&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2014.12.033&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84920962202" target="_blank" aria-label="Open Scopus in new tab">Scopus (1188)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25594174/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2014.12.033&amp;pmid=25594174" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib83" class="citations"><div id="sref83" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref83" title="View in article">82.</a></div><div>Rosenthal, R. ∙ McGranahan, N. ∙ Herrero, J. ...</div><div><strong>DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution</strong></div><div><em>Genome Biol.</em> 2016; <strong>17</strong>:31</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s13059-016-0893-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84959467752" target="_blank" aria-label="Open Scopus in new tab">Scopus (369)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26899170/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs13059-016-0893-4&amp;pmid=26899170" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib84" class="citations"><div id="sref84" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref84-1" title="View in article">83.</a></div><div>Rosenthal, R. ∙ Cadieux, E.L. ∙ Salgado, R. ..., TRACERx consortium</div><div><strong>Neoantigen-directed immune escape in lung cancer evolution</strong></div><div><em>Nature.</em> 2019; <strong>567</strong>:479-485</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1032-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85063265508" target="_blank" aria-label="Open Scopus in new tab">Scopus (180)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30894752/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1032-7&amp;pmid=30894752" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib85" class="citations"><div id="sref85" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref85" title="View in article">84.</a></div><div>Roth, A. ∙ Khattra, J. ∙ Yap, D. ...</div><div><strong>PyClone: statistical inference of clonal population structure in cancer</strong></div><div><em>Nat. Methods.</em> 2014; <strong>11</strong>:396-398</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.2883" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84897954204" target="_blank" aria-label="Open Scopus in new tab">Scopus (402)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24633410/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.2883&amp;pmid=24633410" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib86" class="citations"><div id="sref86" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref86-1" title="View in article">85.</a></div><div>Samstein, R.M. ∙ Lee, C.H. ∙ Shoushtari, A.N. ...</div><div><strong>Tumor mutational load predicts survival after immunotherapy across multiple cancer types</strong></div><div><em>Nat. Genet.</em> 2019; <strong>51</strong>:202-206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41588-018-0312-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85059965982" target="_blank" aria-label="Open Scopus in new tab">Scopus (669)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30643254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41588-018-0312-8&amp;pmid=30643254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib87" class="citations"><div id="sref87" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref87" title="View in article">86.</a></div><div>Seiler, R. ∙ Thalmann, G.N. ∙ Rotzer, D. ...</div><div><strong>CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response</strong></div><div><em>Mod. Pathol.</em> 2014; <strong>27</strong>:87-95</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/modpathol.2013.125" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84891741522" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23887292/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fmodpathol.2013.125&amp;pmid=23887292" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib88" class="citations"><div id="sref88" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref88-1" title="View in article">87.</a></div><div>Shim, J.H. ∙ Kim, H.S. ∙ Cha, H. ...</div><div><strong>HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients</strong></div><div><em>Ann. Oncol.</em> 2020; <strong>31</strong>:902-911</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.annonc.2020.04.004&amp;cf=fulltext&amp;site=annonc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.annonc.2020.04.004&amp;cf=pdf&amp;site=annonc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85085291189" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32320754/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.annonc.2020.04.004&amp;pmid=32320754" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib89" class="citations"><div id="sref89" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89" title="View in article">88.</a></div><div>Shin, D.S. ∙ Zaretsky, J.M. ∙ Escuin-Ordinas, H. ...</div><div><strong>Primary resistance to PD-1 blockade mediated by JAK1/2 mutations</strong></div><div><em>Cancer Discov.</em> 2017; <strong>7</strong>:188-201</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-16-1223" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85011827059" target="_blank" aria-label="Open Scopus in new tab">Scopus (490)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27903500/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-16-1223&amp;pmid=27903500" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib90" class="citations"><div id="sref90" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref90" title="View in article">89.</a></div><div>Shrestha, R. ∙ Nabavi, N. ∙ Lin, Y.Y. ...</div><div><strong>BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma</strong></div><div><em>Genome Med.</em> 2019; <strong>11</strong>:8</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s13073-019-0620-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_89_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85061874412" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30777124/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs13073-019-0620-3&amp;pmid=30777124" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib91" class="citations"><div id="sref91" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref91" title="View in article">90.</a></div><div>Shukla, S.A. ∙ Rooney, M.S. ∙ Rajasagi, M. ...</div><div><strong>Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes</strong></div><div><em>Nat. Biotechnol.</em> 2015; <strong>33</strong>:1152-1158</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nbt.3344" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_90_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84946565788" target="_blank" aria-label="Open Scopus in new tab">Scopus (256)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26372948/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnbt.3344&amp;pmid=26372948" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib92" class="citations"><div id="sref92" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref92-1" title="View in article">91.</a></div><div>Smith, J.C. ∙ Sheltzer, J.M.</div><div><strong>Systematic identification of mutations and copy number alterations associated with cancer patient prognosis</strong></div><div><em>eLife.</em> 2018; <strong>7</strong>:e39217</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.39217" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_91_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85058605162" target="_blank" aria-label="Open Scopus in new tab">Scopus (28)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30526857/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.39217&amp;pmid=30526857" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib93" class="citations"><div id="sref93" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref93-1" title="View in article">92.</a></div><div>Snyder, A. ∙ Makarov, V. ∙ Merghoub, T. ...</div><div><strong>Genetic basis for clinical response to CTLA-4 blockade in melanoma</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2014; <strong>371</strong>:2189-2199</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1406498" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_92_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84918828514" target="_blank" aria-label="Open Scopus in new tab">Scopus (2353)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25409260/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1406498&amp;pmid=25409260" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib94" class="citations"><div id="sref94" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref94-1" title="View in article">93.</a></div><div>Snyder, A. ∙ Nathanson, T. ∙ Funt, S.A. ...</div><div><strong>Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: an exploratory multi-omic analysis</strong></div><div><em>PLoS Med.</em> 2017; <strong>14</strong>:e1002309</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pmed.1002309" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_93_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85020087828" target="_blank" aria-label="Open Scopus in new tab">Scopus (115)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28552987/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pmed.1002309&amp;pmid=28552987" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib95" class="citations"><div id="sref95" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref95-1" title="View in article">94.</a></div><div>Thommen, D.S. ∙ Koelzer, V.H. ∙ Herzig, P. ...</div><div><strong>A transcriptionally and functionally distinct PD-1<sup>+</sup> CD8<sup>+</sup> T&nbsp;cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:994-1004</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0057-z" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_94_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85048343664" target="_blank" aria-label="Open Scopus in new tab">Scopus (233)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29892065/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0057-z&amp;pmid=29892065" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib116" class="citations"><div id="sref116" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref116" title="View in article">95.</a></div><div>Tokunaga, R. ∙ Nakagawa, S. ∙ Sakamoto, Y. ...</div><div><strong>12-Chemokine signature, a predictor of tumor recurrence in colorectal cancer</strong></div><div><em>International Journal of Cancer.</em> 2020; <strong>147</strong>:532-541</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/ijc.32982" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_95_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85084047731" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32191346/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fijc.32982&amp;pmid=32191346" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib96" class="citations"><div id="sref96" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref96-1" title="View in article">96.</a></div><div>Tran, E. ∙ Ahmadzadeh, M. ∙ Lu, Y.C. ...</div><div><strong>Immunogenicity of somatic mutations in human gastrointestinal cancers</strong></div><div><em>Science.</em> 2015; <strong>350</strong>:1387-1390</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad1253" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84949730499" target="_blank" aria-label="Open Scopus in new tab">Scopus (363)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26516200/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad1253&amp;pmid=26516200" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib97" class="citations"><div id="sref97" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref97" title="View in article">97.</a></div><div>Trefny, M.P. ∙ Rothschild, S.I. ∙ Uhlenbrock, F. ...</div><div><strong>A variant of a killer cell immunoglobulin-like receptor is associated with resistance to PD-1 blockade in lung cancer</strong></div><div><em>Clin. Cancer Res.</em> 2019; <strong>25</strong>:3026-3034</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-18-3041" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85065774404" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30765392/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-18-3041&amp;pmid=30765392" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib98" class="citations"><div id="sref98" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref98" title="View in article">98.</a></div><div>Trucco, L.D. ∙ Mundra, P.A. ∙ Hogan, K. ...</div><div><strong>Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanoma</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:221-224</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0265-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_98_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85058061858" target="_blank" aria-label="Open Scopus in new tab">Scopus (27)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30510256/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0265-6&amp;pmid=30510256" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib99" class="citations"><div id="sref99" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref99" title="View in article">99.</a></div><div>Tumeh, P.C. ∙ Harview, C.L. ∙ Yearley, J.H. ...</div><div><strong>PD-1 blockade induces responses by inhibiting adaptive immune resistance</strong></div><div><em>Nature.</em> 2014; <strong>515</strong>:568-571</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature13954" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_99_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84920956732" target="_blank" aria-label="Open Scopus in new tab">Scopus (3130)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25428505/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature13954&amp;pmid=25428505" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib100" class="citations"><div id="sref100" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref100" title="View in article">100.</a></div><div>Turajlic, S. ∙ Litchfield, K. ∙ Xu, H. ...</div><div><strong>Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis</strong></div><div><em>Lancet Oncol.</em> 2017; <strong>18</strong>:1009-1021</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_100_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS1470-2045%2817%2930516-8&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_100_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2FS1470-2045%2817%2930516-8&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_100_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85022069589" target="_blank" aria-label="Open Scopus in new tab">Scopus (324)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28694034/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1470-2045%2817%2930516-8&amp;pmid=28694034" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib101" class="citations"><div id="sref101" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref101" title="View in article">101.</a></div><div>Turajlic, S. ∙ Xu, H. ∙ Litchfield, K. ..., PEACE, TRACERx Renal Consortium</div><div><strong>Tracking cancer evolution reveals constrained routes to metastases: TRACERx Renal</strong></div><div><em>Cell.</em> 2018; <strong>173</strong>:581-594.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_101_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2018.03.057&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_101_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2018.03.057&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_101_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85045083551" target="_blank" aria-label="Open Scopus in new tab">Scopus (215)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29656895/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.03.057&amp;pmid=29656895" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib102" class="citations"><div id="sref102" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref102-1" title="View in article">102.</a></div><div>Van Allen, E.M. ∙ Miao, D. ∙ Schilling, B. ...</div><div><strong>Genomic correlates of response to CTLA-4 blockade in metastatic melanoma</strong></div><div><em>Science.</em> 2015; <strong>350</strong>:207-211</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad0095" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84943516465" target="_blank" aria-label="Open Scopus in new tab">Scopus (1192)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26359337/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad0095&amp;pmid=26359337" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib103" class="citations"><div id="sref103" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref103-1" title="View in article">103.</a></div><div>Van Loo, P. ∙ Nordgard, S.H. ∙ Lingjærde, O.C. ...</div><div><strong>Allele-specific copy number analysis of tumors</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2010; <strong>107</strong>:16910-16915</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1009843107" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-78049248432" target="_blank" aria-label="Open Scopus in new tab">Scopus (524)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20837533/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1009843107&amp;pmid=20837533" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib104" class="citations"><div id="sref104" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref104" title="View in article">104.</a></div><div>Vízkeleti, L. ∙ Ecsedi, S. ∙ Rákosy, Z. ...</div><div><strong>The role of CCND1 alterations during the progression of cutaneous malignant melanoma</strong></div><div><em>Tumour Biol.</em> 2012; <strong>33</strong>:2189-2199</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s13277-012-0480-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_104_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84866484497" target="_blank" aria-label="Open Scopus in new tab">Scopus (33)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23001925/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs13277-012-0480-6&amp;pmid=23001925" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib105" class="citations"><div id="sref105" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref105" title="View in article">105.</a></div><div>Vokes, N.I. ∙ Liu, D. ∙ Ricciuti, B. ...</div><div><strong>Harmonization of tumor mutational burden quantification and association with response to immune checkpoint blockade in non-small-cell lung cancer</strong></div><div><em>JCO Precis. Oncol.</em> 2019; <strong>3</strong></div><div>PO.19.00171</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31832578/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=31832578" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib106" class="citations"><div id="sref106" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref106-1" title="View in article">106.</a></div><div>Vredevoogd, D.W. ∙ Kuilman, T. ∙ Ligtenberg, M.A. ...</div><div><strong>Augmenting immunotherapy impact by lowering tumor TNF cytotoxicity threshold</strong></div><div><em>Cell.</em> 2019; <strong>178</strong>:585-599.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_106_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2019.06.014&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_106_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2019.06.014&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_106_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85069738521" target="_blank" aria-label="Open Scopus in new tab">Scopus (34)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31303383/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.06.014&amp;pmid=31303383" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib107" class="citations"><div id="sref107" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref107-1" title="View in article">107.</a></div><div>Wang, K. ∙ Li, M. ∙ Hakonarson, H.</div><div><strong>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</strong></div><div><em>Nucleic Acids Res.</em> 2010; <strong>38</strong>:e164</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkq603" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_107_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-77956534324" target="_blank" aria-label="Open Scopus in new tab">Scopus (5569)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20601685/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkq603&amp;pmid=20601685" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib108" class="citations"><div id="sref108" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref108" title="View in article">108.</a></div><div>Wang, M.T. ∙ Chen, G. ∙ An, S.J. ...</div><div><strong>Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma</strong></div><div><em>Dis. Esophagus.</em> 2012; <strong>25</strong>:664-670</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/j.1442-2050.2011.01291.x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_108_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84866294247" target="_blank" aria-label="Open Scopus in new tab">Scopus (24)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22150974/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fj.1442-2050.2011.01291.x&amp;pmid=22150974" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib109" class="citations"><div id="sref109" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref109" title="View in article">109.</a></div><div>Wang, L. ∙ Saci, A. ∙ Szabo, P.M. ...</div><div><strong>EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:3503</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-018-05992-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_109_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85052691158" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30158554/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-018-05992-x&amp;pmid=30158554" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib110" class="citations"><div id="sref110" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref110-1" title="View in article">110.</a></div><div>Wasserstein, R.L. ∙ Schirm, A.L. ∙ Lazar, N.A.</div><div><strong>Moving to a world beyond “p &lt; 0.05”</strong></div><div><em>Am. Stat.</em> 2019; <strong>73</strong>:1-19</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/00031305.2019.1583913" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_110_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85063216937" target="_blank" aria-label="Open Scopus in new tab">Scopus (597)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F00031305.2019.1583913" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib111" class="citations"><div id="sref111" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref111-1" title="View in article">111.</a></div><div>Watkins, T.B.K. ∙ Lim, E.L. ∙ Petkovic, M. ...</div><div><strong>Pervasive chromosomal instability and karyotype order in tumour evolution</strong></div><div><em>Nature.</em> 2020; <strong>587</strong>:126-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-020-2698-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_111_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85090112455" target="_blank" aria-label="Open Scopus in new tab">Scopus (2)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32879494/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-020-2698-6&amp;pmid=32879494" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib112" class="citations"><div id="sref112" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref112-1" title="View in article">112.</a></div><div>Wolf, Y. ∙ Bartok, O. ∙ Patkar, S. ...</div><div><strong>UVB-induced tumor heterogeneity diminishes immune response in melanoma</strong></div><div><em>Cell.</em> 2019; <strong>179</strong>:219-235.e21</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_112_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2019.08.032&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_112_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2019.08.032&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_112_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85072208317" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31522890/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.08.032&amp;pmid=31522890" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib113" class="citations"><div id="sref113" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref113" title="View in article">113.</a></div><div>Yang, W. ∙ Soares, J. ∙ Greninger, P. ...</div><div><strong>Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells</strong></div><div><em>Nucleic Acids Res.</em> 2013; <strong>41</strong>:D955-D961</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gks1111" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_113_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84876563391" target="_blank" aria-label="Open Scopus in new tab">Scopus (714)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23180760/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgks1111&amp;pmid=23180760" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib114" class="citations"><div id="sref114" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref114-1" title="View in article">114.</a></div><div>Zhang, J. ∙ Bu, X. ∙ Wang, H. ...</div><div><strong>Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance</strong></div><div><em>Nature.</em> 2018; <strong>553</strong>:91-95</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_114_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-85040189345" target="_blank" aria-label="Open Scopus in new tab">Scopus (229)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29160310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25015&amp;pmid=29160310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib115" class="citations"><div id="sref115" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref115-1" title="View in article">115.</a></div><div>Zhao, B. ∙ Sedlak, J.C. ∙ Srinivas, R. ...</div><div><strong>Exploiting temporal collateral sensitivity in tumor clonal evolution</strong></div><div><em>Cell.</em> 2016; <strong>165</strong>:234-246</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_115_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2016.01.045&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_115_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=10.1016%2Fj.cell.2016.01.045&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_115_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.002&amp;key=2-s2.0-84961654807" target="_blank" aria-label="Open Scopus in new tab">Scopus (56)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26924578/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2016.01.045&amp;pmid=26924578" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div></div></div></section></div></section><div class="core-linked-content">
    

        


    

            

            

            <div data-widget-id="8633d695-b258-4908-b86f-e2c268ec3c6b" data-widget-name="UX3HTMLWidget"><script type="text/javascript">
if($('.content-navigation__body__title').length){
$('.content-navigation__body__title').each(function(){
var html=this.innerHTML;
var div = document.createElement("div");
div.innerHTML = html;
var text = div.textContent || div.innerText || "";
this.innerHTML=text;
});
}
</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="393effff-5b44-4681-a9b4-4f029b3540b7" data-widget-name="UX3HTMLWidget"><style>
.linkback-ad .pb-ad {
    display: block;
   height: auto;
    margin-left: 0px;
    margin-right: auto;
}
</style></div>

            

        

    

        

</div></div></div><div class="core-collateral-aside"><section id="core-collateral-figures"><h2>Figures (14)<button class="js--openFigureViewer"><span>Figure Viewer</span></button></h2><div class="core-collateral-aside-wrapper"><div class="grid"><a class="figure__open__ctrl" href="#fig1" aria-label="Go to Figure&amp;nbsp;1"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.002/asset/b8d55f60-ef3f-43f1-9a39-1822e2a7331f/main.assets/gr1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs1" aria-label="Go to Figure&amp;nbsp;S1"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.002/asset/9bd58c95-f198-4332-ba56-953ce923fa97/main.assets/figs1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig2" aria-label="Go to Figure&amp;nbsp;2"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.002/asset/4d182840-6f06-4171-baf3-38b5c235c468/main.assets/gr2.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs2" aria-label="Go to Figure&amp;nbsp;S2"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.002/asset/fbbf0c63-a020-4f32-8717-d6c0e2435a0a/main.assets/figs2.jpg" aria-hidden="true"></a></div><div id="collapsible-figures" data-expandable="item"><div class="content grid" style="display:none;" role="region" id="collapsible-figures_content"><a class="figure__open__ctrl" href="#fig3" aria-label="Go to Figure&amp;nbsp;3"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.002/asset/1d610540-f0ab-4625-8097-2a1a1f80beda/main.assets/gr3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig4" aria-label="Go to Figure&amp;nbsp;4"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.002/asset/54f2a675-d8b3-4162-98dc-0d49f38b8a66/main.assets/gr4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig5" aria-label="Go to Figure&amp;nbsp;5"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.002/asset/41b78baf-6cfa-4bfb-9052-fe3197331db9/main.assets/gr5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs3" aria-label="Go to Figure&amp;nbsp;S3"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.002/asset/998b51dd-d076-4075-bc1e-3d79183bc1c7/main.assets/figs3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs4" aria-label="Go to Figure&amp;nbsp;S4"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.002/asset/58796cb1-a5ba-42af-89e2-b5d1c4df233f/main.assets/figs4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig6" aria-label="Go to Figure&amp;nbsp;6"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.002/asset/8f25b0df-a056-454a-b593-ec92abd5fb99/main.assets/gr6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig7" aria-label="Go to Figure&amp;nbsp;7"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.002/asset/c97c1a9e-e9f2-4d18-9b64-63d1f8518dd2/main.assets/gr7.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs5" aria-label="Go to Figure&amp;nbsp;S5"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.002/asset/58d6ed1e-6b32-49b9-ae04-55ea33c19d0a/main.assets/figs5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs6" aria-label="Go to Figure&amp;nbsp;S6"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.002/asset/7533e529-f376-4ab3-8e21-8656c871a966/main.assets/figs6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs7" aria-label="Go to Figure&amp;nbsp;S7"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.002/asset/4795cc03-259e-4659-8c47-304dca40c7df/main.assets/figs7.jpg" aria-hidden="true"></a></div><button class="trigger" aria-controls="collapsible-figures_content" aria-expanded="false" tabindex="0" role="button"><span class="expand">Show all figures</span><span class="collapse">Hide figures</span><i class="icon-section_arrow_d" aria-hidden="true"></i></button></div></div></section>
    

        


    

            

            

            <section id="core-collateral-metrics" class="publication-list__axel-section"><h2>Article metrics</h2><div><ul class="publication-list rlist publication-list--list plum-x--lazy-load publication-list--axel js--loaded" data-plum-x-url="/pb/widgets/ux3/publicationList/plumx?widgetId=66dd7e11-7768-4006-93d8-a72b60e2a264&amp;pbContext=%3Bproduct%3Aproduct%3Aelsevier%5C%3Aproduct%5C%3Acell%3Bissue%3Aissue%3Apii%5C%3AS0092867420X00043%3Bwebsite%3Awebsite%3Acell-site%3Bctype%3Astring%3AJournal+Content%3Bjournal%3Ajournal%3Acell%3BpageGroup%3Astring%3AArticle+View%3Bpage%3Astring%3AShow+Full+Text%3Barticle%3Aarticle%3Apii%5C%3AS0092867421000027%3BrequestedJournal%3Ajournal%3Acell%3Bwgroup%3Astring%3ADefault+Website+Group%3BsubPage%3Astring%3AFull+Text" data-pb-mode-enabled="false">
                <li class="publication-list__box publication-list__box-axel">
                    <ul class="rlist axel-list__box">
                        
                        
            <li class="plum-x-wrapper">
                <div class="plum-x plum-x--axel">
                    <div class="plum-x__items">
                        
                    <div class="plum-x__item plum-x-citation">
                        <div class="plum-x__item-num">574</div>
                        <div class="plum-x__item-title">Citations</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-capture">
                        <div class="plum-x__item-num">839</div>
                        <div class="plum-x__item-title">Captures</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-mention">
                        <div class="plum-x__item-num">13</div>
                        <div class="plum-x__item-title">Mentions</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-socialMedia">
                        <div class="plum-x__item-num">1</div>
                        <div class="plum-x__item-title">Social Media</div>
                    </div>    
                
                    </div>
                    <div class="plum-x__details">
                        <div class="plum-x__logo">
                            <img src="/products/marlin/releasedAssets/images/plumx-logo.png" alt="Plum X logo">
                        </div>
                        <a class="plum-x__view-details" href="https://plu.mx/plum/a/?doi=10.1016/j.cell.2021.01.002&amp;theme=plum-jbs-theme&amp;hideUsage=true" target="_blank">
                            <span>View details</span>
                            <span class="sr-only">opens in a new tab</span>
                            <i class="icon-external-arrow" aria-hidden="true"></i>
                        </a>
                    </div>
                </div>  
            </li>
        
                    </ul>
                </li></ul></div></section>

            

        
<section id="core-collateral-supplementary"><h2>Supplemental information (2)</h2><div class="core-collateral-aside-wrapper"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.01.002/attachment/2a586919-a898-4ded-89e3-9710295b2ea4/mmc1.pdf" download="mmc1.pdf"><span id="mmc1-link">PDF (167.89 KB)</span></a><div class="core-description">Document S1. Clinical and sequencing assay data on the CPI1000+ cohort</div></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.01.002/attachment/343f6766-a81b-4e96-ad7a-1ae07bb3a86c/mmc2.xlsx" download="mmc2.xlsx"><span id="mmc2-link">Spreadsheet (56.02 KB)</span></a><div class="core-description">Table S2. Simplified two-paramter multivariable model, related to Figure&nbsp;3</div></div></div></div></section>
    

        


    

            

            

            <section id="core-collateral-relatedArticles" class="axel-related-articles"><h2 id="relatedArticles" class="top axel-related-articles__title" data-title="Related articles">Related Articles</h2><div data-pb-widget-type="ux3-relatedArticles" data-widget-id="8d3844d1-450e-497c-ab75-a63fc41750ac" data-widget-name="AtyponTempUX3RelatedArticlesWidget" data-article-pii="S0092867421000027" class="ux3DeferredOnScrollWidget axel-related-articles__body ux3DeferredLoaded" data-show-more="true">We haven't found any related articles.</div></section>

            

        
</div></div><aside data-core-aside="right-rail"><div class="inner-wrapper">

    

        


    

            

            

            <div data-widget-id="dca7470d-9085-4d21-a6f4-a66397718146" data-widget-name="UX3HTMLWidget"><input type="hidden" id="gptPage" value="cell-videos"></div>

            

        











        <div data-widget-def="literatumAd" data-widget-id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc" class="adplaceholders" style="right: 0px; position: static;">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd alignCenter  widget-verticalAd" id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc">
                
                
                    
                

                <div class="wrapped " id="Marketplace-Recs">
                    
                    <div class="widget-body body body-verticalAd "><div class="verticalAdContainer">
    <div class="verticalAdLabelContainer">
        <div class="verticalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adVert.gif" alt="Advertisement">
        </div>
    </div>
    <div class="verticalAd">
        





        <div class="pb-ad">
            <script src="//cdn.pbgrd.com/core-cell.js" async=""></script>
<div id="pbgrd-skyr-c"><div id="pbgrd-skyr" style="width: inherit; position: relative; background: transparent;"></div></div>
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

        </div>
    

</div></aside><div class="core-authors-details" style="display:none"><section class="core-authors"></section></div></article><div data-extent="article-wrapper"><div class="core-container"></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1016/j.cell.2021.01.002","data-is-retraction":false,"data-is-retired":false}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><template id="figure_nav_template"><a href="#" class="open-in-viewer btn btn-dark figure-pop-btn"><i aria-hidden="true" class="icon-export_citation"></i><span>Open in viewer</span></a></template><div id="figure-viewer" role="dialog" aria-modal="true" aria-label="Figure Viewer" class="showCaption showThumbstrip figure-viewer"><nav class="nav-bar figure-viewer__top"><a href="#" title="Close Figure Viewer" role="button" class="figure-viewer__close"><i aria-hidden="true" class="icon-tools_close"></i></a><div class="figure-viewer__title">Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition</div></nav><div class="frames"><ul class="frames__list"><li><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2021.01.002/asset/b8d55f60-ef3f-43f1-9a39-1822e2a7331f/main.assets/gr1.jpg" height="788" width="762" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/f3909e55-ed7b-4e4c-af08-8cb8ce61728d/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2021.01.002/asset/9bd58c95-f198-4332-ba56-953ce923fa97/main.assets/figs1.jpg" height="622" width="678" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/21e33d05-21ac-44ba-b730-1ab71e258f69/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2021.01.002/asset/4d182840-6f06-4171-baf3-38b5c235c468/main.assets/gr2.jpg" height="941" width="655" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/db282d46-1ab1-43e2-a3a8-b6d905326489/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2021.01.002/asset/fbbf0c63-a020-4f32-8717-d6c0e2435a0a/main.assets/figs2.jpg" height="559" width="506" aria-labelledby="figs2-title" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/2e2234f8-aaf8-416c-bc86-0233384c6826/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2021.01.002/asset/1d610540-f0ab-4625-8097-2a1a1f80beda/main.assets/gr3.jpg" height="941" width="698" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/32526d0c-7386-401b-bfa8-65dcc5432989/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2021.01.002/asset/54f2a675-d8b3-4162-98dc-0d49f38b8a66/main.assets/gr4.jpg" height="959" width="683" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/882422eb-4eb6-4f61-a351-87d6a14109ab/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2021.01.002/asset/41b78baf-6cfa-4bfb-9052-fe3197331db9/main.assets/gr5.jpg" height="698" width="753" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/63e92e88-a0e0-4a4a-988e-7c3114189d74/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2021.01.002/asset/998b51dd-d076-4075-bc1e-3d79183bc1c7/main.assets/figs3.jpg" height="515" width="504" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/45fdef0a-9e38-48e3-b8c0-1827a1ca8e08/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2021.01.002/asset/58796cb1-a5ba-42af-89e2-b5d1c4df233f/main.assets/figs4.jpg" height="462" width="762" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/221e6402-6246-40b5-a3c0-f1c14d7c14f6/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2021.01.002/asset/8f25b0df-a056-454a-b593-ec92abd5fb99/main.assets/gr6.jpg" height="422" width="753" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/3d9c572f-e9f2-497e-aa97-87d5ad60858e/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2021.01.002/asset/c97c1a9e-e9f2-4d18-9b64-63d1f8518dd2/main.assets/gr7.jpg" height="601" width="753" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/ffa3d189-d19e-4e86-b24e-7f1aaf4fbbdc/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2021.01.002/asset/58d6ed1e-6b32-49b9-ae04-55ea33c19d0a/main.assets/figs5.jpg" height="365" width="759" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/fc3e57a5-64be-4d3d-9b0f-a08fcd2e0695/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2021.01.002/asset/7533e529-f376-4ab3-8e21-8656c871a966/main.assets/figs6.jpg" height="581" width="502" aria-labelledby="figs6-title" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/f7402d01-cb2c-4179-8297-825b9ac1defd/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2021.01.002/asset/4795cc03-259e-4659-8c47-304dca40c7df/main.assets/figs7.jpg" height="364" width="762" aria-labelledby="figs7-title" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/0a0074c7-9fa1-4f19-a836-516a9db59e02/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li></ul><a href="#" title="Previous Frame" class="frameButton previousFrameButton frames__prev"><!--span Previous Frame--><i class="icon-arrow_l"></i></a><a href="#" title="Next Frame" class="frameButton nextFrameButton frames__next"><!--span Next Frame--><i class="icon-arrow_r"></i></a></div><div class="caption"><div class="figure-viewer__caption-body"></div></div><div class="toolbar figure-viewer__toolbar"><span class="figure-viewer__counter"></span><a href="#" class="button toggle-caption-button figure-viewer__caption__ctrl"><i aria-hidden="true" class="icon icon-info"></i><span class="label">Hide Caption</span></a><a href="#" class="button download-options-button"><i aria-hidden="true" class="icon icon-gizmo-folder-in download-size-icon"></i><span class="label">Download</span></a><a href="#figures" class="button see-figures figure-viewer__see-figure__ctrl"><i aria-hidden="true" class="icon icon-gizmo-image_figure viewer-size-icon"></i><span class="label">See figure in Article</span></a></div><div class="thumbstrip"><a href="#" class="toggleButton thumbstrip__ctrl"><span>Toggle Thumbstrip</span></a><a href="#" title="Previous Thumbnails" class="thumbstripButton previousThumbstripButton thumbstrip__prev"><i aria-hidden="true" class="icon-arrow_l"></i></a><a href="#" title="Next Thumbnails" class="thumbstripButton nextThumbstripButton thumbstrip__next"><i aria-hidden="true" class="icon-arrow_r"></i></a><div class="thumbstrip__wrapper"><ul class="rlist figure-viewer__thumbslist"><li><div class="thumbnail__label">Figure&nbsp;1</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2021.01.002/asset/b8d55f60-ef3f-43f1-9a39-1822e2a7331f/main.assets/gr1.jpg" height="788" width="762" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/f3909e55-ed7b-4e4c-af08-8cb8ce61728d/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S1</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2021.01.002/asset/9bd58c95-f198-4332-ba56-953ce923fa97/main.assets/figs1.jpg" height="622" width="678" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/21e33d05-21ac-44ba-b730-1ab71e258f69/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;2</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2021.01.002/asset/4d182840-6f06-4171-baf3-38b5c235c468/main.assets/gr2.jpg" height="941" width="655" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/db282d46-1ab1-43e2-a3a8-b6d905326489/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S2</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2021.01.002/asset/fbbf0c63-a020-4f32-8717-d6c0e2435a0a/main.assets/figs2.jpg" height="559" width="506" aria-labelledby="figs2-title" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/2e2234f8-aaf8-416c-bc86-0233384c6826/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;3</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2021.01.002/asset/1d610540-f0ab-4625-8097-2a1a1f80beda/main.assets/gr3.jpg" height="941" width="698" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/32526d0c-7386-401b-bfa8-65dcc5432989/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;4</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2021.01.002/asset/54f2a675-d8b3-4162-98dc-0d49f38b8a66/main.assets/gr4.jpg" height="959" width="683" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/882422eb-4eb6-4f61-a351-87d6a14109ab/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;5</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2021.01.002/asset/41b78baf-6cfa-4bfb-9052-fe3197331db9/main.assets/gr5.jpg" height="698" width="753" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/63e92e88-a0e0-4a4a-988e-7c3114189d74/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S3</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2021.01.002/asset/998b51dd-d076-4075-bc1e-3d79183bc1c7/main.assets/figs3.jpg" height="515" width="504" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/45fdef0a-9e38-48e3-b8c0-1827a1ca8e08/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S4</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2021.01.002/asset/58796cb1-a5ba-42af-89e2-b5d1c4df233f/main.assets/figs4.jpg" height="462" width="762" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/221e6402-6246-40b5-a3c0-f1c14d7c14f6/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;6</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2021.01.002/asset/8f25b0df-a056-454a-b593-ec92abd5fb99/main.assets/gr6.jpg" height="422" width="753" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/3d9c572f-e9f2-497e-aa97-87d5ad60858e/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;7</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2021.01.002/asset/c97c1a9e-e9f2-4d18-9b64-63d1f8518dd2/main.assets/gr7.jpg" height="601" width="753" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/ffa3d189-d19e-4e86-b24e-7f1aaf4fbbdc/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S5</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2021.01.002/asset/58d6ed1e-6b32-49b9-ae04-55ea33c19d0a/main.assets/figs5.jpg" height="365" width="759" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/fc3e57a5-64be-4d3d-9b0f-a08fcd2e0695/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S6</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2021.01.002/asset/7533e529-f376-4ab3-8e21-8656c871a966/main.assets/figs6.jpg" height="581" width="502" aria-labelledby="figs6-title" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/f7402d01-cb2c-4179-8297-825b9ac1defd/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S7</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2021.01.002/asset/4795cc03-259e-4659-8c47-304dca40c7df/main.assets/figs7.jpg" height="364" width="762" aria-labelledby="figs7-title" data-viewer-src="/cms/10.1016/j.cell.2021.01.002/asset/0a0074c7-9fa1-4f19-a836-516a9db59e02/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li></ul></div></div><div class="download figure-viewer__download"><div class="pointer"></div><ul class="rlist downlad__wrapper"><li class="hidden-xs hidden-sm"><a href="/action/downloadFigures?pii=e00489&amp;id=" class="downloadAllButton"><i class="icon icon-gizmo-ppt figure-viewer__download__viewer-size-icon figure-viewer__download__viewer-size-icon--ppt"></i><span class="figure-viewer__download__text"> Download .PPT</span></a></li></ul></div></div><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--inverse"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-do="Digital Object" data-figures="Figures" data-metrics="Article Metrics" data-related="Related articles" data-supplementary="Supplemental information"></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-  widget-compact-all" id="756cf18d-e910-4468-936c-0225ae7c669f">
                
                
                    
                

                <div class="wrapped " id="ad for nucleus-single-molecule-technologies">
                    
                    <div class="widget-body body body-  body-compact-all"><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(21)00002-7';

if(URL_var.indexOf("S0165-6147(17)30205-5") > -1
|| URL_var.indexOf("S0167-7799(18)30204-X") > -1 
|| URL_var.indexOf("S0092-8674(18)31649-0") > -1 
|| URL_var.indexOf("S0092-8674(19)30404-0") > -1 
|| URL_var.indexOf("S1097-2765(18)30756-1") > -1 
|| URL_var.indexOf("S0092-8674(18)31452-1") > -1 
|| URL_var.indexOf("S1097-2765(19)30175-3") > -1 
|| URL_var.indexOf("S0092-8674(18)30852-3") > -1 
|| URL_var.indexOf("S0006-3495(18)30295-9") > -1 
|| URL_var.indexOf("S1097-2765(19)30063-2") > -1 
|| URL_var.indexOf("S0006-3495(17)33208-3") > -1 
|| URL_var.indexOf("S2211-1247(18)31639-5") > -1 
|| URL_var.indexOf("S1097-2765(18)30978-X") > -1 
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-single-molecule-technologies" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-" id="754b1780-1117-4371-9285-9cd7020963d5">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body- "><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(21)00002-7';

if(URL_var.indexOf("S1535-6108(19)30104-7") > -1
|| URL_var.indexOf("S0092-8674(18)31394-1") > -1
|| URL_var.indexOf("S1074-7613(19)30033-0") > -1
|| URL_var.indexOf("S1535-6108(18)30473-2") > -1
|| URL_var.indexOf("S0092-8674(19)30154-0") > -1
|| URL_var.indexOf("S1550-4131(18)30178-5") > -1
|| URL_var.indexOf("S1535-6108(19)30242-9") > -1
|| URL_var.indexOf("S1074-7613(18)30431-X") > -1
|| URL_var.indexOf("S0092-8674(19)30618-X") > -1
|| URL_var.indexOf("S1535-6108(18)30472-0") > -1
|| URL_var.indexOf("S1535-6108(18)30120-X") > -1
|| URL_var.indexOf("S0092-8674(18)31247-9") > -1
|| URL_var.indexOf("S1074-7613(18)30085-2") > -1
|| URL_var.indexOf("S1074-7613(18)30080-3") > -1
|| URL_var.indexOf("S1471-4906(18)30210-2") > -1
|| URL_var.indexOf("S1550-4131(19)30304-3") > -1
|| URL_var.indexOf("S1934-5909(18)30599-X") > -1
|| URL_var.indexOf("S2405-8033(19)30024-X") > -1
|| URL_var.indexOf("S1535-6108(18)30109-0") > -1
|| URL_var.indexOf("S0962-8924(18)30127-2") > -1
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-tumor-immune-microenvironment" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="9c9ff7a1-a035-49f6-a336-600c9419c518" data-widget-name="UX3HTMLWidget"><!-- Start of HubSpot Embed Code --> 

<script type="text/plain" class="optanon-category-4" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/519224.js"></script> 

<!-- End of HubSpot Embed Code --></div>

            

        

    

        


    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget sessionValidationWidget none  widget-none  widget-compact-all" id="0257aef7-6074-4898-a989-1c3f693225a2">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><script>
    $.ajax({
        url: "https://www.cell.com/ssoSessionCheck",
        type: "GET",
        dataType: "jsonp",
        success: function (data) {
            if(data.RefreshSession) {
                location.reload();
            }
        },
        error : function (){
            console.warn("can't validate CSAS session.");
        }
    });
</script></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasSsoUrls none  widget-none  widget-compact-all" id="948bc5c4-8b0d-47be-b5ad-6570559802d1">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><!-- clear SSO URLs after all iFrames are rendered or after passing a time out-->
<script>
    setTimeout(clearSsoUrlsFun,10000);
    var iFramesList = document.getElementById("sso-urls-div").getElementsByTagName("iframe");
    var renderedIFramesCount = 0;
    var numberOfIFrames = iFramesList.length;
    var skipRefresh = false;
    for (var i = 0; i < iFramesList.length; i++) {
        var iFrame = iFramesList[i];
        iFrame.addEventListener("load", function() {
            renderedIFramesCount = renderedIFramesCount + 1;
            if (renderedIFramesCount >= numberOfIFrames)
            {
                clearSsoUrlsFun();
            }
        });
    }

    function clearSsoUrlsFun() {
        if (skipRefresh == false && numberOfIFrames > 0)
        {
            skipRefresh = true;
            $.ajax({
                url: "https://www.cell.com/action/clearSsoUrls",
                type: "GET",
                dataType: "jsonp",
                error : errorCallingAjx
            });
        }
    }

    function errorCallingAjx(){
        console.log("can't delete sso urls .")
    }
</script></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" class="ux3 ">
        
    

        


    

            

            

            <div data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" data-widget-name="ux3-layout-widget" class="fonts-loaded"><div class="footer clearfix">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header widget-horizontalAd" id="a07ee92b-3942-49f8-9186-a2a08fc3fc56">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 4 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="4"></div>
<!-- End AdSlot 4 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="23703bbc-af46-4f3f-a5bb-dd52891ff0ff" data-widget-name="UX3HTMLWidget"><div class="footer__top">
    <div class="footer__logo centered"><a href="/home" title="Cell Press"><!-- Generator: Adobe Illustrator 25.2.1, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 300 72" style="enable-background:new 0 0 300 72;" xml:space="preserve">
<style type="text/css">
	.st0{fill:#007DBC;}
</style>
<g>
	<path class="st0" d="M39.4,7.5c-2.3-0.3-4.4,1.1-4.9,3.3l-1.8,7.4c-0.4,1.8-1.9,3.1-3.8,3.3l-10.5,1.2C7.1,24-1,34.3,0.7,45.6
		c1.3,9,8.6,15.7,17.2,17c2.3,0.3,4.4-1.1,4.9-3.3l1.8-7.4c0.4-1.8,1.9-3.1,3.8-3.3l10.5-1.2c11.3-1.2,19.4-11.6,17.8-22.9
		C55.3,15.4,48.1,8.8,39.4,7.5z M37.1,34l-6.6,0.8c-1.1,0.1-2,0.9-2.3,2l-1.9,8.1c-0.6,2.4-2.5,4.2-5,4.5c-3.8,0.4-7.1-2.4-7.4-6.2
		c-0.3-3.7,2.6-6.8,6.3-7.2l6.6-0.8c1.1-0.1,2-0.9,2.3-2l1.9-8.1c0.6-2.4,2.5-4.2,5-4.5c3.8-0.4,7.1,2.4,7.4,6.2
		C43.7,30.5,40.8,33.6,37.1,34z"></path>
	<rect x="153.1" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M90.2,20.4c7.3,0,8.6,4.8,9.4,7.3h8.8c-0.5-6.2-5.6-14.9-18.2-14.9c-10.9,0-19.4,7.5-19.4,22.3
		c0,14.6,8.1,22.2,19.3,22.2c10.6,0,16.6-6.4,18.4-15.6h-8.8c-1.1,5.2-4.5,7.9-9.4,7.9c-7.5,0-10.5-6.8-10.5-14.4
		C79.7,23.3,85.9,20.4,90.2,20.4z"></path>
	<path class="st0" d="M125.2,24c-13.7,0-15,12.1-15,15.8c0,12.9,6.8,17.1,15.6,17.1c5.4,0,11.6-2.5,13.8-10H131
		c-0.7,2.2-3,3.4-5.3,3.4c-6.6,0-7.1-5.3-7.3-7.7h21.5v-1.5C139.9,27,131.3,24,125.2,24z M118.6,37.4c0.5-4.1,2.5-6.6,6.4-6.6
		c2.6,0,5.9,1.5,6.4,6.6H118.6z"></path>
	<rect x="142" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M174,13.8h-9.8V21h7.2c4.3,0,8.2,0.9,8.2,6.4c0,5.4-3.9,6.4-8.2,6.4h-7.2V41h9.8c10.6,0,14.7-6.7,14.7-13.6
		C188.7,20.5,184.6,13.8,174,13.8z"></path>
	<path class="st0" d="M210.5,24.9c-0.5-0.2-1.2-0.3-1.8-0.3c-4.1,0-8.3,2.7-9.8,6.5h-0.1v-5.7h-8v30.7h8.4V42.3
		c0-5.4,2.1-9.9,8.3-9.9c1,0,2.3,0.1,3,0.3V24.9z"></path>
	<path class="st0" d="M225.6,24.6c-9.3,0-15.7,7-15.7,16.2c0,9.5,6,16.1,15.7,16.1c6.9,0,12-3.1,14.4-10.3h-7.4
		c-0.5,1.9-3.3,4-6.6,4c-4.7,0-7.3-2.4-7.5-7.8h22.1C241.1,33.4,236,24.6,225.6,24.6z M218.4,37.5c0.1-2.4,1.7-6.5,7-6.5
		c4.1,0,5.9,2.3,6.7,6.5H218.4z"></path>
	<path class="st0" d="M260.3,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		C242,54.3,248.9,57,256,57c7,0,14-2.6,14-10.7C270.1,40.6,265.2,38.8,260.3,37.7z"></path>
	<path class="st0" d="M289.8,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		c0.4,8.1,7.3,10.8,14.4,10.8c7,0,14-2.6,14-10.7C299.6,40.6,294.7,38.8,289.8,37.7z"></path>
	<path class="st0" d="M34.1,57.6c0.3-0.2,0.4-0.6,0.4-1c0-0.5-0.2-0.9-0.5-1.1c-0.3-0.2-0.8-0.3-1.4-0.3h-1.9v5.1h0.8V58h0.8
		l1.3,2.2h0.9l-1.4-2.2C33.6,57.9,33.9,57.8,34.1,57.6z M32.5,57.3h-0.9v-1.5h1c0.1,0,0.3,0,0.4,0c0.1,0,0.3,0,0.4,0.1
		c0.1,0,0.2,0.1,0.3,0.2c0.1,0.1,0.1,0.2,0.1,0.4c0,0.2,0,0.3-0.1,0.4c-0.1,0.1-0.2,0.2-0.3,0.2c-0.1,0.1-0.2,0.1-0.4,0.1
		C32.8,57.3,32.6,57.3,32.5,57.3z"></path>
	<path class="st0" d="M35.6,54.2c-0.4-0.4-0.9-0.7-1.4-0.9c-0.5-0.2-1.1-0.3-1.7-0.3c-0.6,0-1.2,0.1-1.7,0.3c-0.6,0.2-1,0.5-1.4,0.9
		c-0.4,0.4-0.7,0.9-1,1.5c-0.2,0.6-0.4,1.2-0.4,1.9c0,0.7,0.1,1.3,0.3,1.8c0.2,0.6,0.5,1,0.9,1.5c0.4,0.4,0.9,0.7,1.4,1
		c0.6,0.2,1.2,0.4,1.8,0.4c0.6,0,1.2-0.1,1.7-0.3c0.5-0.2,1-0.5,1.4-0.9c0.4-0.4,0.7-0.9,1-1.5c0.2-0.6,0.4-1.2,0.4-1.9
		c0-0.7-0.1-1.3-0.4-1.9C36.4,55.1,36,54.6,35.6,54.2z M35.7,59.1c-0.2,0.5-0.4,0.9-0.8,1.2c-0.3,0.3-0.7,0.6-1.1,0.8
		c-0.4,0.2-0.9,0.3-1.4,0.3c-0.6,0-1-0.1-1.5-0.3c-0.4-0.2-0.8-0.5-1.1-0.8c-0.3-0.3-0.5-0.7-0.7-1.2c-0.2-0.5-0.2-1-0.2-1.5
		c0-0.6,0.1-1.1,0.3-1.5c0.2-0.5,0.4-0.9,0.8-1.2c0.3-0.3,0.7-0.6,1.1-0.8c0.4-0.2,0.9-0.3,1.4-0.3c0.5,0,1,0.1,1.4,0.3
		c0.4,0.2,0.8,0.4,1.1,0.8c0.3,0.3,0.6,0.7,0.8,1.2c0.2,0.5,0.3,1,0.3,1.5C36,58.1,35.9,58.6,35.7,59.1z"></path>
</g>
</svg></a></div>
    <div class="footer__social-links">
        <ul class="rlist rlist--inline centered">
            <li><a href="http://on.fb.me/1tgHakh" title="Facebook" target="_blank"><i aria-hidden="true" class="icon-Icon_Facebook"></i></a></li>

            <li><a href="https://www.instagram.com/cellpress/" title="Instagram" target="_blank"><svg width="18px" height="18px" viewBox="0 0 18 18" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-147.000000, -16.000000)" fill-rule="nonzero" fill="#969696"> <g id="Instagram-Logo" transform="translate(147.000000, 16.000000)"> <path d="M9,1.62580645 C11.4096774,1.62580645 11.7,1.62580645 12.6290323,1.68387097 C13.5,1.71290323 13.9935484,1.85806452 14.3129032,2.00322581 C14.7193548,2.17741935 15.0387097,2.3516129 15.3580645,2.67096774 C15.6774194,2.99032258 15.8806452,3.28064516 16.0258065,3.71612903 C16.1419355,4.03548387 16.2870968,4.5 16.3451613,5.4 C16.3741935,6.35806452 16.4032258,6.61935484 16.4032258,9.02903226 C16.4032258,11.4387097 16.4032258,11.7290323 16.3451613,12.6580645 C16.316129,13.5290323 16.1709677,14.0225806 16.0258065,14.3419355 C15.8516129,14.7483871 15.6774194,15.0677419 15.3580645,15.3870968 C15.0387097,15.7064516 14.7483871,15.9096774 14.3129032,16.0548387 C13.9935484,16.1709677 13.5290323,16.316129 12.6290323,16.3741935 C11.6709677,16.4032258 11.4096774,16.4322581 9,16.4322581 C6.59032258,16.4322581 6.3,16.4322581 5.37096774,16.3741935 C4.5,16.3451613 4.00645161,16.2 3.68709677,16.0548387 C3.28064516,15.8806452 2.96129032,15.7064516 2.64193548,15.3870968 C2.32258065,15.0677419 2.11935484,14.7774194 1.97419355,14.3419355 C1.85806452,14.0225806 1.71290323,13.5580645 1.65483871,12.6580645 C1.62580645,11.7 1.62580645,11.4096774 1.62580645,9 C1.62580645,6.59032258 1.62580645,6.3 1.68387097,5.37096774 C1.71290323,4.5 1.85806452,4.00645161 2.00322581,3.68709677 C2.17741935,3.28064516 2.3516129,2.96129032 2.67096774,2.64193548 C2.99032258,2.32258065 3.28064516,2.11935484 3.71612903,1.97419355 C4.03548387,1.85806452 4.5,1.71290323 5.4,1.65483871 C6.3,1.62580645 6.59032258,1.62580645 9,1.62580645 L9,1.62580645 Z M9,0 C6.56129032,0 6.24193548,0 5.28387097,0.0580645161 C4.32580645,0.116129032 3.65806452,0.261290323 3.10645161,0.464516129 C2.52580645,0.696774194 2.00322581,1.01612903 1.50967742,1.50967742 C1.01612903,2.00322581 0.696774194,2.52580645 0.464516129,3.10645161 C0.232258065,3.68709677 0.0870967742,4.32580645 0.0580645161,5.28387097 C0,6.24193548 0,6.56129032 0,9 C0,11.4387097 0,11.7580645 0.0580645161,12.716129 C0.116129032,13.6741935 0.261290323,14.3419355 0.464516129,14.8935484 C0.696774194,15.4741935 1.01612903,15.9967742 1.50967742,16.4903226 C2.00322581,16.983871 2.52580645,17.3032258 3.10645161,17.5354839 C3.68709677,17.7677419 4.32580645,17.9129032 5.28387097,17.9419355 C6.24193548,18 6.56129032,18 9,18 C11.4387097,18 11.7580645,18 12.716129,17.9419355 C13.6741935,17.883871 14.3419355,17.7387097 14.8935484,17.5354839 C15.4741935,17.3032258 15.9967742,16.983871 16.4903226,16.4903226 C16.983871,15.9967742 17.3032258,15.4741935 17.5354839,14.8935484 C17.7677419,14.3129032 17.9129032,13.6741935 17.9419355,12.716129 C18,11.7580645 18,11.4387097 18,9 C18,6.56129032 18,6.24193548 17.9419355,5.28387097 C17.883871,4.32580645 17.7387097,3.65806452 17.5354839,3.10645161 C17.3032258,2.52580645 16.983871,2.00322581 16.4903226,1.50967742 C15.9967742,1.01612903 15.4741935,0.696774194 14.8935484,0.464516129 C14.3129032,0.232258065 13.6741935,0.0870967742 12.716129,0.0580645161 C11.7580645,0 11.4387097,0 9,0 L9,0 Z"></path> <path d="M9,4.38387097 C6.44516129,4.38387097 4.38387097,6.44516129 4.38387097,9 C4.38387097,11.5548387 6.44516129,13.616129 9,13.616129 C11.5548387,13.616129 13.616129,11.5548387 13.616129,9 C13.616129,6.44516129 11.5548387,4.38387097 9,4.38387097 Z M9,11.9903226 C7.34516129,11.9903226 6.00967742,10.6548387 6.00967742,9 C6.00967742,7.34516129 7.34516129,6.00967742 9,6.00967742 C10.6548387,6.00967742 11.9903226,7.34516129 11.9903226,9 C11.9903226,10.6548387 10.6548387,11.9903226 9,11.9903226 Z"></path> <circle id="Oval" cx="13.7903226" cy="4.20967742" r="1.07419355"></circle> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.linkedin.com/company/cell-press/" title="LinkedIn" target="_blank"><i aria-hidden="true" class="icon-linkedin"></i></a></li>
            
                        <li><a href="http://bit.ly/1zq7Q5T" title="Twitter" target="_blank">
                <!--<i aria-hidden="true" class="icon-Icon_Twitter"></i></a>-->
                
                <svg id="xicon" viewBox="0 0 1200 1227" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" role="none"><path fill="#969696" d="M714.163 519.284L1160.89 0H1055.03L667.137 450.887L357.328 0H0L468.492 681.821L0 1226.37H105.866L515.491 750.218L842.672 1226.37H1200L714.137 519.284H714.163ZM569.165 687.828L521.697 619.934L144.011 79.6944H306.615L611.412 515.685L658.88 583.579L1055.08 1150.3H892.476L569.165 687.854V687.828Z"></path></svg> 

                    <style>
                    .footer svg#xicon {
                      height: 16px;
                    }
                    </style>
            </a></li>

            
            <li><a href="/pb-assets/marketing/WeChat/WeChat-1557753222727.jpg" title="WeChat" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-122.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="wechat" transform="translate(122.000000, 17.000000)"> <path d="M12.375,4.5 L12.375,4.5 L12.4875,4.5 L12.4875,4.5 C12.6898579,4.48604473 12.8520408,4.32704187 12.87,4.125 C12.8705905,4.04725572 12.8470025,3.9712499 12.8025,3.9075 C11.94,1.5675 9.4425,0 6.5625,0 C2.9475,0 0,2.52 0,5.625 C0.0313772094,7.34410122 0.895513317,8.94093526 2.3175,9.9075 L1.5675,11.46 C1.49009368,11.6087816 1.52088865,11.7908702 1.64291494,11.9059236 C1.76494122,12.0209769 1.94852501,12.0410168 2.0925,11.955 L4.08,10.8225 C4.61861992,11.0129999 5.17724298,11.1413322 5.745,11.205 C5.86564124,11.2178337 5.98503738,11.1715098 6.06545426,11.0806685 C6.14587113,10.9898272 6.17737153,10.865694 6.15,10.7475 C6.06148727,10.4219419 6.01114891,10.0871918 6,9.75 C6,6.855 8.8575,4.5 12.375,4.5 Z M8.25,3 C8.66421356,3 9,3.33578644 9,3.75 C9,4.16421356 8.66421356,4.5 8.25,4.5 C7.83578644,4.5 7.5,4.16421356 7.5,3.75 C7.5,3.33578644 7.83578644,3 8.25,3 Z M4.5,4.5 C4.08578644,4.5 3.75,4.16421356 3.75,3.75 C3.75,3.33578644 4.08578644,3 4.5,3 C4.91421356,3 5.25,3.33578644 5.25,3.75 C5.25,4.16421356 4.91421356,4.5 4.5,4.5 Z"></path> <path d="M18,9.75 C18,7.2675 15.48,5.25 12.375,5.25 C9.27,5.25 6.75,7.2675 6.75,9.75 C6.75,12.2325 9.27,14.25 12.375,14.25 C12.9568557,14.2502837 13.5364258,14.1772075 14.1,14.0325 L15.96,14.9625 C16.0114248,14.9874074 16.0678613,15.0002339 16.125,15 C16.2497193,14.9993787 16.3659682,14.9367912 16.4351508,14.8330172 C16.5043335,14.7292432 16.5173955,14.5978644 16.47,14.4825 L15.96,13.2075 C17.1784092,12.4716325 17.9450305,11.1723221 18,9.75 L18,9.75 Z M10.5,9 C10.0857864,9 9.75,8.66421356 9.75,8.25 C9.75,7.83578644 10.0857864,7.5 10.5,7.5 C10.9142136,7.5 11.25,7.83578644 11.25,8.25 C11.25,8.66421356 10.9142136,9 10.5,9 Z M14.25,9 C13.8357864,9 13.5,8.66421356 13.5,8.25 C13.5,7.83578644 13.8357864,7.5 14.25,7.5 C14.6642136,7.5 15,7.83578644 15,8.25 C15,8.66421356 14.6642136,9 14.25,9 Z" opacity="0.959999979"></path> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.weibo.com/CellPress" title="Weibo" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-99.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="weibo" transform="translate(99.000000, 14.000000)"> <g transform="translate(0.000000, 3.000000)"> <path d="M13.2402211,7.47054172 C12.9918392,7.39866484 12.821608,7.34902326 12.9514975,7.03290287 C13.232804,6.34602189 13.2622915,5.75359781 12.9571055,5.33095486 C12.3847236,4.5380684 10.8191759,4.58064295 9.02514573,5.30975376 C9.02514573,5.30889193 8.46144724,5.54882627 8.60544724,5.11515185 C8.88150754,4.25435294 8.83953769,3.53386047 8.41043216,3.11759508 C7.43716583,2.17285363 4.84824121,3.15344733 2.62745729,5.3059617 C0.964944724,6.9186238 0,8.62798358 0,10.105855 C0,12.9324952 3.73748744,14.8235294 7.39429146,14.8235294 C12.1877186,14.8235294 15.3768844,11.9501778 15.3768844,9.80576471 C15.3768844,8.50974008 14.2514774,7.77442408 13.2402211,7.47054172 Z M7.40424121,13.5561176 C4.48625126,13.8315595 1.9678794,12.5686293 1.77811055,10.7327524 C1.58870352,8.89773735 3.80098492,7.18579207 6.71861307,6.90948837 C9.63678392,6.63266758 12.1556985,7.89663201 12.3447437,9.73164706 C12.533608,11.5675239 10.3227739,13.2796416 7.40424121,13.5561176 Z M18,5.16875787 C17.9985528,2.31402189 15.5695477,0 12.5728643,0 C12.222995,0 11.9396985,0.270098495 11.9396985,0.603283174 C11.9396985,0.936640219 12.222995,1.20656635 12.5728643,1.20656635 C14.8708945,1.20656635 16.7336683,2.98159781 16.7336683,5.17099863 C16.7336683,5.50435568 17.0173266,5.77428181 17.3668342,5.77428181 C17.7167035,5.77428181 18,5.50435568 18,5.17099863 C18,5.17099863 18,5.1696197 18,5.16875787 Z M15.4841608,5.08016142 C15.1948945,3.73415048 14.0812462,2.67323393 12.6683819,2.39744733 C12.3262915,2.33039672 11.9914372,2.54051163 11.9212462,2.86680164 C11.8506935,3.19309166 12.0712161,3.51179754 12.4133065,3.57919289 C13.3319397,3.75845417 14.0559196,4.44774829 14.2438794,5.32302599 C14.3146131,5.64931601 14.6491055,5.85925855 14.9915578,5.7923803 C15.3338291,5.72498495 15.5541709,5.40627907 15.4841608,5.08016142 Z M5.90761809,8.7069275 C4.7321005,8.9320383 3.93901508,9.87126402 4.1358392,10.8044569 C4.33248241,11.7378222 5.44504523,12.311803 6.62056281,12.0865198 C7.79571859,11.861409 8.58916583,10.922528 8.3921608,9.98899042 C8.19569849,9.0559699 7.08277387,8.48181669 5.90761809,8.7069275 Z"></path> </g> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.youtube.com/user/cellvideoabstracts" title="YouTube" target="_blank"><svg width="18px" height="13px" viewBox="0 0 18 13" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-76.000000, -19.000000)" fill-rule="nonzero" fill="#969696"> <g id="youtube" transform="translate(76.000000, 14.000000)"> <path d="M17.2984219,6.41974219 C16.6486641,5.64735937 15.4490625,5.33232422 13.1580703,5.33232422 L4.84175391,5.33232422 C2.49834375,5.33232422 1.27838672,5.66771484 0.631089844,6.49001953 C0,7.29172266 0,8.47304297 0,10.1080547 L0,13.2243047 C0,16.3917773 0.748792969,18 4.84175391,18 L13.1581055,18 C15.1448555,18 16.2457383,17.7219844 16.9579688,17.040375 C17.688375,16.3413984 18,15.2001211 18,13.2243047 L18,10.1080547 C18,8.38381641 17.951168,7.19553516 17.2984219,6.41974219 Z M11.5560703,12.0963867 L7.77965625,14.0700586 C7.69524609,14.1141797 7.60289062,14.136082 7.51071094,14.136082 C7.40629687,14.136082 7.30212891,14.1079922 7.20987891,14.0521289 C7.03613672,13.9468711 6.93007031,13.7585391 6.93007031,13.5554414 L6.93007031,9.62075391 C6.93007031,9.41800781 7.03585547,9.22985156 7.20924609,9.12452344 C7.38267187,9.01919531 7.59839062,9.01198828 7.77832031,9.10546875 L11.5547344,11.0664141 C11.7468633,11.1661523 11.8675195,11.3645039 11.8678008,11.5809258 C11.8680469,11.7975586 11.747918,11.9961914 11.5560703,12.0963867 Z"></path> </g> </g> </g></svg></a></li>
            
        </ul>
    </div>
</div>

<style>

.ux3 .footer__logo svg {
    max-width: 160px !important;
}

.ux3 .footer__social-links a svg {
    max-width: 26px;
    height: 1.15rem;
    width: auto;
}

.ux3 .footer__social-links a:hover svg path {
    fill: #353535;
}

</style></div>

            

        

    

        


    

            

            
                <div class="footer__bottom text-onDark">
            

            <div data-widget-id="06227714-c621-4651-9879-b0ce5176cccc" data-widget-name="ux3-layout-widget"><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="07e1d276-b4dd-4870-b858-ed74e70d64ef" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Life &amp; medical sciences journals</h2>
		<ul class="rlist clearfix sided">
		<li>
			<a alt="Cell" href="/cell/home">Cell</a>
		</li>
		<li>
			<a alt="Cancer Cell" href="/cancer-cell/home">Cancer Cell</a>
		</li>
		<li>
			<a alt="Cell Chemical Biology" href="/cell-chemical-biology">Cell Chemical Biology</a>
		</li>
		<li>
			<a alt="Cell Genomics" href="/cell-genomics/home">Cell Genomics</a>
		</li>
		<li>
			<a alt="Cell Host and Microbe" href="/cell-host-microbe/home">Cell Host &amp; Microbe</a>
		</li>
		<li>
			<a alt="Cell Metabolism" href="/cell-metabolism/home">Cell Metabolism</a>
		</li>
		<li>
			<a alt="Cell Reports" href="/cell-reports/home">Cell Reports</a>
		</li>
		<li>
			<a alt="Cell Reports Medicine" href="/cell-reports-medicine/home">Cell Reports Medicine</a>
		</li>
		<li>
			<a alt="Cell Stem Cell" href="/cell-stem-cell/home">Cell Stem Cell</a>
		</li>
		<li>
			<a alt="Cell Systems" href="/cell-systems/home">Cell Systems</a>
		</li>
		<li>
			<a alt="Current Biology" href="/current-biology/home">Current Biology</a>
		</li>
		<li>
			<a alt="Developmental Cell" href="/developmental-cell/home">Developmental Cell</a>
		</li>
		<li>
			<a alt="Immunity" href="/immunity/home">Immunity</a>
		</li>
		<li>
			<a alt="Med" href="/med/home">Med</a>
		</li>
		<li>
			<a alt="Molecular Cell" href="/molecular-cell/home">Molecular Cell</a>
		</li>
		<li>
			<a alt="Neuron" href="/neuron/home">Neuron</a>
		</li>
		<li>
			<a alt="Structure" href="/structure/home">Structure</a>
		</li>
		<li>
			<a alt="American Journal of Human Genetics" href="/ajhg/home">American Journal of Human Genetics (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Journal" href="/biophysj/home">Biophysical Journal (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Reports" href="/biophysreports/home">Biophysical Reports (<i>partner</i>)</a>
		</li>	
		<li>
			<a alt="HGG Advances" href="/hgg-advances/home">Human Genetics and Genomics Advances (<i>partner</i>)</a></li>
		<li>
			<a alt="Molecular Plant" href="/molecular-plant/home">Molecular Plant (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy" href="/molecular-therapy-family/molecular-therapy/home">Molecular Therapy (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Methods and Clinical Development" href="/molecular-therapy-family/methods/home">Molecular Therapy Methods &amp; Clinical Development (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Nucleic Acids" href="/molecular-therapy-family/nucleic-acids/home">Molecular Therapy Nucleic Acids (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Oncology" href="/molecular-therapy-family/oncology/home">Molecular Therapy Oncology (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Plant Communications" href="/plant-communications/home">Plant Communications (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Stem Cell Reports" href="/stem-cell-reports/home">Stem Cell Reports (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biochemical Sciences" href="/trends/biochemical-sciences/home">Trends in Biochemical Sciences</a>
		</li>
		<li>
		</li><li>
			<a alt="Trends in Cancer" href="/trends/cancer/home">Trends in Cancer</a>
		</li>
		<li>
			<a alt="Trends in Cell Biology" href="/trends/cell-biology/home">Trends in Cell Biology</a>
		</li>
		<li>
			<a alt="Trends in Ecology and Evolution" href="/trends/ecology-evolution/home">Trends in Ecology &amp; Evolution</a>
		</li>
		<li>
			<a alt="Trends in Endocrinology and Metabolism" href="/trends/endocrinology-metabolism/home">Trends in Endocrinology &amp; Metabolism</a>
		</li>
		<li>
			<a alt="Trends in Genetics" href="/trends/genetics/home">Trends in Genetics</a>
		</li>
		<li>
			<a alt="Trends in Immunology" href="/trends/immunology/home">Trends in Immunology</a>
		</li>
		<li>
			<a alt="Trends in Microbiology" href="/trends/microbiology/home">Trends in Microbiology</a>
		</li>
		<li>
			<a alt="Trends in Molecular Medicine" href="/trends/molecular-medicine/home">Trends in Molecular Medicine</a>
		</li>
		<li>
			<a alt="Trends in Neurosciences" href="/trends/neurosciences/home">Trends in Neurosciences</a>
		</li>
		<li>
			<a alt="Trends in Parasitology" href="/trends/parasitology/home">Trends in Parasitology</a>
		</li>
		<li>
			<a alt="Trends in Pharmacological Sciences" href="/trends/pharmacological-sciences/home">Trends in Pharmacological Sciences</a>
		</li>
		<li>
			<a alt="Trends in Plant Science" href="/trends/plant-science/home">Trends in Plant Science</a>
		</li>
		</ul>
	</div>

	<div class="group">
		<h2 class="group__title">Physical sciences &amp; engineering journals</h2>
		<ul class="rlist clearfix sided">
		  <li><a alt="Cell Biomaterials" href="/cell-biomaterials/home">Cell Biomaterials</a></li>
		  <li>
			<a alt="Cell Reports Physical Science" href="/cell-reports-physical-science/home">Cell Reports Physical Science</a>
		</li>
		<li>
			<a alt="Chem" href="/chem/home">Chem</a>
		</li>
		<li>
			<a alt="Chem Catalysis" href="/chem-catalysis/home">Chem Catalysis</a>
		</li>
		<li>
			<a alt="Device" href="/device/home">Device</a>
		</li>
		<li>
			<a alt="Joule" href="/joule/home">Joule</a>
		</li>
		<li>
			<a alt="Matter" href="/matter/home">Matter</a>
		</li>	
		<li><a alt="Matter" href="/newton/home">Newton</a></li>
		<li>
			<a alt="Trends in Chemistry" href="/trends/chemistry/home">Trends in Chemistry</a>
		</li>			
		</ul>
	</div>

<div class="group">
	<h2 class="group__title">Multidisciplinary journals</h2>
	<ul class="rlist clearfix sided">
	  		<li>
			<a alt="Cell Reports Methods" href="/cell-reports-methods/home">Cell Reports Methods</a>
		</li>
		<li>
			<a alt="Cell Reports Sustainability" href="/cell-reports-sustainability/home">Cell Reports Sustainability</a>
		</li>
		<li>
			<a alt="Heliyon" href="/heliyon/home">Heliyon</a>
		</li>	
		<li>
			<a alt="iScience" href="/iscience/home">iScience</a>
		</li>
		<li>
			<a alt="One Earth" href="/one-earth/home">One Earth</a>
		</li>
		<li>
			<a alt="Patterns" href="/patterns/home">Patterns</a>
		</li>
		<li>
			<a alt="STAR Protocols" href="/star-protocols/home">STAR Protocols</a>
		</li>
		<li>
			<a alt="Nexus" href="/nexus/home">Nexus (<i>partner</i>)</a>
		</li>			
        <li>
			<a alt="The Innovation" href="/the-innovation/home">The Innovation (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biotechnology" href="/trends/biotechnology/home">Trends in Biotechnology</a>
		</li>
		<li>
			<a alt="Trends in Cognitive Sciences" href="/trends/cognitive-sciences/home">Trends in Cognitive Sciences</a>
		</li>
	</ul>
</div>

</div>
</div>

            

        
</div><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="850476de-00cb-4c0d-943c-bf1881da24f9" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="clearfix">
		<div class="group sided">
			<h2 class="group__title">Authors</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Submit article" href="/submit-to-cell-press">Submit article</a>
				</li>
				<li>
					<a alt="Multi-Journal Submission" href="/multi-journal-submission">Multi-Journal Submission</a>
				</li>
				<li>
					<a alt="STAR Methods" href="/star-authors-guide">STAR Methods</a>
				</li>
				<li>
					<a alt="Sneak Peek – Preprints" href="/sneakpeek">Sneak Peek – Preprints</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Reviewers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Reviewers" href="/reviewers">Information for reviewers</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">News &amp; events</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Newsroom" href="/newsroom">Newsroom</a>
				</li>
				<li>
					<a alt="Events" href="/events">Events</a>
				</li>
				<li>
					<a alt="Cell Symposia" href="/symposia">Cell Symposia</a>
				</li>
				<li>
					<a alt="Consortia Hub" href="/consortia">Consortia Hub</a>
				</li>
				<li>
					<a alt="Webinars" href="/webinars">Webinars</a>
				</li>
								<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Multimedia</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Podcast" href="/podcast">Cell Press Podcast</a>
				</li>
				<li>
					<a alt="Cell Press Videos" href="/video">Cell Press Videos</a>
				</li>
				<li>
					<a alt="Color and Comics" href="/comics">Coloring and Comics</a>
				</li>
				<li>
					<a alt="Figure360" href="/video-guidelines">Figure360</a>
				</li>
				<li>
					<a alt="Cell Picture Show" href="/pictureshow">Cell Picture Show</a>
				</li>
				<li>
					<a alt="Research Arc" href="/research-arc">Research Arc</a>
				</li>
			</ul>
		</div>

		<div class="group sided">
			<h2 class="group__title">About</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="About Cell Press" href="/about">About Cell Press</a>
				</li>

				<li>
					<a alt="Open access" href="/open-access">Open access</a>
				</li>
				<li>
					<a alt="COVID Hub" href="/covid-19">COVID Hub</a>
				</li>
				<li>
					<a alt="Sustainability" href="/sustainability">Sustainability hub</a>
				</li>
				<li>
					<a alt="Inclusion and diversity" href="/diversity">Inclusion and diversity</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Contact</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Contact us" href="/contact">Contact us</a>
				</li>
				<li>
					<a alt="Help and Support" href="https://service.elsevier.com/app/overview/cell-press/" target="_blank">Help &amp; Support</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Careers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Careers" href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" target="_blank">Cell Press Careers</a>
				</li>
			</ul>
		</div>
	</div>
</div></div>

            

        
</div><div class="col-sm-4 col-md-2 clearfix">
    

        


    

            

            

            <div data-widget-id="beafac41-1cfc-440b-9b55-74aba4a5612c" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Access</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Subscribe" href="/subscribe">Subscribe</a>
			</li>
			<li>
				<a alt="Claim" href="/activate">Claim</a>
			</li>
			<li>
				<a alt="Read It Now" href="/read-it-now">Read-It-Now</a>
			</li>
			<li>
				<a alt="Recommend to Librarian" href="http://info.cell.com/request-access-to-cell-press-content" target="_blank">Recommend to Librarian</a>
			</li>
			<li>
				<a alt="Publication Alerts" href="/action/showPreferences?menuTab=Alerts">Publication Alerts</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Collections</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Best of Cell Press" href="/bestof">Best of Cell Press</a>
			</li>
			<li>
				<a alt="Cell Press Reviews" href="/reviews">Cell Press Reviews</a>
			</li>
			<li>
				<a alt="Cell Selections" href="/selections">Cell Press Selections</a>
			</li>
			<li>
				<a alt="Nucleus Collections" href="/nucleus">Nucleus Collections</a>
			</li>
			<li>
				<a alt="SnapShots" href="/snapshots">SnapShot Archive</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Information</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="For Advertisters" href="/media-kit">For Advertisers</a>
			</li>
			<li>
				<a alt="For Recruiters" target="_blank" href="/pb-assets/Cell/common/CP-RecruitmentKit-US-2018-LowRes-1712070648.pdf">For Recruiters</a>
			</li>
			<li>
				<a alt="For Librarians" target="_blank" href="https://www.elsevier.com/products/sciencedirect/journals/direct-subscription-journals">For Librarians</a>
			</li>
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms and Conditions</a>
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>
			</li>
		</ul>
	</div>
</div></div>

            

        
</div></div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="779ad11f-7bcd-4a2a-a2cd-8c67b649cbb2" data-widget-name="UX3HTMLWidget"><style>
 
button#cookieBtn {
   text-decoration: none;
   background-color: transparent;
   color: #005789;
   font-weight: bold;
   padding: 0;
   margin: 0;
   font-size: 14px;
}
 
button#cookieBtn:hover {
   text-decoration: underline;
}

</style>
<script>
// HIDE ONETRUST BACKGROUND AFTER USER PRESSES ESCAPE KEY
setTimeout(function(){ 
   $("#onetrust-pc-sdk").on("keydown", function(e) { 
      if (e.keyCode == 27) {  // ESC key
         setTimeout(function(){ 
            $(".onetrust-pc-dark-filter").css("display","none");
         }, 100); 
      }
   });
}, 5000);
</script>

<span class="align-center copy-right">
<hr>
<p align="center"><b>The content on this site is intended for healthcare professionals and researchers across all fields of science.</b></p>
<hr>
<div>
<p>We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the 
      <b><button id="cookieBtn" class="ot-sdk-show-settings" type="button" aria-label="Manage cookie consent preferences">Cookie Settings</button></b> for this site.<br>

All content on this site: Copyright © 2025 Elsevier Inc., its licensors, and contributors. <br>All rights are reserved, including those for text and data mining, AI training, and similar technologies. <br>For all open access content, the relevant licensing terms apply.
</p>
<ul class="rlist--inline">
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms &amp; Conditions</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Help and Support" target="_blank" href="https://service.elsevier.com/app/overview/cell-press/">Help &amp; Support</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Contact" href="/contact">Contact</a>
			</li>
			</ul>
<p>
<a href="https://www.relx.com"><img src="/pb/assets/raw/Health%20Advance/images/relx-1554393210983.png" alt="RELX" rel="nofollow" target="_new"></a></p>
</div>

</span></div>

            

        

    

        


    

            

            

            <div data-widget-id="c5e179c1-156e-41e3-af7f-5e307efa8acf" data-widget-name="UX3HTMLWidget"><style>#brandingRow{
    background-color:#fff;
    padding:7px 26px 7px 30px;
    color:#007DBC;
    font-size:14px;
    clear:both;
    width:100%
}
#brandingRow a{
    text-decoration:none;
    color:#007DBC
}
#brandingRow a:hover{
    text-decoration:underline
}
#brandingRowRight{
    display:inline;
    float:right;
    width:auto;
    padding:0;
    margin:0
}
svg#cp_logo {
  float: none;
  height: 36px;
  width: 36px;
  margin-left: 0px;
  margin-top: 0px;
}

footer hr {
  display: block;
}

@media screen and (max-width: 600px){
    #brandingRow{
        font-size:12px
    }
}
@media screen and (max-width: 750px){
    #brandingRow{
        padding:7px 18px 7px 16px
    }
    svg#cp_logo{
        margin-right:10px
    }
}
@media screen and (max-width: 800px) {
   a#cpIconLnk {
      display: none;
   }
}

.header__wrapper.clearfix .col-xs-6:first-of-type{
    width:55%
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2){
    width:45%
}
@media screen and (min-width: 800px) and (max-width: 1000px){
    .header__wrapper.clearfix .col-xs-6:first-of-type{
        width:75%
    }
    .header__wrapper.clearfix .col-xs-6:nth-of-type(2){
        width:25%
    }
}

</style>

<script>
var partnerx = false;
var overrideEndorsement = "";
var tmpj = $("input[name='journalCode']").attr("value");
	
if (window.location.pathname == "/molecular-therapy-family/home") {
	tmpj = "ymthe";
}
	
var ribbonx = "";
if (tmpj == "ajhg" || tmpj == "bpj" || tmpj == "molp" || tmpj == "xplc" || tmpj == "stemcr" || tmpj == "ymthe" || tmpj == "xhgg" || tmpj == "omtn" || tmpj == "omto" || tmpj == "omtm" || tmpj == "biophysreports" ||  tmpj == "bpr" || tmpj == "xinn" || tmpj == "omton") {
	partnerx = true;
	ribbonx = "<a href='https://www.cell.com' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press partner journal</a>";
} else if (tmpj != "" && tmpj != "undefined" && tmpj != undefined) {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press journal</a>";
} else {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press resource</a>";
}
	
if (window.location.pathname == "/") {
	ribbonx = "";
}
if (overrideEndorsement != "") {
	ribbonx = overrideEndorsement;
}

$(".header__wrapper.clearfix").prepend("<div id='brandingRow'><a href='/' data-aa-name='science that inspires' data-aa-region='cp global header' title='Visit Cell.com'>Science that inspires</a><p id='brandingRowRight'>" + ribbonx + "</p></div>");
	
// handle scrolling effect on article pages
if ($("article").length > 0) {
	var scrollx;
	$(window).scroll(function() {
		scrollx = $(window).scrollTop();
		if (scrollx > 0) { 
			$("#brandingRow").css("display","none"); 
		} else {
			$("#brandingRow").css("display","block");
		}
	});
}

if (window.location.pathname == "/" || partnerx == false) {
               $("<a href='/home' id='cpIconLnk' data-aa-name='cell press logo' data-aa-region='cp global header' title='Cell Press' target='_blank'><svg id='cp_logo' version='1.1' xmlns='http://www.w3.org/2000/svg' xmlns:xlink='http://www.w3.org/1999/xlink' x='0px' y='0px' viewBox='0 0 100 98.1' style='enable-background:new 0 0 100 98.1;' xml:space='preserve' height='100' width='98.1'><path style='fill:#FFFFFF;' d='M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z'/></svg></a>").insertBefore(".header__wrapper.clearfix .journal-logos:eq(0)");
}


</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="1af759b7-9bb6-4413-ada9-51a8333e8fb8" data-widget-name="UX3HTMLWidget"><style>
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-444969 - c#4]*/
    [data-tab-id="changelogTab"] {
        display: none !important;
    }
    
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-518839]*/
    @media (min-width: 769px) {
        .ux3 .quick-search .dropBlock [data-db-target-of],
        .quick-search .dropBlock [data-db-target-of] {
            width: 100vw !important;
        }
    }
</style></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="d7e0813b-a300-497a-ab37-9c3ddaf03e71" data-widget-name="UX3HTMLWidget"><!--
<div class="session-reminder hidden">
    <div class="session-reminder__overlay">
        <div class="session-reminder__dialog">
            <div class="session-reminder__dialog-inner">
                <div class="dialog-header" role="dialog" aria-labelledby="dialog-title" aria-describedby="dialog-desc">
                    <h2 class="dialog-header-title" id="dialog-title">
                        <span>Session Timeout</span>
                        <div class="dialog-timer">(2:00)</div>
                    </h2>
                    <button class="dialog-close" type="button" aria-label="close dialog">
                        <i class="icon-tools_close" aria-hidden="true"></i>
                    </button>
                </div>
                <div class="dialog-body">
                    <p class="dialog-desc" id="dialog-desc">Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If you do not respond within the next minute, you will be automatically logged out.</p>
                    <p class="dialog-expired sr-only" aria-live="polite"></p>
                </div>
                <div class="dialog-footer">
                    <button class="session-reset" type="button">Keep Me Logged In</button>
                </div>
            </div>
        </div>
    </div>
</div>
<a class="sr-only" href="javascript:void(0)" aria-hidden="true"></a>
--></div>

            

        
        </div>
    </div>


































    



















        
        
            
                <script src="/products/marlin/cell/releasedAssets/js/main.bundle-90475670808d5d3eee41.js"></script>
            
        
        
        

    




<script type="text/javascript">
    var pageData =  {"journal":{"specialty":"Cell Press","issn":"0092-8674","name":"Cell"},"page":{"loadTimestamp":"1749589112371","server":"cell","environment":"prod","businessUnit":"ELS:RAP:JBS","noTracking":"","name":"fulltext:html","section":"Cell","language":"en","type":"CP-CA","productName":"JB"},"visitor":{"departmentName":"|ae:ScienceDirect Guests","accessType":"ae:ANON_GUEST|ae:ANON_GUEST","accountId":"ae:838949|ae:228598","accountName":"ae:Cell Guest Account|ae:ScienceDirect Guests","departmentId":"ae:977212|ae:291352","ipAddress":"189.120.74.179","loginStatus":"anonymous","userId":"ae:246228266|ae:12975512"},"content":[{"accessType":"article:free:openaccess","volumeNumber":"184","issueNumber":"3","viewState":"fulltext","format":"MIME-HTML","id":"pii:S0092867421000027","coverDate":"202102","type":"XOCS-JOURNAL:SCOPE-FULL","title":"Metaanalysis of tumor and T cellintrinsic mechanisms of sensitization to checkpoint inhibition","status":"S300"}]};
</script>

<script type="text/javascript">
    if(typeof pageDataTracker !== "undefined") {
        pageDataTracker.trackPageLoad();
    }
</script>
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94dbc985fced4b32',t:'MTc0OTU4OTExMS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94dbc985fced4b32&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;57a02315956f4b2e82817b3dfa99b1a2&quot;}" crossorigin="anonymous"></script>


<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><div id="onetrust-consent-sdk" data-nosnippet="true"><div class="onetrust-pc-dark-filter ot-fade-in" style="z-index:2147483645;"></div><div id="onetrust-banner-sdk" class="otFlat bottom ot-wo-title ot-buttons-fw" tabindex="0" role="region" aria-label="Cookie banner"><div role="dialog" aria-modal="true" aria-label="Privacy"><div class="ot-sdk-container"><div class="ot-sdk-row"><div id="onetrust-group-container" class="ot-sdk-eight ot-sdk-columns"><div class="banner_logo"></div><div id="onetrust-policy"><div id="onetrust-policy-text">We use cookies that are necessary to make our site work. We may also use additional cookies to analyze, improve, and personalize our content and your digital experience. For more information, see our<a class="ot-cookie-policy-link" href="https://www.elsevier.com/legal/cookienotice" target="_blank" aria-label=", opens in a new tab" rel="noopener">Cookie Policy</a></div></div></div><div id="onetrust-button-group-parent" class="ot-sdk-three ot-sdk-columns"><div id="onetrust-button-group"><button id="onetrust-pc-btn-handler" class="cookie-setting-link">Cookie Settings</button>  <button id="onetrust-accept-btn-handler">Accept all cookies</button></div></div></div></div><!-- Close Button --><div id="onetrust-close-btn-container"></div><!-- Close Button END--></div></div><div id="onetrust-pc-sdk" class="otPcCenter ot-hide ot-fade-in" lang="en" aria-label="Preference center" role="region"><div role="dialog" aria-modal="true" style="height: 100%;" aria-label="Cookie Preference Center"><!-- Close Button --><div class="ot-pc-header"><!-- Logo Tag --><div class="ot-pc-logo" role="img" aria-label="Company Logo"><img alt="Company Logo" src="https://cdn.cookielaw.org/logos/static/ot_company_logo.png"></div></div><!-- Close Button --><div id="ot-pc-content" class="ot-pc-scrollbar"><div class="ot-optout-signal ot-hide"><div class="ot-optout-icon"><svg xmlns="http://www.w3.org/2000/svg"><path class="ot-floating-button__svg-fill" d="M14.588 0l.445.328c1.807 1.303 3.961 2.533 6.461 3.688 2.015.93 4.576 1.746 7.682 2.446 0 14.178-4.73 24.133-14.19 29.864l-.398.236C4.863 30.87 0 20.837 0 6.462c3.107-.7 5.668-1.516 7.682-2.446 2.709-1.251 5.01-2.59 6.906-4.016zm5.87 13.88a.75.75 0 00-.974.159l-5.475 6.625-3.005-2.997-.077-.067a.75.75 0 00-.983 1.13l4.172 4.16 6.525-7.895.06-.083a.75.75 0 00-.16-.973z" fill="#FFF" fill-rule="evenodd"></path></svg></div><span></span></div><h2 id="ot-pc-title">Cookie Preference Center</h2><div id="ot-pc-desc">We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our <a href="https://www.elsevier.com/legal/cookienotice/_nocache" target="_blank">Cookie Policy</a> and the list of <a href="https://support.google.com/admanager/answer/9012903" target="_blank">Google Ad-Tech Vendors</a>.
<br>
<br>
You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.
<br>
</div><button id="accept-recommended-btn-handler">Allow all</button><section class="ot-sdk-row ot-cat-grp"><h3 id="ot-category-title"> Manage Consent Preferences</h3><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="1"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-1" aria-labelledby="ot-header-id-1 ot-status-id-1"></button><!-- Accordion header --><div class="ot-acc-hdr ot-always-active-group"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-1">Strictly Necessary Cookies</h4><div id="ot-status-id-1" class="ot-always-active">Always active</div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-1">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
<br><br></p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="1">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="3"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-3" aria-labelledby="ot-header-id-3"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-3">Functional Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-3" id="ot-group-id-3" role="switch" class="category-switch-handler" data-optanongroupid="3" aria-labelledby="ot-header-id-3"> <label class="ot-switch" for="ot-group-id-3"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Functional Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-3">These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="3">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="2"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-2" aria-labelledby="ot-header-id-2"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-2">Performance Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-2" id="ot-group-id-2" role="switch" class="category-switch-handler" data-optanongroupid="2" aria-labelledby="ot-header-id-2"> <label class="ot-switch" for="ot-group-id-2"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Performance Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-2">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="2">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="4"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-4" aria-labelledby="ot-header-id-4"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-4">Targeting Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-4" id="ot-group-id-4" role="switch" class="category-switch-handler" data-optanongroupid="4" aria-labelledby="ot-header-id-4"> <label class="ot-switch" for="ot-group-id-4"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Targeting Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-4">These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="4">Cookie Details List‎</button></div></div></div><!-- Groups sections starts --><!-- Group section ends --><!-- Accordion Group section starts --><!-- Accordion Group section ends --></section></div><section id="ot-pc-lst" class="ot-hide ot-hosts-ui ot-pc-scrollbar"><div id="ot-pc-hdr"><div id="ot-lst-title"><button class="ot-link-btn back-btn-handler" aria-label="Back"><svg id="ot-back-arw" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#656565" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                    l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                    c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                    s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                    L213.13,222.409z"></path></g></svg></button><h3>Cookie List</h3></div><div class="ot-lst-subhdr"><div class="ot-search-cntr"><p role="status" class="ot-scrn-rdr"></p><input id="vendor-search-handler" type="text" name="vendor-search-handler" placeholder="Search…" aria-label="Cookie list search"> <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110" aria-hidden="true"><title>Search Icon</title><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
            s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
            c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
            s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div class="ot-fltr-cntr"><button id="filter-btn-handler" aria-label="Filter" aria-haspopup="true"><svg role="presentation" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 402.577 402.577" xml:space="preserve"><title>Filter Icon</title><g><path fill="#fff" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
      c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
      c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
      C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></button></div><div id="ot-anchor"></div><section id="ot-fltr-modal"><div id="ot-fltr-cnt"><button id="clear-filters-handler">Clear</button><div class="ot-fltr-scrlcnt ot-pc-scrollbar"><div class="ot-fltr-opts" role="list"><div class="ot-fltr-opt" role="listitem"><div class="ot-chkbox"><input id="chkbox-id" type="checkbox" class="category-filter-handler"> <label for="chkbox-id"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div><div class="ot-fltr-btns"><button id="filter-apply-handler">Apply</button> <button id="filter-cancel-handler">Cancel</button></div></div></div></section></div></div><section id="ot-lst-cnt" class="ot-host-cnt ot-pc-scrollbar"><div id="ot-sel-blk"><div class="ot-sel-all"><div class="ot-sel-all-hdr"><span class="ot-consent-hdr">Consent</span> <span class="ot-li-hdr">Leg.Interest</span></div><div class="ot-sel-all-chkbox"><div class="ot-chkbox" id="ot-selall-hostcntr"><input id="select-all-hosts-groups-handler" type="checkbox"> <label for="select-all-hosts-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-vencntr"><input id="select-all-vendor-groups-handler" type="checkbox"> <label for="select-all-vendor-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-licntr"><input id="select-all-vendor-leg-handler" type="checkbox"> <label for="select-all-vendor-leg-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div></div><div class="ot-sdk-row"><div class="ot-sdk-column"><ul id="ot-host-lst"></ul></div></div></section></section><div class="ot-pc-footer ot-pc-scrollbar"><div class="ot-btn-container"> <button class="save-preference-btn-handler onetrust-close-btn-handler">Confirm my choices</button></div><!-- Footer logo --><div class="ot-pc-footer-logo"><a href="https://www.onetrust.com/products/cookie-consent/" target="_blank" rel="noopener noreferrer" aria-label="Powered by OneTrust Opens in a new Tab"><img alt="Powered by Onetrust" src="https://cdn.cookielaw.org/logos/static/powered_by_logo.svg" title="Powered by OneTrust Opens in a new Tab"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- plus minus--><!-- Arrow SVG element --><!-- Accordion basic element --><span class="ot-scrn-rdr" aria-atomic="true" aria-live="polite"></span><!-- Vendor Service container and item template --></div><iframe class="ot-text-resize" sandbox="allow-same-origin" title="onetrust-text-resize" style="position: absolute; top: -50000px; width: 100em;" aria-hidden="true"></iframe></div></div><div id="crossmark-widget" style="display: none;"><div class="crossmark-reset crossmark-overlay"></div><div class="crossmark-reset crossmark-popup"><div class="crossmark-reset crossmark-popup__offset"><div class="crossmark-reset crossmark-popup__inner"><div class="crossmark-reset crossmark-popup__header"><button class="crossmark-reset crossmark-popup__btn-close"><span class="sr-only">__("articleCrossmark.closePopup")</span></button></div><div class="crossmark-reset crossmark-popup__content-wrapper"><iframe class="crossmark-reset crossmark-popup__content" title="Crossmark service - Intentionally blank" aria-hidden="false" tabindex="0" src="https://crossmark.crossref.org/dialog?doi=10.1016%2Fj.cell.2021.01.002&amp;domain=www.cell.com&amp;uri_scheme=https%3A&amp;cm_version=v2.0"></iframe></div></div></div></div></div></body></html>